*

miðvikudagur, 24. október 2018

febrúar, 2007

 

* State-of-the-art blood screening system enables individual donor testing, ensures rapid delivery of West Nile virus-screened blood to hospitals * Blood centers able to meet blood supply demands during high volume emergencies Emeryville, CA - March 2, 2007 - Novartis announced today that the U.S. Food and Drug Administration (FDA) has cleared the Procleix® Tigris® System, the first fully automated nucleic acid testing system, to screen donated blood, organs and tissue for the West Nile virus. Developed by Gen-Probe and marketed by Chiron, a Novartis business, the Procleix Tigris System provides blood centers a fully automated platform for Nucleic Acid Testing (NAT), ensuring rapid delivery of virus-screened blood to hospitals and clinics nationwide. The high-throughput Procleix Tigris System allows blood centers to process 1,000 blood samples in under 14 hours, enabling high volume individual donor testing. "West Nile virus is a serious threat to the nation's blood supply. With rates of human infection increasing in 2006, reducing the spread of West Nile virus and other infectious diseases is a priority for blood centers nationwide," said Donald Doddridge, President-elect of America's Blood Centers and President of Florida Blood Services. "The ability to combine the Procleix West Nile Virus Assay with the Procleix Tigris System will significantly boost the efficiency of blood center operations without sacrificing the level of blood safety." The Procleix Tigris System delivers increased throughput capacity through full automation, including target capture, nucleic acid amplification and detection, in a compact-size instrument. In addition, the system's full automation capabilities allows blood centers to increase blood sample processing during high volume or emergency situations, such as during the peak West Nile virus or mosquito season, without the need for additional resources. "Our goal is to provide innovative and state-of-the-art technologies to blood centers that will effectively safeguard the nation's blood supply against harmful pathogens and improve blood center operations," said Gene Walther, President of Chiron and Global Head of Diagnostics. "The clearance of the Procleix Tigris System is a milestone for the industry and, for the first time, allows blood centers a fully automated nucleic acid testing solution to rapidly detect the West Nile virus, a potentially fatal infectious disease." The Procleix Tigris System has been utilized by select blood centers nationwide to screen for the West Nile virus under an Investigational New Drug (IND) application since August 2004. Since then, millions of units of donated blood have been screened by the system intercepting West Nile virus-positive blood that otherwise may have infected patients with the virus. More about the Procleix® Tigris® System The Procleix® Tigris® System is the first fully automated system for state-of-the art nucleic acid testing (NAT). Developed by Gen-Probe and marketed by Chiron, a Novartis business, the Procleix Tigris System requires minimal operator involvement compared to semi-automated systems. The Procleix Tigris System has been CE-approved for use with the Procleix® Ultrio® Assay for commercial blood screening of HIV, Hepatitis C and Hepatitis B in Europe since 2004. It has also been CE-approved in Europe for use with the Procleix® West Nile Virus Assay since 2006 and is now approved for commercial use in the U.S. with the Procleix West Nile Virus Assay. For more information about the Procleix Tigris System, visit http://www.chiron.com. About West Nile virus (WNV) WNV is a mosquito-borne virus associated with a human form of the disease ranging from mild, flu-like symptoms to severe neurological disease, including encephalitis (inflammation of the brain) and meningitis (inflammation of the spinal cord and membranes of the brain). The first confirmed U.S. death resulting from transmission through donated blood was reported in 2002. In the fall of 2002, the U.S. Food and Drug Administration challenged industry to develop a test for direct detection of WNV in donated blood by the summer of 2003. Within nine months, Gen-Probe and Chiron developed the Procleix West Nile Virus Assay and brought it to market under an IND. According to the U.S. Centers for Disease Control and Prevention, WNV is an epidemic with more than 19,000 human cases of WNV infection reported since 2003, including 644 deaths.[1] Disclaimer This release contains certain forward-looking statements, relating to the Group's business, which can be identified by the use of forward-looking terminology such as "goal", or similar expresssions, or by express or implied discussions regarding potential future sales of Procleix. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Procleix will reach any particular sales levels. In particular, management's expectations regarding Procleix could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected trial results; competition in general; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; increased government, industry, and general public pricing pressures; and other risks and factors referred to in the Company's current Form 20-F on file with the U.S. Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis Vaccines and Diagnostics is a new division of Novartis focused on the development of preventive treatments and tools and was formed following the recent acquisition of Chiron Corporation. The division consists of two activities: Vaccines and Chiron. Novartis Vaccines is the world's fifth-largest vaccines manufacturer and second-largest supplier of flu vaccines in the US. Vaccine products also include meningococcal, pediatric and travel vaccines. Chiron, the blood testing and molecular diagnostics business unit, is dedicated to preventing the spread of infectious diseases through the development of novel blood-screening tools that protect the world's blood supply. Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. Procleix® is a registered trademark of Novartis Vaccines & Diagnostics, Inc. Tigris® is a registered trademark of Gen-Probe Incorporated. References [1] CDC West Nile Statistics, Surveillance, Control CDC Web site http://www.cdc.gov/ncidod/dvbid/westnile/surv&control.htm # # # Media contacts Corinne Hoff Novartis Global Media Relations +41 61 324 9577 (direct) +41 79 248 5717 (mobile) corinne.hoff@novartis.com Sophia Patel Novartis Vaccines and Diagnostics, Global Communications +1 510 923 3365 (direct) +1 415 306 1776 (mobile) sophia.patel@novartis.com e-mail: media.relations@novartis.com or nvd.communications@novartis.com Media materials For images and video related to Novartis Vaccines & Diagnostics, please visit www.thenewsmarket.com/novartisvaccines. Journalists may register and download print-quality images and broadcast-standard video from this site at no charge. --- End of Message --- WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

CHEVY CHASE, MD -- (MARKET WIRE) -- 03/02/07 -- The Ritz-Carlton Hotel Company, L.L.C. has been named the number one company by Training magazine in its "Training Top 125" 2007 survey. The coveted listing selects the 125 best global companies for employee-sponsored workforce training and development. A winner in 1992 and 1999 of the Malcolm Baldrige National Quality Award, The Ritz-Carlton Hotel Company moved up from their 2006 number four Training ranking to score top honors this year. In the March 2007 edition of Training magazine, The Ritz-Carlton Hotel Company was cited for several innovative and highly successful initiatives. "Since this luxury hotel chain developed and implemented its proprietary customer relationship management software 'Mystique' -- which makes it easy to call guests prior to arrival -- in 2005, it has seen an 81 percent user satisfaction rate. To effectively expand use of the system last year, the company's learning division partnered with operations to hold weekly training conference calls, distribute technical training manuals, deploy localized training environments, pre-record Web demos, and deliver knowledge assessments and training dashboards," according to the magazine's editors. "We are extremely proud and gratified that our nearly quarter century commitment to quality training processes has yielded such outstanding recognition. Looking at the other iconic international corporations in the 'Training Top 125' listing, and knowing our quantitative and qualitative scores put The Ritz-Carlton at the top of the list, is independent confirmation that our strategy to stand out as a service leader is working very well," said Simon F. Cooper, president and chief operating officer. In addition to the internal programs offered by the trainers and certified speakers located at The Ritz-Carlton corporate office, and at hotels and resorts around the world, the company also offers organizations the services of its corporate university, The Leadership Center, under the direction of Diana Oreck, vice president, global learning and Leadership Center. Since its inception in 1999, The Leadership Center staff has provided training and guidance to more than 3,000 firms, from airlines to health care facilities, seeking to benchmark The Ritz-Carlton Hotel Company and its techniques for delivering service excellence to its customers. "The extraordinary success of The Leadership Center is the major reason The Ritz-Carlton Hotel Company earned the top ranking in training. Diana Oreck's leadership, her passion for teaching, and her ability to encourage corporations to make service excellence a priority, has made The Leadership Center the premiere program for Training executives," said Kathy Smith, senior vice president of Human Resources. The Ritz-Carlton Hotel Company, L.L.C. of Chevy Chase, Md. (USA) currently operates 61 hotels in the Americas, Europe, Asia, the Middle East and Africa. Over 30 projects are currently underway with openings planned for China, Japan, Russia, Ireland, Dallas, and Denver in 2007. The Ritz-Carlton Hotel Company is the only hospitality company to have twice earned the prestigious Malcolm Baldrige National Quality Award, which recognizes outstanding customer service. For more information contact The Ritz-Carlton toll free reservations at 1 (800) 241-3333, your travel consultant or visit www.ritzcarlton.com. Contact: Vivian Deuschl Corporate Vice President, Public Relations 4445 Willard Avenue, Suite 800 Chevy Chase, Md. 20815 Tel: (703) 941-6225 Fax: (703) 941-7492 Cell: (202) 255-5786 Email: vivian.deuschl@ritzcarlton.com


 

Vancouver, March 2, 2007 - Global Developments, Inc. (PINKSHEETS: GDVM) is pleased to provide the following update with respect to Helixus Productions, a movie production company with which Global has a feature documentary joint venture. Helixus Productions has completed a round of interviews in Hawaii to complement its first and second round of interviews conducted throughout mainland Europe (Cannes, Amsterdam, Hamburg, and Ibiza), United Kingdom (London and Liverpoole), and Southern California. The third round of interviews have included Shep Gordon (manager of Alice Cooper, Racquel Welch, Blondie, and Sharon Stone, among others) and Willie Nelson. Over 50 interviews have been conducted to date for their production of "The Psychedelic Revolution", a 100-minute feature documentary and mini-series which explores the origin, flowering and long-term influence of psychedelia, a subculture that in the 1960s achieved a mass influence. Through interviews with many of its key innovators, the feature will show how revolutionary new art forms were created as an expression of the counterculture and utilized as a tool for tearing down the existing establishment. The documentary is a serious investigation of the phenomenon and long-term impact of this cultural shift. The film features interviews with many of the key innovators, as well as music, period stock footage and current footage of locations of many of the events covered in the film and psychedelic images as transitions. The film is being produced by Karl Ferris, who is recognized as the innovator of psychedelic photography. A Photographer to the "British Rock Elite", Ferris was invited to create their images, costumes, look, and album covers, which he achieved, as the personal photographer to Jimi Hendrix, Eric Clapton, Donovan, Graham Nash, and the Hollies. Karl Ferris met with Jimi Hendrix in 1967, and after showing him his photography, Hendrix remarked to him: "You are doing with photography, what I'm doing with music, going far out beyond the limits". Hendrix then asked Ferris to be his photographer and to re-shoot the UK version of the album Are You Experienced. rl began creating a new look for Jimi Hendrix and his bandmates, carefully designing their clothing, hairstyle, and appearance. He created the famous photograph used for Jimi's first US record album cover, which he also designed. His images appeared on all three US Album covers released during Hendrix's life, Are You Experienced, Axis: Bold as Love, and Electric Ladyland. Karl also created the album cover images for four of Donovan's albums, The Hollies' Evolution, and many others. He was also instrumental in creating their look for the shoots, which then became their recognized public image. During the years 1967-69, Karl Ferris was one of the preferred photographers to the British Rock elite, shooting many photos, as well as designing concert posters and album covers. Ferris also created a stage light show for Pink Floyd, which is believed to be the first ever stage light show in England in 1966. The following is a list of the current interviewees that have participated in the documentary to date: Alan Aldridge (graphic designer; editor, Beatles Illustrated Lyrics) Birgitta Bjerke (fashion designer) Patti Boyd (60s model; wife of George Harrison & Eric Clapton) Jim Byrnes (Juno award winning musician; Genie nominated actor; Highlander) Peter Coyote (actor; 60s political activist The Diggers; San Francisco Mime Troupe) John Densmore (drummer, The Doors) Pamela Des Barres (LA member of Zappa's GTOs; authour 'I'm With the Band') Keith Emerson (musician The Nice; Emerson, Lake & Palmer) Karl Ferris (photographer - Hendrix 'Are You Experienced'; Donovan; The Hollies) Wavy Gravy (Master of Ceremonies, Woodstock; Hog Farm Commune) Christoph Grunenberg (Director - Tate Gallery Liverpool; Curator - exhibit 'Summer of Love') John Van Hamersveld (graphic artist: Beatles 'Magical Mystery Tour', Rolling Stones 'Exile on Main Street'; Jefferson Airplane; 'Endless Summer') Colin Hanton (drummer 'The Quarrymen' - John Lennon's original band) Simon Hayes (Mayfair Publicity - Hendrix, Cream, The Fool) George Hunter (musician, The Charlatans; graphic designer Charlatans, Quicksilver) Mickey Jones (drummer, Bob Dylan's electric 1966 World Tour) Alton Kelly (The Family Dog; poster designer Grateful Dead, Wings, Rolling Stones) Astrid Kirchherr (Hamburg photographer of Beatles; creator of 'moptop') Marijke Koger (graphic designer; The Fool; wardrobe stylist for Beatles) Paul Krassner (co-founder The Yippies; witness Chicago 7 Trial; publisher 'The Realist') Gerard Mankowitz (photographer - Rolling Stones 'Between the Buttons'; Hendrix) Charlotte Martin (60s model; girlfriend of Jimmy Page & Eric Clapton) Bob Masse (60s poster designer - Grateful Dead, Jefferson Airplane, Doors, Steve Miller) Craig McCaw (60s band The Poppy Family; contemporary Laser Light Shows) Dennis McNally (author; publicist, The Grateful Dead) Philippe Mora (60s Australian/London filmmaker/painter; Beatles Illustrated Lyrics) Stanley Mouse (poster/album cover designer: Grateful Dead, Jefferson Airplane) Rocket Norton (musician The Seeds of Time; Prism) Simon Posthuma (The Fool - designer of Beatles' Apple Boutique; inside sleeve 'Sgt. Pepper") RAIN (leading Beatles tribute band) Peter Rawley (60s London Agent) Bob Rock (The Payolas; producer Metallica & Motley Crue) Rock Scully (original manager The Grateful Dead) Bob Seidemann (photographer & graphic designer Blind faith, Grateful Dead, Janis Joplin) Bobby Taylor (60s band 'Bobby Taylor & the Vancouvers', featuring Tommy Chong and Jimi Hendrix; discovered Jackson 5 & Michael Jackson) Fred Turner (Professor Stanford University, 'From Counter Culture to Cyber Culture') Rita Tushingham (actress - 'The Knack and How to Get It'; 'Smashing Time') Klaus Voormann (artist - Beatles' album cover 'Revolver'; musician Mannfred Mann) Bill Wheeler (Wheeler Ranch Commune) Bob Whitaker (photographer - The Beatles' 'Butcher Cover', Cream's 'Disraeli Gears') Herbie Worthington (album cover photographer: Fleetwood Mac 'Rumours') Shep Gordon (manager of Alice Cooper, Racquel Welch, Blondie, and Sharon Stone, among others) Willie Nelson (American singer and songwriter) The film is currently on schedule for release in Summer 2007. About Global Developments Global Developments, Inc. was formed to create a unique investment vehicle representing a growing portfolio of innovative and emerging growth-oriented companies. Global acquires its portfolio companies either as wholly or partially owned subsidiaries, or as an investment where Global is the lead investor. As a result, Global maintains substantial management and operational control, thereby giving it the ability to provide significant oversight and guidance in building value and creating liquidity events for its shareholders. Global invests in companies with solid management, operational excellence, and the potential to grow substantial revenue streams. Please visit http://www.globaldevelopmentsinc.com for more information. Forward-Looking Statements You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as ``will,'' ``anticipates,'' ``believes,'' ``plans,'' ``goal,'' ``expects,'' ``future,'' ``intends,'' and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about Global Developments, Inc. please refer to its Web site at http://www.globaldevelopmentsinc.com. Contact: Global Developments, Inc. Leighton Dean (604) 685-7552 ldean@globaldevelopmentsinc.com Source: GLOBAL DEVELOPMENTS, INC.


 

Amsterdam, 2 March 2007 - Heineken Holding N.V. today announced a change in its shareholding structure. Heineken Holding N.V.'s principal long-term shareholders have decided to combine their shareholdings in a new company called L'Arche Green N.V., established in the Netherlands. L'Arche Green N.V. now has a direct stake in Heineken Holding N.V. of 58.78%. Heineken Holding N.V. will continue to hold a 50.005%-stake in Heineken N.V. L'Arche Green N.V.'s 58.78%-shareholding in the issued share capital of Heineken Holding N.V. results from the combination of the shareholdings of: * L'Arche Holding S.A., the Heineken family's holding company, that owned 50.005% of the shares; * LAC B.V., the Heineken family's holding company, that owned 1.97% of the shares; * Greenfee B.V., the holding company of the Hoijer family, that owned a 6.81%-stake. The new shareholder structure does not affect the number of free-float shares or the ultimate ownership of the combined shareholdings. The owners of L'Arche Holding S.A. and Greenfee B.V. have been shareholders of Heineken Holding N.V. since its establishment in 1952. Press enquiries Véronique Schyns Tel: +31 (0)20 52 39 606 veronique.schyns@heineken.com Investor and analyst enquiries Jan van de Merbel Tel: +31 (0)20 52 39 590 investors@heineken.com


 

Pursuant to article 26 sec 1 WpHG BB MEDTECH AG, Vordergasse 3, 8200 Schaffhausen, Switzerland hereby reports that it and its wholly-owned subsidiary Medhealth N.V., Snipweg 26, Curaçao, Netherlands Antilles increased the holding in own shares as per February 27, 2007 to more than 3% of the proportion of voting rights (a total of 440 507 shares / 3.04% of the proportion of voting rights). For further information please contact: Bellevue Asset Management AG, Seestrasse 16, CH-8700 Küsnacht/Zürich Adrian Brüngger or Dr. Christian Lach, Tel. +41 44 267 67 00. --- End of Message --- WKN: 898194; ISIN: CH0000428661; Index: IGSP; Listed: Investment Companies in SWX Swiss Exchange;


 

Company issues an update to its Stockholders NEW YORK, NY, March 2, 2007, Great West Gold, Inc. (PINKSHEETS: GWGO) wishes to update its stockholders on its plans and to address outstanding issues that are being managed by the Company's new President, Mr Peter J Bezzano. Mr Peter J Bezzano, the President of Great West Gold, Inc. stated that he has, for the past two months, been familiarizing himself with the Company, all outstanding issues affecting the Company's credibility and more importantly, numerous stockholder concerns. He has now, read all of the stockholder communications with the Company and is now fully aware as to the immediate requirements and the demands of our stockholders and the Company's bondholders. OUTSTANDING STOCK DIVIDEND DISTRIBUTIONS:- The Company is immediately resolving the issue of the outstanding stock dividend distributions with the Transfer Agent; this is expected to be resolved without any further delay. This is in respect of the dividend distributions in: Bouse Mining Holdings plc, Ambassador Gold Holdings plc, Golden Eagle Mining Holdings plc, Copperstone Mining Holdings plc and Sentinel Resource Holdings plc. The Company expects to report a satisfactory resolution within days. APPOINTMENT OF NEW AUDITORS: The Company has this matter in hand, certain accounting details are being finalized and upon this completion, the new Auditor appointment will be announced. This is expected to be completed very shortly as there is no reason for any further delays. OUTSTANDING FILINGS: It is the priority of this Company to bring its filings up to date immediately. We foresee no problems in this, given that we expect to appoint the new Auditor within days. APPLICATION TO BE REINSTATED ON THE OTC BB MARKET: This application will be made at such time as the Company's filings are up to date. We do not foresee any problems nor should this exercise take an inordinate amount of time. This application cannot be made until the Company has brought its filings up to date. UPDATE OF CORPORATE WEB SITE: The various changes required to bring to the corporate web site up to date and to make it more informative, have been approved, and will be reflected on the web site within days. FUTURE PLANS: The Company remains committed to enhancing stockholder value and is at this time, continuing the finalization of our stated plans to create to three separately quoted Mining Groups (Two Gold Groups and One Copper Group), each to be quoted individually. The strong commodity prices have attracted a lot of unsolicited interest in this Company, from various third parties. We are at this time, evaluating certain proposals and will hopefully be in a position shortly to report back to our stockholders. We do not intend for this process to be delayed any longer. GENERAL : Further to stockholder inquiries, we can confirm the following : - The Company is not, at this time, contemplating a Reverse Split of its outstanding shares of Common Stock. - The Company is looking at an acquisition in a related Industry but is unlikely to close such an acquisition prior to the distribution of its Mining Assets to its stockholders. - The Forward Split of the Company's Stock has been completed and all stockholders should in possession of their additional shares of Common Stock. About Great West Gold, Inc. Great West Gold, Inc., www.greatwestgold.com, a gold mining exploration stage company, engaged in the acquisition and exploration of mining properties in the United States. The Company has Gold assets through its holdings in "Bouse", "Mockingbird", "Ambassador", "Yaba", "Golden Eagle", "Bonanza", "Storm Cloud", ""Starlight", "Venezia", "Federal", "Buffalo Lime Cap", "Red Cloud", "South Copperstone" and "Gladstone Lookout" Gold Mining Projects. The Company's Copper assets are "Copper Mountain", "Swansea", "Tip Top" and "Mineral Mountain". The Company holds five of these Mining Assets through its 51% holding in Bouse Mining Holdings plc, Copperstone Mining Holdings plc, Ambassador Gold Holdings plc, and Golden Eagle Mining Holdings plc and in Sentinel Resource Holdings plc. The other Mining Exploration Projects are 100% controlled by the Company. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC. Contact:- Great West Gold, Inc. investor@greatwestgold.com Tel : + 44 845 127 4051


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |-------------------------------------------------+-----------------| | Company dealt in | Corus Group Plc | |-------------------------------------------------+-----------------| | Class of relevant security to which the | 50p ordinary | | dealings being disclosed relate (Note 2) | | |-------------------------------------------------+-----------------| | Date of dealing | 1 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------------+--------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------+------------+-------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------+------------+-------+--------+-----| | (2) Derivatives (other than | | | | | | options) | 31,347,131 | 3.313 | | | | | | | | | |-------------------------------+------------+-------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------+------------+-------+--------+-----| | Total | 31,347,131 | 3.313 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Short | 7,800,000 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Long | 7,800,000 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Short | 7,800,000 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Long | 7,800,000 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Short | 7,800,000 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Long | 7,800,000 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Short | 7,947,131 | 603.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Long | 7,947,131 | 603.0000 GBp | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | None | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 02/03/2007 | |------------------------------------------------+------------------| | Contact name | Stephen Platts | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9635 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |---------------------------------------------+---------------------| | Company dealt in | CREST Nicholson Plc | |---------------------------------------------+---------------------| | Class of relevant security to which the | 10p Ordinary | | dealings being disclosed relate (Note 2) | | |---------------------------------------------+---------------------| | Date of dealing | 01 March 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------------+--------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (2) Derivatives (other than | 2,625,000 | 2.3209 | | | | options) | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | Total | 2,625,000 | 2.3209 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | LONG | 100,000 | 613.5600 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 2nd March 2007 | |--------------------------------------------------+----------------| | Contact name | James Feast | |--------------------------------------------------+----------------| | Telephone number | 0207 469 1901 | |--------------------------------------------------+----------------| | If a connected EFM, name of offeree/offeror with | | | which connected | | |--------------------------------------------------+----------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Brink's today signed an additional order with CashGuard worth a total of SEK 13 million. The order consists of security cases with SQS-technology and will be delivered during the first and second quarter of 2007. For some time now, CashGuard and Brink's have been cooperating in the field of dye technologies and the current transaction marks a further development of this cooperation. "We are delighted that Brink's is continuing to demonstrate its confidence in us. The cooperation with Brink's is an important part of our international growth and the order is a confirmation of our strong market position," says Agne Pettersson, CashGuard's Chief Executive Officer. For further information, please contact: Agne Pettersson, Managing Director and Chief Executive Officer, CashGuard AB (publ); Tel: +46-8-732 22 00, agne.pettersson@cashguard.com Facts about CashGuard AB (publ) CashGuard develops and sells products and services for secure and fully automatic cash handling and cash logistics. Via direct sales and distribution partners, CashGuard focuses on retail companies, post offices and banks, as well as on security companies. The CashGuard Group has approximately 170 employees and had sales of SEK 323 million in 2006. CashGuard shares are listed on the Stockholm Stock Exchange.


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |-----------------------------------------------+-------------------| | Company dealt in | Wilson Bowden Plc | |-----------------------------------------------+-------------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |-----------------------------------------------+-------------------| | Date of dealing | 02nd March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 91 | 2,155p | 2,155p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 0 | | | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 02nd March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------+--------------------------| | Company dealt in | Barratt Developments Plc | |----------------------------------------+--------------------------| | Class of relevant security to which | Ordinary Shares | | the dealings being disclosed relate | | | (Note 1) | | |----------------------------------------+--------------------------| | Date of dealing | 01st March 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 23,006 | 1,188p | 1,159p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |------------------------+---------------------+--------------------| | 22,443 | 1,189.80p | 1,157.80p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 02nd March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Leverkusen, 3 February 2007 - Biofrontera AG announced today that 220.582 shares stemming from an unexecuted option, previously held by DZ BANK AG Deutsche Zentralgenossenschaftsbank, were assigned to another bank. This bank will sell the shares to investors contingent upon the approval or directions of the company. The proceeds of the sale will flow to Biofrontera AG. Background: In a private placement of 24 October 2006 investors were granted the option to buy one new Biofrontera share for Euro 15.00 for each two shares purchased in the private placement. Only a minor portion of the option was exercised (compare Ad-hoc release of 16 January 2007). To serve the option, DZ BANK AG had signed up for shares at the lowest issuing price of Euro 1.00 per share. After March 2, 2007, DZ BANK AG would be in the position to freely dispose of the shares. The shares were today transferred to another bank, thus binding their sale to approval and directives of Biofrontera AG. Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen ISIN: DE0006046113 WKN: 604611 Contact: Anke zur Mühlen Biofrontera AG Tel.: +49 (0214) 87 63 222 Fax.: +49 (0214) 87 63 290 e-mail: a.zurmuehlen@biofrontera.com


 

YIT CORPORATION STOCK EXCHANGE RELEASE MARCH 2, 2007 at 14:30 YIT has decided to expand its head office in Käpylä, Helsinki, and agreed on the sale of the extension to RBS Nordisk Renting for EUR 69 million. Furthermore, Ilmarinen Mutual Pension Insurance Company will sell the office premises used by YIT in Käpylä to RBS Nordisk Renting. YIT will develop and build the extension. Upon the completion of the project, YIT will move into the premises under a 15-year lease. The extension will measure about 15,000 m2. Construction will begin in March 2007 and the new office building is slated for completion by the end of 2008. The extension will have workspace for a total of about 600 people. At the same time, the existing commercial premises on the property will be extended and modernized, and a four-storey parking lot will be built mainly underground for the property. For additional information, contact: Sakari Toikkanen, Executive Vice President, YIT Corporation, +358 20 433 2336, sakari.toikkanen@yit.fi Seppo Martikainen, Vice President, Transactions, YIT Construction Ltd, +358 20 433 2905, seppo.martikainen@yit.fi YIT CORPORATION Virva Salmivaara Deputy to the Vice President, Communications Distribution: Helsinki Stock Exchange, principal media, www.yitgroup.com


 

KONE Corporation, Stock Exchange Release, 2 March, 2007 KONE will appeal the European Commission's decision to impose fines of EUR 142 million for anticompetitive practices. The fine will be recognized as cost in the first quarter of the financial year. Sender: KONE Corporation Klaus Cawén Executive Vice President Minna Mars Senior Vice President, Corporate Communications & IR For further information, please contact: Minna Mars, SVP, Corporate Communications & IR , tel. +358 20475 4501 KONE is one of the world's leading elevator and escalator companies. It provides its customers with industry-leading elevators and escalators and innovative solutions for their maintenance and modernization. KONE also provides maintenance of automatic building doors. In 2006, KONE had annual net sales of EUR 3.6 billion and about 29,000 employees. Its class B shares are listed on the Helsinki Stock Exchange in Finland. www.kone.com


 

AMERICAN MARKETS OUTLOOK: U.S. stock markets are expected to open flat to slightly lower Friday, as bulls are comforted that the psychologically important 12,000 level on the Dow Jones Industrial Average has stayed in tact, says Geoff Langham of CMC Markets. "12,280-to-12,340 remains a ceiling for the market in the short term and it would take a move through here to suggest a more sustainable recovery is on the cards," Langham says. On the economic front, the focus turns to the University of Michigan sentiment figures released at 1500 GMT, with "the broad expectation for a reading of around 93," added Langham. CMC markets is calling the Dow Jones Industrial Average to open down 3 points at 12,231, the Nasdaq 100 4 points lower at 1749 and the S&P 500 down 1 point at 1402.1. EUROPEAN MARKETS: European stocks mostly failed to retain early gains in volatile conditions, with investors still cautious after Tuesdays sell-off in the Chinese stock market and subsequent global equities correction. In London, the FTSE 100 index is up 0.2% at 6131, holding steady following three sessions of heavy losses. In Frankfurt, the DAX 30 index is down 0.3% at 6618, while in Paris, the CAC 40 is down 0.2% at 5448. Bunds and gilts are little changed with the market keeping a close eye on global equities. The March bund future is up 0.05 at 116.39, while the June gilt future is up 0.07 at 109.42. In the currency markets, the dollar is mostly higher around midday. At 1125 GMT, the dollar was down at Y117.30. Elsewhere, the euro was down at $1.3160 after German retail sales data proved much softer than the market anticipated and the pound was down at $1.9490. =========================== TOP STORIES: E.ON SAYS NO PERMISSION RECEIVED TO BUY ENDESA SHRS: E.ON AG (EON), which is targeting Spanish rival Endesa SA (ELE) said it hasnt received permission from Spanish and U.S. stock market regulators, CNMV and SEC, to buy Endesa shares. GERMAN JAN RETAIL SALES REAL ADJ -1.4% ON YEAR: German retail sales in January declined less than expected, Federal Statistics Office data showed. (Data Snap by Roman Kessler) LINDE 2006 NET PFT TRIPLES DUE TO ONE-TIME EFFECTS: German industrial gases company Linde AG (LIN.XE) reported a threefold rise in 2006 net profit due to acquisitions and divestments. (By Gangolf Schrimpf) BAYER TO CUT 6,100 JOBS GLOBALLY: German chemical and pharmaceutical company Bayer AG (BAY) confirmed it plans 6,100 job cuts as a result of its acquisition of its German rival Schering. ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: The chances of the Bank of England hiking interest rates again next week have probably risen. (By Nicholas Hastings) =CHARTING EUROPE: European equity indexes are in for a minor 1%-2% upward correction, having fallen by around 6% this week, and after seeing the biggest one day decline since Sep. 11 2001. (By Axel Rudolph) =FOCUS: Oil majors are laying the foundations for potentially lucrative energy deals in Iran, despite the risks, as they face tougher investment prospects in some of the worlds other top energy producing countries. (By Sally Jones) =THE SKEPTIC: The decision by Spanish property group Metrovacesa to divide itself into two may have inadvertently exposed the Spanish real-estate and construction sector to the harsh light of day. (By Martin Fluck) =========================== STILL TO COME ET/GMT COUNTRY PERIOD 0700/1200 US St Louis Fed Pres Poole speaks on energy prices and the US business cycle in Santiago, Chile 1000/1500 US Feb Reuters/Univ Mich Index, final =========================== OTHER NEWS: Bodycote International said it has rejected a cash offer from Sulzer of 325 pence per share. Tobacco company Gallaher Group PLC (GLH.LN) said - in its last set of results as an independent company - that full-year net profit rose 9.2%, and current trading is in line with management expectations. (By Michael Carolan) Telecommunications company Belgacom SA (Belg.BT) posted a stronger-than-forecast 1.5% rise in full-year net profit, but warned of a rocky outlook for 2007 driven by fierce competition and regulatory pressures. (By Anne Jolis) Adecco SA (ADO) reported a 35% rise in full-year net profit thanks to a strong performance in the U.S. and France, and said it was on track to reach its medium-term targets. (By Goran Mijuk) Schroders PLC (SDR.LN) reported a 26% rise in 2006 pretax profit, driven by higher margin products, private banking revenue and gains from equity and bond markets that boosted its funds under management to GBP128.5 billion. (By Margot Patrick) U.K Housebuilder Wilson Bowden PLC (WLB.LN) reported a 1.9% rise in full year pretax profit due to good trading in its David Wilson Homes Unit. (By Lauren Warnell) Price pressure at the euro zones factory gates remained muted in January, as energy prices declined further. (Data Snap by Nina Koeppen) New orders in January for Germanys plant and machinery industry rose 12% on the year, the industry group VDMA said. (Data Snap by Sarah Sloat)


 

SAGA Oil is pleased to inform that the reserve base of extractable oil has been confirmed increased by minimum of 3,6 million barrels of new reserves of higher quality oil from the newly discovered lower production zone. This is the first result from the ongoing production testing on the first well that was put on production cleanup in December last year. Further news on the actual production rates and the process of upgrading reserves is still estimated to be reported within the earlier stated periods as more inflow area is currently being opened up in the targeted zones. The more detailed updates can be found on the company home page, as the CEO Malvin Hoeydal presented an update on the current situation during the EGM on 27 of February. The company has since then been made aware that the presentation failed to be included in the OTC standard press release and we therefore notify about this. For further information, please contact: SAGA Oil ASA - CEO Mr. Malvin Høydal, cell: +47 47422959, email: malvin.hoeydal@sagaoil.no


 

Ericsson (NASDAQ:ERIC) has signed a turnkey contract with the city of Trikala as a total solution provider and prime integrator to implement its pioneering plans for the creation of the first Greek Digital City. Ericsson is the prime integrator for this turnkey FTTx backbone telecommunications infrastructure project, which will bring broadband services to the population. Ericsson is also the sole supplier of switching, WiFi systems and a metropolitan area fiber optic network, as well as related telecom services, such as consulting, deployment, systems integration and customer support, until 2008. The fiber optic Metropolitan Area Network (MAN), extending about 15km throughout the city, will link a range of buildings including the town hall, hospitals, schools and universities, cultural and sporting centers, and trade chamber, as well as the police force, fire service, tax authority, meteorological institute and semi-industrial park of the city. The MAN will be linked to both the National Network of Public Administration (Syzefxis) and the internet, providing high-speed, high-quality broadband services. Among services to be developed, deployed and supported by the MAN are an electronic marketplace for local enterprises, Geographical Information Systems (GIS) for environmental and emergency data, intelligent transport network and health care program a metropolitan-wide emergency response system, urban telework centers and distance-learning courses for the unemployed. This diverse range of services, supported by high-speed broadband, make Trikala the first true Digital City in the country. Michalis Tamilos, Mayor of Triakala, says: "We are confident that with their proven systems integration expertise and solutions, as well as their commitment, Ericsson can help us deliver high-quality services to Trikala's citizens and lead our city into a new era. This project can secure enormous economic prospects and growth for our city." Spyros Nikolaou, CEO, Ericsson Greece, says: "Broadband services are recognized as one of the most critical components of development and improvement of citizens' quality of life. This project will significantly change the everyday life of Trikala's citizens and we are proud that Ericsson, as the market leader, through its leading technology, end-to-end solutions and competent people, is part of this momentous development." Ericsson is shaping the future of mobile and broadband internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more at http://www.ericsson.com FOR FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com About Digital City Visit: www.e-trikala.gr The Digital City concept involves a series of information and communications technology applications applied at the Minicipality through the Greek Information Society Framework Program, e-trikala, that simplify public transactions, reduce telecommunication costs and offer a wide range of end-user services that meet the everyday needs of residents of medium-sized cities. Funded by the Greek Information Society Framework Program, Trikala, the first Digital City in Greece, (C. Folias, Vice Minister of Economy and Finance) recently joined the International Network of E-Communities (INEC) (www.i-nec.com) and with its initiative was formed the first digital Greek community with the participation of the following Municipalities: Trikala, Karditsa, Larisa, Volou, Lamia, Katerini, Grevena, N. Ionia - Magnissias.


 

* On a comparable basis 10.6 percent rise in sales to 10.516 billion euro * On a comparable basis operating profit (EBITDA) up 10 percent to 1.876 billion euro * Increase in dividend from 1.40 euro to 1.50 euro per share proposed Wiesbaden/Munich, March 2, 2007 - The Executive Board of The Linde Group today agreed the financial statements of Linde AG and Linde Group for the fiscal year 2006 and recommended that they be approved by the Supervisory Board. The Supervisory Board will meet on March 9 to approve the financial statements. The key audited financial figures of the Group for fiscal 2006: In the fiscal year 2006, Linde successfully continued its earnings-oriented growth trend and saw a double-digit increase in sales and operating profit (EBITDA). "We have met all of our targets", says Prof. Dr.-Ing. Wolfgang Reitzle, Chief Executive Officer of the Executive Board of Linde AG. "Thanks to the outstanding performance of our employees, we were able to meet all of our business objectives and tackle the difficult challenges of Linde's extensive corporate restructuring at the same time." Sales increased by 30.8 percent to 12.439 billion Euro (2005: 9.511 billion Euro). On a comparable basis that is adjusted for first-time consolidation of the BOC Group plc sales rose by 10.6 percent to 10.516 billion Euro. The operating profit (EBITDA) amounts to 3.830 billion Euro and is therefore more than double that of the previous year (1.705 billion Euro). Special items must be taken into account in this development: a book profit from the sale of KION Group as well as one-time expenses for acquisition and divestment processes. After adjustment for these special items, Linde has improved its EBITDA by 30 percent to 2.216 billion Euro. Without BOC, EBITDA rose by 10 percent to 1.876 billion Euro. Earnings after taxes and minority interests - including special items - rose to 1.838 billion Euro (2005: 514 million Euro). Earnings per share excluding special items were 4.66 Euro (2005: 4.30 Euro). The Executive Board of Linde AG recommends to the Supervisory Board to propose a resolution at the shareholders' meeting on June 5, 2007 to increase the dividend from 1.40 to 1.50 Euro per share. Linde will present detailed information on the fiscal year 2006, the developments in the individual business segments and the prospects of the newly positioned Group at its press conference on annual results on March 12, 2007 in Munich. The Linde Group is a world leading industrial gases and engineering company with more than 53,000 employees working in around 70 countries worldwide. Following the acquisition of The BOC Group the company has gases and engineering sales of approximately 12 billion euro. The strategy of The Linde Group is geared towards earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. For more information, please see The Linde Group online at http://www.linde.com For further information: Press Uwe Wolfinger Telephone: +49.89.35757-1320 Investor Relations Thomas Eisenlohr Telephone: +49.89.35757-1330 --- End of Message --- WKN: 648300; ISIN: DE0006483001; Index: CDAX, DAX, HDAX, Prime All Share; Listed: Amtlicher Markt in Hanseatische Wertpapierbörse zu Hamburg, Prime Standard in Frankfurter Wertpapierbörse, Amtlicher Markt in Frankfurter Wertpapierbörse, Amtlicher Markt in Bayerische Börse München, Amtlicher Markt in Börse Berlin Bremen, Amtlicher Markt in Börse Düsseldorf, Amtlicher Markt in Börse Stuttgart, Freiverkehr in Niedersächsische Börse zu Hannover;


 

Issuers of listed transferable securities are required to provide Oslo Stock Exchange with an annual statement of information made available to the public, cf the Stock Exchange Regulations section 5-2 fifth paragraph. Attached is an annual overview for Funcom N.V for 2006. Oslo, 1 March 2007 Funcom N.V. Funcom N.V. contact: Olav Sandnes, Chief Financial Officer (CFO) olav.sandnes@funcom.com


 

RAUTAKESKO LTD PRESS RELEASE 02.03.2007 AT 10.00 K-rauta Umeå opened at Lagervägen 5, Klockarbäcken in Northern Sweden on 1 March. The store employs 45 people and the store manager is Tommy Rosbäck. The over 9,000 square metre outlet carries a total selection of over 18,000 articles of house technology, gardening, building supplies, tools and interior decoration. "DIY is an ongoing trend and particularly in the north, the trend is upward. Therefore we're very happy to be able to open the third K-rauta in the north of Sweden here in Umeå," says Managing Director Jani Jylhä. K-rauta Umeå is the first of the five K-rauta stores to be opened in Sweden in 2007-2008. According to Industrifakta's survey, Swedish consumers will buy DIY products annually for a total value of about 24 billion kronas during the next couple of years. "K-rauta Umeå is an important new complement to our network. It will enable us to better serve both consumer and professional customers. Rautakesko is intensively seeking to expand the network in Sweden and more new K-rauta stores are expected to open in the near future", says Region Director Jarmo Turunen. The construction project was managed by a Kesko real estate company, KR Fastigheter i Umeå AB, the architectural designer was Hidemark & Stintzing Arkitekter AB, the building supervisor HydraCon Sverige AB and the principal constructor Fastec. The K-rauta chain comprises 40 stores in Finland, 16 in Sweden, five in Latvia and seven in St. Petersburg, Russia. In addition, Rautakesko operates in Norway, Estonia and Lithuania. Further information: Managing Director Jani Jylhä, K-rauta AB, tel. +46 70 431 6960 Region Director Jarmo Turunen, Rautakesko Ltd, tel. +358 50 328 3498 Kesko is a retail specialist whose stores offer quality to the daily lives of consumers through valued products and services at competitive prices. Kesko operates in the Nordic and Baltic countries and Russia. Rautakesko Ltd (www.rautakesko.com) is a division parent company of Kesko Corporation and the market leader in the Finnish hardware and builders' supplies sector. Rautakesko's share of the hardware and builders' supplies trade is about 35%. Rautakesko develops the K-rauta and Rautia chains and is responsible for their marketing, purchasing and logistics services, store network and retailer resources. Rautakesko operates in Finland, Sweden, Norway, Estonia, Latvia, Lithuania and Russia.


 

Frankfurt, March 2, 2007: IFM Immobilien AG, spezialized upon the development and revitalization of commercial real estate with a high potential for appreciation, announces a personell amendment on its Board level. Alongside both the hitherto and the future CEO, Mr Georg Glatzel (45), as of April 1, 2007, Mr Marcus Schmitz (33) is to get in the lead of the financials department, thenceforth taking office as a CFO. Schmitz who holds a degree of business administration (FH), will come from Munich's private banking house Hauck & Aufhäuser where he has been a portfolio manager for European stocks coming along with an overall responsibility for eight funds. Georg Glatzel: "We are very delighted to enlist Mr Schmitz as our future CFO. He is stated as a well known expert on the financials side and in the capital markets business. Together with Mr Schmitz we see ourselves well prepared for the further alignment of IFM Immobilien AG as regards both our operational business and our ongoing and consistent focus on meeting the international capital market's needs." Bernd Michael Weber, the so far CFO of IFM Immobilien AG, will resign from office by March 31, 2007. "It is with great regret that we learn from Mr Weber's abdication. We do thank him for his valuable contribution to the company's success so far whilst accompanying the IPO and the initial stage of the company", Luca Pesarini, Chairman of the Supervisory Board of IFM Immobilien AG, stated. The Board IFM IMMOBILIEN AG Karl-Ludwig-Straße 2 Ulmenstraße 23-25 D-69117 Heidelberg D-60325 Frankfurt p. +49 (0) 6221 434098-0 p. +49 (0) 69 7040386-0 f. +49 (0) 6221 434098-66 f. +49 (0) 69 7040386-25 info@ifm.ag www.ifm.ag For further queries, please contact: GFEI Gesellschaft für Effekteninformation mbH Beethovenstraße 60 D-60325 Frankfurt www.gfei.de p. +49 (0) 69 743037-00 f. +49 (0) 69 743037-06 About IFM Immobilien AG: IFM Immobilien AG is an investor and a project developer of commercial real estate focusing on office and retail utilization. Center of the business activities is the restructuring, the redevelopment and the asset management of commercial real estate as well as the development of appealing marketing respectively rental concepts. The objects being acquired by IFM Immobilien AG, in general show an attractive risk-reward-ratio, high potential for development as well as appreciation and an ever preferable location. With this strategy and its four core competencies, IFM Immobilien AG establishes a re-positioning of real estate thus creating lasting property values. For 20 years, the company's management has been involved in the real estate sector. Since May 19, 2006, IFM Immobilien AG is listed on the Entry Standard of the Frankfurt Stock Exchange.


 

Video interview available now on www.cantos.com with Francis Yuen, Executive Chairman, Pacific Century Insurance * Why sell PCI now? * Role of managment * Impact to shareholders and customers This programming is available in video, audio and transcript. It's free to view. All you need to do is register at www.cantos.com Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses. If you would like to contact us, please email enquiries@cantos.com.


 

2 March 2007 - To further strengthen its offering, and becoming more transparent to the market, Aker Kvaerner will optimise its operations by transforming its existing six business areas into five global business areas. By combining those specialised units which work within the same market segments better, the change results in increased capacity and a stronger offer of services and solutions to all market segments. It will also enable more effective use of the total resources. The change will support the company's stated objective for further profitable growth. Each of the five business areas in the new structure will have global responsibility for the entire value chain, ranging from marketing and technology development through project execution to service and maintenance. The new structure will further leverage the operation, and enable Aker Kvaerner to provide total solutions for the customers. "We are establishing a global business area model which is more customer oriented and will help us reaching our profitable growth objective in the years to come," says Martinus Brandal, President and CEO of Aker Kvaerner. In the new structure, the five global business areas will be: * Field Development (FD), headed by EVP Simen Lieungh * Subsea, headed by EVP Raymond Carlsen * Products & Technologies (P&T), headed by EVP Mads Andersen * Maintenance, Modifications & Operations (MMO), headed by EVP Torleif Gram * Process & Construction (P&C), headed by EVP Jarle Tautra The Executive Management Team will from April 1 consist of President & CEO Martinus Brandal and EVP & CFO Bjorn Erik Naess, together with the five EVPs mentioned above. Gary Mandel is leaving Aker Kvaerner after being nominated Vice Chairman of the Board of Aker American Shipping ASA, which is a listed company at the Oslo Stock Exchange and part of the Aker group of companies. Gary Mandel will also be Chairman, President & CEO of American Shipping Corporation, a 100 per cent owned subsidiary of Aker American Shipping. In his new position as Vice Chairman, Gary Mandel will report to the Chairman of the Board of Directors, Mr. Leif Arne Langoy. "Gary Mandel, together with his teams, has done an outstanding job for Aker Kvaerner for many years", says Mr. Brandal. "As an example of a leader with high performance with respect to HSE, financial results and driving our Values, both Aker Kvaerner and the wider Aker group need to continue to leverage from his leadership and management competence. I am pleased that Gary will continue to work with Aker in his new position. This is also an example of the career opportunities we have in within the Aker Group". The new organisation structure with five global business areas will be effective from April 1, 2007. For external financial reporting, Aker Kvaerner has already had a reporting based on presentation of five segments, but these external reporting segments differ from the new internal structure on some points. With effect for the first quarter of 2007, also Aker Kvaerner's external financial reporting will be based on the new structure, presenting the financial figures for the five business areas. Pro-forma historical numbers for the five business areas in the new structure will be published before the first quarter 2007 financial result is presented at April 25. ENDS For further information, please contact: Media: Torbjørn S. Andersen, SVP Group Communications, Aker Kvaerner. Tel: +47 67 51 30 36, Mob: +47 928 85 542 Investor relations: Lasse Torkildsen, VP Investor Relations, Aker Kvaerner. Tel: +47 67 51 30 39 Career opportunities: Visit http://www.akerkvaerner.com/Internet/CareerCentre AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner comprises several industries, including Oil & Gas, Refining & Chemicals, Mining & Metals and Power Generation. The Aker Kvaerner group is organised in a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA. Aker Kvaerner has aggregated annual revenues of approximately NOK 50 billion and employs approximately 23 000 people in about 30 countries. Aker Kvaerner is part of the Aker Group (www.akerasa.com), a leading multi-industry powerhouse with more than 55 000 employees and NOK 80 billion revenues. Aker owns 40.1 percent of Aker Kvaerner, and the group is also a major European shipbuilder and a significant participant in the fisheries industry. This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com


 

All resolutions were made in accordance with the summons for the Annual General Meeting of I.M. Skaugen ASA held on 1 March 2007. 60.76 per cent of the share capital was represented. The shareholders present were given information about the current operations of the Company. The presentation is available at the web site (www.skaugen.com). All resolutions were made in accordance with the summons for the Annual General Meeting of I.M. Skaugen ASA held on 1 March 2007. 60.76 per cent of the share capital was represented. The shareholders present were given information about the current operations of the Company. The presentation is available at the web site (www.skaugen.com). The following resolutions were passed: The annual general meeting resolved to pay dividends equal to NOK1.75 per share (approx. USD0.28). The share will be trading ex. dividend on 2 March 2007. The dividend will be paid on 14 March 2007. Re. Authorisation to acquire the Company's own shares On 1 March 2006, the company's Ordinary Annual General Meeting granted the Board the authority to acquire treasury shares. The Board of Directors believes that the acquisition of the Company's treasury shares may be right for the Company with a view, inter alia, to improving the shareholders' return. The Board of Directors proposes that this authorisation be renewed. This also assures the company greater financial flexibility. The acquisition of the Company's own shares can for example be relevant in a situation where the Company's equity- and liquidity situation is good, while at the same time there is a limited supply of attractive investment opportunities. The Board of Directors proposes therefore that the Annual General Meeting passes the following resolution: a) The Board of Directors of I.M. Skaugen ASA is hereby granted authorisation to acquire on behalf of the Company up to 2.727.588 of the Company's treasury shares (adjusted for share split in accordance with item 9 on the agenda for today's annual general meeting) with a total nominal value of NOK 40,913,820, corresponding to 10% of the Company's current share capital. b) The highest price that may be paid per share is NOK 200, and the lowest price is NOK 1. c) The acquisition and disposal of the Company's treasury shares may be carried out as deemed appropriate by the Board of Directors not, however, by subscription for the Company's treasury shares. d) The authorisation shall remain in effect for 18 months from 1 March 2007. e) The authorisation for acquiring treasury shares dated 1 March 2006 is suspended. The authorisation is registered in the Register of Business Enterprises. Re. The Board of Directors Karen Helene Ullveit-Moe and Christian Wessel were re-elected for two years. The members of the Board of Directors are thus the following: Erik Eik, Chairman Bertel O Steen Jon-Aksel Torgersen Christian Wessel Karen Helene Ulltveit-Moe Liselott Kilaas Ingelise Arntsen Morits Skaugen, Deputy member Oslo, 2 March 2007 I.M. Skaugen ASA If you have any questions, please contact: Bente Flø, Chief Financial Officer, on telephone +47 23 12 03 30/+47 91 64 56 08 or by e-mail: bente.flo@skaugen.com. This press release is also available on the Internet at our website: http://www.skaugen.com. Listed on the Oslo Stock Exchange, I.M. Skaugen ASA (IMSK) - www.skaugen.com - is a Marine Transportation Service Company engaged in the hassle free transportation of petrochemical gases and LPG, ship-to-ship transfer of crude oil and LNG, as well as the design and construction of smaller and specialized high quality marine vessels. IMSK is a fully integrated shipping company that designs, builds, owns, mans and manages our own ships. IMSK customers are major international companies in the oil and petrochemical industry, whom we serve worldwide from our operations in Dubai (UAE), Freeport and Houston (Texas), Oslo (Norway), Singapore Sunderland (UK), Nanjing, Shanghai, Taizhou, Zhangjiagang and Wuhan (China). IMSK operates recruitment and training programmes in St. Petersburg (Russia) and Wuhan (China) for the crewing of vessels. IMSK employs approx. 1,500 people and currently operates 44 vessels worldwide. The fleet comprises petrochemical gas and LPG carriers, Aframax tankers, vessels and barges for the transportation of gases on the Yangtze River (China) and a small number of workboats for Skaugen PetroTrans (SPT). IMSK has a comprehensive newbuilding project in China where it has two LPG vessels of 3,200 cbm; three purpose designed combination carriers with LPG/Ethylene/VCM and Organic chemicals carrying capability and up to ten advanced 10,000 cbm LNG/LPG/Ethylene gas carriers are on order for Norgas for delivery from beginning 2007 and onwards. IMSK has invested in infrastructure with both a shipyard and a cargo plant maker in China to ensure innovative and flexible vessels at low cost. Six new, purpose designed and built "Aframax sized tankers", are on order for delivery to SPT on a long term Bareboat charter and commencing during 2007.


 

* China is the country worst impacted by hepatitis B, with more than half a million deaths each year [1],[2] * Data show Sebivo gives better viral suppression than lamivudine, the most widely prescribed treatment for chronic hepatitis B * Sebivo recently recommended for European approval, and already available in US under brand name Tyzeka® Basel, March 2, 2007 - Novartis announced today the Chinese regulatory approval of Sebivo® (telbivudine) as a treatment for chronic hepatitis B, a disease estimated to affect more than 100 million people in China[1-3] and considered the second leading cause of death in the country[1]. The decision comes shortly after Sebivo was recommended for approval in the European Union. Sebivo meets an urgent demand for effective therapies that can provide profound and sustained suppression of the hepatitis B virus, reducing the risk of liver disease and improving long-term outcomes for patients[4]. Sebivo will be available in China in April. The need for new therapies is especially pressing in China, where an estimated 10% of the population suffer from chronic hepatitis B[2],[5]. The number of infected people in China represents about one-third of those with the disease worldwide[2]. Despite existing treatments, nearly half a million people in mainland China die each year from liver damage and liver cancer caused by chronic hepatitis B[1],[2]. "Chronic hepatitis B is a major health problem in China, and through treatment, we aim to prevent the progression of the disease by getting the viral load to as low a level as possible," said Prof. Jidong Jia, Director of the Liver Research Center, Beijing Friendship Hospital, Capital Medical University, China. "Sebivo's demonstrated ability to rapidly and profoundly drive down virus levels within the first 24 weeks of treatment, in addition to its favorable safety profile, make it a promising treatment option for patients with chronic hepatitis B." Worldwide regulatory submissions have been based primarily on one-year data from the GLOBE study, the largest worldwide registration trial ever conducted in patients with chronic hepatitis B and the first to include patients from mainland China. The study results demonstrated that Sebivo provided greater viral suppression and significantly greater response on all virologic markers after one year compared to lamivudine, the most widely prescribed treatment. An additional Chinese Phase III trial corroborated these findings and supplemented the filing in China. "The approval of Sebivo in China represents a milestone in treatment for the millions of patients suffering from chronic hepatitis B," said James Shannon, MD, Global Head of Development at Novartis Pharma AG. "We now look forward to receiving final European Commission approval, and to providing chronic hepatitis B patients in Europe with access to this promising new treatment." The positive opinion in Europe was issued on February 22 by the Committee for Medicinal Products for Human Use (CHMP), which reviews drug applications for all 27 countries in the European Union as well as Iceland and Norway. The European Commission generally follows the CHMP's advice and is expected to issue a final decision within two to three months. Sebivo, a once-daily oral treatment, is already approved in 12 countries including Switzerland and the US, where it is marketed as Tyzeka®. Novartis in China Novartis and its predecessor companies have been active in China since 1938 when Ciba opened its office in Shanghai, initially as a provider of dyestuffs and later expanding into the pharmaceutical arena. The Chinese name for Novartis (pronounced Nuo Hua) means Commitment to China, which reflects the company's long-term strategy in the region. The total investment in China now totals over USD 400 million, with two major developments announced in 2006: a manufacturing and development center in Changshu, to be fully operational by the end of 2007, and an integrated biomedical research and development center in Shanghai expected to open in May. Novartis currently ranks as the fourth largest pharmaceutical company in the Chinese hospital market with a compound annual sales growth rate of over 30% during the last five years, and currently has around 2,400 full-time employees in China. About Idenix/Novartis collaboration Novartis Pharma AG and Idenix are co-promoting Sebivo, for the treatment of hepatitis B, and co-developing valtorcitabine, a second hepatitis B compound, and valopicitabine, a hepatitis C compound, under a development and commercialization arrangement established in May 2003. Under this agreement, Novartis and Idenix will co-promote Sebivo, valtorcitabine and valopicitabine in the US, France, Germany, Italy, Spain and the UK. Novartis has the exclusive right to commercialize Sebivo, valtorcitabine and valopicitabine in the rest of the world. Novartis is committed to infectious diseases and is developing a portfolio of complementary mechanisms of action in the treatment of hepatitis B and C, while working to bring innovation for serious hospital infections. Disclaimer The foregoing release contains forward-looking statements which can be identified by the use of terminology such as "will," "aim to," "promising," "look forward to," "expected," "to be," "committed," "developing," "working to bring," or similar expressions, or by express or implied discussions regarding the potential marketing approvals of Sebivo in the EU or in additional countries, or potential future revenue from Sebivo. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Sebivo will be approved for any indications in the EU or any other market, or that Sebivo will reach any particular sales levels. In particular, management's expectations regarding the approval and commercialization of Sebivo could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; competition in general; increased government, industry, and general public pricing pressures; unexpected clinical trial results, including additional analysis of clinical data, or new clinical data; our ability to obtain or maintain patent or other proprietary intellectual property protection; and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. References [1] Sun Z, et. al. Prevention and control of hepatitis B in China. J Med Virol 2002, 67:447-450. [2] Lesmana LA, Leung NW, Mahachai V, et al. Hepatitis B: overview of the burden of disease in the Asia-Pacific region. Liver Int 2006 Dec; 26 Suppl 2: 3-10. [3] Guan Z, Dong Z, Wang Q, et al. Cost of chronic hepatitis B infection in China. J Clin Gastroenterol 2004 Nov; 38(10 Suppl): S175-S178. [4] Hou JL, Yin YK, Xu DZ, et al. A Phase III Comparative Trial of Telbivudine and Lamivudine for Treatment of Chronic Hepatitis B in Chinese Patients: First-Year Results. Presented at: Shanghai-Hong Kong International Liver Congress; March 25-28, 2006. Poster 180. [5] You GB. Treatment of chronic hepatitis B in China. J Gastroenterol Hepatol 2000 May; 15 Suppl: E61-E66. # # # Media contacts Corinne Hoff Novartis Global Media Relations +41 61 324 9577 (direct) +41 79 248 5717 (mobile) corinne.hoff@novartis.com Birgit Gronkowski Novartis Pharma Communications +41 61 324 8790 (direct) +41 79 820 1719 (mobile) birgit.gronkowski@novartis.com e-mail: media.relations@novartis.com Novartis Global Investor Relations International: Ruth Metzler-Arnold +41 61 324 99 80 Katharina Ambühl +41 61 324 53 16 Nafida Bendali +41 61 324 35 14 Jason Hannon +41 61 324 21 52 Richard Jarvis +41 61 324 43 53 North America: Ronen Tamir +1 212 830 24 33 Arun Nadiga +1 212 830 24 44 Jill Pozarek +1 212 830 24 45 Edwin Valeriano +1 212 830 24 56 e-mail: investor.relations@novartis.com --- End of Message --- WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

Santhera Pharmaceuticals (SWX:SANN), a Swiss specialty pharmaceutical company with a focus on neuromuscular diseases, announces today its financial results for 2006. The results reflect the significant progress that the Company has made across all areas of its business including: * Product development, where the Company is preparing to file the Marketing Authorization Approval (MAA) for its lead compound SNT-MC17 (INN: idebenone) for Friedreich's Ataxia (FRDA) in Europe. In addition, the Company is preparing a Phase III trial with SNT-MC17 for FRDA in the US and has two Phase II trials on-going with SNT-MC17 for Duchenne Muscular Dystrophy (DMD) and Leber's Hereditary Optic Neuropathy (LHON); * Partnering, where a collaboration agreement with Oy Juvantia Pharma Ltd, Turku, Finland (Juvantia), has given Santhera access to JP-1730 (INN: fipamezole), a potential treatment for Dyskinesia in Parkinson's Disease (DPD). JP-1730 is expected to enter a Phase IIb trial later in 2007 and; * Financing, where its successful initial public offering (IPO) and subsequent listing on the SWX Swiss Exchange (SWX) has provided Santhera with the funds to support its planned clinical development and marketing activities. At the end of 2006, the Company's cash reserves amounted to CHF 125.7 million. Dr Klaus Schollmeier, Chief Executive Officer, commented: "2006 was a very busy and successful year for Santhera. All our development projects made significant progress, most notably our lead compound SNT-MC17 in Friedreich's Ataxia. Based on positive results from our collaborative study with the US National Institutes of Health, we are now preparing for an early filing for market approval in Europe and for accelerated development timelines in the US." He continued: "Last year, we successfully completed the patient recruitment for a proof-of-concept study of our lead compound in Duchenne Muscular Dystrophy and initiated a further clinical program in a third indication, Leber's Hereditary Optic Neuropathy. On the partnering side, we entered a collaboration with Juvantia for a Phase IIb clinical program for its lead compound JP-1730 in Dyskinesia in Parkinson's Disease." "Through our initial public offering and a preceding private financing round we secured additional funding for the future development of our research and development pipeline," stated Barbara Heller, Chief Financial Officer. "The Company's operating financial performance is in line with our expectations. We also successfully executed our strategy to leverage the potential of SNT-MC17 and to enrich our development pipeline by in-licensing promising drug candidates in neuromuscular diseases. Proceeds from our successful IPO in early November 2006 have provided us with a solid financial basis from which to advance our lead compound to the market." Excellent track record in private and public financing On November 3, 2006, Santhera completed its IPO and subsequent listing on the SWX, raising gross proceeds of CHF 101.8 million including the fully exercised greenshoe. The IPO consisted of a public offering in Switzerland and an international private placement in the EU and the US to QIBs under Rule 144A of 1,131,438 newly issued shares including the greenshoe. The offering, which was priced at CHF 90 per share, was over-subscribed with strong demand from high quality institutional investors in Switzerland, Germany, the US, UK and the Benelux. As far as can be ascertained from the information available, the following shareholders own 5% or more of the Company's capital: NGN Capital (US, Germany) 12.2%, Merlin (UK) 7.7%, Oxford Bioscience (US) 7.1%, 3i (UK) 6.9%, Cominvest (Germany) 6.0%, Schroders (UK) 5.1% and GIMV (Belgium) 5.0%. Santhera's current free float is 38.32%, unchanged since the IPO due to lock-up provisions. Prior to the IPO, in October 2006, Santhera raised CHF 15.8 million in its last private financing round, bringing the total gross proceeds of its private financing in three rounds to CHF 87 million. Additionally, warrants issued in connection with the preceding financing round in December 2005 were converted in conjuction with the IPO. Strong balance sheet with solid cash reserves of CHF 125.7 million at the end of 2006 With CHF 125.7 million cash and cash equivalents on hand at December 31, 2006, Santhera is well positioned to fund its current operations and strategic goals. The Company is investing these funds primarily in its expanding pipeline and the planned set-up of its own specialized marketing and sales organization in the US. Operating result (EBIT) of CHF -28.6 million, expenses focused on research and development Santhera achieved revenues of CHF 0.8 million in 2006 primarily from research funding through a licensing agreement with Biovitrum AB, Stockholm, Sweden (Biovitrum). In 2005, Santhera received up front payments from the two major partnerships with Takeda Pharmaceutical Company Ltd, Osaka, Japan (Takeda), and Biovitrum which together amounted to CHF 13.2 million. The Company's operating expenses amounted to CHF 29.4 million in 2006, up CHF 4.1 million compared to 2005. These additional expenses were predominantly dedicated to research and development activities, which in 2006 accounted for CHF 18.0 million, or 61% of operating expenses. The increase in research and development expenses of CHF 3.5 million over the previous year reflects a shift from pre-clinical research to development, triggered by the clinical trial costs for SNT-MC17. These costs were for preparing and entering two Phase III trials in FRDA and two Phase II clinical trials in two further indications, DMD and LHON. General and administrative expenses of CHF 12.1 million in 2006 were significantly higher than in 2005 (CHF 6.0 million). This was mainly due to the costs of legal and other advisory services in connection with the private financing round, the process of going public, and the negotiation of the agreements with Juvantia, and other business development activities. For the first time, Santhera also incurred marketing and sales expenses which amounted to of CHF 0.3 million. This expenditure is currently reported as part of general and administrative expenses. Other operating income amounted to CHF 0.6 million compared to other operating expenses of CHF 4.7 million in 2005. The total operating expenses in 2006 also include non-cash relevant expenses for share-based payments (non-vested stock options) of CHF 2.6 million and for warrants issued to investors of Juvantia, which accounted for CHF 0.9 million. The cash-relevant operational key figure, the gross operating and investing cash flow, amounted to CHF -25.9 million in 2006 compared to CHF -22.5 million in 2005. This figure is based on the operating result, excluding non-cash charges such as expenses for stock options, amortization and depreciation, issuance of warrants and net of gross profit. Santhera is focusing on keeping its recurring general and administrative expenses to a minimum in order to support its investments in research and development and planned investments in its sales and marketing organization in the US. However, the Company has been investing in and is further committed to its corporate governance and risk management activities to ensure that they meet international standards. The Company's risk mangement activities are focused on the careful management of its cash-burn and minimizing its financial risks. The net financial result amounted to CHF 0.6 million in 2006, substantially higher than in 2005 (CHF -0.9 million), mainly due to higher interest income and the issuance of warrants in connection with the financing round in 2005. Over the course of 2006, Santhera repaid loans from tbg Technologiebeteiligungsgesellschaft mbH, Bonn, Germany (tbg), totalling CHF 2.6 million, substantially reducing the Company's interest rate burden. The remaining oustanding amount under a second loan agreement with tbg amounts to CHF 1.4 million. Cash-relevant incremental expenses directly attributable to equity financings are expensed through the equity statement and amounted to CHF 10.1 million in 2006 and to CHF 0.3 million in 2005. The expenses in 2006 covered both the private financing round and the IPO. Proven success in partnering Santhera has a strong track record in executing its strategy by selectively partnering its marketing activities in certain markets, in adding development programs within its key fields of expertise and in out-licensing non-core businesses. In July 2006, Santhera entered into a co-operation agreement with Juvantia for the development of Juvantia's product candidate JP-1730 in DPD. This agreement is designed to generate the additional clinical data required prior to starting pivotal clinical trials. In connection with this co-operation agreement, the Company and Juvantia's investors signed an option agreement that grants Santhera the right to purchase Juvantia if certain conditions are met. The Company has not made any upfront payment in cash but as an option premium, issuing 9,818 warrants to Juvantia's investors to acquire Santhera shares. Outlook and financial management Santhera's cash-burn in 2007 is expected to increase compared to 2006 reflecting the successful development of the Company's pipeline with SNT-MC17 in two Phase III and two Phase IIa trials and JP-1730 in a Phase IIb trial. Cash will also be invested in ongoing pre-clinical research activities as well as in business development with the goal of further growing the pipeline externally. In addition, by the end of 2007, the Company plans to start building its marketing organization in the US. As part of its business strategy, Santhera intends to focus its commercial activities on the North American markets while out-licensing marketing rights in Europe and other regions. As a result, milestone and upfront payments from such partnering agreements represent an important part of the Company's financing activities. First revenues from products are expected to be achieved following the planned launch of SNT-MC17 for FRDA in Europe by Takeda, expected in the second half of 2008. Key financial figures Balance Sheets (IFRS, consolidated, in CHF thousands) Dec 31, 2006 Dec 31, 2005 Cash and equivalents 125,662 31,268 Noncurrent assets 34,260 32,993 Other current assets 2,472 14,451 Total assets 162,394 78,712 Equity 152,048 66,147 Noncurrent liabilities 1,758 4,773 Current liabilities 8,588 7,792 Total equity & liabilities 162,394 78,712 Changes of 2005 figures are mainly due to changes in reporting currency from EUR to CHF. Income Statements (IFRS, consolidated, in CHF thousands) 2006 2005 Gross profit 781 13,756 R&D expenses -17,985 -14,542 G&A expenses -12,052 -6,012 Other expenses 617 -4,719 Operating result (EBIT) -28,639 -11,517 Financial result 562 -867 Result before taxes -28,077 -12,384 Income taxes -181 748 Net loss -28,259 -11,636 Changes of 2005 figures are mainly due to changes in reporting currency from EUR to CHF. Cash Flow summary (IFRS, consolidated, in CHF thousands) 2006 2005 Gross operating/investing cash flow -25,897 -22,512 Cash and cash equivalents at January 1 31,268 16,302 Cash and cash equivalents at December 31 125,662 31,268 Changes of 2005 figures are mainly due to changes in reporting currency from EUR to CHF. (The 2006 consolidated financial statements of Santhera Pharmaceuticals Holding AG can be found on the Company's website at www.santhera.com) Update on Santhera's current development pipeline * SNT-MC17 in FRDA: A recent clinical trial conducted in collaboration with the US National Institutes of Health (NIH) has shown improvement of both neurological parameters and activities of daily living scores. These positive results were achieved after six months treatment with SNT-MC17 at daily doses of 900 mg or 2,250 mg for adult patients. Based on these positive data and under a new guideline of the European Medicines Agency (EMEA) on clinical trials in small populations, Santhera is preparing to file a Marketing Authorization Approval (MAA) in Europe in summer 2007. If everything goes according to plan, it is hoped that the product could be launched in Europe in the second half of 2008 by Santhera's marketing partner Takeda. The ongoing Phase III trial in Europe will be continued to collect additional safety and efficacy data in a wider population of FRDA patients. In the US, Santhera has filed a new protocol for a pivotal Phase III trial under its open IND (Investigational New Drug) and is awaiting a Special Protocol Assessment (SPA) meeting with the US Food and Drug Administration (FDA). The new protocol for this Phase III trial reflects the major findings from the collaborative NIH trial regarding neurological endpoints and the effective doses. Santhera expects that this Phase III trial will require significantly fewer patients and will be considerably shorter in terms of treatment times than originally planned. Patient recruitment is expected to start in summer 2007. * SNT-MC17 in DMD: Patient recruitment of a Phase IIa proof-of-concept study has been completed. Results from this study are expected in the second half of 2007. Subject to a positive outcome, Santhera intends to seek protocol advice from the EMEA and the FDA in order to prepare for a pivotal Phase III program. Meanwhile, orphan drug designation for SNT-MC17 in DMD has been granted in both the EU and the US. * SNT-MC17 in LHON: The study centers in Germany and the UK have been opened recently and are ready to recruit patients for this Phase IIa proof-of-concept trial. The study, designed to assess the efficacy of SNT-MC17 on the progression of vision loss in symptomatic people with LHON, features a special statistical protocol allowing for interim analyses. Meanwhile, Santhera has received orphan drug designation in both the US and the EU. * JP-1730 in DPD: Currently, final toxicity studies and formulation work are being performed in order to prepare a Phase IIb trial which is due to start in the US in the second half of 2007 under Juvantia's open IND. This one-month efficacy trial is designed to confirm prior positive Phase IIa clinical data obtained from a larger cohort of patients. * * * Presentation of the 2006 results Santhera invites the media and analysts to attend presentations given by the Company's management on Friday March 2, 2007, at 09:00 CET (for media) and 11:00 CET (for analysts) at the Park Hyatt Zurich, Beethoven-Strasse 21, in Zurich, Switzerland. For Further Information, Contact Santhera Pharmaceuticals Klaus Schollmeier, Chief Executive Officer phone: +41 (0)61 906 89 52 klaus.schollmeier@santhera.com Barbara Heller, Chief Financial Officer phone: +41 (0)61 906 89 54 barbara.heller@santhera.com Thomas Staffelbach, VP Public & Investor Relations phone: +41 (0)61 906 89 47 thomas.staffelbach@santhera.com Media Contacts: Citigate Dewe Rogerson David Dible phone: +44 207 638 95 71 david.dible@citigatedr.co.uk About Santhera Santhera Pharmaceuticals (SWX:SANN) is a Swiss specialty pharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of severe neuromuscular diseases. Santhera's vision is to become a leading specialty pharmaceutical company offering therapies for a number of indications in this area of high unmet medical needs which includes many orphan indications with no current therapy. Santhera currently has four clinical-stage development programs, three of which are investigating its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's Hereditary Optic Neuropathy (LHON). The fourth clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease (DPD) in cooperation with Juvantia, the compound's owner. The most advanced program, SNT-MC17 in FRDA, is in preparation for filing in Europe and in Phase III clinical development in the US while the other clinical programs are in Phase II. For further information, please visit www.santhera.com. Disclaimer/Forward-looking Statements This news release is not and under no circumstances is to be construed as a solicitation, offer, or recommendation, to buy or sell securities issued by Santhera. Santhera makes no representation (either express or implied) that the information and opinions expressed in this news release are accurate, complete or up to date. Santhera disclaims, without limitation, all liability for any loss or damage of any kind, including any direct, indirect or consequential damages, which might be incurred in connection with the information contained in this news release. Forward-looking statements and other information contained in this release involve risks and uncertainties. Such statements reflect the current views, intentions and estimates of the Company. They are based on assumptions that may be inaccurate. Results could differ materially from those anticipated. Certain of these forward-looking statements can be identified by the use of forward-looking terminology such as "believe", "expect", "may", "are expected to", "will", "will continue", "should", "would be", "seek" or "anticipate" or by discussions of strategy, plans or intentions. Furthermore, the Company does not assume any obligation to update these forward-looking statements. --- End of Message --- WKN: A0LCUK; ISIN: CH0027148649; Index: SPI, SPIEX, SSCI; Listed: Main Market in SWX Swiss Exchange;


 

Successful financial year - sharp rise in revenues in all divisions, higher profitability in textiles and optics Horgen, March 2, 2007 - The unaudited accounts for 2006 show that orders received by the Group increased 25% to CHF 477.0 million (2005: 382.5 million). Revenues grew 32% to CHF 461.0 million (2005: 349.1 million). All divisions contributed to this sharp rise: SSM Textile Machinery +26%, Satisloh +22% and Ismeca Semiconductor +69%. Satisloh's share of the Group's total revenues is over 50%. The Group reported an operating result (EBIT) of CHF 37.3 million (2005: 12.4 million). SSM Textile Machines accounted for one third of this figure, while Satisloh generated two thirds. Although Ismeca Semiconductor succeeded in eliminating the previous year's heavy loss, it only achieved break-even for the year just ended. Net income came to CHF 33.4 million (2005: 19.0 million). Factoring out approximately CHF 8 million in divestment proceeds earned in 2005, this is three times the previous year's figure. The Group posted liquidity of CHF 78 million at the end of 2006. Deduction of interest-bearing liabilities produced a net cash position of CHF 68 million. The equity ratio stood at 60%. Schweiter Technologies is holding its annual results press conference today at the Hotel Marriott, Neumühlequai 42, in Zurich, beginning 11.00 a.m. Key figures Total Total Change Schweiter Technologies Group (in CHF millions) 2006 2005 Orders received 477.0 382.5 +25% Gross revenues 461.0 349.1 +32% Operating result 37.3 12.4 +201% as % of gross revenues 8.1% 3.6% Net income from continuing operations 33.4 11.1 +201% Net income 33.4 19.0 * +76% Segment information by division (in CHF millions) SSM Textile Machinery Orders received 108.4 84.3 +29% Gross revenues 104.8 83.0 +26% Operating result 12.4 7.7 +61% as % of gross revenues 11.8% 9.3% Satisloh Orders received 254.0 221.3 +15% Gross revenues 242.3 198.5 +22% Operating result 26.0 13.2 +97% as % of gross revenues 10.7% 6.6% Ismeca Semiconductor Orders received 114.6 76.9 +49% Gross revenues 113.5 67.3 +69% Operating result -0.2 -8.5 - as % of gross revenues - - * of which income from discontinued operations: CHF 7.9 million SSM Textile Machinery There was a sharp increase in demand for textile machines, driven in particular by rapid expansion in Turkey and the Indian subcontinent, where volumes doubled year-on-year. Together, they accounted for around 40% of total revenues. After several years of low demand for air texturing, there was a marked revival in both this segment and in monofilament hardware - the main reason being the successful market launch of the new PW 2 generation of machines. The 26% rise in revenues while headcount remained steady resulted in a significant improvement in results and margins. At 12%, the operating margin was once again very satisfactory. Satisloh Satisloh posted pleasing growth in both revenues and results. There were considerable advances in the "surfacing" (+50%), "consumables" (+25%) and "spare parts" (+35%) business segments, in particular. The US market remained the primary growth driver (+22%), although Europe expanded appreciably in the wake of the successful launch of freeform technology. At CHF 26 million, EBIT doubled year-on-year and the margin rose to a highly respectable 11%. Ismeca Semiconductor As expected, the second half of the year was characterized by weaker demand. Revenues for 2006 as a whole were nonetheless good, at CHF 113 million or almost 70% higher than the previous year. The division broke even in 2006, but nevertheless fell far short of the target operating result. This was due to a persistent price war, lower margins upon entering market segments with great potential for the future, and cost overlaps connected with the building up of production facilities in Malaysia. As of the end of the year, these plants had a workforce of around 120, or approximately one third of the planned total. Outlook All divisions began the new financial year with healthy order books. SSM Textile Machines is profiting from the ongoing prosperity and expansion of the sector overall, as well as its own lean structures. Satisloh looks likely to widen margins further as volumes remain high. There has been a slight improvement in Ismeca Semiconductor's gross margin following the determined implementation of relocation to Asia. Volume trends for the year as a whole will have a lasting impact on results. Schweiter Technologies AG, Neugasse 10, CH - 8812 Horgen, Switzerland Telefon +41 1 718 33 11 Fax +41 1 718 34 51 info@schweiter.com www.schweiter.com The media release can be downloaded from the following link: --- End of Message --- WKN: 879123; ISIN: CH0010754924; Index: SPI, SPIEX, SSCI; ;


 

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- March 01, 2007 -- Skygold Ventures Ltd. (Skygold) (TSX VENTURE: SKV), a Vancouver-based resource company ,and its partner Wildrose Resources Ltd. (Wildrose) (TSX VENTURE: WRS), today announced assay results from an additional 6 diamond drill holes on the Spanish Mountain gold property in south-central British Columbia that continue to expand the project's Main Zone. Drilling beneath the Imperial Metals pit has confirmed the downward extension of the known mineralization that was the target of a bulk sample of 1908 tonnes whose grade was determined to be 3.02 g/t gold. Previous interpretations would have indicated that the Central Main Zone comes to surface at the pit. Hole 562 intersected 3 separate zones that totalled 105.5 m of mineralization and weight averaged 1.27 g/t gold including 46.5 metres grading 1.56 g/t gold indicating the zone is open at depth. Hole 557 has intercepted 54.36 m of mineralization in 2 separate zones weight averaging 1.17 g/t gold including 42.0 m of 1.21 g/t gold. Mineralization within the Main Zone is associated with at least three separate, sub-parallel, stratigraphic horizons up to 500 metres wide and up to 135 metres thick. Geophysics completed in 2006, in conjunction with drilling and surface sampling has defined these favourable horizons over at least 2.5 kilometres. The extent of drilling within the Main Zone to date has tested only 20% of this area. As previously reported, drilling within the Main Zone has significantly increased its east west extent to at least 740 metres while regional drilling has intersected gold mineralization 1.5 kilometres west of the Main Zone. Hole locations in plan view relating to geophysical signatures can be viewed on the company website, www.skygold.ca. Results for a further 24 reverse circulation and 11 diamond drill holes are pending. Results are expected within the next few weeks. The new results include a selection of holes drilled within the middle stratigraphic horizon stepping out to the west of the Main Zone. All 6 holes have intercepted meaningful mineralization. The following table summarizes the most significant results from the Central Main Zone. ---------------------------------------------- Hole id from to interval Au g/t ---------------------------------------------- 544 31 41.5 10.5 1.16 ---------------------------------------------- ---------------------------------------------- 547 63.5 81 17.5 1.02 ---------------------------------------------- ---------------------------------------------- 553 57 84 27 0.76 ---------------------------------------------- incl. 57 67.5 10.5 1.23 ---------------------------------------------- ---------------------------------------------- 557 29 41.36 12.36 (ii)1.02 ---------------------------------------------- and 92.5 134.5 42 (ii)1.21 ---------------------------------------------- ---------------------------------------------- 562 14 50.5 36.5 (ii)0.87 ---------------------------------------------- incl. 38 49 11.0 2.03 ---------------------------------------------- 93 139.5 46.5 (ii)1.56 ---------------------------------------------- 228 2262.5 34.5 1.04 ---------------------------------------------- incl. 228 250.5 22.5 (ii)1.33 ---------------------------------------------- ---------------------------------------------- 563 68.5 91 22.5 1.02 ---------------------------------------------- incl. 68.5 82 13.5 1.37 ---------------------------------------------- 128.5 143.87 15.37 0.84 ---------------------------------------------- incl. 128.5 136 7.5 1.07 ---------------------------------------------- (i) Represents drill hole intercept width (ii) Intercepts used in weight averaging Eco Tech Laboratory Ltd. of Kamloops B.C., an accredited laboratory, is conducting the sample preparation and analyses. Skygold/Wildrose is submitting standards, blanks and duplicates into the sample stream to maintain quality control. All gold analyses will utilize standard screen metallic assay techniques. Robert Darney, P.Geo., and J.W. (Bill) Morton, P. Geo., are the qualified persons (as defined in NI 43-101) who have reviewed this news release. The company will be exhibiting at the Prospectors and Developers Conference in Toronto March 4th Interested participants can visit management at Booth # 2531. On Behalf of the Board, SKYGOLD VENTURES LTD Doug Fulcher, President About Skygold Ventures Ltd. Skygold Ventures is a Vancouver-based resource company exploring for precious metals in North America. Its shares trade on the TSX-V exchange under the symbol SKV. Skygold's Spanish Mountain property, located near the historic town of Likely in south-central British Columbia, is one of the top gold prospects of the Cariboo region. Although Spanish Mountain has a long history of exploration, results from the past four years have produced the most convincing evidence to date that this exciting property may contain the source of some of the Cariboo's richest placer finds. The Spanish Mountain project is a joint venture between Skygold and Wildrose Resources Ltd. Skygold owns a 70% interest and Wildrose holds a 30% participating interest. This news release may contain certain "Forward-Looking Statements" within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time with the TSX Venture Exchange, the British Columbia Securities Commission and the US Securities and Exchange Commission. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Contacts: B&D Capital Partners Brad Aelicks (604) 685-6465 SOURCE: Skygold Ventures Ltd.


 

With sales revenue standing at TEUR 944 (prev. yr. TEUR 1.867) for proportionate purchase costs of TEUR 814 (prev. yr. TEUR 1.101), investment earnings stand at a total of TEUR 3.685. This includes a first-time yield of intersts of our 100% affiliated holding Equity A GmbH and additions to our book values of investment due to aovo Touristik AG going public on 22.12.06. The financial result of U.C.A. stands at TEUR 320 (prev. yr. TEUR 3.230) and includes both price gains from the sales of securities and a net interest yield. The provisional result from ordinary activities (before tax) of U.C.A. AG amounts to TEUR 3.197 (previous year TEUR 3.544) up to 31.12.06. According to the German Commercial Code, the book value of the total investment portfolio amounts to TEUR 8.100 up to 31.12.06. It includes listed investments (Aovo Touristik and Datapharm) as well as associated companies, including the Deutsche Technologie Beteiligungs AG with their five technology companies, including the publicly quoted Plan Optik and Intercard. Free liquidity of U.C.A-Group (U.C.A. AG, Equity A Beteiligungen GmbH, Deutsche Technologie Beteiligungen AG) amounts to about TEUR 28.000. With this background, the general meeting on 10.07.2007 shall propose a dividend for each share amounting to at least previous year's level. The management is optimistic with regard to the outlook for 2007 and 2008. The board of management is anticipating significantly increased sales and investment earnings compared to the previous year within the U.C.A. Group. U.C.A. Aktiengesellschaft The Management Contact: Investor Relations Oliver Schulte Tel. : + 49 (0) 89 - 99 31 94-25 E-mail: investor.relations@uca.de --- End of Message --- WKN: 701200; ISIN: DE0007012007 ; Listed: Freiverkehr in Frankfurter Wertpapierbörse, M:access in Bayerische Börse München;


 

Corio has signed an agreement for the acquisition of a 100%-interest in "Adacenter" shopping centre currently under development in Adapazari for approximately USD 65 million. In addition, Corio has been invited to take a 7%-interest in the potentially large scale project Acibadem which will be developed in Istanbul. The transactions are forecast to generate a net yield of at least 8% in the first full year of operation.


 

Acting on its authorization to acquire up to 10% of its shares the H. Lundbeck Supervisory Board has resolved to initiate a share buyback program. Under the program H. Lundbeck will buy own shares for an amount of up to DKK 6 billion until end of 2007, cf. stock exchange announcement number 166 on 17th August 2005. During any one single trading day a maximum of 25% of the average daily trading volume of Lundbeck shares on the Copenhagen Stock Exchange, calculated over 20 days prior to each trading date, will be bought back, as the share buyback program is implemented in accordance with the provisions of the European Commission's regulation no. 2273/2003 of December 22, 2003. At least once every seven trading days, Lundbeck will issue an announcement in respect of the transactions made under the program. The following transactions have been made under the program: No. of shares Average Transaction value purchase price (DKK) (DKK) Accumulated, last 17,610,324 134.9425 2,376,381,682 announcement 21 February 2007 137,295 160.5716 22,045,677 22 February 2007 143,778 159.1887 22,887,826 23 February 2007 - - - 26 February 2007 - - - 27 February 2007 145,282 154.8322 22,494,328 28 February 2007 62,040 149.6811 9,286,218 1 March 2007 - - - Accumulated under the 18,098,719 135.5397 2,453,095,731 program Pursuant to Section 28 of the Danish Securities Trading Act and following the above buyback it is hereby announced that Lundbeck owns a total of 4,809,576 own shares at a nominal value of DKK 5, equal to 2.27% of the total number of 212,155,154 shares. The content of this release does not change the Lundbeck Group's previously announced expectations as announced in connection with reporting for the 3rd quarter 2006 financial result. Lundbeck contacts Steen Juul Jensen Vice President +45 36 43 30 06 Investors: Media: Mads Bjerregaard Pedersen Caroline Broge Investor Relations Officer Media Relations Manager +45 36 43 41 04 +45 36 43 26 38 Jacob Tolstrup Investor Relations Manager, North America +1 201 350 0187 Stock Exchange Release No 259 - 1 March 2007 About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2005, the company's revenue was DKK 9.1 billion (approximately EUR 1.2 billion or USD 1.5 billion). The number of employees is approximately 5,000 globally. For further information, please visit www.lundbeck.com


 

Acquisitions of Axento and Fedimmo Growth in value of portfolio Substantial increase in book value During this first quarter of the 2006/2007 fiscal year, Befimmo has succeeded in completing two major acquisitions consistent with its strategy of growing its medium- and long-term cash flows. In addition to its first foreign venture through the acquisition of the Axento project in Luxembourg, Befimmo has succeeded in buying 90% of the shares of Fedimmo SA offered for sale by the Belgian Government. The full press release can be downloaded from the following link:


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |--------------------------------------------+----------------------| | Company dealt in | J Sainsbury Plc | |--------------------------------------------+----------------------| | Class of relevant security to which the | 28 and 4/7p ordinary | | dealings being disclosed relate (Note 2) | | |--------------------------------------------+----------------------| | Date of dealing | 28 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------+--------------------+--------------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------+------------+-------+------------+-------| | (1) Relevant securities | | | | | | | | | | | |-------------------------+------------+-------+------------+-------| | (2) Derivatives (other | | | | | | than options) | | | 0.00 | 0.000 | | | | | | | |-------------------------+------------+-------+------------+-------| | (3) Options and | | | | | | agreements to | 26,000,000 | 1.506 | 25,000,000 | 1.448 | | purchase/sell | | | | | | | | | | | |-------------------------+------------+-------+------------+-------| | Total | 26,000,000 | 1.506 | 25,000,000 | 1.448 | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Long | 1,000,000 | 506.0000 GBp | |----------+------------+---------------------------+---------------| | CFD | Long | 216,000 | 510.6493 GBp | |----------+------------+---------------------------+---------------| | CFD | Short | 575,677 | 515.0133 GBp | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | None | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) YES +-------------------------------------------------------------------+ | Date of disclosure | 01/03/2007 | |------------------------------------------------+------------------| | Contact name | Stephen Platts | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9635 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) +----------------------------------------------------------------------+ |Product |Written or|Number of |Exercise|Type, e.g.|Expiry date| |name, |purchased |securities to |price |American, | | |e.g. call| |which the option |(Note 2)|European | | |option | |or derivative | |etc | | | | |relates | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |5,000,000 |540 GBp |American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |7,500,000 |540 GBp |American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |5,000,000 |580 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |7,500,000 |580 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |5,000,000 |480 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |7,500,000 |480 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |5,000,000 |520 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |7,500,000 |520 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |1,000,000 |520 GBp |American |15/06/2007 | |option | | | | | | +----------------------------------------------------------------------+ Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |----------------------------------------------+--------------------| | Company dealt in | Gallaher Group plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | 10p Ordinary | | dealings being disclosed relate (Note 2) | | |----------------------------------------------+--------------------| | Date of dealing | 28 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------------+--------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (2) Derivatives (other than | 7,661,371 | 1.1659 | | | | options) | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | Total | 7,661,371 | 1.1659 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per unit | | name, | (Note 6) | (Note 7) | (Note 5) | | e.g. CFD | | | | |----------+------------+--------------------------+----------------| | CFD | LONG | 100,000 | 1127.5635 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 1st March 2007 | |--------------------------------------------------+----------------| | Contact name | James Feast | |--------------------------------------------------+----------------| | Telephone number | 0207 469 1901 | |--------------------------------------------------+----------------| | If a connected EFM, name of offeree/offeror with | | | which connected | | |--------------------------------------------------+----------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Awilco Offshore (AWO) has exercised an option with PPL to build a 375ft jackup drilling rig with drilling depth of 30.000 ft. The rig will be named WilConfidence. The rig is to be delivered in the second quarter of 2009, and has a delivered cost of USD 149 mill. The delivered cost includes contract price with the yard, site supervision, pipe handling equipment, spare parts and finance costs during construction. Awilco Offshore has one remaining option for the construction of one further semi submersible drilling rig at Yantai Raffles Shipyard in China. Oslo, 1 March 2007 For further information, please contact: Sigurd E. Thorvildsen, Chairman (+47 977 42121) Henrik Fougner, Managing Director (+47 906 88608) Awilco Offshore has invested in eight jack-up drilling rigs (of which six are under construction), three semi submersible drilling rigs under construction and two accommodation units in operation. The company also holds one option for the construction of one further semi submersible drilling rig.


 

Espoo, Finland - Nokia, the world leader in mobile communications, and Glu Mobile, a leading global publisher of mobile games, announced today that Glu will be publishing a selection of mobile games and content on the N-Gage platform. Glu's portfolio of top-rated games includes original titles like Super K.O. Boxing!, Stranded and the Ancient Empires franchise, as well as titles based on major brands from Atari, Harrah's, Hasbro, Microsoft, PlayFirst, PopCap Games and Sony. "Glu Mobile is one of the driving forces in the mobile gaming industry and we're excited to be working with them to bring premium mobile game experiences to our N-Gage platform," said Gregg Sauter, Director, Games Publishing, Nokia. "Glu's reputation and experience in creating compelling mobile games makes them a natural fit for the N-Gage platform." "We're excited to be part of Nokia's mobile gaming efforts, and are impressed with the offering that Nokia has brought together with its new N-Gage Platform," said Kristian Segerstråle, Managing Director, EMEA, Glu Mobile. "The combination of Nokia's hardware and mobile platform vision and expertise along with Glu's top-rated, quality mobile games will deliver consumers a truly unique immersive entertainment experience." The first Glu title currently planned for the platform is World Series of Poker® Texas Hold'em (WSOP), which allows players to compete at tables with up to eight mobile gamers against WSOP champions such as Chris "Jesus" Ferguson and Scott Fischman. World Series of Poker Texas Hold'em is among the portfolio of games, applications and wallpapers that Glu is developing and publishing based on a multi-year, worldwide alliance with Harrah's License Company, LLC, an affiliate of Harrah's Entertainment, Inc. (NYSE: HET). About N-Gage Nokia is an innovator in mobile, interactive entertainment and is re-defining the mobile gaming experience. Starting in 2007, Nokia's N-Gage platform will allow consumers around the world to easily find, buy, play and manage premium quality mobile games on upcoming Nokia Nseries multimedia computers and other Nokia S60 devices. N-Gage offers a global games platform that includes community features that allow users to easily interact with friends and share gaming experiences - anytime, from anywhere Nokia is working with the world's leading publishers to deliver a broad portfolio of exciting, high quality games. www.n-gage.com About Nokia Nokia is a world leader in mobile communications, driving the growth and sustainability of the broader mobility industry. Nokia connects people to each other and the information that matters to them with easy-to-use and innovative products like mobile phones, devices and solutions for imaging, games, media and businesses. Nokia provides equipment, solutions and services for network operators and corporations. About Glu Mobile Glu is a leading global publisher of mobile games. Its portfolio of top-rated games includes original titles Super K.O. Boxing!, Stranded and the Ancient Empires franchise, and titles based on major brands from Atari, Harrah's, Hasbro, Microsoft, PlayFirst, PopCap Games, SEGA and Sony. Founded in 2001, Glu is based in San Mateo, California and has offices in London, Hong Kong, France, Germany and Brazil. Consumers can find high quality, fresh entertainment created exclusively for their mobile phones wherever they see the 'g' character logo or at www.glu.com. GLU MOBILE, GLU, and the 'g' character logo are trademarks of Glu Mobile. All other names and trademarks are trademarks or registered trademarks of their respective owners. Media Enquiries: Nokia, Multimedia Communications Tel. +358 7180 45667 Nokia Communications Tel. +358 7180 34900 Email: press.office@nokia.com Glu Mobile Kathy de Leon 650.532.2421 Kathy.deleon@glu.com Glu Mobile EMEA Asam Ahmad +44 20 3100 1174 asam.ahmad@glu.com www.nokia.com --- End of Message --- ISIN: FI0009000681; Index: DJ STOXX Large 200, DJ STOXX 50; Listed: Nordic list (Large Cap) in THE HELSINKI STOCK EXCHANGE;


 

PHOENIX, March 1, 2007 (PRIME NEWSWIRE) -- First Solar, Inc. (Nasdaq:FSLR) announced today that Bruce Sohn has joined the Company as President. Mr. Sohn was formerly a senior executive at Intel Corporation and has served on the Board of Directors of First Solar since 2003. He will report to Mike Ahearn, Chief Executive Officer of First Solar. "Bruce's extensive experience managing large organizations, growing operations and replicating factories will significantly strengthen our team," said Michael Ahearn, Chief Executive Officer. "We have benefited greatly from Bruce's advice and guidance as a board member and we are honored that he has accepted our offer to increase his role by joining First Solar." During his 24 years at Intel, Mr. Sohn played a leadership role in developing and manufacturing leading-edge semiconductor technology. He served as an integral part of the start-up team at five fabs, acted as program manager for Intel's conversion to 300mm wafers, and managed two of Intel's largest fabs. Mr. Sohn is a Materials Science and Engineering graduate from the Massachusetts Institute of Technology, a senior member of the IEEE and a certified Jonah. He has been a guest lecturer at MIT, Stanford and other universities. About First Solar First Solar, Inc. (Nasdaq:FSLR) manufactures solar modules with an advanced thin film semiconductor process that significantly lowers solar electricity costs. By enabling clean renewable electricity at affordable prices, First Solar provides an economic alternative to peak conventional electricity and the related fossil fuel dependence, greenhouse gas emissions and peak time grid constraints. The First Solar, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=3052 For First Solar Investors This release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934. The forward-looking statements in this release do not constitute guarantees of future performance. Those statements involve a number of factors that could cause actual results to differ materially, including risks associated with the company's business involving the company's products, their development and distribution, economic and competitive factors and the company's key strategic relationships and other risks detailed in the company's filings with the Securities and Exchange Commission. First Solar assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein. CONTACT: First Solar, Inc. For media inquiries, contact: Paula Vaughnn +1 (602) 414-9322 pvaughnn@firstsolar.com Edelman Justine Troy +1 (212) 704-8280 jtroy@ar-edelman.com


 

WALTHAM, MA- - March 1, 2007--OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a clinical-stage biotechnology company developing novel therapeutics to treat cancer and eye diseases, today announced that John A. Kollins has joined the Company as Senior Vice President and Chief Business Officer. Mr. Kollins brings with him a proven track record of completing major in-licensing and out-licensing transactions. As Chief Business Officer for OXiGENE, Mr. Kollins will be responsible for all business development activities as well as commercial strategy for OXiGENE. "We are thrilled to have John join us," commented Richard Chin, President and Chief Executive Officer for OXiGENE. "We believe that, by hiring someone of his experience and talent, OXiGENE will be able to capitalize on the growing interest among potential partners in OXiGENE's drug candidates." "I'm looking forward to joining the talented team at OXiGENE during an exciting time in the company's evolution. Having had the opportunity as an investor to broadly survey the biopharmaceutical landscape, I am particularly impressed by OXiGENE and its prospects for continued success," said Mr. Kollins. Mr. Kollins has nearly 20 years of pharmaceutical and biotechnology industry experience, specifically in strategic marketing, new product development and business development. He also has significant experience working with investors, and most recently served as an independent consultant to a healthcare-focused investment fund, as well as several public and private biopharmaceutical companies. In his extensive career, he has been particularly successful in establishing collaborative and productive R & D partnerships. He started his career as a Product Manager with Immunex and held roles in marketing and business development at Elan Pharmaceuticals, Inc. He previously held positions as Chief Business Officer at CovX (San Diego, CA), Vice President, Business Development at Renovis, Inc. (South San Francisco, CA) and SurroMed, Inc. (Mountain View, California). He successfully developed and implemented business development strategies at each of these companies. Mr. Kollins graduated from Duke University with a B.S.E. (Mechanical Engineering and Materials Science) degree and earned his MBA at the University of Virginia's Darden Graduate School of Business. About OXiGENE, Inc. OXiGENE is a biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases. The Company's major focus is the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property position and therapeutic development expertise to bring life saving and enhancing medicines to patients. Safe Harbor Statement This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the future clinical development of the Company's clinical-stage product candidates under development, CA4P and OXi4503. Any or all of the forward-looking statements in this press release may turn out to be wrong. Forward-looking statements can be affected by inaccurate assumptions OXiGENE might make or by known or unknown risks and uncertainties. Additional information concerning factors that could cause actual results to materially differ from those in the forward-looking statements is contained in OXiGENE's reports to the Securities and Exchange Commission, including OXiGENE's Form 10-Q, 8-K and 10-K reports. However, OXiGENE undertakes no obligation to publicly update forward-looking statements, whether because of new information, future events or otherwise. Please refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2005 for a description of these risks. CONTACT: OXiGENE, Inc. Investor Relations 781-547-5900 SOURCE: OXiGENE, Inc.


 

Rotterdam, 1 March 2007 PRESS RELEASE Robeco increases its stake in Transtrend to 100% Robeco has increased its stake in the Rotterdam-based managed futures trader Transtrend to 100%. Robeco took a 49% stake in January 2002. Since then, assets under management have grown from EUR 290 million to EUR 2.8 billion. In recent years, Transtrend's Diversified Trend Program ('DTP') has once again shown attractive results. Transtrend's largest investment scheme, Transtrend DTP's Enhanced Risk (USD) subset, realized results of 12.8%, 6.0% and 12.0% in 2004, 2005 and 2006 respectively, while the average annual return since inception in 1995 amounts to 18.0% with a maximum intermediate drawdown (on month-end basis) of 9.4%. Robeco CEO George Möller: "The past years have been better than we could have hoped for at the outset. Robeco's distributive power combined with Transtrend's ever-powerful engine has led to spectacular growth." Most of the assets under management are managed in Transtrend's Luxembourg-based funds. The Robeco Multi Market bonds, structured by Robeco on the basis of Transtrend's DTP, have turned out to be a success. These bonds are primarily aimed at retail clients who combine the attractive results of Transtrend's DTP with principal protection and a relatively low entry amount. In connection with its total takeover, founder Gerard van Vliet will leave Transtrend as managing director and shareholder. Gerard van Vliet: "Twenty years after inventing Transtrend as a project, it has grown into something bigger than I could ever have dreamed of. The secret of Transtrend's success is the ability to form and maintain a talented and motivated team, combining this with clear focus and keen philosophy: to generate investment results in an intelligent and systematic manner on the basis of trend-related market movements. I have nothing more to add to this now; I will leave that to the next generation. The management board that succeeds me has worked at my side for many years and has played a decisive role in Transtrend's successful development. I look forward to following their continued success in the future." About Robeco Robeco provides discretionary asset-management products and services, as well as a complete range of mutual funds to a large number of institutional and retail clients worldwide. Robeco's product range encompasses fixed-income and equity investments, as well as balanced accounts, money-market funds and alternative investments. Robeco distributes its funds for the retail market directly, and through other financial institutions. Several of its mutual funds, including the flagship Robeco N.V., are listed on major European stock exchanges such as Amsterdam, Paris, Frankfurt and London. Robeco services its clients not only from its head office in Rotterdam but also from its European offices in Belgium, France, Germany, Spain and Switzerland. In the United States, Robeco has offices in New York, Boston, Greenbrae, Los Angeles, Honolulu en Toledo (Harbor Capital Advisors). Robeco also has an office in Bahrain and an office in Japan. Robeco is the center for asset management within the Rabobank Group and has full operational independence. The combination of the highest credit ratings from the major international rating agencies and the highest Sustainability Cluster Score within the banking sector reflects the high added value Rabobank has always offered its investors, members, clients and employees. Ronald Florisson, Robeco Corporate Communications Office: +31 - 10 - 224 28 10 Mobile: +31 - 6 - 53,831,586 E-mail: ronald.florisson@robeco.nl


 

Press Release HUGO BOSS AG recommends dividend increase for fiscal 2006 Metzingen, March 1, 2007. Based on the success achieved in fiscal 2006 and positive expectations regarding the Company's continuing performance, the Supervisory Board and Managing Board of HUGO BOSS AG will propose to the Annual Shareholders' Meeting to raise the dividend by 19 cents to EUR 1.19 (2005: EUR 1.00) per common share and EUR 1.20 (2005: EUR 1.01) per preferred share. At today's meeting the Supervisory Board accepted the financial statements of HUGO BOSS AG and deemed approved the consolidated financial statements of the HUGO BOSS Group established by the Managing Board as of December 31, 2006. The financial statements report an increase in sales of 14% for the fashion group (currency adjusted: also 14%), from EUR 1,309 million to EUR 1,496 million. Earnings before taxes rose by 14% to EUR 180 million (2005: EUR 157 million), and net income by 19% to EUR 129 million (2005: 108 million). Further information on HUGO BOSS AG can be found on our website at www.group.hugoboss.com. If you have any questions, please contact: Philipp Wolff Director of Communication Phone: +49 (0) 7123 94-2375 Fax: +49 (0) 7123 94-2051 Christoph Löhrke Head of Investor Relations Phone: +49 (0) 7123 94-2552 Fax: +49 (0) 7123 94-2035


 

(Holzminden/Frankfurt) Symrise AG has today completed and signed lenders into ¤800 million of syndicated credit facilities. The transaction was arranged and underwritten in the context of the IPO of Symrise by Barclays Capital, the investment banking division of Barclays Bank PLC, and Commerzbank Aktiengesellschaft, acting as Mandated Lead Arrangers and Bookrunners. Syndication was launched in January 2007 and attracted strong support from major domestic and international banks, resulting in a significant oversubscription and an exceptionally low decline rate. The 5-year facilities are split between a ¤500 million term loan and a ¤300 million revolving facility, to refinance existing debt and for general corporate purposes. The margin is set at 60 basis points p.a. over EURIBOR, tied to a leverage grid. Two levels of participation were offered in syndication - Arrangers at ¤60 million and Co-Arrangers at ¤40 million. www.symrise.com Press inquiries: red roses communications Kirchhoff Consult AG Katja Derow Dr Kay Baden Tel. +49 (0) 40 46 96 77 0 10 Tel. +49 (0) 40 60 91 86 50 --- End of Message --- WKN: SYM999; ISIN: DE000SYM9999; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Prime Standard in Frankfurter Wertpapierbörse;


 

TORONTO, ONTARIO -- (MARKET WIRE) -- March 01, 2007 -- Nortel (TSX: NT)(NYSE: NT) - NORTEL FINANCIAL UPDATE 8:30 a.m. Eastern Time Thursday, March 1, 2007 What: Nortel will host a teleconference/audio webcast with the media and investment community to provide a financial update and a brief Q&A. Who: - Mike Zafirovski, President and CEO, Nortel - Peter Currie, Executive Vice President and CFO, Nortel - Terry Glofcheskie, Vice President, Investor Relations, Nortel - Ronald Alepian, Vice President, Corporate Communications, Nortel When: 8:30 a.m. ET, Thursday, March 1, 2007 Where: To participate in the audio teleconference and Q&A, please call - 1-888-211-4395 (North America ONLY) - 1-416-641-6444 (International) To take part in the audio Webcast, please visit - http://www.nortel.com/corporate/pressroom/events/050107/index.html Please dial in at least 15 minutes prior to the start of the event. What you'll need: What You Need To "Attend" the audio Webcast - - A Pentium PC P133 or faster - Sound card with speakers or headphones - 28.8 Kbps modem or higher - RealPlayer G2 required, available at www.real.com Replay: A replay of the audioconference will be available at 10:30 a.m. ET. at: North America 1-800-383-0935 International 1-402-530-5545 Passcode: 21331817# Audio webcast replay: http://www.nortel.com/corporate/pressroom/events/050107/index.html Contacts: Nortel Investor Relations 1-888-901-7286 or (905) 863-6049 Email: investor@nortel.com Nortel Ann Fuller Media Relations (613) 768-1208 Email: afuller@nortel.com Website: www.nortel.com SOURCE: Nortel


 

- Financial restatements principally due to third party actuarial calculation errors originating prior to 2000 on liabilities for employee benefit plans and timing errors on the recognition of revenue - Preliminary unaudited Q4 2006 results announced on February 7th are not materially impacted by the restatement: -- Q4 revenues at $3.32 billion, up 10.2% and 8.9% for full-year 2006 -- Q4 Gross margin slightly above 40% -- Year-end cash of $3.50 billion, up $900 million fro TORONTO, ONTARIO -- (MARKET WIRE) -- March 01, 2007 -- Nortel Networks(1) Corporation (TSX: NT)(NYSE: NT) today announced that it is delaying the filing with the U.S. Securities and Exchange Commission ("SEC") of its annual report on Form 10-K for the year ended December 31, 2006 (the "2006 Form 10-K") and its corresponding filings under Canadian securities laws. All dollar amounts in this press release are in U.S. dollars. The Company has identified certain errors primarily through discussions with Nortel's North American pension and post-retirement plan actuaries and through Nortel's ongoing remediation efforts with respect to its previously reported internal control deficiencies. As a result, Nortel and its principal operating subsidiary Nortel Networks Limited ("NNL") will restate their financial results for 2004, 2005 and the first nine months of 2006, and will make adjustments to periods prior to 2004. "This restatement has no material impact to our fourth quarter 2006 operating expectations or performance. During 2006, we have implemented significant remedial measures and other actions to address our internal control weaknesses. This has resulted in a substantial reduction of control weaknesses as at year end and represents a major milestone in our journey toward consistent, reliable and timely financial reporting," said Peter Currie, Nortel executive vice president and CFO. "We will conclude the restatement and complete our regulatory filings within the timely filer period." "Nortel made tremendous progress advancing its business transformation plan in 2006, and today's announcement does not slow our progress or divert our focus," said Mike Zafirovski, Nortel president and CEO. "Our expected fourth quarter results show measurable operating and financial improvements. We are a stronger, more competitive company today and we will continue to drive our progress into 2007 and beyond." The restatement will primarily correct third party actuarial calculation errors embedded in Nortel's North American pension and post-retirement plans and revenue incorrectly recognized in prior periods that should have been deferred to later periods. These matters have been fully discussed with the Staff of the SEC including as part of the Company's responses to Staff comments on Nortel's periodic filings with the SEC. The Company currently expects revisions to its previously reported 2006 nine month results resulting in increases in revenues and improvements in net earnings of approximately $24 million and $15 million, respectively, as well as revisions to its previously reported 2005 and 2004 financial results reflecting reductions in revenue of approximately $28 million and $33 million and increases in net loss of approximately $87 million and $42 million, respectively. With respect to financial results prior to 2004, the Company currently expects revisions reflecting negative impacts on revenue of approximately $27 million and negative impacts on net earnings of approximately $5 million, in the aggregate. The Company expects to file its and NNL's 2006 Form 10-K by no later than March 16, 2007. The Company will therefore file with the SEC a Form 12b-25 Notification of Late Filing relating to the delay in filing its 2006 Form 10-K and indicating that the filings will be made within the permitted 15-day period. The Company has notified the New York Stock Exchange and the Toronto Stock Exchange of the delay in filing the 2006 Form 10-Ks. The Company expects to report and host an investor call on its operating and financial performance for the fourth quarter and full year 2006 in conjunction with the filing of its 2006 Form 10-K. Updated Preliminary Results for Fourth Quarter Operating Performance Fourth quarter 2006 revenues are expected to be approximately $3.32 billion, up 10.2 percent from $3.01 billion for the same period in 2005. Gross margin in the quarter is expected to be at slightly above 40% of revenue, with a strong contribution from the LG joint-venture and CDMA, up from 38.8% in the fourth quarter of 2005. Spending (SG&A and R&D) for the fourth quarter of 2006 is expected to be approximately $1.18 billion. Cash as at December 31, 2006 was approximately $3.50 billion, up about $900 million from September 30, 2006. This includes approximately $300 million of gross proceeds from the sale of certain assets and liabilities of the UMTS Access business to Alcatel-Lucent. The results set forth in this press release, including expected restatement impacts, are preliminary and unaudited and reflect known restatement adjustments. These results are subject to change as a result of any adjustments arising from the restatement process, subsequent events and the completion of the audit of the financial statements by Nortel's independent auditors. Internal Controls As noted above, many of the errors that are being corrected have come to light as a result of management having implemented remedial measures and other actions to significantly improve Nortel's internal control over financial reporting, which Nortel believes individually and in the aggregate have addressed most of the internal control issues with respect to the previously reported five material weaknesses. As at December 31, 2006, Nortel expects to eliminate the majority of these five material weaknesses, although it continues to have a material weakness in the area of revenue recognition. Restatement As a result of the previously announced pension plan changes, third party actuarial firms retained by the Company performed re-measurements of the U.S. and Canadian pension and post-retirement plans in the third quarter of 2006, at which time one of these firms discovered potential errors (generally originating in the late 1990s) in the historical actuarial calculations they had originally performed on the U.S. pension plan assets. Throughout the fourth quarter of 2006 and into 2007, the Company investigated these potential errors, including a review by the Company and its third party actuaries of each of the Company's significant pension and post-retirement benefit plans. As a result of this review, the Company determined that it had understated its historical pension expense with respect to the U.S. and Canadian plans by approximately $104 million across several years and currently expects a negative impact to its previously reported 2006 nine months pension expense and net earnings of approximately $18 million and revisions to its previously reported financial results for 2005 and 2004 reflecting an increased pension expense and increases in net loss of approximately $48 million and $40 million, respectively. For periods prior to 2004, these errors are expected to positively impact pension expense and net earnings by approximately $2 million, in the aggregate. As a result of the significant ongoing remedial efforts to address Nortel's internal control material weaknesses and other deficiencies, the Company also expects to correct for additional, individually immaterial errors identified throughout 2006. These errors related mainly to revenue recognition errors with revenue having generally been recognized prematurely in prior years when it should have been deferred and recognized in later periods. The Company expects revisions to its previously reported 2006 nine months results reflecting positive impacts on revenue of approximately $24 million and a reduction of net loss of approximately $33 million, and revisions to its previously reported 2005 and 2004 financial results reflecting negative impacts on revenue of approximately $28 million and $33 million, and on net loss of approximately $39 and $2, respectively. For periods prior to 2004, these errors are expected to negatively impact revenue by approximately $27 million and net earnings by approximately $7 million, each in the aggregate. Restatement Impact As a result of the breach or anticipated breach of certain provisions of NNL's US$750 million support facility (the "Support Facility") with Export Development Canada ("EDC") related to the required restatement by NNL of certain of its prior period results, absent a waiver, EDC will have the right to refuse to issue additional support and to terminate its commitments under the Support Facility, subject to a 30 day cure period with respect to certain provisions. As at February 28, 2007, there was approximately $144 million of outstanding support under the Support Facility. NNL will request a waiver from EDC to permit continued access to the Support Facility. There can be no assurance that NNL will receive such a waiver. As noted above, the Company expects to file its and NNL's 2006 Form 10-Ks within the cure period. As the Company expects to file its 2006 Form 10-K within the 15-day period permitted by Rule 12b-25, and NNL expects to file its 2006 Form 10-K by the applicable March 31, 2007 deadline, it is anticipated that the delay announced today will not result in a breach or anticipated breach of provisions with respect to Nortel's outstanding indebtedness and related indentures. Further, the delay does not impact upon the previously announced timing of the Company's Annual Shareholders' Meeting scheduled for May 2, 2007. About Nortel Nortel is a recognized leader in delivering communications capabilities that make the promise of Business Made Simple a reality for our customers. Our next-generation technologies, for both service provider and enterprise networks, support multimedia and business-critical applications. Nortel's technologies are designed to help eliminate today's barriers to efficiency, speed and performance by simplifying networks and connecting people to the information they need, when they need it. Nortel does business in more than 150 countries around the world. For more information, visit Nortel on the Web at www.nortel.com. For the latest Nortel news, visit www.nortel.com/news. Certain statements in this press release may contain words such as "could", "expects", "may", "anticipates", "believes", "intends", "estimates", "targets", "envisions", "seeks" and other similar language and are considered forward-looking statements or information under applicable securities legislation. These statements are based on Nortel's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which Nortel operates. These statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and the actual outcome may be materially different. Further, actual results or events could differ materially from those contemplated in forward-looking statements as a result of the following: (i) risks and uncertainties relating to Nortel's business including: significant competition, competitive pricing practice, cautious capital spending by customers, industry consolidation, rapidly changing technologies, evolving industry standards, frequent new product introductions and short product life cycles, and other trends and industry characteristics affecting the telecommunications industry; any material, adverse affects on Nortel's performance if its expectations regarding market demand for particular products prove to be wrong; the sufficiency of recently announced restructuring actions; any negative developments associated with Nortel's suppliers and contract manufacturing agreements including our reliance on certain suppliers for key optical networking solutions components; potential penalties, damages or cancelled customer contracts from failure to meet delivery and installation deadlines and any defects or errors in Nortel's current or planned products; fluctuations in foreign currency exchange rates; potential higher operational and financial risks associated with Nortel's efforts to expand internationally; potential additional valuation allowances for all or a portion of Nortel's deferred tax assets if market conditions deteriorate or future results of operations are less than expected; a failure to protect Nortel's intellectual property rights, or any adverse judgments or settlements arising out of disputes regarding intellectual property; any negative effect of a failure to maintain integrity of Nortel's information systems; changes in regulation of the telecommunications industry or other aspects of the industry; any failure to successfully operate or integrate strategic acquisitions, or failure to consummate or succeed with strategic alliances; Nortel's potential inability to attract or retain the personnel necessary to achieve its business objectives or to maintain an effective risk management strategy; (ii) risks and uncertainties relating to Nortel's liquidity, financing arrangements and capital including: any inability of Nortel to manage cash flow fluctuations to fund working capital requirements or achieve its business objectives in a timely manner or obtain additional sources of funding; high levels of debt, limitations on Nortel capitalizing on business opportunities because of covenants in outstanding indebtedness, or on obtaining additional secured debt pursuant to the provisions of indentures governing certain of Nortel's debt issues; Nortel's below investment grade credit rating; any increase of restricted cash requirements for Nortel if it is unable to secure alternative support for obligations arising from certain normal course business activities, or any inability of Nortel's subsidiaries to provide it with sufficient funding; any negative effect to Nortel of the need to make larger defined benefit plans contributions in the future; exposure to customer credit risks or inability of customers to fulfill payment obligations under customer financing arrangements; or any negative impact on Nortel's ability to make future acquisitions, raise capital, issue debt and retain employees arising from stock price volatility and any declines in the market price of Nortel's publicly traded securities; and (iii) risks and uncertainties relating to Nortel's prior restatements and current restatement and related matters including: the negative impact on Nortel and NNL of their announced restatement in this press release; legal judgments, fines, penalties or settlements, or any substantial regulatory fines or other penalties or sanctions, related to the ongoing regulatory and criminal investigations of Nortel in the U.S. and Canada; the significant dilution of Nortel's outstanding equity capitalization resulting from the approval of its class action settlement; any significant pending or future civil litigation actions not encompassed by Nortel's class action settlement; any unsuccessful remediation of Nortel's material weaknesses in internal control over financial reporting resulting in an inability to report Nortel's results of operations and financial condition accurately and in a timely manner; Nortel's inability to access, in its current form, its shelf registration filed with the United States Securities and Exchange Commission (SEC); or any breach by Nortel of the continued listing requirements of the NYSE or TSX causing the NYSE and/or the TSX to commence suspension or delisting procedures. For additional information with respect to certain of these and other factors, see Nortel's Annual Report on Form10-K and other securities filings with the SEC. Unless otherwise required by applicable securities laws, Nortel disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. (1)Nortel, the Nortel logo and the Globemark are trademarks of Nortel Networks. Nortel will host a teleconference/audio webcast to provide more details on this announcement. TIME: 8:30 AM ET on Thursday, March 1, 2007. To participate, please call the following at least 15 minutes prior to the start of the event. Teleconference: North America: 1-888-211-4395 International: 1-416-641-6444 Webcast: http://www.nortel.com/corporate/pressroom/events/050107/index.html Replay: (Available one hour after the conference) North America: 1-800-383-0935 International: 1-402-530-5545 Passcode: 21331817# Webcast: http://www.nortel.com/corporate/pressroom/events/050107/index.html Contacts: Nortel Ann Fuller Media (613) 298-2883 Email: afuller@nortel.com Nortel Investors 1-888-901-7286 or (905) 863-6049 Email: investor@nortel.com Website: www.nortel.com SOURCE: Nortel


 

Summary: The board of directors in Pharmexa A/S has today approved the audited financial report for the financial year 2006. The report shows a loss of DKK 169.1 million which is in accordance with the company's latest published expectations.


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | AXA Investment Managers UK | | | Limited | |--------------------------------------+----------------------------| | Company dealt in | RHM Plc | |--------------------------------------+----------------------------| | Class of relevant security to which | Ordinary shares | | the dealings being disclosed relate | | | (Note 2) | | |--------------------------------------+----------------------------| | Date of dealing | 28/02/07 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------------------------------+ | | Long | Short | | | | | |---------------+--------------------------+------------------------------------------------| | |Number |Number | | | (%) | (%) | |---------------+--------------------------+------------------------------------------------| |(1) Relevant |6,851,358 (1.97%) | | |securities | | | | | | | |---------------+--------------------------+------------------------------------------------| |(2) Derivatives| | | |(other than | | | |options) | | | | | | | |---------------+--------------------------+------------------------------------------------| |(3) Options and| | | |agreements to | | | |purchase/sell | | | | | | | |---------------+--------------------------+------------------------------------------------| |Total |6,851,358 (1.97%) | | | | | | +-------------------------------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +--------------------------------------------------------------------------+ |Class of | Long | Short | |relevant | | | |security: | | | | | | | |---------------+----------------------------+-----------------------------| | |Number |Number | | | (%) | (%) | |---------------+----------------------------+-----------------------------| |(1) Relevant | | | |securities | | | | | | | |---------------+----------------------------+-----------------------------| |(2) Derivatives| | | |(other than | | | |options) | | | | | | | |---------------+----------------------------+-----------------------------| |(3) Options and| | | |agreements to | | | |purchase/sell | | | | | | | |---------------+----------------------------+-----------------------------| |Total | | | | | | | +--------------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | SOLD | 150,000 | 3.90p | | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short (Note | Number of securities | Price per | | name, | 6) | (Note 7) | unit (Note | | e.g. CFD | | | 5) | |----------+------------------+------------------------+------------| | | | | | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 01/03/07 | |---------------------------------------------------+---------------| | Contact name | Jetin Vithal | |---------------------------------------------------+---------------| | Telephone number | 0207 003 2813 | |---------------------------------------------------+---------------| | If a connected EFM, name of offeree/offeror with | N/A | | which connected | | |---------------------------------------------------+---------------| | If a connected EFM, state nature of connection | N/A | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

AMERICAN MARKETS OUTLOOK: U.S. stock markets are expected to open higher Thursday, buoyed by Federal Reserve Chairman Ben Bernankes comments on the state of the economy. Bernanke said Wednesday that the Federal Reserve was monitoring market developments but had seen nothing that would cause it to change its positive outlook. The comments calmed investors nerves following one of the worst Wall Street trading sessions in years Tuesday and boosted U.S. equity futures, says CMC Markets Geoff Langham. CMC Markets is calling the Dow Jones Industrial Average to open up 17 points at 12,285, the Nasdaq 100 up six points at 1767 and the S&P 500 up 2.6 points at 1409.4. Data for release include January personal income and spending, the February ISM manufacturing index, January construction spending and February auto sales. EUROPEAN MARKETS: European shares are mostly higher. In London, the FTSE 100 is up 0.8% at 6218.20, showing little reaction to a jump in U.K. PMI manufacturing. In Frankfurt, the DAX is up 0.1% at 6725, with Deutsche Telekom down and Merck up, both following the release of results. In Paris, the CAC is up 0.4% at 5536.12. Bunds are lower, losing their "safe-haven" appeal after European equity markets posted small gains. The March bund future is down 0.07 at 116.14. Gilts are down on the jump in U.K. PMI, with the June gilt down 0.15 at 109.13. The dollar is mixed around midday and the yen is higher as the market waits to see if fresh losses in Chinese and Japanese stock markets will push the U.S. market lower as well. The dollar is down at Y118.15. The euro is down at $1.3224 and the pound is down at $1.9626. =========================== TOP STORIES: DEUTSCHE TELEKOM SWINGS TO 4Q NET LOSS ON JOB CUTS CHARGE: Deutsche Telekom (DT) swung to an unexpected net loss of EUR898 million in the fourth-quarter as it decided to book most of the costs for shedding 32,000 jobs in the quarter. (By Joon Knapen) SWISS RE 2006 NET NEARLY DOUBLES: Swiss Reinsurance Co. (RUKN.VX) said 2006 full-year net profit nearly doubled and said it would buy back shares worth up to CHF6 billion over the next three years. (By Goran Mujik) EU THREATENS NEW FINES AGAINST MICROSOFT: The European Union threatened Microsoft Corp. (MSFT) with new fines, saying the software giant had failed to live up to legal promises to provide competitors with updated, complete and reasonably priced information on work-group servers. (AP) BAT SHARES JUMP ON PROFIT NEWS: British American Tobacco PLC (BTI) posted a 7.3% rise in full-year net profit and said it would significantly increase both its annual dividend and its share buyback program after a review of its capital structure. (By Michael Carolan) ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: Carry trades may well return but they are unlikely to resume as before. (By Nicholas Hastings) =FOCUS: Converium Holding AGs (CHR) crucial ratings upgrade late Wednesday by Standard & Poors gives the Swiss reinsurer more ammunition to fend off the hostile bid launched by French competitor Scor SA (SCO) and may help it remain independent, analysts said. (By Goran Mijuk) =CHARTING EUROPE: This column achieved a 77.5% correct forecast rate in January, starting the year on a positive note, especially on forecasts for ICE Brent crude futures which could have netted a $5.85 gain. (By Axel Rudolph) =ASSET CLASS: The bad economic news coming out of the U.S. is building momentum. (By Alen Mattich) =========================== STILL TO COME ET/GMT COUNTRY/PERIOD 0730/1230 US Feb Challenger Layoffs Survey 0830/1330 US Jan Personal Income 0830/1330 US Jan Personal Spending 0830/1330 US Feb 24 Jobless Claims 1000/1500 US Feb 17 DJ-BTMU Business Barometer 1000/1500 US Feb ISM Mfg Index 1000/1500 US Jan Construction Spending 1030/1530 US Feb 23 US Energy Dept Natural Gas Stocks 1100/1600 UK Feb JPMorgan Global PMI Manufacturing 1200/1700 US Tsy Secy Paulson speaks in Washington 1630/2130 US Money Supply N/A US Feb Auto Sales =========================== OTHER NEWS: Consumer-price inflation in the euro zone was stable at 1.8% in February, broadly in line with the European Central Banks target of price stability, preliminary data from the European Unions statistics office showed. (By Nina Koeppen) Euro-zone manufacturing output and price levels continued rising at a relatively brisk pace in February, contrasting with slowing growth elsewhere in the world.(By Paul Hannon) Telefonica SA (TEF) posted a 12.2% decrease in fourth-quarter net profit, as it consolidated recent acquisitions, but gave no update on the timing of its much-anticipated sale of Endemol, in which it owns 75%. (By Jason Sinclair) Aviva PLC (AV.LN), the U.K.s largest insurance group by market capitalization, said that its worldwide operating profit rose 12% for 2006 on profitable growth in long-term savings and life insurance. (By Victoria Howley) The purchasing managers index for the U.K. manufacturing sector rose to 55.4 in February from 53.2 in January, market sources said, indicating activity in the sector grew at a significantly more rapid pace than had been expected. (By Paul Hannon) Spirent Communications PLC (SPM) posted a wider full-year pretax loss and said markets continued to be highly competitive, sending its shares sharply lower at open. (By Peter Stiff) Gestevision Telecinco SA (TL5.MC) posted an 8.2% rise in 2006 net profit, as it maintained its pace as Spains top television broadcaster, despite new competition from startup rivals. (By Christopher Bjork) InBev (INB.BT), the worlds biggest brewer by volume, more than doubled fourth-quarter profits after surging demand for beer in emerging markets such as Brazil and Russia. (By Carolyn Henson) Swiss industrial company Sulzer AG (SUN.EB) reported a 73% increase in 2006 net profit and a rise in the dividend, and added it sees continued good business this year. (By Martin Gelnar) Abertis Infraestructuras SA (ABE.MC) said its full-year net profit rose 4%, bolstered by the consolidation of recently acquired assets. (By Santiago Perez) National Express Group (NEX.LN) reported a 15% rise in underlying pretax profit, partly boosted by its Spanish coach and bus business, Alsa. (By Emma Charlton and Rod Stone) U.K. Newspaper group Trinity Mirror PLC (TNI.LN) reported a 4.8% decline in adjusted full year revenues and said it expected to dispose of titles in the second and third quarters. (By Daniel Thomas) Royal Bank of Scotland Group PLC (RBS.LN) reported a 14% rise in full-year 2006 underlying pretax profit, spurred by double-digit contributions from corporate markets and in global banking and markets. (By Henry Teitelbaum) PartyGaming PLC (PRTY.LN) reported a 5.7% fall in annual underlying profit, hit by the worlds biggest online gambling groups exit from the lucrative U.S. market in October after the government shut down the industry. (By Lilly Vitorovich)


 

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------------+--------------------| | Company dealt in | Wilson Bowden Plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |----------------------------------------------+--------------------| | Date of dealing | 28th February 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 1602 | 2,168p | 2,168p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 4602 | 2,169p | 2,168p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +------------------------------------------------------------------+ | Date of disclosure | 1st March 2007 | |----------------------------------------------+-------------------| | Contact name | Seema Soni | |----------------------------------------------+-------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+-------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+-------------------| | Nature of connection (Note 6) | Connected Advisor | +------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Third Advance Value Realisation Company announces that its top ten holdings as at 28th February 2007 were as follows:- UK Treasury Bills Scapa Group Plc Dawson International Plc Zotefoams Plc Harvey Nash Group Plc Sondex plc Bioquell Plc Phoenix IT Grp Quantica Plc Financial Objects Plc No other assets which represented more than 5% of gross assets were held on 28th February 2007. ---END OF MESSAGE---


 

Ericsson (NASDAQ:ERIC) has delivered a new GSM/GPRS access network to Telefónica Móviles' subsidiary, Movistar, the leading mobile operator in Perú, with more than 5 millions suscribers. As part of the agreement signed between both companies, Ericsson has provided the nationwide infrastructure to allow the GSM/GPRS radio access network as well as a complete range of services, such as service administration, planning and optimization of the network, among others. Cesar Linares, CEO of Movistar Perú, says: "With this new network provided by Ericsson, Movistar fulfilled one of its principal goals for the present year, which is to extend its coverage in provinces and to continue giving the first quality services to its current and future clients, with the best quality in communication services ". Enrique Norero, President, Ericsson Perú, says: "We are very proud to support Movistar in driving the development of telecommunications in Perú, by delivering solutions that promote the communication and the adoption of innovative mobile services in the country". Ericsson is shaping the future of Mobile and Broadband Internet communications through its continuous technology leadership. Providing innovative solutions in more than 140 countries, Ericsson is helping to create the most powerful communication companies in the world. Read more at www.ericsson.com FURTHER INFORMATION, PLEASE CONTACT Ericsson Media Relations Phone: +46 8 719 6992 E-mail: press.relations@ericsson.com About Movistar Perú Movistar Perú is the trademark of mobile phone service of Telefonica's Group in Perú, and has the leadership of this market with around 5 million subscribers. In February 2006, it developed its first GSM services in 24 departments of the country in only two months, a record time in the mobile worldwide industry.


 

Reykjavik (IFN) Icelandic generic pharmaceuticals company net profit in 2006 amounted to EUR103 million, compared to EUR81 million in 2005, which is a 27% increase, Actavis said on Thursday.Reported revenue in the fourth quarter increased by 80% to EUR350.2 million , compared to EUR194.5 million in the same period in 2005.Revenue in 2006 increased by 138.2% to EUR1,379.9 million, compared to EUR579.3 million in 2005, reflecting a first full year contribution from Alpharma?s human generics division, acquired in December 2005Underlying revenue for the fourth quarter increased by 17.1% and by 9.4% for the year reflecting strong organic growth in Eastern Europe and North America, Actavis said.The EBITDA margin was 19.9% for the quarter and 20.8% for the year as a whole. Excluding distribution in Bulgaria, the EBITDA margin was 21.7% for the quarter and 22.3% for the year.?This is another strong performance for the Group, where we have delivered on our EBITDA and net income targets for the year," Actavis President & CEO, Robert Wessman said."We have continued to grow our business, both organically and through strategic acquisitions, achieving double-digit underlying growth in CEEA and the US and expanding our operations in key markets including Russia and Romania. The strength in our underlying business combined with our potential to drive further efficiencies across the Group, provides us with a solid platform for future growth,? said Wessman.


 

STOCKMANN plc ANNUAL REPORT/ANNUAL ACCOUNTS March 1, 2007, at 11.45 Stockmann has published its Annual Report 2006 in Finnish, Swedish and English. The Annual Report is available on the company's website www.stockmann.com where a printed copy can be ordered. STOCKMANN plc Hannu Penttilä CEO DISTRIBUTION Helsinki Stock Exchange Principal media


 

(IFN) German chemical and pharmaceutical company Merck KGaA in 2007 expects a sharp decline in sales of its best selling generic drug DuoNeb, the companys annual report shows.Sales by Mercks generic drugs division depend heavily on respiratory treatment DuoNeb, Merck said. In 2005, the drug contributed around 15% of the divisions EUR1.82 billion sales, after its sales rose to EUR269 million from EUR252 million.However, Merck said Thursday that government authorities in the U.S. continue to analyze changes in Medicare reimbursement for inhalation products and Merck expects a final decision in the first half of 2007.In addition, lawsuits concerning the products patent protection are still pending in the U.S.Due to these developments, Merck expects "a sharp decline in sales of DuoNeb, potentially also at short notice," it said.The Darmstadt, Germany-based company in January said it was evaluating a potential sale of its generics drugs unit and on Wednesday started to contact potential acquirers.Indias company Ranbaxy Laboratories Ltd as well as Icelands Actavis Group have already expressed their interest in buying the asset.


 

(IFN) Icelandic generic pharmaceuticals company Actavis Group said Thursday its U.S. manufacturing and marketing division, Actavis U.S., has received approval from the U.S. Food & Drug Administration to market Ranitidine Oral Solution USP. Due to Actavis first-to-file status, the FDA has granted Actavis a 180-day marketing exclusivity that will commence with the distribution of the product in the coming weeks. Ranitidine Syrup, the generic equivalent of GlaxoSmithKlines Zantac Syrup, will be available in the 15 mg/mL strength. Ranitidine Syrup is indicated for the treatment and prevention of ulcers, gastroesophageal reflux disorder, and to treat conditions due to high acid secretion. Annual brand sales of Ranitidine Syrup in the U.S. were approximately USD121 million for the 12 months ending December 2006, according to IMS Health data. (END) Icelandic Financial News (IFN) is available on Factiva, a joint venture between Reuters and Dow Jones Newswires, FT.COM, LexisNexis, Comtex, Gale and Thomson via the Nordic Business Report.


 

Please find enclosed the presentation of the Preliminary Fourth Quarter and Financial Year 2006 Results, held in the morning on Thursday March 1, 2007. Oslo March 1, 2007


 

Sponda sells two land sites in Vantaa for roughly MEUR 35 In a sales contract signed today, Sponda Plc is selling a registered real estate company called Kiinteistö Oy Vantaan Erikas to the city of Vantaa for roughly MEUR 35. The real estate company owns about 72 hectares of land in the Lapinkylä and Piispankylä districts of Vantaa. The sale is related to an agreement made by the Finnish government and Sponda Plc concerning Sponda's acquisition of Kapiteeli Plc that gives the Finnish government the right to repurchase certain land sites intended for residential development (Stock Exchange Release issued by Sponda on 31 January 2007). The disposal has no impact on Sponda's result. Selling these sites is part of Sponda's strategy to sell certain property assets for EUR 300-500 million in order to refinance the loan raised to finance the Kapiteeli acquisition. Sponda Plc Further information: Kari Inkinen, President and CEO, GSM: +358 (0)400-402 653 Erik Hjelt, SVP, Legal Affairs and Treasury, GSM: +358 (0)400-472 313 Sponda Plc is a real estate company specializing in commercial properties mainly in the Helsinki metropolitan area. Sponda's business concept is to own, lease and develop office, retail and logistics properties into environments that promote the business success of its clients. The fair value of Sponda's investment properties is approximately EUR 2.6 billion euros and the leasable area is around 2 million m². Sponda is the largest real estate investment company listed on the Helsinki Stock Exchange.


 

Meðalaðsókn á leiki í ensku úrvalsdeildinni hefur minnkað þrátt fyrir að leikvangar Arsenal og Manchester United hafi verið stækkaðir til muna. Margir hallast að því að félögin verði að bregðast við með því að lækka aðgöngumiðaverð næsta keppnistímabil.


 

Skipuleggjendur Wimbledon tennismótsins hafa staðfest að þeir muni á þessu ári bjóða jafnhá verðlaun í karla- og kvennaflokki, eins og gert er á öðrum meistaramótum í tennis.


 

Í fyrsta skipti í sögunni hefur kostunarmarkaðurinn (e. sponsorship market) í Bretlandi farið yfir 450 milljónir punda, 58,5 milljarða króna. Samkvæmt niðurstöðum rannsóknafyrirtækisins Ipsos MORI Sport & Sponsorship var markaðurinn metinn til 451 milljón punda á árinu 2006, sem er 5,37% hækkun frá 2005. Aukningin endurspeglar einstakt ár í kostunarmálum í bresku íþróttalífi þar sem gerðir voru stórir samningar í knattspyrnu, krikkett og Formúla 1 svo dæmi séu nefnd.


 

Pöyry's Infrastructure & Environment business group has been awarded two important projects related to urban environmental engineering. The total value of the contracts is EUR 2.5 million. The municipality of the City of Brno, the Czech Republic, is preparing plans for the city's civic and industrial development, and has assigned Pöyry for planning the general arrangement of the dewatering system. Pöyry's assignment comprises hydraulic calculations of the 950 km long sewerage network and hydraulic evaluation and water quality modelling of 38 waterways. The public utility SIAAP (Syndicat Intercommunal d'Assainissement de l'Agglomération Parisienne) in charge of wastewater management in the area of Paris, France is upgrading the main wastewater treatment plant Seine Aval to comply with EU regulations for treatment of nitrogen and phosphorus pollution. The plant is the largest one in Europe with a daily average flow of 2.1 million cu. m/d and serves a population equivalent of 6 million. Pöyry has been assigned for the project management of feasibility studies comprising technical and financial supervision and selection of the optimal upgrading solution. Pöyry is a global consulting and engineering firm focusing on the energy, forest industry and infrastructure & environment sectors. Pöyry's net sales in 2006 amounted to about EUR 620 million and it employs 6400 experts. PÖYRY PLC Satu Perälampi Investor Relations Manager Additional information by: Ladislav Ruzicka, Senior Consultant, Pöyry Environment a.s., Czech Republic tel. +420 541 554 279 Didier Carron, President, Pöyry Environment S.A., France tel. +33 4 7291 8370 www.poyry.com DISTRIBUTION: Major media


 

DJIA 12302.28 +86.04 +0.70% Nasdaq 2423.30 +15.44 +0.64% S&P 500 1410.39 +11.35 +0.81% FTSE 100 6171.50 -114.60 -1.82% Xetra DAX 6715.44 -104.21 -1.53% CAC40 5516.32 -72.07 -1.29% Above are closing prices Nikkei 225 17381.77 -222.30 -1.3% Hang Seng 19548.76 -102.75 -0.5% S&P/ASX 200 5798.30 -18.30 -0.3% Taiwan Index 7678.67 -223.20 -2.8% S.Korea Kospi Closed Shanghai Comp 2831.57 -48.13 -1.7% Dow Future 12263.00 -11.00 -0.1% NASDAQ Future 1765.25 -0.25 0.0% S&P Future 1406.50 -2.50 -0.2% Above are as of 0550 GMT USD/JPY 118.27-28 -0.18% Range 118.86 - 118.15 EUR/USD 1.3224-25 -0.06% Range 1.3239 - 1.3217 AUD/USD 0.7871-74 -0.06% Range 0.7880 - 0.7858 GBP/USD 1.9624-29 -0.08% Range 1.9652 - 1.9617 USD/CHF 1.2184-87 -0.06% Range 1.2199 - 1.2175 Above are as of 0550 GMT vs NY close USD/JPY Vol Option Contract 7.8%/8.1% EUR/USD Vol Option Contract 5.85%/6.25% AUD/USD Vol Option Contract 6.62%/6.88% GBP/USD Vol Option Contract 5.95%/6.20% USD/CHF Vol Option Contract 6.9%/7.5% Above are 1-Mo prices as of 0600 GMT 2Y Tsy 100 7/32 -2/32 4.64% +3.5 5Y Tsy 100 16/32 -6/32 4.52% +4.2 10Y Tsy 100 16/32 -13/32 4.56% +4.9 10Y JGB 1.6500% +0.0250 Closing Treasury prices vs prior NY close; JGB as of 0550 GMT Asian Spot Gold $675.25 +$6.90 +1.0% Comex Gold $675.20 +%2.70 +0.4% Brent Crude Oil $61.54 -$0.35 -0.6% Above are as of 0500 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: European stock markets are likely to struggle at the open, as the global correction continues. Government bond prices are set for a mixed start, consolidating recent gains, while the euro is steady. Metal prices are recovering recent losses and oil is slightly lower. STOCKS: Investors are still reluctant to return to the market in numbers, leaving European stocks generally lower at the open. However, higher oil and commodity prices will lift the London FTSE into positive territory. U.K. spreadbettor CMC Markets is calling the FTSE up 16 points at 6187, but the CAC down 10 at 5506 and the DAX down 7 at 6708. "We expected a correction in the early stages of the year. Its a sign that were going to see a rock solid year," said Heino Ruland at Steubing in Frankfurt. "I think that a sideways movement is more than desirable. The markets have been very strong. Everyone was expecting a correction but no one knew what the trigger would be. In the end it was China," added Ruland. Wall Street rebounded fitfully Wednesday from the previous sessions 416-point plunge, as investors took comfort from comments by Federal Reserve Chairman Ben Bernanke but still showed signs of unease about the economy. Bernankes remarks to Congress that he still expects moderate economic growth gave some investors confidence to look for bargains. A recovery in some overseas markets following a worldwide selloff Tuesday also lent some support to U.S stocks, but the advance lacked some conviction. "Its typical that you get a bounce back the next day," said Joseph V. Battipaglia, chief investment officer at Ryan Beck & Co. "Now were essentially flat on the year. Can we go up from here or down? That sorting-out process will continue now." In corporate news, Merck & Co. regained some ground after the drugmaker issued a first-quarter profit forecast that surpassed estimates of Wall Street analysts and raised its profit target for the year. Sprint Nextel rose 4.6 percent after the nations third largest wireless carrier said fourth-quarter profit rose 33 percent on stronger revenue. Motorola rose 5% on its statement that activist investor Carl Icahn, already a leading shareholder in the cellphone manufacturer, has notified the company that he may buy more shares. Icahn previously made known he wants a seat on Motorolas board of directors, reportedly to increase the companys $4.4 billion debt level and return more cash to investors. Homebuilders saw additional selling after a Commerce Department report that new-home sales plunged 16.6% in January, the largest fall in 13 years. Major Asian markets were trading lower Thursday as investors watched developments in Shanghai, where an early selloff had erased about half the gains from the previous day. "It looks like there is more selling on the cards, not as aggressive as yesterday, but it looks like there are a few late stragglers that have come in and decided to lighten up their position," said Andrew Clarke, a sales trader with Societe Generale in Hong Kong. "There is a distinct possibility that local investors are waiting to see what the foreigners are going to do." Former Fed Chairman Alan Greenspan speaking at an investment banking forum in Tokyo Thursday, toned down his warning that the U.S. might slip into a recession later this year, saying he doesnt think such an economic slowdown is "probable." FOREX: The euro is steady against the dollar, drawing support from buying against the yen. The euro has resistance at $1.3259, with support at $1.3170. Michael Woolfolk, senior currency strategist at the Bank of New York, said Bernankes comments Wednesday "tried to put a positive spin on the U.S. economic outlook, and I think he was intellectually honest. His comments were helpful in calming some frayed nerves." Many traders are still betting that yen carry trades could see some more unwinding as investors reassess the market. "Unless dollar and euro can recoup their recent highs (versus the yen) of Y122 and Y159.60, further carry unwinding is likely in the near term - although every correction in euro/yen has proven to be a buying opportunity since June 2005," said Tim Mazanec, senior currency strategist at Investors Bank and Trust in Boston. BONDS: European government bond prices are likely to open mixed but could to try later to extend gains from Wednesday if stocks remain weak. Investors are looking to government debt to shelter them from growing risks. "The equity market influence should easily overshadow the economic data. With 10-year annual yields on bunds approaching major support at 3.90%, any recovery in equity markets is likely to prompt profit-taking," said Marc Ostwald, an analyst at Insinger de Beaufort. The U.S. Treasurys market cooled off Wednesday, drawing prices gradually lower as equity markets began to recover from the previous days losses and as Bernanke offered reassurance on the outlook for U.S. growth Earlier Wednesday, the government revised down its estimate of fourth quarter gross domestic product growth to 2.2% from 3.5%. Bernanke said that downward revision "is more consistent with our view of the economy than the original numbers." "Truth be told, the focus remains on equities and the credit default swaps market," said Bernd Wuebben, government bond strategist at BNP Paribas. Thursday brings an update on the Feds preferred price pressure gauges, personal consumption expenditure. This will be followed by Februarys reading on manufacturing activity from the Institute of Supply Managers. Prices of Japans government debt lost ground as investors hedged buys in 10-year issues and took a cautious view ahead of the next CPI report. ENERGY: Oil prices dropped 11 cents to $61.68 Thursday, a day after prices hit a two-month high following a U.S. government report that stockpiles of gasoline and distillates, which include heating oil and diesel fuel, dropped last week by a larger amount than analysts had forecast. "The oil market has essentially brushed off the correction in the equities market and is focusing on the U.S. inventory report, which was quite bullish," said energy analyst Victor Shum, of Purvin & Gertz in Singapore "I think in the near term we can expect a lot of volatility in the oil market," Shum said, noting continuing concerns over Iran. METALS: Spot gold gained $6.90 to $675.25 from the New York close, but remains in a range of $660 to $682, traders said. The February rally in LME copper and zinc could have been a blip in a longer downtrend, said BNP Paribas, noting weaker U.S. economic data and a lack of copper bids from China buyers. LME 3-month copper was at $6,085/ton, up $70 on the London PM kerb and zinc was up $20 at $3,500/ton. (MORE TO FOLLOW) Dow Jones Newswires March 01, 2007 01:45 ET (06:45 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 01 Mar 2007 06:45 GMT =DJ EUROPEAN MORNING BRIEFING: Market Weakness Persists -2- CALENDAR: Thursday, March 1, 2007 GMT Expected Previous 0750 FRA Jan PPI 0.0%MM -0.1%MM +1.7%YY +2.7%YY 0845 ITA Feb Italy RBS/ADACI PMI Mfg 53.8 53.5 0850 FRA Feb France RBS/CDAF PMI Mfg 52.7 52.4 0855 GER Feb Germany RBS/BME PMI Mfg 58.3 58.5 0900 EU Feb RBS/NTC euro-zone PMI Mfg 55.5 55.5 0930 UK Jan Lending to Individuals +GBP11.6B 0930 UK Feb Monetary & Financial Statistics 0930 UK Jan Mortgage Lending +GBP10.6B 0930 UK Jan Mortgage Approvals 113K 0930 UK Jan Consumer Credit +GBP1.0B 0930 UK Feb CIPS PMI Mfg 1000 ITA Feb Provisional CPI +0.2%MM +0.1%MM +1.7%YY +1.7%YY 1000 ITA Feb Cities CPI 1000 EU Feb Euro-zone Inflation, flash estimate +1.9%YY +1.9%YY 1100 UK Distributive Trades Survey +30 1100 ITA Annual GDP 0.0% 1100 ITA Annual General Govt Debt 1230 US Feb Challenger Layoffs Survey +15.2% 1330 US Jan Personal Income +0.3% +0.5% 1330 US Jan Personal Spending +0.4% +0.7% 1330 US Feb 24 Jobless Claims -7K -27K 1500 US Feb 17 DJ-BTMU Business Barometer -0.2% 1500 US Feb ISM Mfg Index 50.0 49.3 1500 US Jan Construction Spending -0.4% -0.4% 1530 US Feb 23 US Energy Dept Natural Gas Stocks (in -223 billion cubic feet) 1600 UK Feb JPMorgan Global PMI Mfg 52.8 1700 US Tsy Secy Paulson speaks in Washington 2130 US Money Supply N/A GER EU defense ministers informal meeting; EU Foreign Policy Chief Solana attends N/A UK Feb CML Market Commentary N/A UK OECD Secy Gen Gurria visits the UK N/A US Feb Auto Sales 16.1M 16.7M -By Dennis Baker; Dow Jones Newswires; dennis.baker@dowjones.com (MORE TO FOLLOW) Dow Jones Newswires March 01, 2007 01:45 ET (06:45 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 01 Mar 2007 06:45 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events Abertis Infraestructuras (ABE.MC): FY Earnings Average net profit (Co, 21 analysts): EUR528.4M (EUR510.9M) Average EBITDA: EUR2.09B (EUR1.20B) Average revenue: EUR3.25B (EUR1.91B) Note: Higher financing costs linked to recent buys expected to be partially offset by higher sales. Revenue is seen up, backed by the acquisition of Sanef (415156.FR). Focus will be on any comments on Sanef integration. Andritz (ANDR.VI): FY Earnings Average net profit (DJ, 5 analysts): EUR102.9M (EUR79M) Average EBIT: EUR148.8M (EUR107M) Average order intake: EUR2.81B (EUR1.98B) Average sales: EUR2.52B (EUR1.74B) Note: Results were driven by strong demand, especially from the renewable energy sectors, and the first-time inclusion of subsidiary VA Tech Hydro. UBS says Andritz continues to benefit from pulp capex in low-cost regions, and demand for stainless steel equipment remains solid. Aviva (AV.LN): FY Earnings Average operating profit (Co, 24 analysts): GBP3.3B (GBP2.9B) Note: FY 06 operating profit seen up on a strong performance from the UK life insurance business, analysts say. The forecast is based on the average of 24 broker estimates provided by the company. Analysts are sanguine about pensions lapses, assuming that Aviva delivers on its promise that changes in assumptions will be offset by other factors and will not hit the bottom line. British American Tobacco (BTI): FY Earnings Average pre-exceptional EPS (DJ, 6 analysts): GBP98.4p (GBP89.4p) Note: Profit is expected to benefit from the continued growth of emerging markets such as Brazil and India as well as the groups cost cutting program. Analysts will focus on any comments on further cost cutting, with some expecting a new multimillion pound program to be announced. Any news on Italian restructuring and factory closure is also sought, as is the possibility of an increase in share buybacks. Deutsche Telekom (DT): 4Q Earnings Average net profit (Co, 8 analysts): EUR667M (EUR1.02B) Average sales: EUR15.84B (EUR15.52B) Note: Deutsche Telekom is expected to report a drop in 4Q net profit due to earnings declines at its fixed-line and IT services businesses. Sales are seen up driven by growth at its wireless unit. But all eyes will be on strategy update of new CEO Rene Obermann. He is expected to announce plans to stop the decline of the business in Germany and further cost cuts. Company had already reported preliminary 06 numbers in late Jan. Dexia (DEXB.BT): 4Q Earnings Average net profit (DJ, 4 analysts): EUR795M (EUR553M) Average underlying profit: EUR507M (EUR449M) Note: The result is boosted mainly by the first-time inclusion of Turkeys Denizbank earnings and a EUR275M or so capital gain from the sale of Banque Artesia Nederland as well as EUR50M from the sale of its Banksys stake. Analysts will be focussing on Denizbank results seen around EUR26M and the underlying figures. No shocks foreseen. Finmeccanica (FNC.MI): FY Earnings Average preliminary EBIT (DJ, 4 analysts): EUR858M (EUR735M) Average revenue: EUR12.87B (EUR10.95B) Note: Analysts say the earnings boost should reflect proceeds from the flotation of 60% of rail and transportation unit Ansaldo STS last March, along with a good performance by helicopter unit AgustaWestland and defense electronics operations. Analysts forecast revenue grew 18% last year to EUR12.87B from EUR10.95B in 05. Finmeccanica itself has forecast 06 EBIT of EUR840M to EUR860M, and revenue of EUR12.7B to EUR13B. Holcim (HOLN.VX): FY Earnings Average net profit (DJ, 4 analysts): CHF2.0B (CHF1.54B) Average EBITDA: CHF5.9B (CHF4.76B) Average sales: CHF23.51B (CHF18.47B) Note: Expected to release around 0600 GMT. Sales and profit driven by strong demand and edge in emerging markets. The company seen exceeding its organic growth goals. Outlook and dividend increase eyed. The gearing is expected to stand at above 60%, far below the companys targeted 80%-10% range. InBev (INB.BT): 4Q Earnings Average net profit (Co, analysts): EUR374M (EUR358M) Average revenue: EUR3.53B (EUR3.24B) Note: Analysts say growth will be driven by rising volumes in Latin America and acquisitions in Asia, as well as cost-savings in Western Europe. The main focus, however will be on any outlook or new targets the company provides, as well as any comment on speculation of a tie-up with Anheuser-Busch (BUD). Jeronimo Martins (JMT.LB): FY Earnings Average net profit (DJ, 4 analysts): EUR111M (EUR110.4M) Average EBITDA: EUR323M (EUR308.3M) Average sales: EUR4.41B (N/A) Note: Expected to report a rise supported by continued expansion in Portugal and Poland. A rise in operating expenses related to an aggressive expansion plan are seen limiting gains in EBITDA and net profit. Focus will be on expansion plans in Poland. National Express (NEX.LN): FY Earnings Average normalized pretax profit (Co, 10 analysts): GBP151M (GBP135.3M) Average diluted EPS: GBP73p (GBP76.3p) Note: Analysts are expecting strong performances from both the companys U.K. rail unit and its Spanish coach and bus business, Alsa. PartyGaming (PRTY.LN): FY Earnings Average underlying profit (Co, 6 analysts): $564.8M ($583.3M) Average revenue: $1.10B ($977.7M) Note: Expected to report that underlying profit, or clean EBITDA which strips out share option costs and exceptional items fell. The fall follows the groups exit from the lucrative US market in October after the US outlawed the industry. "The current trading update and potential for upgrades, driven by revenue growth and margin, remains the key area of focus for us on March 1," house broker Dresdner Kleinwort says. PGNiG (PGN.WA): 4Q Earnings Average net profit (DJ, 5 analysts): PLN242.8M (PLN329.3M) Average EBIT: PLN241.5M (PLN382.8M) Average sales: PLN4.34B (PLN4.02B) Note: Profits hit by higher prices of imported gas, which was only partly offset by stronger PLN. Analysts are looking for signs confirming expectations of improved profitability in 07 due to higher gas tariff. PKN Orlen (PKN.WA): 4Q Earnings Average consolidated net profit (DJ, 6 analysts): PLN223.8M (PLN314M) Average net profit: PLN320.8M (N/A) Average sales: PLN12.47B (PLN12.97B) Note: Expected to report a drop in consolidated net profit, largely due to one-off charge from the sale of its Czech unit. Excluding the charge, net profit expected to rise. Apart from the charge, quarterly results hit by inventory valuation due to lower crude oil prices and maintenance shutdowns but damage likely to be partly offset by higher refining and retail volumes, analysts say. Reuters (RTRSY): FY Earnings Average trading profit (Co, 11 analysts): GBP308M (GBP334M) Average adjusted EPS: GBP16.5p (N/A) Average revenue: GBP2.5B (GBP2.4B) Note: Expected to post trading profit, or operating profit from continuing operations before restructuring charges associated with acquisitions, down due to ongoing investment in its Core Plus growth program. Constant currency revenue growth seen at around 6%. Analysts are likely to quiz the company on the growth prospects of the Core Plus program, organic revenue growth forecasts for 2007 and possible acquisition strategy. Royal Bank of Scotland (RBS.LN): FY Earnings Average pretax profit before integration costs, amortization and interest (Co, 18 analysts): GBP9.350B (GBP8.251B) Average adjusted EPS: GBP194.5p (N/A) Note: Dividend seen +15% to 83p. Analysts expect good organic growth and tight cost control in foreign markets and stable credit at home, with corporate lending and insurance seen as bright spots. But Citigroup is cautious due to profit issues at Citizens in the US and UK claims inflation. Sulzer (SUN.EB): FY Earnings Average net profit (DJ, 3 analysts): CHF219M (CHF130M) Average sales: CHF2.85B (CHF2.50B) Note: Expected to report before market opening an increase in 06 net profit, strong demand and continued efficiency gains. Company expected to announce new financial targets. Any update on future acquisition strategy will be eyed. Swiss Re (RUKN.VX): FY Earnings Average net profit (DJ, 5 analysts): CHF3.66B (CHF2.3B) Note: The gain is expected to have been boosted by the acquisition of General Electrics (GE) reinsurance unit and thanks to a benign claims environment. The 05 net profit figure, which has been adjusted from the reported CHF1.45B 05 net profit to reflect Swiss Res change to the US GAAP accounting standard this year. Premiums are expected to rise 15% to CHF31B from an adjusted CHF26.89B, also due to the recent acquisition. Analysts will be on the lookout for comments about price developments in the non-life market and suggestions about more Admin Re deals, in which Swiss Re buys closed life insurance operations. (MORE TO FOLLOW) Dow Jones Newswires March 01, 2007 01:45 ET (06:45 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 01 Mar 2007 06:46 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events -2- Synthes (SYST.VX): FY Earnings Average net profit (DJ, 4 analysts): $537.5M ($436M) Note: Expected to report at 0600 GMT. Growth seen stemming from a rise in sales, particularly in the trauma and spinal divisions and on firm demand in the US. Attention also likely to focus on comments relating to possible reimbursement for Prodisc. Telefonica (TEF): FY Earnings Average net profit (DJ, 6 analysts): EUR6.13B (EUR4.45B) Average operating income before depreciation and amortization: EUR19.53B (EUR15.28B) Average revenue: EUR52.57B (EUR37.88B) Note: The consolidation of recent purchases and the sale of Telefonica Publicidad e Informacion (TPI.MC) is seen driving the results. Focus will be on any indications Telefonica will sell its majority stake in the production company Endemol Entertainment Holding (34569.AE) or buy a stake of Telecom Italias (TI) holding company, Union Fenosa (UNF.MC): FY Earnings Average net profit (DJ, 6 analysts): EUR627M (EUR823M) Average EBITDA: EUR1.89B (EUR1.48B) Note: Fall seen caused by absence of significant asset disposals, after 05 numbers were skewed by EUR577M in capital gains. Focus on any updates on M&A hopes and dreams. Unipetrol (BAAUNIPE.PR): 4Q Earnings Average consolidated net loss (DJ, 5 analysts): CZK837M (CZK1.48B net profit) Average EBIT: CZK129M loss (CZK1.44B) Note: Analysts say the loss is on the negative difference between book value and sale price of Kaucuk (sold in 4Q) and losses from unscheduled shutdowns at two of the companys refineries. Lower global oil prices and the stronger CZK in the period are seen helping Unipetrols whole-year result X5 Retail Group (FIVE.LN): FY Earnings Average net profit (DJ, 5 analysts): $97.5M ($120.2M) Average EBITDA: $271.6M (N/A) Average revenue: $3.49B ($2.37B) Note: Expected to report 06 net profit down due to interest expenses and costs related to the companys management option program. Revenue seen up thanks to new store openings. Numbers due 0700 GMT. OTHER SCHEDULED EVENTS: Aberforth Smaller Companies (ASL.LN): AGM Adolfo Dominguez (ADZ.MC): FY Earnings Aker American Shipping (AKASA.OS): 4Q Earnings Aker (AKER.OS): 4Q Earnings Amica Wronki (AMC.WA): 4Q Earnings Antena 3 de Television (A3TV.MC): FY Earnings Arena Leisure (ARE.LN): FY Earnings Arksteel: 4Q Earnings Atlanta Poland (ATP.WA): 4Q Earnings ATM (ATM.WA): 4Q Earnings Bankers Investment Trust (BNKR.LN): AGM Barlinek (BRK.WA): 4Q Earnings BB Biotech (BIO.EB): FY Earnings BB Medtech (MED.EB): FY Earnings Beiersdorf (BEI.XE): FY Earnings Bezeq Israel Telecom (BEZQ.TV): FY Earnings Bioton (BIO.WA): 4Q Earnings Bodegas Riojanas (RIO.MC): FY Earnings Boryszew (BRS.WA): 4Q Earnings Broker Fm (RMF.WA): 4Q Earnings Campofrio (CPF.MC): FY Earnings CCC (CCC.WA): 4Q Earnings Central European Media (BAACETV.PR): FY Earnings Cersanit (CST.WA): 4Q Earnings Ciech (CIE.WA): 4Q Earnings ComArch (CMR.WA): 4Q Earnings Corporate Synergy Group (CSG.LN): FY Earnings Correa (Nicolas) (NEA.MC): 4Q Earnings Credito Artigiano (CRA.MI): FY Earnings CSM (34426.AE): FY Earnings DaimlerChrysler (DCX.XE): February Revenue Deutscher Industrie Service (DDE.XE): FY Earnings Dogi International Fabrics (DGI.MC): 4Q Earnings EasyJet (EZJ.LN): AGM Ebro Puleva (EVA.MC): FY Earnings Echo Investment (ECH.WA): 4Q Earnings Efekt (EFK.WA): 4Q Earnings Eldorado (EDR.WA): 4Q Earnings Elzab (ELZ.WA): 4Q Earnings EMC Instytut Medyczny (EMC.WA): 4Q Earnings Energomontaz Polnoc (EPN.WA): 4Q Earnings Energomontaz Poludnie (EPD.WA): 4Q Earnings Ercros (ECR.MC): FY Earnings Erg (ERG.MI): 4Q Earnings Eriks (35038.AE): FY Earnings Eurocash (EUR.WA): 4Q Earnings Farmacol (FCL.WA): 4Q Earnings Fasing (FSG.WA): 4Q Earnings Filtrona (FLTR.LN): FY Earnings Fomento de Construcciones y (FCC.MC): FY Earnings Generale de Sante (4447.FR): FY Earnings Gestevision Telecinco (TL5.MC): FY Earnings Getin Holding (GTN.WA): 4Q Earnings Golden Ocean Group Limited (GOGL.OS): 4Q Earnings Grupo Inmocaral (FFR.MC): FY Earnings Hexagon Composites (HEX.OS): FY Earnings Hoop (HOP.WA): 4Q Earnings Hunting (HTG.LN): FY Earnings Hyprop Investments (HYP.JO): FY Earnings IM Skaugen (IMSK.OS): AGM Impel (IPL.WA): 4Q Earnings Impexmetal (IPX.WA): 4Q Earnings (MORE TO FOLLOW) Dow Jones Newswires March 01, 2007 01:46 ET (06:46 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 01 Mar 2007 06:46 GMT =DJ EUROPEAN MORNING BRIEFING: Div Payments & Ex Div Dates Autoliv Inc (ALIV-SDB.SK): 1Q 2007 Dividend Payment Date Computerland UK (CPU.LN): 1H 2006 Dividend Payment Date JPMorgan Fleming Claverhouse (JCH.LN): 4Q 2006 Dividend Payment Date SSL International (SSL.LN): 1H 2006 Dividend Payment Date Sysopen Digia (SYS1V.HE): FY 2006 Ex-Dividend Date Victrex (VCT.LN): FY 2006 Dividend Payment Date Wyeth (500095.BY): 4Q 2006 Dividend Payment Date (END) Dow Jones Newswires March 01, 2007 01:46 ET (06:46 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 01 Mar 2007 06:46 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events -3- Indo Internacional (IDO.MC): FY Earnings Indykpol (IND.WA): 4Q Earnings Inter Cars (CAR.WA): 4Q Earnings Interavanti (INA1S.HE): AGM Internet Group (IGR.WA): 4Q Earnings Inypsa Informes Y Proyectos (INY.MC): FY Earnings Irena (Huta Szkla) (IRE.WA): 4Q Earnings Itesoft (ITE.FR): FY Earnings J. Martins (JMT.LB): FY Earnings JC Auto (JCA.WA): 4Q Earnings Keller Group (KLR.LN): FY Earnings Keskisuomalainen (KSLAV.HE): FY Earnings KGHM Polska Miedz (KGH.WA): 4Q Earnings Klaipedos Baldai (10297.LH): FY Earnings Koelner (KLR.WA): 4Q Earnings Kopex (KPX.WA): 4Q Earnings Kredyt Bank (KRB.WA): FY Earnings Kruszwica (KSW.WA): 4Q Earnings Lacie Group (5431.FR): 1H Earnings Lastas (LAST-B.KO): FY Earnings Lena Lighting (LEN.WA): 4Q Earnings Lingotes Especiales (LGT.MC): FY Earnings Lubawa (LBW.WA): 4Q Earnings Magna NFI: 4Q Earnings Max Bank (MAX.KO): FY Earnings Merck KGaA (MRK.XE): FY Earnings Mostostal Export (MSX.WA): 4Q Earnings Mostostal Warszawa (MSW.WA): 4Q Earnings Mostostal Zabrze (MSZ.WA): 4Q Earnings Muza (MZA.WA): 4Q Earnings Netia (NET.WA): FY & 4Q Earnings NFI Jupiter (JPR.WA): 4Q Earnings Nicox (7413.FR): FY Earnings NKT Cables (KBL.WA): 4Q Earnings Nowa Gala Ceramika (CNG.WA): 4Q Earnings Obrascon Huarte Lain (OHL.MC): FY Earnings Octava NFI (08N.WA): 4Q Earnings Okmetic (OKM1V.HE): FY Earnings Olvi (OLVAS.HE): FY Earnings Opoczno (OPO.WA): 4Q Earnings Pacific Horizon (PHI.LN): 1H Earnings Papeles & Cartones Europa (PAC.MC): FY Earnings PEKAES (PEK.WA): 4Q Earnings Polmos (PLS.WA): 4Q Earnings Polnord (PND.WA): 4Q Earnings Polska Grupa Farmaceutyczna (PGF.WA): 4Q Earnings Premier Utilities Trust (PUT.LN): FY Earnings Prochem (PRM.WA): 4Q Earnings Proha (ART1V.HE): FY Earnings Prosper (PSP.WA): 4Q Earnings Rathbone Brothers (RAT.LN): FY Earnings Redan (RDN.WA): 4Q Earnings Revus Energy (REVUS.OS): 4Q Earnings Sagentia Group (SGA.LN): FY Earnings Semperit Holding (SEM.VI): FY Earnings Senior (SNR.LN): FY Earnings Sotogrande (STG.MC): 4Q Earnings Spirent Communications (SPT.LN): FY Earnings SSK Suomen Saastajien (SSK1S.HE): AGM Stepstone (STP.OS): 4Q Earnings Swallowfield (SWL.LN): 1H Earnings Swissmed (SWD.WA): 4Q Earnings Tableros De Fibras (TFI.MC): FY Earnings Tarsus Group (TRS.LN): FY Earnings Techmex (TEX.WA): 4Q Earnings Tele Atlas (23394.AE): FY Earnings Ten Cate (Koninklijke) NV (37574.AE): FY Earnings Trinity Mirror (TNI.LN): FY Earnings UK Coal (UKC.LN): FY Earnings Unipapel (UPL.MC): FY Earnings UTAir (TMAT.RS): FY Earnings Vistula (VST.WA): 4Q Earnings Wilmington Group (WIL.LN): 1H Earnings Zaklady Miesny Duda (DUD.WA): 4Q Earnings Zardoya Otis (ZOT.MC): 4Q Earnings (MORE TO FOLLOW) Dow Jones Newswires March 01, 2007 01:46 ET (06:46 GMT) Copyright (c) 2007 Dow Jones & Company, Inc.


 

Fred. Olsen Production ASA (OTC-listed) which indirectly is 57.7% owned by Bonheur ASA and Ganger Rolf ASA, has today published the following announcement: First Olsen Pte.Ltd, a wholly owned subsidiary of Fred.Olsen Production ASA (FOP), has entered into an agreement with Maersk Oil Qatar (MOQ) for the upgrading of the capacity of the Knock Nevis floating, storage and offloading vessel (FSO) currently on contract to MOQ on the Al- Shaheen field, offshore Qatar. The upgrade project targets a 25% increase in the liquid handling capacity of the vessel. All FOP- related capital expenditure is refundable by MOQ and there is a compensation arrangement in place which is expected to yield an increase in the EBITDA contribution of 3-5 MUSD over the remaining life of the contract. The 564,000 dwt Knock Nevis, which is the world's largest vessel, is on contract to MOQ until August 2009. MOQ may terminate the contract as from August 2007. For further inquiries, please contact Paal Hylin, Chief Operating Officer, Fred.Olsen Production ASA, +47 905 16 702 Oslo 1st March, 2007


 

Veidekke has been awarded another road construction contract in Kista by the City of Stockholm. The contract price is approx. SEK 75 million. In connection with the development of 3,000 dwellings and a number of office buildings in Kista, Veidekke Anläggning Öst AB has been commissioned to undertake a comprehensive extension of Torshamngatan and construct a new road between Hanstavägen and Torshamngatan (Kista Gård, Stage II). The contract includes asphalting and levelling. The work is already underway and will be completed in the course of 2009. Veidekke Anläggning Öst AB is also in the process of converting Hanstavägen in Kista (Kista Gård, Stage I) for the City of Stockholm. The contract price for Stage I is about SEK 100 million. For more information, please contact: Veidekke Anläggning Öst AB, Project Manager Robert Lindfors, tel. +46 8635 61 68, +46 733 55 99 55. VEIDEKKE ASA


 

Schibsted has on 15 and 16 February entered into an agreement with Kaupthing, giving them the right to sell up to 1,439,202 shares (corresponding to 19.7% of the shares and votes) in Stavanger Aftenblad ASA ("Aftenbladet") for NOK 231.50 per share and coverage of NOK 2.31 in broker's fee. The option expired on 28 February 2007 1700 CET. Kaupthing's interest in the agreement was taken over by Montrica Global Opportunities Master Fund ("Montrica"), who owns a total of 1,446,209 shares in Aftenbladet. Schibsted has on 28 February entered into an agreement with Montrica, giving them the right to sell up to 1,446,209 shares in Aftenbladet to Schibsted for NOK 250 per share. This agreement replaces the first, which expired 28 February at 1700 CET. According to the new agreement, the right to sell can be exercised from the third business day prior to expiration date and on the expiration date, 1 May 2008. Until 1 April 2008, Schibsted has the opportunity to determine that the expiration dateshall be 1 May 2009. In this case, the right can be exercised from the third working day prior to the new expiration date and on the new expiration date. In this case the strike price will be NOK 278 per share. If Media Norge is established prior to the date on which the option may be exercised, the right applies for a number of Media Norge shares. The number of shares and the price is calculated based on the exchange ratio in the merger. To fulfil the obligations in the merger plan relating to Schibsted holding a maximum of 50.1% of the shares in Media Norge, Schibsted will need to procure that the sales are sold to a third party. Schibsted currently holds 2,368,640 shares in Aftenbladet, corresponding to 32.3% of the shares and votes. If the right to sell is fully exercised by Montrica and Media Norge is not established, Schibsted will own a total of 3,819,849 shares, equalling 52.1% of the shares and votes. Schibsted is represented at the Board of Directors in Aftenbladet. Contact persons: CFO Trond Berger, tel.: +47 91 68 66 95 EVP Schibsted Norway Birger Magnus, tel.: +47 90 03 00 93 Oslo, 28 March 2007 SCHIBSTED ASA --- End of Message --- ISIN: NO0003028904; ;


 

1 March 2007 - Aker, Aker Kværner, and Aker Yards have joined forces to establish the company Aker Innovation. By exploiting the industrial and financial expertise of its three owners, Aker Innovation will identify new industrial projects that it will develop into profitable companies. Aker Innovation is currently developing several potential projects. Together with the listed company DOF Subsea, Aker Innovation has identified interesting opportunities within subsea well intervention services for deepwater offshore fields, and is planning to establish a new company Aker Oilfield Services. The planned new company will be a leading subsea well intervention company. According to current plans, Aker Kvaerner would deliver complete well access & control equipment and services in addition to complete wireline well intervention equipment and services. DOF would deliver marine crew and other operational services. Aker Yards would design and construct the state of the art well intervention vessels. Further details of Aker Oilfield Services will be announced at a later stage. Value creation in Aker Innovation "With the establishment of Aker Innovation we are creating a vehicle for the long-term, industrial cooperation among Aker, Aker Kværner, and Aker Yards that we have called Aker's value-creating triangle," says Leif-Arne Langøy, Aker Board Chairman and President and CEO. The two listed companies Aker Drilling and Aker Floating Production, which have a combined market capitalization of nearly NOK 4 billion, are the direct outgrowth of the industrial cooperation that Aker Innovation is tapping. Through their joint ownership of Aker Innovation, all three founders: Aker, Aker Kværner, and Aker Yards will receive future ownership interests in the new projects and companies that are developed. As in the past, the companies in Aker's value-creating triangle can supply expertise and technology to new projects. Aker owns 67 percent of Aker Innovation, while Aker Kværner and Aker Yards each own 16.5 percent of the company. The founding companies' capital contributions to Aker Innovation will be determined by the company's capital needs for future projects. Aker Innovation's Board of Directors comprises the following members: Leif-Arne Langøy, Bengt A. Rem, and Nils Are Karstad Lysø of Aker's group management; Aker Kværner's President and CEO Martinus Brandal; and Aker Yards' President and CEO Karl Erik Kjelstad. ENDS For further information, please contact: Media: Torbjørn S. Andersen, SVP Group Communications, Aker Kvaerner. Tel: +47 67 51 30 36, Mob: +47 928 85 542 Investor relations: Lasse Torkildsen, VP Investor Relations, Aker Kvaerner. Tel: +47 67 51 30 39 Career opportunities: Visit http://www.akerkvaerner.com/Internet/CareerCentre AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner comprises several industries, including Oil & Gas, Refining & Chemicals, Mining & Metals and Power Generation. The Aker Kvaerner group is organised in a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA. Aker Kvaerner has aggregated annual revenues of approximately NOK 50 billion and employs approximately 23 000 people in about 30 countries. Aker Kvaerner is part of the Aker Group (www.akerasa.com), a leading multi-industry powerhouse with more than 55 000 employees and NOK 80 billion revenues. Aker owns 40.1 percent of Aker Kvaerner, and the group is also a major European shipbuilder and a significant participant in the fisheries industry. This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com


 

Live analyst presentation on www.cantos.com with Richard Harvey, CEO, and Andrew Moss, FD, Aviva (LSE:AV) - The live video presentation will be available from 0930GMT This programming is available in video, audio and transcript. It's free to view. All you need to do is register at www.cantos.com Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses. If you would like to contact us, please email enquiries@cantos.com.


 

(Oslo, 1 March 2007) Block Watne Gruppen secured a net order intake of NOK 177.8 million during February, compared with NOK 140.8 million for February 2006. This represents an increase of 26.3 per cent. The total net order intake for the year so far is NOK 261.1 million, a decrease of 8.6 per cent compared with the same period of 2006 (NOK 285.6 million). See also enclosed graph "New orders per month" from 2005 till date. Block Watne Gruppen reports its order intake on a monthly basis. Further information from: Lars Nilsen, president and CEO, Block Watne Gruppen ASA, tel: +47 23 24 60 00 Ketil Kvalvik, chief financial officer, Block Watne Gruppen ASA, tel: +47 23 24 60 42, +47 90 77 13 15


 

Amsterdam, 1 March 2007 Financial highlights * Total revenue generated by the Company was ¤2,627 million in 2006 (2005: ¤2,525 million) excluding revenue from discontinued operations France and Italy; * Getronics' total organic revenue growth on a comparable basis[1] is 0.8% in 2006; * Service revenue increased by 7% tot ¤2,280 million. Organic service revenue growth on a comparable basis was 2.3% in 2006; * Service revenue as a percentage of total revenue increased to 86.8% in 2006 compared to 84.0% in the previous year; * EBITAE from continuing operations was ¤117 million (2005: ¤143 million), resulting in an EBITAE margin of 4.5% (2005: 5.7%), and included ¤38 million of employee benefit plan related gains, including ¤15 million in curtailment gains of which ¤6 million resulted from aligning long-term benefit plans in the Netherlands as part of the integration of PinkRoccade; * The operating result was ¤23 million (2005: ¤99 million), including ¤65 million impairment of goodwill, ¤21 million acquisition integration expenses, and ¤16 million amortisation of acquired intangible assets; * Net result from continuing operations amounted to ¤-54 million (2005: ¤60 million) including ¤63 million of net financial expenses and ¤14 million in income tax expense; * Net result from total operations amounted to ¤-145 million, including ¤91 million loss from discontinued operations; * Earnings per ordinary share from continuing operations was ¤-0.44 (2005: ¤0.54); * Operating cash flow from continuing operations amounted to ¤51 million (2005: ¤-5 million); and * Net borrowings amounted to ¤285 million (2005: ¤157 million). [1] Service revenue on a comparable basis: comparable service revenue for 2005 and 2006 as if Getronics and PinkRoccade were combined as of 1 January 2005, instead of 14 March 2005. Downloaf full release in pdf format About Getronics With some 25,000 employees in more than 25 countries and approximate revenues of EUR 2.6 billion, Getronics is a leading international provider of Information and Communication Technology (ICT) services and solutions. Applying its expertise in workspace management, applications, and consulting and transformation services, Getronics helps organisations raise their performance and increase the productivity of their people, by providing them with the ability to share information and to work together efficiently, securely and effectively, wherever and whenever they need. Getronics headquarters are in Amsterdam, with regional offices in Boston and Singapore. Getronics' shares are traded on Euronext Amsterdam ('GTN'). For further information about Getronics, visit www.getronics.com. Press enquiries Investor enquiries Getronics Corporate Communications Getronics Investor Relations Tel: +31 20 586 1581 Tel: +31 20 586 1982 media@getronics.com investor.relations@getronics.com


 

STAVANGER, 1 March 2007 - Revus Energy (OSE: REVUS) today announced total operating revenues of NOK 296.2 million (USD 48.3 million) in 2006, of which NOK 79.8 million (USD 13 million) was in the fourth quarter. Revus is continuing to build its position on the Norwegian Continental Shelf, recently adding nine new licenses to its portfolio following the APA 2006 license awards. Highlights * Production in fourth quarter was 2,047 boepd * Year end reserves of 33.8 mmboe with contingent resources of 30.2 mmboe * PDO application submitted for the Yme project * PDO application submitted for Vega South (Fram B) * Astero appraisal well proved additional volumes of hydrocarbons * Nine licenses awarded in APA 2007 * Private placement of NOK 218 million successfully concluded * Loan agreement of NOK 900 million signed with DnB * An average oil price of USD 59.89 was realised in the fourth quarter Key Figures +-------------------------------------------------------------------+ | Figures in NOK | Q4 2006 | Q4 2005 | Year | Year | Year | | million | | | 2006 | 2005 | 2004 | |------------------+---------+---------+---------+---------+--------| | Operating | 79.8 | 119.0 | 296.2 | 309.7 | 48.1 | | revenues | | | | | | |------------------+---------+---------+---------+---------+--------| | Oil & gas | 188.355 | 268.336 | 794.125 | 827.312 | 88.771 | | production | | | | | | | (boe*) | | | | | | |------------------+---------+---------+---------+---------+--------| | Exploration | 58.3 | 55.3 | 205.4 | 73.9 | 4.4 | | expenses | | | | | | |------------------+---------+---------+---------+---------+--------| | Net income | -13.9 | -2.8 | -41.1 | 4.8 | -4.9 | | (loss) | | | | | | +-------------------------------------------------------------------+ *boe - barrels oil equivalent Harald Vabø, CEO of Revus, says; "We are very excited about the company's continued development. We demonstrated significant value creation in 2006, and the prospects forward are promising. Following the recent license awards Revus now holds one of the largest acreage positions in the Norwegian North Sea. We are embarking on an extensive drilling programme where we expect to participate in a total of 12-16 wells within the next two years. This programme has the potential to add more than 100 million barrels of reserves." "A very successful private placement and a new loan agreement gives Revus a solid base to fund this drilling campaign and grow the company further", adds Vabø. A full interim report and investor presentation can be accessed from Revus' website: www.revus.no For further information, contact: Harald Vabø, CEO, telephone: +47 91 71 12 09, e-mail: harald.vabo@revus.no Downloadable photo material at www.revus.no or order from: mia.mackay@revus.no About Revus: Revus Energy is an independent Norwegian upstream E&P company listed on the Oslo Stock Exchange. The company's business concept is to find opportunities for growth in the mature areas of the Norwegian continental shelf, through a portfolio of fields in production, discoveries and exploration projects. Revus places great emphasis on building a highly qualified organisation and forming close relationships to partners. The company has 34 employees and a number of collaboration partners. For more information about Revus Energy, see www.revus.no


 

London, UK/Bergen, Norway, March 1, 2007. Vizrt Ltd. (Frankfurt Prime Standard, Oslo Main List: VIZ), provider of TV broadcast graphics, maps and asset management systems, announces today, that it has received orders worth over USD 1.2 million to supply real-time, high-definition 3D graphics and map software to BBC Scotland's new prestigious Pacific Quay facility in Glasgow, as well as the news department of BBC's London Regional station. Most of the deal will be recognized this quarter. This order is fully in line with the potential behind Vizrt's recent acquisition strategy, since the high-profile BBC Scotland project has now ordered Vizrt's core software as well as software from its subsidiaries' Curious World Maps and Ardendo, which specialises in Media Asset Management systems. The order comes on top of an Ardendo order received in 2006, totalling approximately USD 1.8 million, of which app. USD 1.3 million was recognized in 2006 and the remainder in 2007. The BBC Scotland order was placed by systems integrator TSL, on behalf of the BBC's main contractor Siemens. About Vizrt: Vizrt offers a new vision for content creation and delivery with an end-to-end solution from ingest to visualization. Our solution combines Vizrt's true 2D/3D graphics tools with Curious Software's World Maps and Ardendo's Asset Management. Running on non proprietary software, the combination of these unique cutting edge products ensures a seamless workflow from conception to multi-format distribution. The latest addition to the Vizrt product range is the Viz|Multi Platform Solution. Vizrt's product suite is used by the world's leading broadcasters including: CNN, CBS, Fox, BBC, Sky, ITN, ZDF, Star TV, TV Today, CCTV and NHK. Also, many world-class production houses and corporate institutions, including both the New York and London Stock Exchanges, utilize Vizrt solutions. Vizrt is a public company traded on the Frankfurt Prime Standard and on the Oslo Main List: VIZ, ISIN: IL0010838154. For further information please refer to www.vizrt.com Press contacts: Ofra Brown CFO +47 2169 2790 ofra@vizrt.com Kathrine Wallace +47 9171 4545 kwa@vizrt.com SCHWARZ Financial Communication Frank Schwarz +49 611 1745 398 11 schwarz@schwarzfinancial.com This press release contains forward-looking statements with respect to the business, financial condition and results of operations of Vizrt and its affiliates. These statements are based on the current expectations or beliefs of Vizrt's management and are subject to a number of risks and uncertainties that could cause actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements. These risks and uncertainties relate to changes in technology and market requirements, the company's concentration on one industry, decline in demand for the company's products and those of its affiliates, inability to timely develop and introduce new technologies, products and applications, and loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of the company to differ materially from those contemplated in such forward-looking statements. Vizrt undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. --- End of Message --- WKN: 926501; ISIN: IL0010838154; Index: Prime All Share, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart;


 

Official inauguration to be held for the new location along Berlin's Salzufer in the Charlottenburg District/ (Berlin, March 1, 2007) Stock-listed medical device manufacturer, W.O.M. WORLD OF MEDICINE AG, announced today that after seven years, the Group want to relocate its headquarters back to Berlin, the city on the Spree. On the occasion of the official inauguration of its new offices along Berlin's Salzufer, in the Charlottenburg District, CEO Peter P. Wiest stated: "We still require the official approval of the general shareholders in order to take this step. An important reason for the relocation is the incomparability of the region, which is both the center of politics as well as a nexus for scientific and medical decision makers". The Company's history is rooted in Berlin, and the pivotal corporate management of operations has been carried out in Berlin for the past two years, as WORLD OF MEDICINE's entire three-person Management Board have resided there since that time. "Our Ludwigsstadt/Upper Franconia offices, which became the headquarters for the Group seven years ago, will continue to retain its vital significance as a superior production site", continued Peter P. Wiest. As a development-oriented corporation, WORLD OF MEDICINE benefits from the unique environment in Berlin, comprised of approximately 80 production-based medical technology firms, roughly 70 clinics, 4 multidisciplinary universities and 7 universities for the applied sciences. "Joint clinical studies with renowned partners, such as Vivantes-Klinikum Neukölln, Charité, and the Helios-Klinikum Berlin-Buch, as well as joint association-based research projects with Berlin companies, research institutes, and universities make it possible to tap into new product fields at an acceptable cost", explained Peter P. Wiest. CFO Andreas Schröteler: "Of course, as a highly innovative company, we intend to strengthen the Berlin location, and express this objective specifically through the headquarters relocation. With annual sales of roughly ¤31 million, the Company employs approximately 75 employees at its Berlin offices". WORLD OF MEDICINE and its technologies are paving the way for Minimally Invasive Surgery - or MISâ for short. This approach involves safe and gentle surgical procedures that are not conducted through major incisions, but through keyhole or puncture incisions instead. The Company is the global market leader in a niche of this future market. Today, Thursday, March 1, 2007, at 10:30 a.m., WORLD OF MEDICINE will hold a press conference at: Salzufer 8, 10587 Berlin.Stefanie Gehrke (IR/PR), Tel. +49 (0) 30 399 81 566, 0172-402 67 40, stefanie.gehrke@womcorp.com, Photo archive at : www.world-of-medicine.de --- End of Message --- WKN: 663739; ISIN: DE0006637390; Index: CDAX, Prime All Share, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

News release Converium Holding Ltd, Zug Zug, Switzerland - February 28, 2007 - Converium management reiterates its support of the Board's decision to reject unsolicited offer The management of Converium reaffirms today its unanimous support of the Board's decision to reject the unsolicited offer by SCOR, at CHF 21.1 per share, for the whole of the share capital of Converium, based on closing share prices at February 16, 2007, that was published on February 26, 2007. The Board of Directors of Converium continues to believe that SCOR's acquisition currency is weak: based on today's closing share price of SCOR, the actual value of the SCOR offer equates to CHF 19.48 (exchange rate EUR/CHF 1.6125), failing to recognize Converium's stand alone franchise value. Converium further informs that in light of the conditions to an upgrade of its financial strength ratings, it commissioned a study analyzing settlements of SEC investigations concerning financial and other performance data. The study analyzed settlements compared with market capitalization and prior year earnings in more than 100 cases between July 30, 2002 and February 20, 2007, including approximately 65 cases relating to companies with market capitalizations of less than USD 5 billion. The settlements in those cases (USD 5 billion market cap and under) ranged from USD 0 to USD 50 million. If the previously announced SEC inquiries regarding non-traditional insurance and reinsurance products were ultimately settled within that range, Converium does not believe that the ultimate resolution would have a material adverse impact on our financial strength. However, Converium expresses no opinion and makes no prediction regarding the timing or substance, including amount, of the ultimate resolution of the SEC inquiry or whether and when we will achieve a ratings upgrade. Despite Converium's efforts to commission a comprehensive study, there can be no assurance that the study was entirely comprehensive. In addition, the SEC may, and likely will, consider factors other than market capitalization and earnings in determining the appropriate resolution of their inquiry and Converium cannot assure that this will not result in fines or penalties in excess of the range suggested by the study. Converium has made it a policy not to provide any quarterly or annual earnings guidance and it will not update any past outlooks for full-year earnings. It will, however, continue to provide investors with perspectives on its value drivers, certain financial guidance for the full year, its strategic initiatives and those factors critical to understanding its business and operating environment. Enquiries Beat W. Werder Marco Circelli Head of Public Relations Head of Investor Relations beat.werder@converium.com marco.circelli@converium.com Phone: +41 44 639 90 22 Phone: +41 44 639 91 31 Fax: +41 44 639 70 22 Fax: +41 44 639 71 31 Dr. Kai-Uwe Schanz Inken Ehrich Chief Communication & Corporate Investor Relations Specialist Development Officer inken.ehrich@converium.com kai-uwe.schanz@converium.com Phone: +41 44 639 90 94 Phone: +41 44 639 90 35 Fax: +41 44 639 70 94 Fax: +41 44 639 70 35


 

Industry-Leading Subscriber-Centric Solution Manages Both Content and Connectivity With Single, Unified Platform TORONTO -- (MARKET WIRE) -- 02/28/07 -- Syndesis, a leader in OSS solutions powering the new communications subscriber experience, today announces the introduction of Syndesis(R) IPTV Express(TM), a unique IPTV service fulfillment solution that manages both IPTV service content and connectivity across telecommunications networks with a single, unified platform. IPTV Express is a subscriber-centric fulfillment solution that dramatically simplifies and accelerates IPTV service design, creation and activation. It is based on production-proven technology that is central to IPTV deployments at five of the industry's most prominent communications service providers (CSPs) in North America and Europe. A new, targeted solution bundle capturing the best practices for IPTV fulfillment, IPTV Express is being unveiled at IPTV World Forum in London, UK, on March 5-7, 2007. IPTV Express offers comprehensive fulfillment for both content and connectivity, with groundbreaking capabilities for automatic orchestration between the two. The solution integrates seamlessly into existing processes, systems and infrastructure and can be deployed on its own for full end-to-end fulfillment management or in conjunction with existing systems. The IPTV Express solution is built on a highly flexible Syndesis platform that can be extended to support fulfillment of multiple IP services -- including IPTV, VoIP, Triple Play, Quad Play and others -- over a converged next-generation network. With IPTV Express, CSPs can: -- Manage advanced IPTV services that deal with individualized channel configurations, enable remote DVR settings, establish regional blackouts and substitutions and enable automated customer PIN resets. -- Establish zero-touch provisioning of services, including auto- configuration of set-top boxes, to fully automate and simplify IPTV service fulfillment. -- Offer High Definition TV (HDTV) by automatically configuring network connectivity to meet Quality of Service (QoS) and policy requirements of HDTV, independent of underlying network technologies. -- Support efficient rollouts and upgrades of Residential Gateways through pre-integration with auto configuration servers that utilize TR-069 or equivalent functionality. -- Speed time-to-market and reduce risk with Syndesis' off-the-shelf support for leading IPTV vendors such as Alcatel, Microsoft, 2wire and more. -- Leverage a graphically rich service creation environment to speed new service definition, enabling faster time-to-market for competitive offerings. "We are proud to be at the heart of the industry's most advanced IPTV service offerings and to be a market leader in IPTV service delivery solutions," said Mark Nicholson, Chief Technology Officer for Syndesis. "Innovation, integration and flawless delivery are critical for service providers who want to achieve high performance and profitable growth in IPTV. In partnership with Syndesis, telecommunications companies have a robust, stable and scalable platform to enable delivery of television programming and interactive services over multi-vendor legacy and next-generation networks. Syndesis remains committed to building on its 20-year track record of successful service delivery solutions for the benefit of our growing customer base." "Service providers looking to launch IPTV offerings face a host of operational challenges, including ensuring that the infrastructure can provide the needed connectivity to support the desired service experience," said Larry Goldman, Co-Founder and Senior Analyst of OSS Observer. "Syndesis, with its experience in connectivity activation and its expansion into application configuration, is positioned to help service providers manage the complex interdependencies and requirements of both connectivity and content, providing a distinct operational advantage to service providers." Additional information about Syndesis IPTV Express is available by visiting booth 86 at the IPTV World Forum, which is being held March 5-7 at the Olympia 2 in London, UK, or at www.syndesis.com. About Syndesis (www.syndesis.com) Syndesis is the worldwide leader in OSS solutions powering the new communications subscriber experience, with production-proven solutions for advanced service offerings, such as Triple/Quad Play, VoIP and IPTV, and advanced architectures, such as IMS. Syndesis empowers the world's leading communications service providers to deliver new network and application experiences for their customers. Renowned for customer success, in-depth network expertise and off-the-shelf support for more technologies and equipment than any other communications software developer, Syndesis is the vendor of choice in deployments at leading service providers worldwide including AT&T, Bell Canada, BT, Cingular, COLT, NuVox, Qwest, Swisscom, Telecom Italia, Telefonica, Telstra, TELUS, Verizon Business and Verizon Wireless. Press Contact: Christine Payne PR Manager + 1 (416) 526-4878 payne@syndesis.com


 

Double digit growth in Central and Eastern Europe and North America Actavis Group ("ACT"), the international generic pharmaceuticals company, announces its results for the fourth quarter and full year ended 31 December 2006. Highlights * Reported revenue in the fourth quarter increased significantly by 80.0% to EUR350.2 million (4Q2005: EUR194.5 million) and by 138.2% to EUR1,379.9 (2005: EUR579.3 million), reflecting a first full year contribution from Alpharma's human generics division, acquired in December 2005 * Underlying revenue for the quarter increased by 17.1% (4Q 2005 pro forma: EUR299.1 million) and by 9.4% for the year (2005 pro forma: EUR1260.9 million) reflecting strong organic growth in Eastern Europe and North America * On a divisional basis: * Pro-forma sales in Central & Eastern Europe and Asia ("CEEA") increased to EUR148.6 million for the quarter (4Q 2005 pro forma: EUR113.2 million). Underlying growth was 31.3% in the quarter and 17.9% for the year. * Pro-forma sales in North America increased 28.9% to EUR92.0 million for the quarter (4Q 2005 pro-forma: EUR71.4 million), representing underlying growth of 28.9% and 12.5% for the full year. * Sales in Western Europe, Middle East and Africa increased 13.1% on a pro-forma basis to EUR76.9 million for the quarter (4Q 2005 pro forma: EUR68.0 million), but were unchanged for the year due to price erosion, especially in Germany. * Third-party sales declined 25.5% to EUR33.8 million for the quarter and by 6.5% for the year due to pricing pressure following the recent health care reforms in Germany. * The EBITDA margin was 19.9% for the quarter and 20.8% for the year as a whole. Excluding distribution in Bulgaria, the EBITDA margin was 21.7% for the quarter and 22.3% for the year. * Net profit was EUR32.5 million for 4Q and EUR102.7 million for the full year. Underlying net profit increased by 1.5% for the quarter and increased 71.7% for the year (excluding one time costs related to the attempted acquisition of PLIVA and amortisation of purchased intangibles). * Underlying diluted earnings per share was up 16.7% to EUR0.03190 for the full year. * Actavis completed strategic acquisitions in the US, Russia and India, all of which are expected to deliver revenue growth and further reductions in supply chain costs going forward. * The Group continued to leverage its strong pipeline through 113 product and market launches in the quarter, making a total of 376 launches for the year. Actavis President & CEO, Robert Wessman, commented: "This is another strong performance for the Group, where we have delivered on our EBITDA and net income targets for the year. We have continued to grow our business, both organically and through strategic acquisitions, achieving double-digit underlying growth in CEEA and the US and expanding our operations in key markets including Russia and Romania. The strength in our underlying business combined with our potential to drive further efficiencies across the Group, provides us with a solid platform for future growth."


 

Straumborg ehf., a company which is financially related to Brynja Halldórsdóttir, a member of the Board of Directors of Kaupthing Bank hf., has today, on February 28, 2007, extended a forward contract by closing a previous contract, cf. notice dated 29 December 2006, with a sale of 117,500 shares in the Bank at a price of 882.80 ISK pr. share and by purchasing the same number of shares with a forward contract. The maturity date of the forward contract is 14 March 2007, at which time the shares will be delivered at the price of 888,89 ISK per share. Brynja Halldórsdóttir owns 9,206 shares in the bank. Parties financially related to Brynja Halldórsdóttir own 14,112,048 shares in the bank. Following the transactions parties financially related to Brynja Halldórsdóttir own 4,817,500 shares in the Bank according to forward contracts.


 

Seventh European Airline to Order the Aircraft TORONTO, ONTARIO -- (MARKET WIRE) -- February 28, 2007 -- Bombardier Aerospace announced today that Adria Airways, the national carrier of Slovenia, has placed a firm order for two Bombardier CRJ900 86-seat regional jetliners. "Adria will be the seventh European airline and 12th worldwide to order the CRJ900 aircraft," said Steven Ridolfi, President, Bombardier Regional Aircraft. "With orders for 175 aircraft, many placed over the last 18 months, we see evidence that customers are recognizing the advantages of the CRJ900 aircraft in terms of economy, efficiency and passenger comfort." Adria joins other European carriers Air Nostrum, Air One, Atlasjet Airlines, Lufthansa CityLine, MAT Macedonian Airlines and My Way Airlines which have ordered the CRJ900 airliner. Adria Airways has been a Bombardier customer since March 1997 when it placed an initial order for two Bombardier CRJ200 LR 50-passenger regional jets. It currently operates seven of these aircraft. "The Bombardier CRJ900 will allow us to do two things, increase capacity beyond 50 seats and replace the Airbus A320 where passenger loads are insufficient to support the larger aircraft," said Tadej Tufek, Chief Executive Officer, Adria Airways. "The CRJ900 is the most efficient and economical way to reach these two goals." Adria Airways is also the Bombardier CRJ Recognized Service Facility (RSF) in Europe, providing heavy maintenance for all models of the CRJ Series. About Bombardier A world-leading manufacturer of innovative transportation solutions, from regional aircraft and business jets to rail transportation equipment, Bombardier Inc. is a global corporation headquartered in Canada. Its revenues for the fiscal year ended Jan. 31, 2006, were $14.7 billion US and its shares are traded on the Toronto Stock Exchange (BBD). News and information are available at www.bombardier.com. Bombardier, CRJ, CRJ200 and CRJ900 are trademarks of Bombardier Inc. or its subsidiaries. Notes to Editors Images of Adria Airways CRJ900 aircraft are available in our Multimedia Library at: www.aero.bombardier.com/htmen/F15.jsp Contacts: Bombardier Aerospace Marc Holloran 416-375-3030 www.bombardier.com


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |--------------------------------------------+----------------------| | Company dealt in | J Sainsbury Plc | |--------------------------------------------+----------------------| | Class of relevant security to which the | 28 and 4/7p ordinary | | dealings being disclosed relate (Note 2) | | |--------------------------------------------+----------------------| | Date of dealing | 27 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------+--------------------+--------------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------+------------+-------+------------+-------| | (1) Relevant securities | | | | | | | | | | | |-------------------------+------------+-------+------------+-------| | (2) Derivatives (other | | | | | | than options) | | | 640,323 | 0.037 | | | | | | | |-------------------------+------------+-------+------------+-------| | (3) Options and | | | | | | agreements to | 26,000,000 | 1.506 | 25,000,000 | 1.448 | | purchase/sell | | | | | | | | | | | |-------------------------+------------+-------+------------+-------| | Total | 26,000,000 | 1.506 | 25,640,323 | 1.485 | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Short | 225,323 | 521.0827 GBp | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | None | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) YES +-------------------------------------------------------------------+ | Date of disclosure | 28/02/2007 | |------------------------------------------------+------------------| | Contact name | Stephen Platts | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9635 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) +----------------------------------------------------------------------+ |Product |Written or|Number of |Exercise|Type, e.g.|Expiry date| |name, |purchased |securities to |price |American, | | |e.g. call| |which the option |(Note 2)|European | | |option | |or derivative | |etc | | | | |relates | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |5,000,000 |540 GBp |American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |7,500,000 |540 GBp |American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |5,000,000 |580 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |7,500,000 |580 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |5,000,000 |480 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |7,500,000 |480 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |5,000,000 |520 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |7,500,000 |520 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |1,000,000 |520 GBp |American |15/06/2007 | |option | | | | | | +----------------------------------------------------------------------+ Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |----------------------------------------------+--------------------| | Company dealt in | Gallaher Group plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | 10p Ordinary | | dealings being disclosed relate (Note 2) | | |----------------------------------------------+--------------------| | Date of dealing | 27 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------------+--------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (2) Derivatives (other than | 7,561,371 | 1.1507 | | | | options) | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | Total | 7,561,371 | 1.1507 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per unit | | name, | (Note 6) | (Note 7) | (Note 5) | | e.g. CFD | | | | |----------+------------+--------------------------+----------------| | CFD | LONG | 180,000 | 1130.1290 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 28th February 2007 | |----------------------------------------------+--------------------| | Contact name | James Feast | |----------------------------------------------+--------------------| | Telephone number | 0207 469 1901 | |----------------------------------------------+--------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |----------------------------------------------+--------------------| | If a connected EFM, state nature of | | | connection (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Voting Rights and Capital In accordance with the Disclosure and Transparency Rules, Hat Pin plc ("Hat Pin") confirms that its issued share capital as at 28 February 2007 comprises 24,153,232 ordinary shares of 2.5p each. All of the ordinary shares have equal voting rights, and none of the ordinary shares is held in treasury. The total number of voting rights in Hat Pin is therefore 24,153,232 This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Hat Pin under the Disclosure and Transparency Rules. ---END OF MESSAGE---


 

Ixonos Plc Press release February 28, 2007 Ixonos Plc has invited Jorma Hanhimäki, Director, Line Management of Telecommunications Business Unit, and Timo Kaisla, CEO of Ixonos Project Management Services, to join the company's management team from 27 February 2007. Jorma Hanhimäki, age 45, acted in 2001-2005 as CEO of Vega Technologies Oy, the software development service company that Ixonos acquired in October 2005. Hanhimäki has a long experience of the software product business. Timo Kaisla, age 37, acted in 2000-2006 as CEO of Service 4 Mobile Oy, the project management service company Ixonos acquired in June 2006. Previously Kaisla has worked with Orange, Vodafone, Nokia and several Finnish telecom operators. In addition to Hanhimäki and Kaisla, Ixonos' Management Team comprises CEO and President Kari Happonen, CFO Petteri Mussalo, CAO Risto Alvejuuri, director of the Telecommunications Business Unit Kari Liuska, director of the Systems Services Business Unit Asko Vainionpää and, representing the personnel, Shop Steward Taisto Takkumäki. Ixonos operates in the IT and ICT service markets, offering its customers flexible software development, maintenance and project management solutions that support their competitiveness and risk management. Ixonos's services range from expert work and consultation to software project deliveries and software maintenance services with comprehensive responsibility. Ixonos's clientele comprises leading mobile and smartphone manufacturers operating on the global markets, mobile network suppliers and telecom operators as well as Finnish finance companies and public administration organisations. Ixonos has its headquarter in Helsinki and local offices in Tampere, Turku, Salo, Jyväskylä, Oulu, Rovaniemi and Kemi, a subsidiary in Haapajärvi and in Tallinn (Estonia), too. The number of personnel exceeds 600. The company is listed on the Nordic Exchange, in the Small Cap segment, in sector Information Technology. The company's turnover was EUR 39,2 million in 2006. Operating profit was EUR 3,9 million. For additional information, please contact: Ixonos Plc Kari Happonen, phone +358 424 2231, mobile +358 400 700 761. kari.happonen@ixonos.com


 

Sponda Plc will sell two land sites with an aggregate area of 58 hectares in the Hakuninmaa and Honkasuo districts of Helsinki to Solidium Oy, a company owned by the Finnish government, for EUR 30 million. The sale is related to an agreement made by the Finnish government and Sponda Plc concerning Sponda's acquisition of Kapiteeli Plc that gives the Finnish government the right to repurchase certain land sites intended for residential development (Stock Exchange Release issued by Sponda on 31 January 2007). The disposal has no impact on Sponda's result. Selling these sites is part of Sponda's strategy to sell certain property assets for EUR 300-500 million in order to refinance the loan raised to finance the Kapiteeli acquisition. Sponda Plc Further information: Kari Inkinen, President and CEO, GSM: +358 (0)400-402 653 Erik Hjelt, SVP, Legal Affairs and Treasury, GSM: +358 (0)400-472 313 Sponda Plc is a real estate company specializing in commercial properties mainly in the Helsinki metropolitan area. Sponda's business concept is to own, lease and develop office, retail and logistics properties into environments that promote the business success of its clients. The fair value of Sponda's investment properties is approximately EUR 2.6 billion euros and the leasable area is around 2 million m². Sponda is the largest real estate investment company listed on the Helsinki Stock Exchange.


 

Posting a 58 percent increase in operating income, pre-tax profits of DKK 205 million, and a return on equity of 53 percent before tax, Saxo Bank reports another year of expansion in 2006. COPENHAGEN Saxo Bank has released its annual report for 2006, revealing yet another year of expansive growth figures for the investment bank. Net profits before tax were DKK 205 million down from DKK 222 million in 2005. Operating income rose 58 percent from DKK 634 million in 2005 to a record high DKK 1,002 million in 2006. Operating costs - including major investments in the future growth -rose 93 percent. The bank's return on equity before tax was 53 percent before tax, and 38 percent after tax. "Once again, we have experienced solid growth in earnings in our FX trading operations, and satisfactory growth in earnings in CFD's and futures contracts," said Saxo Bank co-CEO Lars Seier Christensen, in a comment on the earnings report. "We can only be pleased with our new global structure and the record earnings level, which also reflects the general growth in number of clients during the year." Client deposits grew by DKK 2 billion in 2006, totalling DKK 5.7 billion at year's end against DKK 3.7 billion at the start of the year. Growth in client deposits was attributed to direct client business as well as Saxo Bank's growing roster of white-label partnerships with financial institutions who market the bank's trading platform in their own name and corporate identity. Shareholders equity after dividends rose 43 percent from DKK 284 million in 2005 to DKK 385 million in 2006. The result further consolidated the bank's financial standing, presenting favorable conditions for a continuation of the current, high-growth trend. Investment in future growth The sizable increase in operating costs was due to major investments, including a doubling in personnel and the opening of new offices in London and Singapore. Saxo Bank expanded its workforce by more than 400 in 2006, with particular focus on sales, service and marketing capacities, along with IT, operations and other functions central to the value chain. The bank currently employs more than 900 people worldwide, and the expansion is expected to continue. No formal announcement has been made regarding future office sites for the bank. Offering his comment on the annual report and the outlook for 2007, co-CEO Kim Fournais said:" Our new global structure, with offices in Copenhagen, London, Singapore, Marbella and St. Petersburg, demands more skilled employees who are self-directed and team-oriented. Meeting this challenge will be crucial to implementing the bank's strategy for growth." About Saxo Bank A/S Saxo Bank A/S is a modern investment bank specializing in online investments in the international Capital Markets. Saxo Bank enables clients to trade currencies, shares, CFD contracts, futures, options and other derivatives as well as portfolio management via our online trading platform - SaxoTrader. SaxoTrader has been internally developed by Saxo Bank and is available to today's investor directly through Saxo Bank or through one of our global partnerships as an integral part of their own infrastructure. One of Saxo Bank's significant areas of business is White Labelling, which is the development of tailored versions of the online trading platform to other banks and brokerage houses. Saxo Bank has more than 70 White Label Partners and thousands of clients in 177 countries. The bank's website www.saxobank.com has approx. 65,000 visitors every day. Saxo Bank currently employs more than 900 employees from 45 different countries. The bank is headquartered in Denmark, with operating offices in London and Singapore, and an IT development center in St. Petersburg, Russia. Further information please contact: Saxo Bank - Rebecca K. Engmann - Financial Writer e-mail: rke@saxobank.com - telephone: 001 203 762 74 73


 

Business Process Outsourcing Leader Announces New Name; Rolls Out Brand to 65,000 Associates, Clients and Partners Worldwide NASHVILLE, TN -- (MARKET WIRE) -- February 28, 2007 -- The recently merged ClientLogic and SITEL Corporation today unveiled a new brand to communicate its commitment to associates and clients and usher in a new outsourced customer care business process outsourcing (BPO) leader. As part of a new brand strategy, the company announced it will adopt the name Sitel and bring to market a new Sitel offering a broader range of opportunities for associates, clients and customers. "This merger was not about combining two great companies to form one, large company," said Dave Garner, president and CEO of the new Sitel. "The merger was about taking two great companies and creating the best. The new Sitel will set the industry standard for outsourced customer care and re-define what it means to be an outsourcing partner." Continued Garner, "Companies around the world will look to the new Sitel to manage their most valuable asset -- their customers. They will also look to the new Sitel to introduce new services that add value and identify ways to improve customer care beyond the bottom line. Sitel will meet and exceed these challenges in partnership with our clients and associates and together we will earn the recognition and respect the outsourced customer care industry deserves." Analysts estimate that 85% of global customer care functions are performed in-house, presenting significant BPO market growth potential as these functions are increasingly outsourced. According to analyst group IDC, the global customer care BPO services market is expected to grow from $51.4 billion in 2005 to $92.2 billion in 2010. To hear more from Dave Garner about raising the bar for the customer care industry and to learn more about the Sitel brand, please visit http://www.sitel.com/brandlaunch. The new Sitel brand strategy was unveiled worldwide to associates, clients and partners in 28 countries last week in a series of global Sitel "Brand Week" events. Key elements of the new Sitel brand strategy include: -- A new company logo that visually bridges the best of both companies and symbolizes the new Sitel's strong history and global brand leadership. -- An executive management team with deep expertise and a proven track record of success across geographies, services and vertical markets. -- A new website (www.sitel.com) featuring the combined company's culture and core values of integrity and teamwork. -- A new Sitel brand video distributed to 65,000 associates worldwide to communicate the company's shared vision, passion and purpose. -- A quarterly Sitel newsletter for associates and clients to increase industry awareness and provide outsourcing best practices, challenges and success. What Clients Are Saying Abril "We are looking forward to working with the new Sitel to bring global solutions and best practices to the Brazilian market," said Ana Dávalos, Planning and Customer Service Director for Abril, one of Latin America's largest and most influential communications groups. "As a long-time partner of SITEL, this merger will bring new expertise and processes to our business -- from training to technology solutions -- that will help us expand our capabilities and make Brazil a global example for best-in-class customer care." EarthLink, Inc. "The customer care outsourcing industry is consolidating and this merger is a great example of two leading companies coming together to elevate the industry," said John Bowden, Group VP, Customer Support, EarthLink, Inc. "As a client of both companies, I am looking forward to working with the new Sitel to aggressively champion the power of the right-shore outsourcing strategy and showcase its award-winning potential. Excellence in execution is a driving factor for EarthLink and the new Sitel and we look forward to working side by side to deliver best-of-breed ideas and solutions that revolutionize outsourced customer care." Hewlett Packard "The new Sitel will bring many new opportunities for our business both financially and geographically, especially in the Latin America region," said Eduardo Rodriguez, Hewlett Packard Operational Manager, Brazil Solution Center. "Sitel's increased global presence and best-in-class methodologies will help us grow into new markets and strengthen the level of service we offer our customers." Toshiba "We have always been impressed with the quality of ClientLogic's front-line associates and management team and the personalized care they give our business and our customers," said Gary Evans, Head of Services, Computer Systems Division at Toshiba. "Our expectations for the new Sitel are even higher and we look forward to the increased service capabilities, greater flexibility and benefits of scale this merger will bring." About the new Sitel Sitel is a global Business Process Outsourcing (BPO) leader. Formed by the merger of ClientLogic and SITEL in January 2007, the new company meets clients' customer care and transaction processing needs through 65,000 associates in 28 countries. The new Sitel provides world-class solutions from on-shore, nearshore and offshore locations across 145+ facilities throughout North America, South America, EMEA and Asia Pacific. The new company's award-winning services provide clients with the strategic insight, scale and diversity of offerings to ensure the best return on their customer investment. The company is privately held and majority owned by Canadian diversified company, Onex Corporation. Media Contacts: Amit Shankardass Sitel +1 615.301.7274 amit.shankardass@sitel.com Mike Farber/Dawn Sullivan Schwartz Communications +1 781.684.0770 sitel@schwartz-pr.com


 

THE DATE OF SATAMA'S ANNUAL GENERAL MEETING HAS BEEN CHANGED The date of Satama Interactive Plc's Annual General Meeting 2007 has been changed. New date is March 21, 2007 at 15:00. Notice of the Annual General Meeting will be issued during week 9. SATAMA INTERACTIVE PLC Jarmo Lönnfors CEO ADDITIONAL INFORMATION Martti Ojala, CFO, tel. +358 207 581 637 DISTRIBUTION HEX Helsinki Exchanges Prominent media sources


 

28 February 2007 - BP on behalf of the BP Licences has entered into final clarifications with Aker Kværner in a view to award contract for the steel substructure to the Valhall Re-Development Project in the North Sea. Contract award is subject to partner deciding to proceed and governmental approval of the plan for development and operation (PDO). PDO will be submitted to the authorities at the end of first quarter 2007. The contract value is approximately NOK 450 million. The contract will be executed by the fabrication yard Aker Kvaerner Verdal in Mid-Norway, and includes procurement, fabrication, load-out and sea-fastening of the steel jacket substructure and piles for fastening the jacket to the seabed. The fabrication will start at Aker Kvaerner Verdal at the turn of the year, and the project will reach its peak manpower of approximate 300 personnel in June 2008. The main reason for developing a new field centre at the Valhall is the subsidence of the existing field centre and the need to operate more efficiently. The new centre will consist of an integrated processing and housing platform, which will become operative in 2010. The jacket will be installed one year ahead of this. With the new platform in place, the Valhall field will probably continue to be on stream until 2050. The Valhall Re-Development jacket will be number 34 in the series of jackets delivered from Aker Kvaerner Verdal. The yard has over the last 20 years more or less continuously had project execution of jackets. "The continuity in fabricating jacket structures combined with efficiency improving year by year has result in a very streamlined and efficient project execution model for this type of project, and has made it possible to win in a tough international competition", says Bjørnar Skjevik, President of Aker Kvaerner Verdal. Aker Kvaerner Verdal is currently building the Blind Faith hull for Chevron in USA. This project will be delivered in the second quarter 2007, and will be connected to the topside in shallow water outside Corpus Christi, Texas during the summer 2007. Facts: The Valhall field is situated in approximately 75 metres of water, south in the Norwegian sector of the North Sea, close to the Danish sektor, and is being developed by BP Norge (operator) together with its partners, Hess Norge AS, Shell Norge AS and Total E&P Norge AS. Steel jacket substructure dimensions: Height : 106 meters Weight : appr. 7.500 tonnes Piles. : appr. 4.000 tonnes Start fabrication : December 2007 / January 2008 Delivery : Spring 2009 Contract : PC (Procurement and Construction) ENDS For further information, please contact: Media: Tove Strand Trana, Communication Manager, Aker Kvaerner Verdal. Tel. +47 74 07 45 09, Mob: +47 46 40 11 03 Investor relations: Lasse Torkildsen, Vice President, Investor Relations, Aker Kvaerner. Tel: +47 67 51 30 39 Suppliers: Dag Joar Lund, Vice President Commercial. Tel. direct: +47 74 07 45 72. Mobile +47 95129434 Career opportunities: Visit http://www.akerkvaerner.com/Internet/CareerCentre AKER KVÆRNER ASA, through its subsidiaries and affiliates ("Aker Kvaerner"), is a leading global provider of engineering and construction services, technology products and integrated solutions. The business within Aker Kvaerner comprises several industries, including Oil & Gas, Refining & Chemicals, Mining & Metals and Power Generation. The Aker Kvaerner group is organised in a number of separate legal entities. Aker Kvaerner is used as the common brand/trademark for most of these entities. The parent company in the group is Aker Kværner ASA. Aker Kvaerner has aggregated annual revenues of approximately NOK 50 billion and employs approximately 23 000 people in about 30 countries. Aker Kvaerner is part of the Aker Group (www.akerasa.com), a leading multi-industry powerhouse with more than 55 000 employees and NOK 80 billion revenues. Aker owns 40.1 percent of Aker Kvaerner, and the group is also a major European shipbuilder and a significant participant in the fisheries industry. This press release may include forward-looking information or statements and is subject to our disclaimer, see our web-pages www.akerkvaerner.com


 

In conformity with Rule 5.6.1 of the Disclosure and Transparency Rules sourcebook, the Company hereby notifies the market of the following: The Company's issued share capital as at today's date consists of 59,337,822 ordinary shares of 25p each with voting rights. There are no such shares held in treasury. The above figure (59,337,822) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. John Geddes Company Secretary 0131 459 8180 28.2.07 ---END OF MESSAGE---


 

Elanders nominating committee has announced its proposal to the Annual General Meeting on 26 April 2007 to elect Hans-Olov Olsson and Kerstin Paulsson as new members of the Board of Directors. Hans-Olov Olsson, born 1941, has a M.Sc. from University of Göteborg. He has more than 40 years of experience in the automotive industry and held a number of executive positions in Volvo in Sweden and internationally, the latest as President and Chairman of the Board of Volvo Cars 2000 - 2006. During 2006 he was also a member of Executive Management in Ford with responsibility for the Ford Corporation's global brand and marketing strategies. Hans-Olov Olsson is also Chairman of the trade organisation Teknikföretagen. In addition, he is a member of the Board of the Confederation of Swedish Enterprises, Vattenfall AB, Lindab International AB and Höganäs AB. Kerstin Paulsson, born 1963, has a Masters of Science from the University of Technology at Lund. She is currently CEO and partner in the IT company Netsoft Lund AB. She was previously Head of Development at the Kockums Group. Kerstin Paulsson is a member of the Foundation for Knowledge and Development and a member of the Board of Lifco AB. "We are very pleased that we could engage Hans-Olov Olsson and Kerstin Paulsson in Elanders. Their solid experience in the automotive industry, electronics and IT will have considerable strategic significance for Elanders' future performance since the Group has vital customer segments in these areas," says Carl Bennet, Chairman of the Board of Elanders. The Board has also proposed re-election of Carl Bennet Chairman) Ingegerd Gréen, Patrick Holm (President and CEO), Göran Johnsson, Johan Stern and Tore Åberg. Gunilla Jönson has declined to stand for re-election. Proposals in other matters the nominating committee is responsible for will be presented in the Notice to attend the Annual General Meeting. The members of the Elanders nominating committee are its Chairman Carl Bennet (Carl Bennet AB), Gustav Douglas (Investment AB Latour), Göran Erlandsson (representative for the small shareholders), Nils Petter Hollekim (Odin Funds) Björn Lind (SEB Funds) and Caroline af Ugglas (Skandia Liv). For the Elanders AB (publ) nominating committee Carl Bennet Chairman For further information please contact the chairman of the nominating committee at telephone +46 300 50 200 or via e-mail carl.bennet@carlbennetab.se


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | AXA Investment Managers UK | | | Limited/AXA Framlington | | | Investment Management Limited | |-----------------------------------+-------------------------------| | Company dealt in | Premier Foods Plc | |-----------------------------------+-------------------------------| | Class of relevant security to | Ordinary shares | | which the dealings being | | | disclosed relate (Note 2) | | |-----------------------------------+-------------------------------| | Date of dealing | 27/02/2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------------------------------+ | | Long | Short | | | | | |---------------+--------------------------+------------------------------------------------| | |Number |Number | | | (%) | (%) | |---------------+--------------------------+------------------------------------------------| |(1) Relevant |26,961,685 (5.43%) | | |securities | | | | | | | |---------------+--------------------------+------------------------------------------------| |(2) Derivatives| | | |(other than | | | |options) | | | | | | | |---------------+--------------------------+------------------------------------------------| |(3) Options and| | | |agreements to | | | |purchase/sell | | | | | | | |---------------+--------------------------+------------------------------------------------| |Total |26,961,685 (5.43%) | | | | | | +-------------------------------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +--------------------------------------------------------------------------+ |Class of | Long | Short | |relevant | | | |security: | | | | | | | |---------------+----------------------------+-----------------------------| | |Number |Number | | | (%) | (%) | |---------------+----------------------------+-----------------------------| |(1) Relevant | | | |securities | | | | | | | |---------------+----------------------------+-----------------------------| |(2) Derivatives| | | |(other than | | | |options) | | | | | | | |---------------+----------------------------+-----------------------------| |(3) Options and| | | |agreements to | | | |purchase/sell | | | | | | | |---------------+----------------------------+-----------------------------| |Total | | | | | | | +--------------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | Purchase | 1,631 | 3.17p | | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short (Note | Number of securities | Price per | | name, | 6) | (Note 7) | unit (Note | | e.g. CFD | | | 5) | |----------+------------------+------------------------+------------| | | | | | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 28/02/2007 | |--------------------------------------------------+----------------| | Contact name | Tariq Ghandour | |--------------------------------------------------+----------------| | Telephone number | 0207 003 2805 | |--------------------------------------------------+----------------| | If a connected EFM, name of offeree/offeror with | N/A | | which connected | | |--------------------------------------------------+----------------| | If a connected EFM, state nature of connection | N/A | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

AMERICAN MARKETS OUTLOOK: U.S. stock markets are expected to open higher Wednesday in a rebound after plunging Chinese stocks Tuesday prompted Wall Streets heaviest slide since Sept. 11, 2001. "Volatility levels are obviously through the roof currently, so whilst the GDP figures out later today could provide direction for the markets, the bigger picture is still China," says GFT Global Markets Martin Slaney. "Traders will be wary of getting back into the market until we get some clarity on the rumored interest rate hike and tax restructuring there (in China)," he adds. Preliminary U.S. fourth-quarter GDP is due at 1330 GMT. Other data for release include February Chicago PMI, January new home sales and the latest crude oil stocks inventory. GFT Global Markets is calling the Dow Jones Industrial Average to open up 49 points at 12,265, the Nasdaq 100 up 1.5 points at 1757.7 and the S&P 500 up five points at 1405. EUROPEAN MARKETS: European shares are mostly lower amid continued risk aversion sparked by falling U.S. stocks Tuesday. In London, the FTSE 100 is down 0.7% at 6239.90, with miners once more leading the rout as investors continue to worry about global economic growth. In Frankfurt, the DAX is down 0.8% at 6766.20, with E.ON and Munich Re leading fallers. In Paris, the CAC is down 0.7% at 5548.22. March bunds are little changed after euro-zone unemployment and harmonized CPI data for January that met market expectations. The March bund future is up 0.15 at 116.30, while the March gilt is up 0.06 at 107.77. In the currency market, a calmer day in global financial markets than Tuesday is helping the dollar to rebound. The dollar is up at Y118.52. The euro is down at $1.3187 and the pound is down at $1.9546. =========================== TOP STORIES: ENDESAS FUTURE GETS MURKIER AFTER ENEL MOVE: The battle for control of Endesa SA (ELE) entered its most confusing stage yet, after Italian power utility Enel SpA (EN) acquired a 10% stake in the company, leaving the rest of players scrambling for cover. (By David Roman) HBOS FULL-YEAR PROFIT RISES 14%: HBOS PLC (HBOS.LN) reported a 14% rise in full-year underlying pretax profit, backed by a healthy economy in the U.K. and well-controlled costs. (By Henry Teitelbaum) MUNICH RE 4Q NET PROFIT DOWN 52%: German reinsurer Munich Re AG (MUV2.XE), the worlds second-largest reinsurer by gross premiums, reported a 52% drop in fourth-quarter net profit - notably on lower net investment income. (By Ulrike Dauer) ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: The yen should get some more support - at least for now - as global markets once again turn wary of risk. (By Nicholas Hastings) =CHARTING EUROPE: European equity indexes declined as forecast by this column Tuesday morning, but did so at a much faster pace than anticipated with several futures indexes having made their sharpest one day decline since Sep. 11 2001. The excessive fear in the market might lead to a short, sharp correction lower being made, but with a buying opportunity not being far off. (By Axel Rudolph) =ASSET CLASS: Whatever the causes of the sharp market moves in the past couple of days, one thing is certain: investors are rediscovering risk. (By Alen Mattich) =========================== STILL TO COME ET/GMT COUNTRY/PERIOD 0700/1200 US Feb 23 MBA Refinancing Index 0830/1330 US 4Q GDP, prelim 0945/1445 US Feb Chicago PMI 1000/1500 US Jan New Home Sales 1030/1530 US Feb 23 US Energy Dept Crude Oil Stocks 1030/1530 US Feb 23 US Energy Dept Distillate Stocks 1030/1530 US Feb 23 US Energy Dept Gasoline Stocks 1105/1605 EU ECB Chief Trichet speaks on the euro zone in Brussels =========================== OTHER NEWS: The annual rate of consumer price inflation in the euro zone fell unexpectedly in January, to 1.8% from 1.9% in December, despite a sharp rise in German value-added tax that month, data from the European Unions statistics agency showed. (By Nina Koeppen) Euro-zone unemployment declined to a fresh all-time series low in January, with the jobless rate now almost a full percentage point lower than a year earlier, data from the European Union statistics Eurostat agency showed. (By Ilona Billington) The headline measure of U.K. consumer confidence weakened in February as optimism about the economic outlook waned and consumers became less willing to make big purchases. (By Paul Hannon) German unemployment again surprised on the upside in February as companies hired more workers and offered more jobs. (By Roman Kessler) U.K. house prices grew strongly in February, despite three Bank of England interest rate hikes since August 2006, as a lack of supply continues to push prices higher, the Nationwide Building Society said. (By Ilona Billington) Switzerland-based cement and building aggregates company Holcim Ltd. (HOLN.VX) said its recent expansion in India, strong markets and efficiency gains boosted its 2006 net profit by 39%, and announced a higher dividend. (By Martin Gelnar) Serco Group PLC (SRP.LN) reported a 38% increase in full-year pretax profit, driven by GBP3 billion of new business, and said it will continue to achieve double-digit growth and improving margins this year. (By Molly Dover) Irish Life & Permanent PLC (IPM.DB) posted a 18% rise in full-year net profit, driven by higher mortgage and life insurance sales. (By Quentin Fottrell) Bouygues SA (12050.FR) said its net profit rose a higher-than-expected 50% last year, thanks to strong growth from its construction and road building divisions, and forecast 8% revenue growth for 2007. (By Greg Keller) Reinsurer Converium Holding AG (CHR) unveiled its medium-term strategy and plans for a future share buyback, a move seen as aimed at fending off a hostile bid by competitor Scor SA (SCO). (By Goran Mijuk) Wolters Kluwer NV (39590.AE) said fourth-quarter adjusted net income rose 11% , due in part to revenue growth and increased cost savings. It reiterated its full year 2007 targets. (By Roberta Cowan) Alpha Bank SA (ALPHA.AT) said that 2006 net profit rose 25%, due to strong growth in consumer lending, both in Greece and in neighboring Balkan markets. (By Alkman Granitsas) Beleagured online sports betting and gaming company Sportingbet PLC (SBT.LN) reported a 54% jump in second quarter underlying group operating profit, with the third quarter off to a good start. (By Lilly Vitorovich) Anglo-Dutch IT services provider LogicaCMG (LOG.LN) reported a 29.5% jump in full year 2006 net profit resulting from organic growth and acquisitions of several other computer services firms. (By Daniel Thomas) U.K. leisure group Whitbread (WTB.LN) said trading had strengthened throughout the year, and pointed to a strong performance at the companys full year results. (By Jackie Range)


 
Hitt og þetta
28. febrúar 2007

EPT Disclosure

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |-------------------------------------------+-----------------------| | Company dealt in | Monterrico Metals Plc | |-------------------------------------------+-----------------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |-------------------------------------------+-----------------------| | Date of dealing | 27th February 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 4000 | 353p | 353p | | | | | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 4000 | 353p | 353p | | | | | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +-------------------------------------------------------------------+ | Date of disclosure | 28th February 2007 | |-------------------------------------------+-----------------------| | Contact name | Seema Soni | |-------------------------------------------+-----------------------| | Telephone number | 0207 992 1565 | |-------------------------------------------+-----------------------| | Name of offeree/offeror with which | Monterrico Metals Plc | | connected | | |-------------------------------------------+-----------------------| | Nature of connection (Note 6) | Connected Financial | | | Advisor | +-------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

TietoEnator Corporation Stock Exchange Release 28 February 2007, 12.00 am EET An annual summary of TietoEnator's stock exchange releases and announcements in 2006 is available on the company's website at the address www.tietoenator.com/Press room. Some of the information included in the releases might be out of date. Further information is available from Senior Vice President, Communications and Investor Relations Päivi Lindqvist, tel. +358 9 8626 3276. TIETOENATOR CORPORATION DISTRIBUTION Helsinki Stock Exchange Stockholmsbörsen Principal Media TietoEnator is among the leading architects in building a more efficient information society and one of the largest IT services providers in Europe. TietoEnator specializes in consulting, developing and hosting its customers' business operations in the digital economy. The Group's services are based on a combination of deep industry-specific expertise and the latest information technology. TietoEnator has about 16 000 experts in close to 30 countries. www.tietoenator.com


 

(Bermuda, February 28, 2007) BW Offshore Limited ("BW Offshore") has today acquired 6.5 million shares in APL ASA, corresponding to approximately 14.8% of the shares and votes of APL ASA ("APL"). BW Offshore now holds 24.9% of the shares and votes in APL. BW Offshore has today acquired 6,500,000 shares (14.8%) in APL, bringing the total holding in the company up to 10,915,000 shares (24.9%). The Board of Directors of APL and BW Offshore have previously agreed to recommend to their shareholders a combination of the two companies, creating a major force in the global FPSO market with a strong platform for future growth. Please refer to earlier announcements for more information about the combination. For further information, please contact: Svein Moxnes Harfjeld, CEO BW Offshore + 47 41 40 48 86 Background information: BW Offshore Limited BW Offshore is a global provider of floating, production and storage vessels (FPSOs) to the oil and gas industry. The company is listed on the Oslo Stock Exchange and employ some 650 people worldwide of whom 140 work in the management office in Oslo. In addition we have offices in Mexico, Nigeria, Mauritania, Singapore and Malaysia. We have 25 years of experience from tanker-based conversion projects and global operation of production and storage vessels. BW Offshore is part of the BW Group, one of the world's largest maritime groups. For more information, please visit www.bwoffshore.com


 

(IFN) Second bids are due to be submitted on March 23 in the sale by Icelands Novator Holdings of a majority stake in the Bulgarian Telecommunications Co., said a person familiar with the situation on Tuesday.Around half a dozen parties are likely to take part in the second round comprising about four private equity firms and two strategic buyers, said another person familiar with the proceedings.Turkish incumbent Turk Telekom and Turkish mobile operator Turkcell (TKC), are likely to be in the frame as strategic bidders, the first person added. Turkcell recently agreed a $3 billion loan facility with its bankers to finance potential acquisitions and strategic investments in addition to general corporate purposes.Novator Holdings has the option to buy Viva Ventures Holding GmbH, the holding company that owns 65% of BTC. Viva is owned by Boston-based private equity firm Advent International Corp.The option was granted to Novator by Advent last January and runs out in June 2008. It involves a payment by Novator that would be used to refinance Viva and enable Advent and its financial partners to exit the business.Novator, which is controlled by Icelandic billionaire Thor Bjorgolfsson, appointed Lehman Brothers earlier in the year to explore its options including the sale of the stake, said people familiar with the situation.First round bids were submitted in mid-February in the sale process.BTC was privatized when Advent bought the 65% stake through Vienna-based investment vehicle Viva in 2004. The rest of BTC is floated on the Sofia stock exchange. BTC has a market capitalization of about EUR1.7 billion. Source:  Dow Jones Newswires


 

Private equity fund EQT V ("EQT") has signed a definitive agreement to acquire 100% of Dako, a leading Denmark-based supplier of systems for cancer diagnostics in pathology laboratories. The total consideration for the transaction is DKK 7.25 billion Dako is one of the world's leading developers, manufacturers and marketeers of systems for cancer diagnostics in pathology laboratories. In 2006 Dako generated sales of more than DKK 1,700 million, corresponding to a growth rate of 10% compared to 2005. With more than 1,250 employees and a presence in more than 20 countries, Dako covers most of the global pathology markets with reagents, instruments and software for high-quality, safe diagnosis. Dako is currently owned by the Harboe family (61%), Novo Nordisk (27%) and others (12%). The total consideration for the transaction is DKK 7.25 billion (enterprise value). "The Dako Group has been a family-controlled business ever since its inception in 1966. The family and its shareholders have now decided to find a buyer who can take the company forward and further develop the business, maintaining the Dako name and brand. We are convinced that Dako and our employees will have greater growth potential with EQT as the new owner," says Sonnich Fryland, Chairman of Dako's Board of Directors. "The Corporate Management of Dako is very satisfied that EQT, with its industrial approach, has acquired our company. Over the past two years we have worked hard to refocus the business of the Dako group to improve both growth and profitability. We now have a new growth strategy, we have new products in our pipeline, and with the support from EQT we will be able to make the investments necessary to accelerate our growth even further. Dako has the strongest brand name in the pathology market. By having industrial support from a financially strong owner, we will be able to expand our successful business model going forward," says Patrik Dahlén, CEO and President of Dako. The EQT equity funds have a strong track record of fostering growth and value creation in the companies they own. Over the past 12 years the funds have invested in 43 companies in Europe, resulting in an annual average increase in sales and number of employees of 11% during the EQT funds' ownership period. "EQT is very pleased to add Dako into our portfolio. Dako has a powerful position in an exciting growth market in cancer diagnostics. Our intention is to support management in the further development of the company in accordance with the strategy as outlined by management. Dako will remain headquartered in Copenhagen, Denmark, and we will continue to build on the Dako brand in order to realize Dako's full potential," says Ole Andersen, Senior Partner at EQT Partners. The transaction is conditional upon the approval of the relevant competition authorities and the approval of the transaction by a shareholders meeting in Dako. Lehman Brothers is acting as exclusive financial advisor to the Dako Group and its shareholders. Bech Bruun is providing legal advice to the Dako Group and its shareholders. A new Board of Directors will be appointed by EQT and Dako's Corporate Management. Media contacts: EQT Johan Hähnel, Communications & PR, +46 706 056 334 Dako A/S Anne Thommesen, Corporate Communications, +45 40 63 95 93 Dako A/S is a Denmark-based, world leading provider of systems for cancer diagnostics. Hospital and research laboratories worldwide use Dako products to make precise diagnoses and determine the most effective treatment of patients suffering from cancer. With more than 1250 employees and a presence in more than 20 countries, Dako covers most of the global pathology markets. Remaining markets are covered by distributors in 50 countries. www.dako.com


 

DJIA 12216.56 -415.70 -3.29% Nasdaq 2407.87 -96.65 -3.86% S&P 500 1399.16 -50.21 -3.46% FTSE 100 6286.10 -148.60 -2.31% Xetra DAX 6819.65 -207.94 -2.96% CAC40 5588.39 -174.15 -3.02% Above are closing prices Nikkei 225 17530.95 -588.90 -3.3% Hang Seng 19568.54 -579.33 -2.88% S&P/ASX 200 5816.50 -161.10 -2.7% Taiwan Index Closed S.Korea Kospi 1415.28 -39.32 -2.7% Dow Future 12195.00 +15.00 +0.1% NASDAQ Future 1750.00 -0.50 0.00% S&P Future 1398.25 +3.00 +0.2% Above are as of 0550 GMT USD/JPY 118.22-24 +0.25% Range 118.72 - 117.88 EUR/USD 1.3216-21 -0.23% Range 1.3247 - 1.3212 AUD/USD 0.7876-79 -0.04% Range 0.7884 - 0.7854 GBP/USD 1.9615-18 -0.03% Range 1.9643 - 1.9619 USD/CHF 1.2191-95 +0.15% Range 1.2194 - 1.2174 Above are as of 0550 GMT vs NY close USD/JPY Vol Option Contract 8.35%/8.60% EUR/USD Vol Option Contract 6.14%/6.36% AUD/USD Vol Option Contract 6.83%/7.18% GBP/USD Vol Option Contract 5.98%/6.23% USD/CHF Vol Option Contract 7.20%/7.80% Above are 1-Mo prices as of 0454 GMT 10Y JGB 1.6200% -0.0150 2Y Tsy 100 4/32 +5/32 4.68% -8.2 5Y Tsy 100 13/32 +11/32 4.54% -8.1 10Y Tsy 100 16/32 +17/32 4.56% -6.9 Closing Treasury prices vs prior NY close; JGB as of 0550 GMT Asian Spot Gold $669.50 -$14.85 -2.2% Comex Gold $664.10 -$19.80 -2.8% Brent Crude Oil $60.70 -$0.66 -1.1% Above are as of 0500 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: European stock markets are set to tumble again following Wall Streets heaviest slide since Sept. 11 2001. Meanwhile, the euro is lower against the dollar, while prices of government debt are likely to gain. Oil and metals are lower in Asian trading. STOCKS: Worries about the U.S. economy will continue to weigh, with European markets expected to suffer further heavy losses at the open. U.K. spreadbettor Cantor Index is calling the FTSE down 89 points at 6197, the DAX down 133 at 6686 and the CAC down 70 at 5518. "It really is a growth story," said Peter Dixon, an economist at Commerzbank. "Markets took a fairly positive view on what Bernanke was telling them about U.S. growth," he added, referring to Federal Reserve chief Ben Bernankes recent testimony about the U.S. economy. However, "it looks as if (Wednesdays) fourth-quarter gross domestic product numbers are going to be revised down heavily from 3.5% provisional estimate to close to 2.25%. That is the kind of move that tells markets that things arent quite as great as we thought." In M&A news, Italian power utility Enel snapped up a 10% stake in Spanish electricity provider Endesa for EUR39 a share, according to The Wall Street Journal, in a move that will help Endesa foil a takeover bid by German rival E.On as competition heats up in the Europes rapidly consolidating energy industry. Wall Street stocks had their worst day of trading since the Sept. 11 terror attacks, hurtling the Dow Jones industrials down more than 400 points on a worldwide tide of concern that the U.S. economy may stumble. The drop hit every sector across the market, and a total of $632 billion in market value was shed, according to Standard & Poors Corp. "This corrective consolidation phase isnt just going to be one day, but we dont believe this is going to be a bear market," said Bob Doll, BlackRocks global chief investment officer of equities. Still, traders dwindling confidence took another blow from data showing that the economy may be decelerating more than anticipated. A Commerce Department report that orders for durable goods in January dropped by the largest amount in three months exacerbated jitters about the direction of the U.S. economy. "It looks more and more like the economy is a slow growth economy," said Michael Strauss, chief economist at Commonfund. "Moderate economic growth is good - an abrupt stop in economic growth scares people." The market had been expecting the government on Wednesday to revise its estimate of fourth-quarter GDP growth down to an annual rate of about 2.2 percent from an initial forecast of 3.5 percent. Some traders worried it could come in even lower. Asian stocks were posting sharp losses for a second straight session Wednesday, extending the dramatic decline that rippled around the world following the biggest one-day decline in China shares in over a decade. But Chinas market, as measured by the Shanghai Composite, stabilized and even ticked slightly higher at one point Wednesday. Dealers believed the regional correction would end soon. FOREX: The euro and dollar are regaining some of their heavy losses against the yen, but the European currency is falling against the greenback. Another slew of fresh U.S. data could hit the dollar Wednesday, particularly as economists expect fourth-quarter gross domestic product report to undergo a hefty downward revision. The market will digest additional housing data, with the release of a new home sales report, and economists expected a moderate 3.6% decrease in sales in January. The euro has resistance at $1.3260 and support at EUR1.3190, traders said. BONDS: European government bond markets remain in good shape for more gains, after futures contracts hit seven-week highs Tuesday on continuing concerns over tension between the U.S. and Iran, and the U.S. subprime mortgage sector. Euro-zone M3 money supply growth for January showed a rise of 9.8% on the year, unchanged from December. "Money growth continues to support the case advocated by the most hawkish members of the ECB governing council," said Luigi Speranza, an analyst at BNP Paribas. "However, the downward trend in growth of loans to the private sector suggests the policy tightening is gradually having an impact on the economy. This should soon filter through the entire M3 aggregate." David Brown, chief European economist at Bear Stearns, said "fast monetary growth is obviously helping finance quicker expansion in the euro zone, but not at the cost of higher secondary inflation risks in the ECBs view. This should reinforce the ECBs case for a further rate hike next month." Treasury bond prices staged a sharp rally Tuesday as investors, rattled by a plunge in stock prices and continued concerns over the U.S. subprime mortgage market, sought a safe haven in government bonds. All eyes now turn to Wednesdays fourth quarter gross domestic product. John Canavan, market analyst with Stone & McCarthy in New York, said that a lower 2.2% GDP figure has now all but been priced into the government bond market after Tuesdays strong rally, with a number under 2% needed "to sustain any upside in Treasurys." Barring that, Treasurys should see some profit-taking Wednesday, Canavan said, with the 10-year trading in a 4.60%-4.63% yield range, though thats all dependent on whether or not global equity markets hold steady. The Federal Reserve must keep the economy clear of inflation, Dallas Federal Reserve President Richard Fisher said Tuesday evening. But Fisher also noted that the nations economic growth is "slowing." Japans government debt market rallied in line with Treasurys, while local data presented a mixed picture. Japanese retail sales dropped for the third straight month in January but production of cars, trucks and buses in Japan rose 4.2 percent on the year. ENERGY: Oil prices fell in Asia trading as Tuesdays plunge in Chinas benchmark stock index sent ripples through Asian markets and raised worries about reduced demand from the worlds second largest oil consumer. April Nymex was down $1.13 to $60.33 a barrel. "The reaction to the fall in the Chinese stock market is really a short-term overreaction," said Victor Shum, an energy analyst with Purvin & Gertz in Singapore. "The Chinese economy will remain a major growth engine in the global economy. Perhaps whats more important is the health of the U.S. economy." The U.S. Energy Information Administration will report later Wednesday on the nations fuel inventories, which analysts expect to show declines in gasoline and distillate stockpiles. METALS: Spot gold was last at $669.50/oz, recovering on short-covering from a low in New York of $658.00 but down from high of $688.75. "The main uptrend is still intact" for gold, said Robert Rennie, chief FX strategist at Australias Westpac Bank. "Weve still got some way to go (on the downside) before were challenging the bigger picture story for gold." LME copper is likely to consolidate in a $6,000-$6,100 range, as will copper futures at Shanghai Futures Exchange, during the rest of the week, but may rise again in early March on a strong demand outlook, said Cai Luoyi at China International Futures (Shanghai). LME 3-month was down at $6,135/ton, down $85 from the PM kerb. (MORE TO FOLLOW) Dow Jones Newswires February 28, 2007 01:48 ET (06:48 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 28 Feb 2007 06:48 GMT =DJ EUROPEAN MORNING BRIEFING:Mkts To Take Fresh Battering-2 CALENDAR: Wednesday, February 28, 2007 GMT Expected Previous 0700 GER Jan Labor Market Statistics 0745 FRA Jan Unemployment 8.6% 8.6% -20K -22K 0745 FRA Feb Consumer Confidence Survey -23 -24 0900 ITA Dec Large firms labor indicators 0930 UK Feb Mortgage Lending +GBP5.7B 1000 EU Feb Business Confidence Survey 109.0 109.2 1000 EU Feb Indus Confidence Survey +5 +5 1000 EU Feb Consumer Confidence Survey -6 -7 1000 EU Feb Business climate indicator for the euro 1.28 1.40 area 1000 ITA Jan PPI +3.8%YY +5.2%YY 1000 EU Jan Harmonized CPI -0.4%MM +0.4%MM +1.9%YY +1.9%YY 1000 EU Jan Unemployment 7.4% 7.5% 1015 EU ECB settles long-term refi tender 1030 UK Feb Consumer Confidence Survey -7 1100 EU Jan CPI Core, final -0.7%MM +0.4%MM +1.8%YY +1.6%YY 1100 UK Jan House Price Index +0.3%MM +9.3%YY 1200 US Feb 23 MBA Refinancing Index -5.4% 1330 US 4Q GDP, prelim +2.2% +3.5% 1350 US New York Fed Pres Geithner speaks on liquidity and financial markets in New York 1445 US Feb Chicago PMI 50.0 48.8 1500 US Jan New Home Sales -3.6% +4.8% 1530 US Feb 23 US Energy Dept Crude Oil Stocks (in +1.2M +3.7M barrels) 1530 US Feb 23 US Energy Dept Distillate Stocks (in -2.6M -5M barrels) 1530 US Feb 23 US Energy Dept Gasoline Stocks (in -1.6M -3.1M barrels) 1605 EU ECB Chief Trichet speaks on the euro zone in Brussels N/A GER Feb New Car Registrations N/A UK European Economic Advisory Groups "Report on the European Economy 2007" -By Dennis Baker; Dow Jones Newswires; dennis.baker@dowjones.com (MORE TO FOLLOW) Dow Jones Newswires February 28, 2007 01:48 ET (06:48 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 28 Feb 2007 06:48 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events Agfa-Gevaert (AGFB.BT): 4Q Earnings Average net loss (DJ, 5 analysts): EUR75.8M (EUR38M net profit) Average EBIT, before restructuring charges: EUR103.8M (EUR111M) Note: Net loss is due to heavy restructuring charges (around EUR180M). Analysts concerns are focused on raw materials silver and aluminum prices which could hit costs, and the USD weakness, which could hit sales vs US competitors. News of the ongoing restructuring process also in view. Alpha Bank (ALPHA.AT): FY Earnings Average net profit (DJ, 6 analysts): EUR641M (EUR502M) Average net interest income: EUR1.43B (EUR1.22B) Note: Net profit forecast does not include an estimated special tax charge of EUR74M as a result of one-off change in Greek tax legislation. Net interest income is seen up on strong loan growth in core Greek market and also in Southeast Europe. But NII numbers for 2005 will be adjusted to account for sale of Alphas insurance unit announced last October. Atos Origin (5173.FR): FY Earnings Average net profit (FactSet 22, analysts): EUR294.00M loss - EUR157.6M profit (EUR235M) Note: A Paris-based analyst says forecasts variation is due to different estimates of the impact of the companys profit warnings. Adds 06 is seen as a "major accident." On February 5, Atos Origin posted a 38% drop in operating profit to EUR247M for 06 from EUR399M a year ago, due to a steep drop in UK revenues and unveiled a a restructuring plan aimed at boosting margins. Bouygues (12050.FR): FY Earnings Average net profit (FactSet Estimates, 19 analysts): EUR1.12B (EUR832M) Average operating profit: EUR1.92B (EUR1.85B) Average revenue: EUR26.4B (N/A) Note: Analysts will be looking for mobile telecom EBITDA margin, dividend growth and first guidance for 2007 revenue. Converium (CHR): FY Earnings Average net profit (DJ, 4 analysts): $38M ($68.7M) Note: Converium is in the process of being taken over by Scor (SCO). The drop is mainly due to a charge linked to the sale of its US business. Analysts will ignore the results and concentrate instead on Converiums outlook comment and focus on management and board arguments as to why shareholders shouldnt accept Scors current CHF3.1B bid. Converium has so far rejected Scors offer, saying shareholders could expect more value if Converium remains independent. Erste Bank (EBS.VI): FY Earnings Average net profit (DJ, 6 analysts): EUR891.8M (EUR716M) Average pretax profit: EUR1.46B (EUR1.22B) Average net interest income: EUR3.15B (EUR2.79B) Average commission income: EUR1.45B (EUR1.26B) Average trading income: EUR278M (EUR242M) Note: Earnings were driven mainly by first-time inclusion of Romanian BCR, Deutsche Bank says. Deutsche Bank expects Erste Bank to see ongoing strong growth momentum from Eastern European countries and robust performance in Austria. Grupa Lotos (LTS.WA): 4Q Earnings Average net profit (DJ, 6 analysts): PLN89.84M (PLN120M) Average EBIT: PLN114.9M (PLN145M) Average sales: PLN3.35B (N/A) Note: Average net profit and average EBIT figures for 2005 have been adjusted for asset revaluation. Analysts say lower refining margins and falling crude oil prices as well as negative inventory valuation impact are the main reasons for weaker performance. However, Lotoss own, much cheaper, crude oil production is seen cushioning negative trends and meeting FY profit target of PLN657M. HBOS (HBOS.LN): FY Earnings Average pretax profit, before exceptional items (Co, 20 analysts): GBP5.43B (GBP4.84B) Average EPS, before items: GBP98.8p (N/A) Note: The dividend is expected to rise 12% to 40.6p. Analysts at Keefe, Bruyette & Woods see good cost control, strong equity-related life insurance sales and possible share buybacks. Downside risks lay in endowment mis-selling claims and charges for personal unsecured lending. Irish Life & Permanent (IPM.DB): FY Earnings Average operating EPS (DJ, 5 analysts): $1.69 ($1.35) Note: NCB Stockbrokers sees the life business delivering 55% operating profit growth and the banking business posting 21% profit growth;. "We remain upbeat about the growth prospects for the group," NCB adds. Komercni Banka (BAAKOMB.PR): FY Earnings Average net profit (DJ, 6 analysts): CZK9.15B (CZK8.91B) Average interest income: CZK15.67B (CZK14.66B) Note: Analysts expect Komercni to post strong growth in mortgage and consumer loans, while income from fees is seen flat on the year due to fierce market competition. Analysts say higher provisioning levels should be expected following the banks increase in lending. LogicaCMG (LOG.LN): FY Earnings Average revenue (Co, 12 analysts): GBP2.66B (GBP1.83B) Average group adjusted operating profit: GBP217M (GBP120.7M) Average adjusted basic EPS: GBP10.5p-GBP10.6p (GBP7.4p) Note: Analysts see growth driven by acquisitions of IT services firms Unilog and WM-Data in the past year. Analysts will look for an update on WM-Data integration and further detail on recent Telecoms Unit selloff. Michael Page (MPI.LN): FY Earnings Average pretax profit (Co, 17 analysts): GBP97M (GBP66.1M) Average EPS: GBP19.0p (GBP14.4p) Note: These gains are seen driven by strong growth in the job market. Munich Re (MUV2.XE): 4Q & FY Earnings Average 4Q net profit (DJ, 11 analysts): EUR627M (EUR1.34B) Average FY net profit: EUR3.44B (EUR2.7B) Average FY after-tax profit: EUR3.5B (EUR2.75B) Forecast range: EUR3.2B - EUR3.4B Note: Data expected to reflect significant decline in capital investment result, possible write-downs/reserve boosts and slightly lower premiums vs 4Q 05, which was boosted by EUR1.15B one-off gain from swapping HVB (HVM.XE) shares into UniCredit (UC.MI) shares. Low natural-disaster claims and EUR400M tax gain not seen offsetting the downside. Higher 2006 dividend vs EUR3.10 in 2005 is expected, potential additional charges for asbestos claims, strategy in weakening rate cycle will be eyed. Prokom Software (PKM.WA): 4Q Earnings Average consolidated net profit (DJ, 7 analysts): PLN25.49M (PLN36.33M) Average EBIT: PLN50.12M (PLN58.33M) Average sales: PLN542.5M (PLN701M) Note: Analysts say the problem is a lack of new public sector IT and hardware orders as growing small-business sales cannot offset the negative trend. Publicis Groupe (13057.FR): FY Earnings Average EBITA (DJ, 7 analysts): EUR691M (EUR649M) Note: Publicis has already reported FY 06 organic revenue growth of 5.6%, which was above market consensus, on sales of EUR4.39B, +6.3% from EUR4.13B in FY 05 following strong level of fourth-quarter account wins. Analysts will be pressing the company for further details on progress with the acquisition of Digitas, which Publicis bought in 2006. Serco (SRP.LN): FY Earnings Average pretax profit (Co, 13 analysts): GBP111.8M (GBP77.9M) Average sales: GBP2.6B (GBP2.3B) Note: Profit growth is seen driven by selective bidding for contracts as well as growth through acquisitions and operational improvements, say analysts. TrygVesta (TRYG.KO): 4Q Earnings Average net profit (DJ, 5 analysts): DKK998M (DKK496M) Average pretax profit: DKK1.26B (DKK678M) Note: Results seen boosted by low claims and strong equity return. 4Q combined ratio seen 85.7% versus 91.7% in 4Q 05. Expense ratio seen 16.2% versus 16.8% in 4Q 05. Eyes on eventual change in capital policy including a combination of dividend and share buy backs. Focus also on price competition. UCB (UCB.BT): FY Earnings Average net profit on continued operations (DJ, 4 analysts): EUR283M (EUR270M) Average REBIT: EUR428M (EUR437M) Note: Profits seen driven by strong sales of epilepsy drug Keppra. But with analysts predicting some lean years ahead, the market is keen to hear any news on pipeline drugs, particularly possible blockbuster Cimzia in Crohns Disease and rheumatoid arthritis. Any earnings guidance for year ahead also keenly anticipated Wolters Kluwer (39590.AE): 4Q Earnings Average net profit (DJ, 3 analysts): EUR98M (EUR70M) Forecast EPS range: EUR1.45 - EUR1.55 Average sales: EUR979M (EUR932M) Note: Net profit is seen rising due to fewer restructuring charges than last time and overall underlining improvement after three years of restructuring. Reiteration of FY07 targets including 4% organic growth, otherwise no surprises are seen. Main focus Wednesday will be on any news regarding divesting of the Education unit and what will be done with the proceeds. (MORE TO FOLLOW) Dow Jones Newswires February 28, 2007 01:48 ET (06:48 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 28 Feb 2007 06:48 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events -2- OTHER SCHEDULED EVENTS: Aalberts (33134.AE): FY Earnings Acerinox (ACX.MC): FY Earnings Adolfo Dominguez (ADZ.MC): FY Earnings Aedian (400592.FR): 1H Earnings Alchemia (ALC.WA): 4Q Earnings Allergy Therapeutics (AGY.LN): 1H Earnings Alpha Pyrenees (ALPH.LN): FY Earnings Apator (APT.WA): 4Q Earnings Apranga (10233.LH): FY Earnings Artumas Group (AGI.OS): 4Q & FY Earnings August Equity Trust (AGE.LN): FY Earnings Banco de Castilla (CAS.MC): FY Earnings Banco Espanol de Credito (BTO.MC): AGM Barratt Developments (BDEV.LN): 1H Earnings BATM Advanced Communications (BVC.LN): FY Earnings Ben Bailey (BBC.LN): FY Earnings Benefon (BNFSV.HE): FY Earnings Betbrokers (BETB.LN): FY Earnings Biolitec (BIB.XE): 2Q Earnings Brewin Dolphin Holdings (BRW.LN): AGM Card Guard (CARDG.EB): 4Q Earnings Carecapital Group (CARE.LN): FY Earnings CIE Automotive (CIE.MC): FY Earnings Civica (CIV.LN): AGM Communisis (CMS.LN): FY Earnings Compagnie des Alpes (5332.FR): AGM Compel Group (CGR.LN): 1H Earnings Computerland Poland (CPL.WA): 4Q Earnings Conseptor (CNS.OS): 4Q Earnings Corporacion Financiera Alba (ALB.MC): FY Earnings Cosmote Mobile (COSMO.AT): EGM Dane Elec Memory (3677.FR): FY & 4Q Earnings DGA (DGA.WA): 4Q Earnings Dialog Semiconductor (DLG.XE): FY Earnings Dieteren (DIE.BT): FY Earnings Done Solutions (DSO1V.HE): FY Earnings Draegerwerk (DRW3.XE): FY Earnings DynaPel Systems (DYNA.OS): 4Q Earnings Egetaepper (EGE-B.KO): Q3 Earnings Eicom (EIC.LN): 3Q Earnings Erg (ERG.MI): 4Q Earnings Eurofins Scientific (3825.FR): FY Earnings Fabasoft (FAA.XE): Q3 Earnings FADESA Inmobiliaria (FAD.MC): FY Earnings Federico Paternina (PAT.MC): FY Earnings FLSmidth & Co (FLS.KO): FY Earnings Fly Me Europe (FLY-B.SK): EGM FORTEC Elektronik (FEV.XE): 1H Earnings Fosen Trafikklag (FOS.OS): 4Q Earnings Frontline (FRO.LN): 4Q Earnings Gartmore European Investment (GEO.LN): AGM Gerry Weber International (GWI1.XE): FY Earnings GfK (GFK.XE): FY Earnings Globe Trade Centre (GTC.WA): 4Q Earnings Golay-Buchel Holding (GOL.EB): Trading Update Goodtech (GOD.OS): 4Q Earnings Grainger Trust (GRI.LN): AGM Groupe Diffusion Plus (5344.FR): 1H Earnings Groupe Steria (7291.FR): FY 2006 Earnings Harju Elekter (HAE1T.ET): FY 2006 Final Earnings Heliad Equity Partners GmbH & (HPB.XE): FY Earnings Henderson Group (HGI.LN): FY Earnings Hutmen (HTM.WA): 4Q Earnings I Grandi Viaggi (IGV.MI): AGM & EGM ICM Computer (ICM.LN): 1H Earnings IMAREX NOS (IMAREX.OS): 4Q Earnings Indykpol (IND.WA): 4Q Earnings Invalda (10227.LH): FY Earnings Isra Vision Systems (ISR.XE): Q1 Earnings Kampa Haus (KPH.XE): FY Earnings Kenmore European Industrial (KEIF.LN): FY Earnings Klaipedos Juru (11615.LH): FY Earnings (MORE TO FOLLOW) Dow Jones Newswires February 28, 2007 01:48 ET (06:48 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 28 Feb 2007 06:48 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events -3- Kredyt Bank (KRB.WA): FY Earnings KWS Saat (KWS.XE): 1H Earnings Latvijas Gaze (GZE1R.RG): FY Earnings Lifosa (11669.LH): FY Earnings Luxo (LUX.OS): FY Earnings March Networks (MNW.LN): Q3 Earnings MCI Management (MCI.WA): 4Q Earnings MediCult (MEC.OS): 4Q Earnings Metrovacesa (MVC.MC): FY Earnings Mid Wynd (MWY.LN): 1H Earnings MorphoSys (MOR.XE): FY Earnings Morse (MOR.LN): 1H Earnings MPC (MPC.XE): FY Earnings Muenchener Rueckversich (MUV2.XE): FY Earnings NH Hoteles (NHH.MC): FY Earnings Nordic Aluminium (NOA1V.HE): FY Earnings Norse Energy Corp (NEC.OS): FY Earnings NTR Holding (NTR-B.KO): FY Earnings Odim (ODIM.OS): 4Q Earnings Opera Software (OPERA.OS): 4Q Earnings Oral Hammaslaakarit (ORA1V.HE): FY Earnings Palfinger (PAL.VI): FY Earnings Parken Sport & Entertainment (PARKEN.KO): Q2 Earnings PC-WARE Information (PCW.XE): Q3 Earnings Pepees (PPS.WA): 4Q Earnings PhotoCure (PHO.OS): FY Earnings Plast-Box (PLX.WA): 4Q Earnings Polcolorit (PLT.WA): 4Q Earnings Poligrafica san Faustino (PSF.MI): FY Earnings Polimex Mostostal Siedlce (PXM.WA): 4Q Earnings Pragmatica Holding (PRG.EB): FY Earnings Praterm (PTM.WA): 4Q Earnings Proximagen Neuroscience (PRX.LN): FY Earnings Pure Wafer (PUR.LN): 1H Earnings QSC (QSC.XE): FY Earnings Rakentajain Konevuokraamo: FY Earnings Ringkjobing Landbobank (RILBA.KO): AGM Ropczyce Zaklady Magnezytowe (RPC.WA): 4Q Earnings Roskilde Bank (ROSK.KO): AGM Rotork (ROR.LN): FY Earnings Rytu Skirstomieji (12638.LH): FY Earnings Scana Industrier (SCI.OS): 4Q & FY Earnings SeaDrill (SDRL.OS): 4Q Earnings SIS International (0529.HK): 1H Earnings Skotan (SKT.WA): 4Q Earnings Sniace: FY Earnings Sondagsavisen (SOEN.KO): FY Earnings Sportingbet (SBT.LN): 2Q Earnings Stalexport (STX.WA): FY Earnings Stalprodukt (STP.WA): 4Q Earnings Stalprofil (STF.WA): 4Q Earnings Starman (SMN1T.ET): FY Earnings Swiecie Mondi Packaging Paper (MPP.WA): FY Earnings Sysopen Digia (SYS1V.HE): AGM Systar (5285.FR): 1H Earnings Tandberg Storage (TST.OS): EGM TAS (TAS.MI): FY Earnings TDG (TDG.LN): FY Earnings Temenos Group (TEMN.EB): FY Earnings Thrane & Thrane (THRAN.KO): 3Q Earnings Trintech Group (TTP.XE): 4Q Earnings Tubacex (TUB.MC): FY Earnings Turvatiimi Corp (TUT1V.HE): FY Earnings UTEK Corporation (UTK.LN): 4Q & FY Earnings Utenos Trikotazas (10932.LH): FY Earnings Vakaru Skirstomieji: FY Earnings Viaggi del Ventaglio (VVE.MI): AGM Victor International (VIINT.KO): FY Earnings Westbury Property Fund (WPF.LN): FY Earnings Whitbread (WTB.LN): Trading Update Yawal (YWL.WA): 4Q Earnings ZEG (Zaklady Elektroniki (ZEG.WA): 4Q Earnings Zemaitijos Pienas (12186.LH): FY Earnings Zenitel (ZENT.BT): FY 2006 Earnings (MORE TO FOLLOW) Dow Jones Newswires February 28, 2007 01:48 ET (06:48 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 28 Feb 2007 06:48 GMT =DJ EUROPEAN MORNING BRIEFING: Div Payments & Ex Div Dates Aquarius Platinum (AQP.AU): 1H 2007 Ex-Dividend Date Artwork Systems (ARTS.BT): FY 2006 Dividend Payment Date Ashtead Group (AHT.LN): 1H 2006 Dividend Payment Date AXA Property Trust (APT.LN): Q3 2006 Dividend Payment Date Bankers Investment Trust (BNKR.LN): FY 2006 Dividend Payment Date BHP Billiton (BLT.LN): 1H 2007 Ex-Dividend Date Blue Chip Value & Inc (BCV.LN): 3Q 2006 Ex-Dividend Date Carclo (CAR.LN): 1H 2006 Ex-Dividend Date Charter European Trust (CPE.LN): FY 2006 Ex-Dividend Date City Merchants High Yield (CHY.LN): 4Q 2006 Dividend Payment Date City of London Investment (CTY.LN): 2Q 2007 Dividend Payment Date Compagnie des Alpes (5332.FR): FY 2006 Dividend Payment Date Compel Group (CGR.LN): 1H 2007 Ex-Dividend Date Domino Printing Sciences (DNO.LN): FY 2006 Ex-Dividend Date F&C Capital & Income Inv Tst (FCI.LN): 1Q 2007 Ex-Dividend Date Faes Farmaceuticos (FAE.MC): 3Q 2006 Dividend Payment Date Galliford Try (GFRD.LN): 1H 2007 Ex-Dividend Date Heath (Samuel) (HSM.LN): 1H 2006 Ex-Dividend Date Heavitree Brewery (HVT.LN): FY 2006 Ex-Dividend Date Henderson Far East Income (HFE.LN): 1Q 2007 Ex-Dividend Date Hitt (35815.AE): FY 2006 Dividend Payment Date IG Group Holdings (IGG.LN): 1H 2006 Dividend Payment Date Imperial Chemical Industries (ICI.LN): FY 2006 Ex-Dividend Date ING UK Real Estate Income (IRET.LN): 1H 2007 Dividend Payment Date Jones Apparel Group (JNY): 4Q 2006 Ex-Dividend Date JPMorgan Income & Capital IT (JPI.LN): 4Q 2006 Ex-Dividend Date Jupiter Dividend & Growth (JDT.LN): 4Q 2006 Dividend Payment Date Jupiter Primadona (JPG.LN): 1H 2007 Ex-Dividend Date Kone (KNEBV.HE): FY 2006 Ex-Dividend Date New City High Yield Trust (NCY.LN): 2Q 2007 Dividend Payment Date Northern Foods (NFDS.LN): 1H 2006 Ex-Dividend Date Photo-Me International (PHTM.LN): 1H 2006 Ex-Dividend Date PZ Cussons (PZC.LN): 1H 2006 Ex-Dividend Date Reckitt Benckiser (RB.LN): FY 2006 Ex-Dividend Date Schroder Split Investment Fund (SCS.LN): 1Q 2007 Ex-Dividend Date Spring Group (SRG.LN): FY 2006 Ex-Dividend Date Standard Life Investments (SLI.LN): 1H 2007 Dividend Payment Date Throgmorton Trust (THRG.LN): FY 2006 Ex-Dividend Date United Drug (UDG.DB): FY 2006 Dividend Payment Date Wimpey (George) (WMPY.LN): FY 2006 Ex-Dividend Date Witan Investment Trust (WTAN.LN): 1H 2007 Ex-Dividend Date (END) Dow Jones Newswires February 28, 2007 01:48 ET (06:48 GMT) Copyright (c) 2007 Dow Jones & Company, Inc.


 

SOLTEQ PLC STOCK EXCHANGE ANNOUNCEMENT 28.2.2007 An annual summary of Solteq Corporation's stock exchange releases and notifications in 2006 is available on the company's website at www.solteq.com/stock-exchange-bulletins. SOLTEQ PLC For further information, please contact: CFO Antti Kärkkäinen, Tel +358 20 1444 393 or +358 40 8444 393 e-mail antti.karkkainen@solteq.com Distribution: Helsinki Stock Exchange Key media


 
Hitt og þetta
28. febrúar 2007

Q4 2006 Results

The NEC Board has on February 27, 2007 approved the Q4-06 report for Norse Energy Corp. ASA NEC reported USD 1, 9 million EBITDA in the fourth quarter due to lower Coral production. NEC posted an operating income (EBIT) of minus 3, 7 million. Several non cash entries affected the Q4 financial during the quarter. The company ended 2006 with 2P reserves and resources of 56.6 million BOE, an increase of 25, 4 million, or 81% compared to 2005 (no resources classified in 2005). Our proven (1P) reserves increased 74% during the year to 30,2 million BOE which replaced more than 10 times our 2006 production of 0.76 million BOE. See attachments. Contact: Anders Kapstad, CFO Phone: +47 67 51 61 12 Cell: +47 918 17 442


 

Hamburg, Germany | Oxford, UK | Amagasaki-City, Japan - Evotec AG (Frankfurt Stock Exchange: EVT) and Interprotein Corporation (previously IntercytoNanoScience Co., Ltd.) proudly announce today that they have signed a collaboration agreement on Interprotein's Interleukin 6 (IL-6) inhibitors programme for the development of novel, orally active drugs treating inflammatory diseases. IL-6 is a crucial cytokine involved in the onset and progression of inflammatory diseases such as e.g. rheumatoid arthritis and cachexia. Based on in silico drug design, Interprotein discovered a number of hit molecules. On the basis of these structures Evotec will use their expertise in medicinal chemistry, computational chemistry and profiling to fully optimise the compounds and to develop potent inhibitors for IL-6. Mr. Masato Hosoda, President and CEO of Interprotein, said: "We are excited about the collaboration with Evotec, which has a leading position in drug discovery and development and a proven track record in progressing drug candidates into development. Ongoing anti-IL6 antibody clinical trials provide evidence that the inhibition of IL-6 is significantly effective in inflammatory diseases. We believe that orally available drugs have the potential to supersede antibody therapy and furthermore, we hope that this programme will prove that small molecule compounds may have the potential to inhibit such protein-protein interactions." Dr. Mark Ashton, Executive Vice President Business Development Services Division from Evotec said: "We were impressed by the results of Interprotein's in silico work. Our medicinal chemists look forward to optimising the molecules identified and to supporting Interprotein with potent drug candidates for this very interesting target. We really enjoyed the excellent atmosphere developed between Evotec and Interprotein during the scientific and commercial discussions." Contact: Anne Hennecke, Senior Vice President, Investor Relations & Corporate Communications, Evotec AG, Phone: +49-40-56081-286, anne.hennecke@evotec.com --- End of Message --- WKN: 566480; ISIN: DE0005664809 ; Index: TecDAX, Prime All Share, CDAX, HDAX, MIDCAP, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

Reservoir Exploration Technology ASA (RXT) announced today unaudited results for the forth quarter 2006. - As guided in our Q3 2006 report we have growth in both revenue and EBITDA for the fourth quarter 2006. The results are in line with our expectations, CEO of RXT, Michael Scott, comments. EBITDA for the quarter was USD 5.0 million, compared to 4.5 million in Q3 2006 and minus 1.3 million in Q4 2005. Revenue was USD 19.3 million compared to 16.4 million in Q3 2006 and 5.0 million in Q4 2005. Net profit was USD 0.2 million compared to 1.9 million in Q3 and a loss of 2.0 million in Q4 2005. Cash flow from operations was USD 7.9 million compared to 1.6 million in Q4 2005. - RXT has in 2006 firmly established itself as the leading provider of the highest quality and most cost efficient multi component data acquisition. We will continue to grow and we aim to double our capacity within the end of 2007 to meet the growing demand, Scott continues. RXT has outstanding tenders valued at more than USD 300 million, and as a result of double capacity within 2007 RXT's market share will be in excess of 50%. For further information, please contact CFO Odd Erik Rudshaug at RXT. Phone : + 47 67828517 Cell : + 47 41612858 Fax : + 47 67828501 About RXT Reservoir Exploration Technology ASA (RXT) is a marine geophysical company specializing in multi component seismic sea-floor acquisition. Multi component seismic solves several imaging challenges that cannot be resolved with towed streamer seismic, and targets improved oil recovery from existing fields. The technology also gives better data quality for exploration, and is also the solution where towed streamers are impractical due to high density of platforms and/ or shallow waters. The Company has offices in Oslo, London and Houston. RXT is listed on the stock exchange in Norway (OSE ticker: RXT). Additional information is available at www.rxt.com.


 

Vancouver, February 28, 2007: Buck Morrow, the President of Northland Resources Inc., is pleased to provide an update on Northland's bulk sampling program at its 100% owned Stora Sahavaara iron-copper project in Norrbotten County, northern Sweden. The local excavation contractor, Snells Entrepenad AB, has completed clearing the overlying glacial till and preparing the access ramp for the start of the underground phase of the bulk sample. Preparation of the underground portal will begin next week and equipment for the underground phase has begun to arrive on site. After completion of a short access haulage into the magnetite, the contractor will blast a 30-40m long adit entirely within the magnetite from which a bulk sample of approximately 400 cubic meters, or roughly 1,000 tonnes of material, will be collected for the pilot-plant scale testwork program designed by Corus Consulting. Northland has posted photographs of the on-going work on the Gallery page of its website at www.northlandresourcesinc.com and a short video of the work will be posted soon. In June 2006, the Company retained Corus Consulting to supervise a comprehensive investigation of the optimum treatment route for magnetite ore from Stora Sahavaara (see news release dated June 29, 2006). Their work- in addition to the design and supervision of the bulk sampling program- will comprise of a testwork program to determine the optimum beneficiation route for the ore, development of a flowsheet, and a pelletizing testwork program. The results of the early stages of metallurgical test work at Stora Sahavaara are very encouraging and suggest that Stora Sahavaara can produce a viable, commercial grade pellet feed (see Northland's news releases dated February 12 and 15, 2007). Northland has delineated a NI43-101 compliant resource at Stora Sahavaara (see news release dated May 18, 2006). Using a 25% Fe cut off, the magnetite body contains: Category Tonnes Fe % Cu % Measured 77,063,210 43.32 0.080 Indicated 44,634,770 43.28 0.076 Inferred 23,346,373 41.76 0.051 Qualified Person Resource estimates were prepared by third party consultant (Bart Stryhas, PhD Structural Geology); the resource model and estimates were subsequently reviewed by Chlumsky Armbrust & Meyer L.L.C. ("CAM") an independent, mineral resource, consulting and engineering group based in Lakewood, Colorado USA. CAM believes that the Stora Sahavaara resource and resource model have been prepared according to accepted engineering practice for a project at this level of development. Vance V. Thornsberry, P.Geol., Vice-President of Exploration for Northland Resources, is the Qualified Person as defined in NI43-101, and has verified that the information presented in this release has been accurately summarized from the reports quoted herein. Background Northland Resources Inc. is a well-structured, debt free junior exploration company with a portfolio of high quality iron, gold, and base metal exploration projects in Sweden and Finland. ON BEHALF OF THE BOARD "Buck Morrow" NORTHLAND RESOURCES INC. The TSX Venture Exchange has not reviewed and does not take responsibility for the accuracy of this release. CONTACT INFORMATION Northland Resources Inc. Buck Morrow, President Ralph Rushton / Karen Davies, Investor Relations Toll Free: 1-866-719-8962 www.northlandresourcesinc.com


 

Deep Sea Supply PLC acquired today 621,000 own shares. The shares were acquired in the market at an average price of NOK 18,8 per share. Following this acquisition, the Company owns in total 621,000 own shares. 27 February 2007 Deep Sea Supply


 

MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX) today announced its financial results according to International Financial Reporting Standards (IFRS) for the three-months' period and fiscal year ending December 31, 2006. The Company achieved Group revenues of EUR 53.0 million, a positive cash flow from operations of EUR 16.3 million, and a net profit of EUR 6.0 million. Highlights of the Year 2006: * Therapeutic segment: Conclusion of three new multi-year partnerships with Schering-Plough, OncoMed Pharmaceuticals as well as Japanese pharmaceutical group Daiichi Sankyo; Extension and substantial enlargement of three existing collaborations including Pfizer, Roche and Novartis * Partnered pipeline: Substantial growth of partnered pipeline to 43 therapeutic antibody projects (up from 29 at the beginning of 2006); European Phase 1 clinical trials with HuCAL-derived antibody from partnership with Roche to treat Alzheimer's disease are ongoing. First preliminary clinical data of HuCAL-derived antibody from partnership with GPC Biotech suggest that antibody is well tolerated, hints of anti-tumor activity were observed * Proprietary pipeline: Development of lead compound MOR103 and MOR202 remain on track; MorphoSys confirms plan to submit all necessary information to regulatory authorities and ethics committees to start clinical trials for MOR103 for rheumatoid arthritis in H2 2007; For MOR202, a formal pre-clinical candidate was selected and MorphoSys intends to continue the pre-clinical development * Research segment: Consolidation of Research Antibody segment through acquisition of the Serotec Group in January 2006 and successful integration * Successful private placement of 384,338 shares raising gross proceeds of approx. EUR 17.1 million * Presentation of new RapMAT antibody technology as one visible result of the ongoing technology development process "Antibodies comprise the largest class of biotherapeutic agents and one of the most important life sciences research tools," stated Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG. "In 2006, MorphoSys cemented its position as one of the pre-eminent players in the antibody space. We expect increasing demand for antibodies and antibody-related capabilities in both the therapeutic and research segments to continue to drive MorphoSys's growth in the years ahead." "Both operationally and financially speaking, 2006 represented another banner year for MorphoSys," commented Dave Lemus, Chief Financial Officer of MorphoSys AG. "Looking ahead, we believe we are ideally positioned to capitalize on the expanding and lucrative trade for both antibody therapeutics and research reagents." Financial Review for the fiscal year 2006 (IFRS): Under International Financial Reporting Standards (IFRS), revenues for the year 2006 amounted to EUR 53.0 million (2005: EUR 33.5 million), an increase of 58 % over the prior year. Revenues arising from the Therapeutic Antibodies segment accounted for 65 % or EUR 34.7 million of total revenues. The AbD segment, formerly the Research Antibodies segment, generated 35 % or EUR 18.3 million of total revenues. MorphoSys's revenue growth was driven primarily by revenues arising from extended deals, success-based payments from existing collaborations, as well as the inclusion of Serotec Group revenues, contributing 23 % of total revenues. Total operating expenses including stock-based compensation for the full year 2006 were EUR 46.9 million (2005: EUR 27.3 million), representing an increase of 72 % over the prior year. Cost of goods sold (COGS), arising solely from the AbD segment, amounted to EUR 8.0 million (2005: EUR 2.5 million), and largely reflected the inclusion of the Serotec Group in MorphoSys Group accounts. Research and development expenses rose by EUR 3.5 million to EUR 17.5 million in 2006 (2005: EUR 14.0 million). The increase in R&D expenses mainly resulted from higher expenses for product and technology development amounting to EUR 3.0 million. Sales, general and administrative expenses increased by EUR 10.6 million to EUR 21.4 million (2005: EUR 10.8 million). The increase mainly derived from the inclusion of the Serotec Group in the amount of EUR 8.3 million, higher S,G&A personnel costs at MorphoSys AG in Munich, and integration costs associated with acquired companies. Non-cash charges related to stock-based compensation amounted to EUR 1.2 million (2005: EUR 1.1 million). Non-operating expenses, including taxes, amounted in 2006 to EUR 0.1 million (2005: Non-operating expenses of EUR 1.5 million). As a result of the forecast for taxable income in 2007, a deferred tax asset on tax loss carry-forwards has been capitalized which reduced tax expenses by ¤ 1.2 million. For the full year 2006 MorphoSys posted a net profit of EUR 6.0 million compared to a net profit of EUR 4.7 million in the same period of the previous year. The resulting diluted earnings per share for the year 2006 amounted to EUR 0.93 (2005: earnings per share of EUR 0.83). On December 31, 2006, the Company had EUR 66.0 million in cash, cash equivalents, and marketable securities, compared to the EUR 53.6 million balance as of December 31, 2005. The increased cash item mainly derived from higher cash inflows as a result of the expanded operational activity and from a capital increase successfully executed in March 2006. The number of issued shares at December 31, 2006 was 6,715,322 shares, compared to 6,025,863 at December 31, 2005. Fourth Quarter of 2006 (IFRS): In the fourth quarter of 2006, the Company generated revenues of EUR 14.0 million, compared to EUR 9.7 million in the same quarter of 2005, an increase of 44 %. Total operating expenses amounted to EUR 15.7 million, compared to EUR 7.3 million in the same quarter of 2005. The increase of operating expenses was mainly due to higher product and technology development cost in addition to restructuring costs in the UK, in the fourth quarter of 2006. The resulting net loss for the fourth quarter 2006 was EUR 0.1 million, compared to a net profit of EUR 0.8 million in the fourth quarter of 2005. Financial Outlook for 2007 MorphoSys is projecting total revenues of EUR 60 to 65 million, and profit from operations for the MorphoSys Group of EUR 7 to 10 million for the fiscal year 2007. Of total Group revenues, the Therapeutic Antibodies segment will provide approximately two thirds of Group revenues, the AbD segment one third. The Company will provide detailed guidance in today's press conference and conference call. MorphoSys will hold a public conference call today at 10:30 CET to present the Annual Financial Results 2006 and report on current developments. Dial-in number for the Conference Call (listen-only): Germany: +49 (0)89 9982 99912 For U.K. residents: +44 (0)20 7806 1958 Please dial in 10 minutes before the beginning of the conference. In addition, MorphoSys offers participants the opportunity to follow the presentation through a simultaneous slide presentation online at http://www.morphosys.com. Approximately two hours after the press conference, a slide-synchronized audio replay of the conference will be available on http://www.morphosys.com. For further information please contact: Dr. Claudia Gutjahr-Löser, Head of Corporate Communications, Tel: +49 (0) 89 / 899 27-122, gutjahr-loeser@morphosys.com or Mario Brkulj, Manager Public Relations, Tel: +49 (0) 89 / 899 27-454, brkulj@morphosys.com About MorphoSys: MorphoSys develops and applies innovative technologies for the production of synthetic antibodies, which accelerate drug discovery and target characterization. Founded in 1992, the Company's proprietary Human Combinatorial Antibody Library (HuCAL) technology is used by researchers worldwide for human antibody generation. The Company currently has licensing agreements and/or research collaborations with Bayer-Schering (Germany/USA), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (USA), Centocor Inc. (USA), Daiichi Sankyo & Co., Ltd. (Japan), GPC Biotech AG (Germany), Hoffmann-La Roche AG (Switzerland), ImmunoGen Inc. (USA), Merck & Co., Inc. (USA), Novartis AG (Switzerland), Novoplant GmbH (Germany), OncoMed Pharmaceuticals, Inc. (USA), Pfizer Inc. (USA), ProChon Biotech Ltd. (Israel), Schering-Plough (USA), Shionogi & Co., Ltd. (Japan), Xoma Ltd. (USA) and others. Additionally, MorphoSys is active in the antibody research market through its AbD Serotec business unit. The business unit was founded in 2003 for the purpose of exploiting the MorphoSys non-therapeutic antibody markets. MorphoSys' activities in the research antibody segment were significantly strengthened through the acquisition of the U.K. and U.S.-based Biogenesis Group in January 2005 and Serotec Group in 2006. For further information please visit the corporate website at: http://www.morphosys.com/. Statements included in this press release which are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements" for purposes of the safe harbour provided by Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The company cautions readers that forward-looking statements, including without limitation those relating to the company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Factors that may affect future operations and business prospects include, but are not limited to, clinical and scientific results and developments concerning corporate collaborations and the company's proprietary rights and other factors described in the prospectus relating to the company's recent public offering. HuCAL(R) and HuCAL GOLD(R) are registered trademarks of MorphoSys AG, RapMAT(TM) is a trademark of MorphoSys AG.


 

Zug, Switzerland - February 28, 2007 - Converium reports 2006 income from continuing operations of USD 215 million, net income of USD 57 million and presents its value-focused medium-term strategy. Converium today presents its road map to generate a sustainable return on equity of 14% by 2009. The key elements of Converium's medium-term value creation strategy are: growing business volume to USD 3 billion by 2009, whilst reducing the combined ratio to 96%; boosting capital efficiency by seeking shareholder approval to return USD 300 million to shareholders through the use of hybrid capital; increasing returns on investment and further improving cost-efficiency of operations. Converium's value creation strategy is supported by a strong financial performance in 2006, with the following highlights: * USD 215.0 million income from continuing operations * USD 57.1 million net income, including the negative impact from discontinued operations, net of tax of USD 157.9 million * USD 1,980.9 million gross premiums written * 96.3% non-life combined ratio * USD 1,846.0 million shareholders' equity * CHF 0.20 per share proposed dividend for 2006 Inga Beale, CEO, commented: "I am very pleased with our strong financial results for 2006. Based on a robust franchise and significant operational improvements we have accomplished a remarkable turnaround. I am convinced that the strategic path charted today sets both ambitious and obtainable goals. It rests on a capital base of approximately USD 2 billion, sound operating profitability, strong support from clients and brokers as well as talented employees who are committed to capturing the growth opportunities following a ratings upgrade. I strongly believe that we can achieve our growth and profitability targets based on the comprehensive management of all relevant value drivers." Converium's road map for sustainable value creation Converium is committed to achieving a sustainable return on equity of 14% by 2009. The underlying strategy will be built on fundamental improvements in underwriting, capital management, asset management and operations. Growing the business while improving profitability Converium aims to grow its gross premiums written by more than one third to USD 3 billion by 2009 based on total gross premiums written for 2007, expected to be in the range of USD 2.2 billion. Converium expects to win back a significant share of business with existing customers following a ratings upgrade. The Company expects to be able to regain market share in all lines of business, but primarily in specialty areas such as Credit & Surety and Agribusiness where Converium used to be among the global leaders. In addition, the Company expects to capture opportunities from fast-growing emerging markets where Converium can build on strong client relationships and a regional infrastructure. Converium is further committed to improving underwriting profitability to a combined ratio of around 96% in 2009. This objective is expected to be achieved based on the following four elements: First, the fronting fee on Converium's Global Aerospace Underwriters Ltd (GAUM) business will decrease following a ratings upgrade; second, the long-tail business with the Medical Defence Union (MDU) which is economically profitable even at a combined ratio of more than 100% will lose weight in Converium's overall portfolio; third, following a ratings upgrade, the Company is committed to rebalancing its book of business towards non-proportional business and attractive specialty lines at lower expected combined ratios; and, fourth, with growing business volumes Converium expects a reduced administrative expense ratio. Boosting capital efficiency by returning capital to shareholders and using more hybrid capital Following a ratings upgrade, Converium will be in a position to more efficiently leverage its balance sheet. Converium currently has significantly lower balance sheet leverage than its peers. The Company will seek to take advantage of beneficial financing conditions, and, shortly after a ratings upgrade, issue hybrid debt to USD 500 million. The funds raised will refinance current outstanding hybrid debt, and allow for USD 300 million to be returned to shareholders following shareholder approval. Greater efficiency in the use of capital is expected to bring down the weighted average cost of capital to under 9% by that date. Converium believes that its overall capital situation will allow for a sustainable dividend pay-out ratio of 25%-35%. Increasing sustainable investment yield Based on Converium's state-of-the-art expertise in Asset-Liability-Management and its new strategic partnership with Deutsche Asset Management, the Company expects to achieve significant sustainable improvements in its investment yield. One of the specific measures envisaged is a more sophisticated management of Converium's fixed-income securities portfolio. Strong financial performance in 2006 Income from continuing operations up six-fold For 2006, Converium reported income from continuing operations of USD 215.0 million compared with USD 34.1 million for the same period in 2005, equivalent to 13.0% return on equity. Converium's 2006 figures demonstrate the quality of the Company's underlying book of business, the absence of any major catastrophic events, as well as a satisfactory net investment income. The significant increase in profit is driven by an improvement in the non-life combined ratio from 107.0% in 2005 to 96.3% in 2006. In addition, Converium's results were positively impacted by the net favorable impact of prior accident years on the technical result of USD 52.1 million. Net income for 2006 amounted to USD 57.1 million, reflecting an overall negative impact on net income of USD 157.9 million from the sale of Converium's North American operations. Growth in business volume reflective of stable franchise For the year ended December 31, 2006, gross premiums written increased by 1.3% to USD 1,981 million. Net premiums written increased by 3.9% to USD 1,852 million, showing a resilient franchise and visible progress made towards the Company's turnaround in 2006. However, net premiums earned decreased by 19.7% to USD 1,812 million due to lower earned premiums from prior underwriting years reflecting the impact of the ratings downgrade in 2004. For the year ended December 31, 2006, net premiums written in Standard Property & Casualty Reinsurance increased by USD 77.9 million, or 10.5%, Specialty Lines decreased by USD 8.3 million, or 1.1% and net premiums written in the Life & Health Reinsurance segment decreased by USD 0.7 million, or 0.2%. Satisfactory net investment income result and investment yield (continuing operations) Converium's net investment income from continuing operations increased by 1.0% to USD 260.4 million for the year ended December 31, 2006 as compared with USD 257.8 for the same period in 2005. The average total invested assets from continuing operations was USD 6,147.4 million, which was a slight increase on the 2005 amount of USD 6,139.1 million. Our average net investment income yield (pre-tax) from continuing operations for the year was 4.2%, comparable with the prior year, reflecting similar market conditions and asset allocation. Fourth quarter performance impacted by sale of US operations The net loss in the fourth quarter of 2006 was USD 121.3 million, reflecting the one-off negative impact from the loss on sale of Converium's North American operations in December of 2006 of USD 190.1 million. The return on equity from continuing operations was 14.9%, compared with 4.2% for the fourth quarter of 2005. Gross premiums written over the quarter were USD 428.1 million, an increase of 10.7% on the prior year quarter. The combined ratio for the fourth quarter of 2006 was 93.5%, benefiting from the absence of major natural catastrophes during the period. Key financial metrics (USD, unless noted) Three months ended Twelve months ended December 31, 2006 December 31, 2006 (unaudited) (unaudited) * Gross premiums written 428.1 1,980.9 * Income from continuing 86.4 255.5 operations, before taxes * Income from continuing 70.6 215.0 operations[1] * (Loss)/income from -191.9 -157.9 discontinued operations[2] * Net income -121.3 57.1 * Segment income[3] 107.7 327.0 * Non-life combined ratio[4] 93.5% 96.3% * Average annualized net 4.3% 4.2% investment income yield (pre-tax) * Shareholders' equity from 1,846.0 1,846.0 continuing operations * Return on shareholders' 14.9% 13.0% equity[5] (annualized) * Basic earnings per share 0.48 1.47 from continuing operations * Diluted earnings per share 0.48 1.45 from continuing operations * Basic (loss) earnings per -0.83 0.39 share from net income * Diluted (loss) earnings per -0.82 0.38 share from net income Considerations on SCOR's pre-announcement: Converium's strategy expected to deliver more value The Board of Directors of Converium has noted the announcement of an offer by SCOR, at CHF 21.1 per share, for the whole of the share capital of Converium, based on closing share prices at February 16, 2007, that was published on February 26, 2007. The Board strongly believes that the offer fails to recognize Converium's full stand alone value potential. In addition, the Board stresses the fact that Converium offers shareholders potential value upside due to its flexibility to return capital. Converium's Board considers SCOR's acquisition currency to be weak: the cash part of SCOR's offer would be financed by Converium's excess capital and Converium shareholders would assume significant risk with a stretched combined balance sheet. Further, given the significant stock element in the offer, Converium shareholders would require more visibility on SCOR's stand alone value potential. Converium's Board of Directors is convinced that the Company's current share price does not reflect its full upside value following a ratings upgrade which Converium has made great progress to achieving on its own. SCOR's unsolicited approach also entails incalculable business and integration risk. Converium's 2006 Annual Report will be available in electronic format on 20 March 2007. The Annual General Meeting is planned to take place on 10 May 2007. Enquiries Beat W. Werder Marco Circelli Head of Public Relations Head of Investor Relations beat.werder@converium.com marco.circelli@converium.com Phone: +41 44 639 90 22 Phone: +41 44 639 91 31 Fax: +41 44 639 70 22 Fax: +41 44 639 71 31 Dr. Kai-Uwe Schanz Inken Ehrich Chief Communication & Corporate Investor Relations Specialist Development Officer inken.ehrich@converium.com kai-uwe.schanz@converium.com Phone: +41 44 639 90 94 Phone: +41 44 639 90 35 Fax: +41 44 639 70 94 Fax: +41 44 639 70 35 About Converium Converium is an independent international multi-line reinsurer known for its innovation, professionalism and service. Today Converium employs about 500 people in 15 offices around the globe and is organized into three business segments: Standard Property & Casualty Reinsurance, Specialty Lines and Life & Health Reinsurance. Converium has a "BBB+" financial strength rating (Credit Watch positive) from Standard & Poor's and a "B++" financial strength rating (outlook positive) from A.M. Best Company. Important Disclaimers This document contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. It contains forward-looking statements and information relating to the Company's financial condition, results of operations, business, strategy and plans, based on currently available information. These statements are often, but not always, made through the use of words or phrases such as 'seek to', 'expects', 'aims' 'should continue', 'believes', 'anticipates', 'estimates' and 'intends'. The specific forward-looking statements cover, among other matters, our combined ratio, return on equity and premium volume and expense reduction targets, our plans to use capital more efficiently and to return capital to shareholders, the reinsurance market, the Company's operating results, the Company's dividend policy, our ability to obtain an upgrade of our financial strength rating and the consequences of such an upgrade, the prospects for improving our results, investment yield and market share. Such statements are inherently subject to certain risks and uncertainties. Actual future results and trends could differ materially from those set forth in such statements due to various factors. Such factors include whether we are able to secure an upgrade of our financial strength ratings; our ability to refinance our outstanding indebtedness and increase our use of hybrid capital; uncertainties of assumptions used in our reserving process; risk associated with implementing our business strategies and our capital improvement measures; cyclicality of the reinsurance industry; the occurrence of natural and man-made catastrophic events with a frequency or severity exceeding our estimates; acts of terrorism and acts of war; changes in economic conditions, including interest and currency rate conditions that could affect our investment portfolio; actions of competitors, including industry consolidation and development of competing financial products; a decrease in the level of demand for our reinsurance or increased competition in our industries or markets; our ability to expand into emerging markets; our ability to enter into strategic investment partnerships; a loss of our key employees or executive officers without suitable replacements being recruited within a suitable period of time; our ability to address material weaknesses we have identified in our internal control environment; political risks in the countries in which we operate or in which we reinsure risks; the passage of additional legislation or the promulgation of new regulation in a jurisdiction in which we or our clients operate or where our subsidiaries are organized; the effect on us and the insurance industry as a result of the investigations being carried out by the US Securities and Exchange Commission, New York's Attorney General and other governmental authorities; our ability to regain past customers following any rating upgrades and the resolution of the investigations being carried out by the US Securities and Exchange Commission, New York's Attorney General and other governmental authorities; changes in our investment results due to the changed composition of our invested assets or changes in our investment policy; failure of our retrocessional reinsurers to honor their obligations or changes in the credit worthiness of our reinsurers; our failure to prevail in any current or future arbitration or litigation; and extraordinary events affecting our clients, such as bankruptcies and liquidations, and other risks and uncertainties, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission (including, but not limited to, our Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission) and the SWX Swiss Exchange. The Company does not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Additional information and where to find it: In connection with the offer by SCOR, Converium expects to file a solicitation/recommendation statement with the Securities and Exchange Commission (the "SEC"). Investors and security holders are strongly advised to read these documents when they become available because they will contain important information about the tender offer and the proposed merger. Copies of the solicitation/recommendation statement will be available free of charge at the SEC's web site at www.sec.gov, or at Converium's website at www.converium.com. IRS Circular 230 disclosure: To ensure compliance with requirements imposed by the Internal Revenue Service, we inform you that any U.S. tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein. [1] Continuing operations information (including prior periods presented) excludes the operating results of the North American operations and the loss on sale of Converium Holdings (North America) Inc. in the fourth quarter of 2006. [2] Included in loss on sale are net unrealized losses on available-for-sale securities, the currency impact and deferred income tax balance of USD 18.6 million that previously have been recognized in other comprehensive income (equity) and are realized upon the sale of the North American operations. [3] Segment income is defined as net premiums earned plus total investment results minus losses, loss expenses and life benefits, acquisition costs and other operating and administration expenses, excluding Corporate Center. [4] Non-life combined ratio is defined as ongoing non-life loss ratio (to net premiums earned) plus ongoing non-life acquisition costs ratio (to net premiums earned) plus ongoing non-life administration expense ratio (to net premiums written). [5] Based on shareholders' equity from continuing operations at the beginning of the period.


 

The extraordinary General Meeting in SAGA Oil ASA was held on 27 February 2007. All issues were resolved in accordance with the notice of the extraordinary General Meeting. Enclosed are the meeting minutes and the presentation held by CEO Malvin Høydal.


 

Berlin, February 27, 2007 - Jerini AG (FSE:JI4) announced today, following a pre-NDA meeting with the United States Food and Drug Administration (FDA), its plans to submit a New Drug Application (NDA) for Icatibant in the treatment of hereditary angioedema (HAE) in the third quarter 2007. In the pre-NDA meeting, the company reviewed with the agency its plans for submission of manufacturing, preclinical, clinical, and safety data to support the NDA for Icatibant. "The pre-NDA meeting and dialogue with the FDA have provided us with clarity for our NDA submission package," stated Jens Schneider-Mergener, CEO of Jerini. "Jerini remains committed to rapidly bringing HAE patients a new treatment option that could help them better manage their disease." Audio Webcast and Conference Call Jerini will host an audio webcast including an open question and answer session on February 28, 2007 to discuss the above information. Date: Wednesday, February 28, 2007 Time: 3:00 p.m. CET / 9:00 a.m. ET Telephone Access: +49 (0)69 9897 2633 Germany +44 (0)20 7365 1832 UK +1 718 354 1157 USA +41 (0)1 800 9659 Switzerland Please dial-in 10 minutes prior to start of the conference call. Online Access The replay of the audio webcast will be available on the Jerini website (www.jerini.com) two hours after completion of the conference call. FAST-1 and FAST-2 Clinical Trials Jerini conducted two multi-center, double-blind Phase III studies for the subcutaneous treatment of HAE. In the FAST-1 study, comparing Icatibant against placebo, 54 patients were randomized in the United States, Canada, Australia, and Argentina. In the FAST-2 study, comparing Icatibant against tranexamic acid, 74 patients were randomized at clinical sites in 10 European countries and Israel. In both the FAST-1 and FAST-2 trials, randomized patients used visual analog scale (VAS), symptom scores, and Clinical Global Impression (CGI) to evaluate the clinical efficacy of Icatibant or the comparator. About Icatibant Icatibant, a synthetic peptidomimetic, works by blocking the B2 receptor as an antagonist to the peptide-hormone bradykinin. Bradykinin has been shown to be elevated in HAE patients and responsible for edema formation during HAE attacks. Icatibant has been granted orphan drug status for the treatment of angioedema by the FDA and the EMEA, potentially securing, upon approval, market exclusivity for seven and ten years, respectively. In addition, the FDA has granted fast-track designation to Icatibant in the indication HAE. Icatibant's subcutaneous administration, excellent safety profile demonstrated in clinical studies to date, and its one-year-stability at room temperature, all offer key benefits to HAE patients. About Jerini AG Jerini is a pharmaceutical company based in Berlin, Germany, focusing on the discovery, development, and commercialization of novel peptide-based drugs. The company pursues disease indications that have limited or no treatment options and has built a drug pipeline composed of its own programs, as well as others in collaboration with established partners. In September 2006, Jerini reported Phase III clinical results of Icatibant in the subcutaneous treatment of hereditary angioedema. Based on its technology platform, Jerini has also established several in-house development programs, which address indications within the therapeutic areas of ophthalmology, oncology, and inflammatory disease. ISIN: DE0006787476 For questions, please contact: Stacy Wiedenmann Director Investor Relations & Corporate Communications Jerini AG Invalidenstr. 130 10115 Berlin T + 49 - 30 - 97893 - 285 X + 49 - 30 - 97893 - 105 wiedenmann@jerini.com --- End of Message --- WKN: 678747; ISIN: DE0006787476; Index: CDAX, Prime All Share, TECH All Share; Listed: Prime Standard in Frankfurter Wertpapierbörse, Amtlicher Markt in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Börse Düsseldorf;


 

Ad-hoc Announcement pursuant § 15 German Securities Trading Act - mandatory information for Europe-wide distribution Berlin, February 27, 2007 - Jerini AG (FSE:JI4) announced today, following a pre-NDA meeting with the United States Food and Drug Administration (FDA), its plans to submit a New Drug Application (NDA) for Icatibant in the treatment of hereditary angioedema (HAE) in the third quarter 2007. In the pre-NDA meeting, the company reviewed with the agency its plans for submission of manufacturing, preclinical, clinical, and safety data to support the NDA for Icatibant. ISIN: DE0006787476 For questions, please contact: Stacy Wiedenmann Director Investor Relations & Corporate Communications Jerini AG Invalidenstr. 130 10115 Berlin T + 49 - 30 - 97893 - 285 X + 49 - 30 - 97893 - 105 wiedenmann@jerini.com


 

VANCOUVER, British Columbia, February 27, 2007 - Maple Seal Homes Ltd. "MSH" http://www.maplesealhomes.com the wholly owned Canadian subsidiary of Maisonette International Enterprises Ltd. "the Company" (PINKSHEETS:MAEN) http://www.maisonetteworld.com is pleased to announce that it has received a verbal commitment for one or more homes to be shipped in France before the end of the Summer of 2007. Maple Seal Homes has received several inquiries from France but this time it has received a firm verbal commitment for its first project to be shipped by the Summer of 2007. MSH has met with its European partner and has been discussing the projects and is looking forward to start production of its first project destined for France. In addition to this particular project, MSH is working on several larger commercial projects for the years 2007 and 2008. In addition to its efforts in France, MSH is in contact with its U.K. partner in order to gauge the timing of the potential building of up to twenty eight new homes on a pristine golf course in the United Kingdom and move on to more such projects. MSH is expected to hear more on this project by June 2007, where about four to eight homes are to be shipped first and the remainder, depending on the success of the first shipment, will be shipped in 2008. The Company is very pleased with the progress of its partnerships in the UK, France and the USA and is planning to push its sales efforts further once the first wave of sales bring sufficient funds to warrant more aggressive sales efforts. MSH is expecting to ship up to 100,000 square feet per year from 2010 onward if all the technicalities of selling in the European market are solved and if market conditions allow such a bold projection. MSH does not see a slowdown in the timber housing market in Europe and is actually seeing an increased awareness of the environmental advantages of building with a natural material such as wood. The Company is continuing its efforts to grow its market in Europe and will publish more news for its shareholders once it has made further progress. About Maisonette International Enterprises Ltd. Maisonette International Enterprises Ltd. is a publicly held holding company incorporated in Nevada, USA. Its primary asset is a 100% wholly owned Canadian company called Maple Seal Homes Ltd. (www.maplesealhomes.com) with its primary activity being the sale and distribution of panelized prefabricated housing and building materials for the general public and professionals. Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors affecting the Company's operations, markets, products and prices and other factors discussed in the Company's various filings with the Securities and Exchange Commission. There may be other factors not mentioned above that may cause actual results to differ materially from any forward-looking information. Media Contact: Globus Media Ltd. investors@maisonetteworld.com www.maisonetteworld.com


 

"Battle of the Americas" Produced and Directed by Jeff Margolis Spans North, South, Latin America and the Caribbean in Hopes to Find the Newest Member of Los Ultimos Heroes CORAL SPRINGS, FL-- Feb 27, 2007 - TFM Group, a subsidiary of Global Realty Development Corporation, (GRD) (OTCBB: GRLY) today announced the newest music reality show to span two continents - the "Battle Of The Americas". "Los Ultimos Heroes" will search for their one final member. The audition process, which begins in June 2007 goes from the United States (Los Angeles, Phoenix, San Antonio, Miami, New York and Chicago), to the Caribbean (Puerto Rico), to Latin America (Mexico and Columbia), and all the way to South America (Brazil, Chile and Argentina). Forty six contestants from around the globe will come together in Orlando, Florida, to be reduced to the final twelve and compete for world stardom and the number one spot in Los Ultimos Heroes. The series will launch from Orlando, Florida and broadcast across the Americas. Viewer and live audience interactive voting from each participating country will create a fierce showdown and a true world cup style music reality show. "With the success of both 'American Idol' and 'Rockstar' - 'Battle of the Americas' will bring entertainment to the next level," said Roy Sciacca, President of TMF Group. "By taking the show into one of the most powerful markets on earth, the Latin market, and then giving the audience in over a dozen countries a chance to participate, we are truly building a music reality show on steroids." The newest music reality show will garner the glitz and glamour of the Oscars from Jeff Margolis, worldwide series producer and director of the "Battle of the Americas", who has directed the Academy Awards, Golden Globes, Grammy's and American Music Awards. In addition, Hank Cohen who stands at the helm of production company Trifecta Entertainment brings over 20 years of television experience to the project. About TFM Group TFM Group is committed to providing the best in all forms of television, film and music. TFM is initially focused on Latin crossover entertainment to the 45 Million Latino consumers in North America, 370 Million in South America and 150 Million in Central America and Puerto Rico. TFM is preparing to stand at the forefront of the Latino consumer market, specializing in all aspects of entertainment, including Television, Film, Music, World Tours, Major Events and Home Video/DVD. The strength of TFM is the result of its highly reputable and continuously growing management team. The knowledge and experience that each team member brings consistently supports the growing success of each division at TFM. In addition, TFM's seasoned management team forms relationships with some of the world's leading entertainment companies and top distribution channels worldwide. About Global Realty Development Corp. Global Realty Development Corp. (OTCBB: GRLY) is an international land development company operating through various real estate development subsidiaries. Global acquired MJD Films and the majority interest in the TFM Group and is focused on pursuing opportunities in the entertainment and gaming industry. For further information about Global Realty Development Corp, please visit http://www.grdcorporation.com Safe Harbor Statement Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of GLOBAL officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future GLOBAL actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and GLOBAL has no specific intention to update these statements. Contact: Redwood Consultants, LLC 415-884-0348 InvestorInfo@RedwoodConsultants.com 5W Public Relations 212-999-5585 kmercuri@5wpr.com


 

Members of Free Online Community Share Diet Experiences and Help Each Other Unlock the Secrets of Weight Loss LOS ANGELES, CA -- (MARKET WIRE) -- February 27, 2007 -- fatsecret.com launched today as a unique, independent online social network and resource for people interested in weight loss to learn about different diet programs and benefit from the collective experience of their peers around the world. fatsecret.com's proprietary platform enables members to share their diet experiences, support one another and find out what really works. In addition to providing members with tools to achieve their goals, the site aggregates and sorts community-generated content including recipes, tips, posts, journals and weight loss performance data. All content is tagged to a recognized diet program or specific topic in an easy-to-use format. Members can also create and share their own customized diet plans. "fatsecret was inspired by the realization that when it comes to weight management it's not a one size fits all world; different diets work for different people," said founder Rodney Moses. "The site was created to empower dieters with independent, user-generated information that cuts through the confusion and marketing hype surrounding most popular weight loss programs. It's the online destination for dieters seeking to connect with a grassroots community of supportive, motivated people who are on the same journey, and share similar needs and goals." fatsecret provides a uniquely practical and personal sense of what each major weight loss program is about. Members collaborate and learn together from the collective success and failure of the entire fatsecret community. These shared contributions help members make better dieting decisions. fatsecret is not affiliated or associated with any diet/fitness program or product. Membership is free, and while only members can contribute content, visitors can access most of the site. "Unlike narrowly focused commercial diet sites, fatscecret facilitates open discussion on virtually every popular weight loss program including Atkins, Weight Watchers, The South Beach Diet, Sonoma Diet, Fat Smash and the Fat Flush Plan," added Moses. "It's also different from subscription-based weight loss communities and free online diet forums or blogs, which offer limited functionality. We believe fatsecret has what it takes to become the leading web destination for all things diet-related." While there are more diet and weight loss programs than ever to chose from, the number of overweight and obese adults, and increasingly children, in industrialized nations continues to rise. fatsecret is a unique social media application designed to address this public health issue by helping people achieve their weight loss goals. More information about fatsecret is available at www.fatsecret.com. Contact: Erik Deutsch ExcelPR Group (323) 851-2300 x112 erikd@excelpr.com SOURCE: fatsecret.com


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |--------------------------------------------+----------------------| | Company dealt in | J Sainsbury Plc | |--------------------------------------------+----------------------| | Class of relevant security to which the | 28 and 4/7p ordinary | | dealings being disclosed relate (Note 2) | | |--------------------------------------------+----------------------| | Date of dealing | 26 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |--------------------------+-------------------+--------------------| | | Number | (%) | Number | (%) | | | | | | | |--------------------------+------------+------+------------+-------| | (1) Relevant securities | | | | | | | | | | | |--------------------------+------------+------+------------+-------| | (2) Derivatives (other | | | | | | than options) | | | 415,000 | 0.024 | | | | | | | |--------------------------+------------+------+------------+-------| | (3) Options and | | | | | | agreements to | 26,000,000 | 1.51 | 25,000,000 | 1.43 | | purchase/sell | | | | | | | | | | | |--------------------------+------------+------+------------+-------| | Total | 26,000,000 | 1.51 | 25,415,000 | 1.46 | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Short | 415,000 | 527.3951 | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +----------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry |Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+----------+--------------| |Short put| | | | | | | | option | Writing | 1,000,000 | 520 | American |15/06/2007| 21.50 GBp | |---------+------------+-------------------+--------+----------+----------+--------------| |Long call| | | | | | | | option | Purchase | 1,000,000 | 480 | American |15/06/2007| 9.00 GBp | |---------+------------+-------------------+--------+----------+----------+--------------| |Long call| | | | | | | | option | Purchase | 1,000,000 | 580 | American |15/06/2007| 9.00 GBp | |---------+------------+-------------------+--------+----------+----------+--------------| |Short put| | | | | | | | option | Writing | 1,000,000 | 540 | American |15/06/2007| 22.00 GBp | +----------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) YES +-------------------------------------------------------------------+ | Date of disclosure | 27/02/2007 | |------------------------------------------------+------------------| | Contact name | Stephen Platts | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9635 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) +----------------------------------------------------------------------+ |Product |Written or|Number of |Exercise|Type, e.g.|Expiry date| |name, |purchased |securities to |price |American, | | |e.g. call| |which the option |(Note 2)|European | | |option | |or derivative | |etc | | | | |relates | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |5,000,000 |540 GBp |American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |7,500,000 |540 GBp |American |15/06/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |5,000,000 |580 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |7,500,000 |580 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |5,000,000 |480 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |7,500,000 |480 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |5,000,000 |520 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |7,500,000 |520 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |1,000,000 |520 GBp |American |15/06/2007 | |option | | | | | | +----------------------------------------------------------------------+ Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Espoo, Finland - Nokia announced today that the Administrative Law Judge overseeing the investigation initiated by Qualcomm against Nokia in the United States International Trade Commission (ITC) has ordered a stay of the proceedings until further notice. The trial had been scheduled to begin on March 5, 2007. On June 9, 2006 Qualcomm filed a complaint with the ITC requesting an investigation into the alleged infringement by Nokia's GSM products of six Qualcomm patents. The ITC subsequently initiated an investigation on July 10, 2006. Nokia is confident that it has not infringed any Qualcomm patents that are at issue in this investigation. Additionally, since Qualcomm filed its complaint, it has voluntarily withdrawn three of the six patents from the suit. The remaining three are all from the same patent family. Nokia believes the patent withdrawal reflects on the weakness of Qualcomm's case. If the case is not dismissed before the stay is lifted Nokia welcomes the opportunity to prove that the claims regarding the three remaining patents have no more merit than those Qualcomm has already voluntarily withdrawn. Nokia is a leading innovator in the wireless space and has built one of the strongest and broadest intellectual property portfolios in the industry, with over 11,000 patent families. Since the early 1990's Nokia has invested approximately ¤30 billion in research and development. About Nokia Nokia is a world leader in mobile communications, driving the growth and sustainability of the broader mobility industry. Nokia connects people to each other and the information that matters to them with easy-to-use and innovative products like mobile phones, devices and solutions for imaging, games, media and businesses. Nokia provides equipment, solutions and services for network operators and corporations. Media Enquiries: Nokia Strategy and Technology Communications Tel: +44 7917 231 929 Nokia Communications Tel: +358 7180 34900 E-mail: press.office@nokia.com www.nokia.com


 

Evox Rifa Group Oyj Stock Exchange Release on February 27, 2007 * Net sales of 2006 were EUR 89.8 million (EUR 79.9 million in 2005). Net sales increased by 12 percent compared to the previous year. * Operating profit was 1.9 million (loss EUR 7.5 million). Operating profit includes EUR 1.2 million of one-time gain from real estate sales and EUR 0.9 million of one-time restructuring costs. In 2005 one-time costs were EUR 5.4 million. * Loss before taxes was EUR 0.2 million (loss EUR 8.7 million) * Earnings per share were EUR -0.005 (EUR -0.052) * Order backlog on December 31, 2006 was EUR 23.2 million (EUR 17.7 million) * The Board of Directors proposes that no dividend be distributed for the fiscal period. ECONOMIC DEVELOPMENT IN 2006 Net Sales Net sales of the Group totalled EUR 89.8 million (EUR 79.9 million in 2005). During the 2006, demand was at a good level in all Evox Rifa's market areas. Europe was still the main market area of the Group, and the market share there remained at the level of the previous year. Evox Rifa's major customers continued expanding their activities in China, but globally Europe kept its position as the major location for manufacturing of industrial and automotive electronics. The North American market was steadily recovering during 2006. The share of the Group's sales to the industrial electronics increased compared to the previous year and it was now 68 percent (59 percent in 2005). Deliveries to the end customers were carried out through contract manufacturers more often than earlier. Profit Operating profit of the Group in 2006 was EUR 1.9 million (loss EUR 7.5 million) and loss before taxes was EUR 0.2 million (loss EUR 8.7 million). The operating loss includes EUR 1.2 million of one-time gains from the sale of production facilities in Sweden and UK and EUR 0.9 million of one-time costs which resulted from the relocation and restructuring activities in the US and Europe. The one-time costs in 2005 were EUR 5.4 million. Earnings per share were EUR -0,005 (EUR -0.052) and shareholders' equity per share was EUR 0.036 (EUR 0.041). Evox Rifa Group has received product reclamations the processing of which is still in process. The management believes that the provisions made in the balance sheet of the Group will cover currently assessable compensation risk. Order backlog The order backlog of the Group was EUR 23.2 million at the end of 2006 (EUR 17.7 million at the end of 2005). The order backlog remained on a good level in the last quarter of 2006 and it is expected to remain such in the first quarter of 2007. FINANCIAL STATUS AND CAPITAL EXPENDITURE Liquid assets of the Group were EUR 1.3 million (EUR 2.4 million) and the equity ratio was 12.9 % (13.9%) at the end of 2006. If the convertible capital loan was included in the shareholders' equity, equity ratio was 23.3 %. The Group's net interest costs were EUR 1.4 million (EUR 1.4 million). Exchange rate gains and losses totalled EUR -0.5 million (+0.4). Even though the operative cash flow improved towards the end of the year, the Group's financial position continued to be tight. The expansion of production at the Finnish plant, the restructuring of the Swedish operations, the low profitability of the Finnish plant and the increased need for working capital reduced the Group's liquidity. In June 2006 the Group agreed with its main financiers on the conditions of a EUR 2.2 million working capital financing, and in December on a EUR 3.3 million investment and working capital financing. The Group's financing agreements include standard terms regarding the change of ownership. The real estate deal in Sweden was closed in March 2006. BHC Components Ltd. reached an agreement on the sales conditions of its production facility in June, and it will continue as a lessee in the premises. Total revenues from the real estate sales were EUR 6.0 million. Evox Rifa Group Oyj issued a convertible capital loan in March 2005, which was subscribed by EUR 5.6 million. No interest can be paid on the convertible loan in 2006 due to lack of distributable profits in the financial statements of December 31, 2006. Interest on the convertible capital loan, EUR 0.3 million, however, reduces the result of 2006. Gross investments into manufacturing equipment at the Group's Finnish, British, Chinese and Indonesian plants were EUR 1.0 million (EUR 4.0 million). SHARES AND SHARE CAPITAL The nominal value of the shares of Evox Rifa Group Oyj is EUR 0.05, the number of shares was 178.156.018 on December 31, 2006 and the share capital was EUR 8.908.400,90. Due to subscriptions of 935.000 new shares by share options, the share capital increased by 47.350 euros. PERSONNEL The average number of personnel of Evox Rifa Group was 1391 in 2006 (1320 in 2005). The number of personnel increased at the plants in Asia and Finland. At the end of 2006, 54 % (54%) of the Group personnel were employed in Asia. At the Finnish plant there were 26 persons, whose temporary employment contracts were not renewed. THE BOARD'S PROPOSAL FOR DIVIDEND DISTRIBUTION The Board of Directors propose to the Annual Shareholders' Meeting that no dividend be distributed for the fiscal period. BUSINESS DEVELOPMENT Net sales of the electrolytic capacitors product group were EUR 48.3 million in 2006 (EUR 40.8 million in 2005). The profitability of the product group continued on a favourable level and demand was strong in all market areas. The Nantong plant in China started producing screw terminal electrolytic capacitors at the end of 2005. During 2006, the plant's profitability improved and stabilised its position as a component supplier to industrial electronics. Net sales of the film capacitor product group were EUR 41.5 million (EUR 39.1 million in 2005). Demand was strong in all market areas, and capacity utilization rates of the plants were on a good level. The high prices of energy and raw materials caused pressure on gross margins. The Kalmar plant in Sweden was closed at the end of 2005, and the main part of its production was transferred to Finland. The start up of paper capacitor production in Finland was more difficult than expected. This caused substantial losses especially during the first quarter of the year. SIGNIFICANT EVENTS AFTER DECEMBER 31, 2006 On February 19, 2007 Kemet Corporation announced its intention to launch a public offer to acquire all the shares of Evox Rifa Group Oyj. OUTLOOK FOR THE YEAR 2007 The year 2006 was a period of strong demand, and stable demand is expected to continue, especially in the industrial and automotive electronic sectors. However, the visibility of the market demand and market conditions is weakened by increased inventory levels in the supply chain and high prices of raw materials and energy. The sales development of Evox Rifa Group's most important customers is expected to continue at a steady pace, and the growth of the business operations in Asia of the major partners of the Group is expected to continue. The increased need for working capital and the low profitability of the Finnish plant have tied up Group's liquid funds. As the capacity utilization rates of the plants are expected to stay at a good level and the Chinese plant is expected to tie up more working capital, the financial situation of the Group will still be tight. The profitability of the electrolytic capacitors product group is estimated to stay good. The film and paper capacitors product group is expected to improve its performance along with the improving profitability of the Finnish plant. The figures of this Financial Report are unaudited. In Espoo on February 27, 2007 EVOX RIFA GROUP OYJ Tuula Ylhäinen President & CEO For further information please contact: Evox Rifa Group Oyj, Tuula Ylhäinen, President & CEO, tel.+358 9 5406 5001 Distribution: Helsinki Stock Exchange, Main Media


 

Today, SimCorp's Board of Directors reviewed and approved the Group's annual report 2006. The annual report shows among other things that the company posted the best results in SimCorp's history with an EBIT of EUR 35.5m (DKK 265m) and an EBIT margin of 26.5 %. Revenue increased 31 % to EUR 134m (DKK 999m).


 

ZEELAND, MI -- (MARKET WIRE) -- February 27, 2007 -- Gentex Corporation (NASDAQ: GNTX), the leading supplier of automatic-dimming rearview mirrors to the worldwide automotive industry, has announced that it is shipping interior auto-dimming mirrors for the 2007 Volvo C30. Gentex auto-dimming mirrors automatically darken to reduce glare from the headlamps of vehicles approaching from the rear. The brighter the glare, the darker the mirrors become, making nighttime driving safer. The 2007 C30 offers an auto-dimming mirror with a compass display as part of a convenience package available on specific trim levels. The C30's primary markets are in Europe, including Italy, the United Kingdom, Germany and Spain. "Volvo's target market for the C30 is the younger buyer which will introduce Gentex products to a new generation of Volvo customers," said Gentex Senior Vice President Enoch Jen. Founded in 1974, Gentex Corporation (NASDAQ: GNTX) is an international company that provides high-quality products to the worldwide automotive industry and North American fire protection market. Based in Zeeland, Michigan, the Company develops, manufactures and markets interior and exterior automatic-dimming automotive rearview mirrors that utilize proprietary electrochromic technology to dim in proportion to the amount of headlight glare from trailing vehicle headlamps. Many of the mirrors are sold with advanced electronic features, and approximately 96 percent of the Company's revenues are derived from the sales of auto-dimming mirrors to nearly every major automaker in the world. FINANCIAL MEDIA AND INVESTOR CONTACT: Connie Hamblin 616/772-1800 GENERAL MEDIA CONTACT: Craig Piersma 616/772-1800 EXCHANGE: The NASDAQ Stock Market SYMBOL: GNTX WEBSITE: www.gentex.com


 

VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- February 27, 2007 -- Keegan Resources Inc. (TSX VENTURE: KGN) - Keegan is pleased to release the results of 24 additional holes from the saprolite resource definition program at Esaase. The total area covered now is approximately 780 meters along strike by 300 meters width, (see www.keeganresources.com for a map showing drill hole locations and cross-sections). Significant intercepts were encountered in 23 of 24 holes being released. Highlights include 30 meters of 8.64 g/t Au, 43 meters of 1.72 g/t Au, 66 meters of 1.19 g/t Au, and 7 meters of 22.56 g/t. Evaluation of the results in plan and section show a series of moderately to steeply dipping zones of gold mineralization that have excellent grade continuity along and between sections. As a result of the moderate dip on most sections, the favorable topography which is falling off steeply to the west in the down dip direction and the notable increase in grades seen in the larger RC samples, Keegan believes that these zones will continue to develop significant resources at a considerable distance down dip from the current drill pattern. Additionally, based on the fact that many holes ended in excellent gold mineralization, Keegan plans to expand the current drill program with deeper holes which will be targeted to test the depth of mineralization. Keegan will also be drilling aggressive step out holes to the west to test the down dip extension and width of the existing mineralized zones. Table 1. New Gold Intercepts from Keegan's Esaase RC Program ----------------------------------- ----------------------------------- HOLEID From To Width Grade HOLEID From To Width Grade ----------------------------------- ----------------------------------- KERC030 21 49 28 0.81 KERC046 5 30 25 1.51 ----------------------------------- ----------------------------------- KERC030 85 91 6 2.67 KERC047 11 20 9 2.87 ----------------------------------- ----------------------------------- KERC031 0 12 12 1.54 KERC047 29 38 9 0.56 ----------------------------------- ----------------------------------- KERC031 48 75 27 1.19 KERC047 145 155 10 1.27 ----------------------------------- ----------------------------------- KERC031 84 99 15 1.38 KERC048 55 61 6 0.77 ----------------------------------- ----------------------------------- KERC032 1 9 8 2.25 KERC048 77 84 7 1.01 ----------------------------------- ----------------------------------- KERC032 15 22 7 1.14 KERC049 87 99 12 0.52 ----------------------------------- ----------------------------------- KERC032 59 77 18 4.77 KERC049 111 118 7 0.53 ----------------------------------- ----------------------------------- including 61 62 1 60.00 KERC050 4 21 17 0.65 ----------------------------------- ----------------------------------- including 64 65 1 63.00 KERC050 146 156 10 1.91 ----------------------------------- ----------------------------------- KERC033 2 32 30 8.64 including 146 147 1 15.61 ----------------------------------- ----------------------------------- including 5 6 1 214.32 KERC051 35 52 17 1.29 ----------------------------------- ----------------------------------- including 22 23 1 15.85 KERC052 16 22 6 1.15 ----------------------------------- ----------------------------------- KERC033 56 57 1 23.96 KERC052 94 114 20 2.00 ----------------------------------- ----------------------------------- KERC034-39 in previous news release KERC053 no significant intercepts ----------------------------------- ----------------------------------- KERC040 28 41 13 1.31 KERC054 2 8 6 0.87 ----------------------------------- ----------------------------------- KERC040 57 71 14 2.92 KERC054 113 140 27 0.81 ----------------------------------- ----------------------------------- KERC040 86 125 39 0.99 KERC055 16 47 31 0.82 ----------------------------------- ----------------------------------- KERC041 34 44 10 1.02 KERC055 60 65 5 0.99 ----------------------------------- ----------------------------------- KERC041 52 94 42 1.54 KERC055 80 85 5 1.86 ----------------------------------- ----------------------------------- KERC041 105 114 9 1.02 KERC056 27 49 22 2.26 ----------------------------------- ----------------------------------- KERC041 120 125 5 0.97 including 47 48 1 25.68 ----------------------------------- ----------------------------------- KERC042 7 24 17 0.86 KERC056 57 65 8 1.08 ----------------------------------- ----------------------------------- KERC042 30 54 24 1.31 KERC056 103 109 6 0.71 ----------------------------------- ----------------------------------- including 50 51 1 16.95 KERC057 47 92 45 1.16 ----------------------------------- ----------------------------------- KERC042 68 75 7 0.95 KERC057 107 112 5 1.53 ----------------------------------- ----------------------------------- KERC042 99 122 23 1.43 KERC058 63 70 7 22.56 ----------------------------------- ----------------------------------- KERC043 71 89 18 3.96 KERC058 78 87 9 0.94 ----------------------------------- ----------------------------------- KERC043 85 86 1 57.32 KERC059 57 90 43 1.72 ----------------------------------- ----------------------------------- KERC044 34 43 9 1.26 KERC060 0 7 7 0.67 ----------------------------------- ----------------------------------- KERC045 36 45 9 2.85 KERC060 14 22 8 2.06 ----------------------------------- ----------------------------------- including 43 44 1 22.66 KERC060 31 39 8 1.33 ----------------------------------- ----------------------------------- KERC045 52 118 66 1.19 KERC060 52 69 17 0.64 ----------------------------------- ----------------------------------- KERC046 5 30 25 1.51 ----------------------------------- Dan McCoy, President and CEO of Keegan states: "These results continue to demonstrate the excellent gold grade continuity necessary for a low cost, open pit gold mining operation, the drilling to date has not constrained the deposit in any direction and the regional scale of the fault structure hosting mineralization suggests that there is substantial room for a significant additional resources to be identified." Richard Haslinger, P. Eng., is the Qualified Person with respect to NI 43-101 at Esaase. RC samples were taken at one meter intervals under dry drilling conditions by geologic and resource consultant RSG Global, Inc. utilizing drilling and sampling techniques widely accepted in resource definition studies of other West African gold deposits. All drill samples are weighed on site and assayed using standard 30 gram fire assay with atomic absorption finish by Transworld Laboratories (GH) Ltd. in Tarkwa, Ghana. QA/QC programs using internal and external standard samples, reassays, and blanks indicate good accuracy and precision in a large majority of standards assayed. Keegan has begun a series of assay retests and will also check for nugget effect using bottle roll leach tests. A preliminary metallurgical program is also being designed. Intercepts were calculated using a minimum of a 0.3 g/t cut off at beginning and end of the intercept and allowing for no more than four consecutive samples (four meters) of less than 0.3 g/t within the intercept. All internal intercepts above 10 g/t Au are reported within the intercept. Intercepts of less than 5 meters were not reported except when individual samples assayed greater than 10 g/t Au. Intercepts less than 5 meters wide were not reported except where exceeding 10 g/t Au. About Keegan Resources Keegan is a junior gold company offering investors the opportunity to share ownership in the rapid exploration and development of high quality, pure gold assets. The Company owns the right to earn 90% of its flagship Esaase and Asumura gold projects located in Ghana, West Africa. Managed by highly skilled and successful board members and advisors, Keegan efficiently executes its project development plans and is well financed with no debt. Keegan is also strongly committed to the highest standards for environmental management, social responsibility, and health and safety for its employees and neighbouring communities. Keegan trades on the TSX-VEN under the symbol KGN. More information about Keegan is available at www.keeganresources.com. On Behalf of the Board Dan McCoy, Ph.D., President & CEO This release includes certain statements that may be deemed forward-looking statements. All statements in this release, other than statements of historical facts, that address future production, reserve potential, exploration drilling, exploitation activities and events or developments that the Company expects are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and those actual results or developments may differ materially from those projected in the forward-looking statements. For more information on the Company, Investors should review the Company's filings that are available at www.sedar.com. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release. Contacts: Keegan Resources Inc. Investor Relations (604) 683-8193 or Toll Free: 1-800-863-8655 (604) 683-8194 (FAX) Email: info@keeganresources.com Website: www.keeganresources.com SOURCE: Keegan Resources Inc.


 

Sale of Sprutan 6, Norrköping Oslo (27 February 2007) : Norgani Hotels ASA has sold to Portieren Norrköping AB, for the sale of a mixed used property in Norrköping, Sweden for SEK 46 m. The sale is in line with Norganis strategy to actively develop its portfolio of Scandinavian hotels and divest non core business properties. The property Sprutan 6, Norrköping has a lettable area of about 7000 square meters of which 3785 is hotel. It comprises the Best Western Princess Hotel with 119 rooms. The sales price is in accordance with book value. The acquisition value is SEK 43.3 m and the cash flow from the sale amounts to SEK 2.7 m. Norgani will after this own 40 hotels in Sweden. For further information, please contact Kjell Sagstad, CEO Norgani Hotels ASA Mob: +47 92 21 30 20 With a portfolio of more than 70 hotels in the Nordic region, Norgani Hotels is Europe's fifth largest hotel property investor. Through size and specialization Norgani has a knowledge of and insight in the hotel industry, creating a unique platform for development of hotel properties and business in cooperation with operators and brands. The share is listed on the Oslo Stock Exchange. www.norgani.no


 

Aker Yards is pleased to invite you to attend the Capital Markets Day on 28 March 2007 in Oslo. President & CEO, Mr Karl Erik Kjelstad and the management team will give you insights into Aker Yards' operations and strategy. Wednesday 28 March from 12:30 CET to 17:00 CET A light lunch will be served at 12:00. Location: Oslo Concert Hall, Oslo, Norway Following the presentations, there will be a Q&A session chaired by Terje Fatnes, analyst, SEB Enskilda and Arne Egil Rønning, Analyst, Fondsfinans. The event is organized by the Norwegian Society of Financial Analysts (NFF). Please register by sending an e-mail to eh@akeryards.com. After the event, all presentations will be available at www.akeryards.com. If you need assistance with hotel bookings, please contact Aker Yards. Best regards, Tore Langballe SVP Corporate Communications and Investor Relations Phone: +47 24 13 00 00 Aker Yards ASA is an international shipbuilding group focusing on sophisticated vessels. The Group has a strong position in terms of innovation, product range, technology, experience, and capacity. The product range includes cruise ships & ferries, merchant vessels, and offshore & specialized vessels. Aker Yards comprises 17 yards in Brazil, Finland, France, Germany, Norway, Romania and Ukraine. Aker Yards has approximately 20 000 employees. www.akeryards.com


 

SOLTEQ PLC STOCK EXCHANGE RELEASE 27.2.2007 Solteq Plc's shareholders are hereby invited to the Annual General Meeting of shareholders to be held on the company's premises in Eteläpuisto 2 C, Tampere, March 23, 2007, at 3 p.m. The following issues will be discussed in the meeting: 1. Matters pertaining to the Annual General Meeting of Shareholders under article 12 of the Articles of Association The members of the Board of Directors Shareholders representing more than 50 per cent of the shares have announced that they will propose to the Annual General Meeting that five members are elected to the Board of Directors and that present board members Ali U. Saadetdin, Seppo Aalto, Ari Heiniö, Veli-Pekka Jokiniva and Jukka Sonninen are re-elected. Dividend distribution The Board of Directors proposes that dividend is decided according section 2.2. 2. The Board of Directors' other proposals to the Annual General Meeting of Shareholders. 2.1. Transferring funds from the equity account governed by the Annual General Meeting to the distributable equity fund. The Board of Directors propose that the equity account formed in the extraordinary general meeting on 9.9.2005 and governed by the general meeting of shareholders, an amount of 5.962.338,50 euros is transferred to the distributable equity fund. The distributable equity fund is a fund based on the new Finnish Companies Act and may be used among other things to dividend distribution or other distribution of funds. 2.2. Authorising the Board of Directors to decide on dividend distribution or other distribution of funds from the distributable equity fund. The Board of Directors propose that it is authorized to decide on dividend distribution or other distribution of funds from the distributable equity fund or both, totalling altogether a maximum of 0,10 euros per share. The authorization is proposed to be valid until the beginning of the next Annual General Meeting. 2.3. Increase of share capital The Board of Directors propose that the company's share capital is increased from 993.654,69 euros to one million (1.000.000) euros by transferring the respective amount from the distributable equity fund. 2.4. Authorizing the Board of Directors to decide on acquiring the company's own shares The Board of Directors propose that it is authorized to acquire the company's own shares so that the amount in the possession of the company does not exceed 10 percent of the company's total shares at that moment. The shares can be acquired in order to develop the company's capital structure, finance and execute acquisitions or similar arrangements or used as part of the incentive scheme of the personnel or convey otherwise or be invalidated. The shares can be acquired in other proportion than the shareholders' holdings. The shares are to be acquired through public trading and at market price. The acquiring is to be done with the unrestricted shareholders' equity. The authorization is proposed to be valid until the next Annual General Meeting of Shareholders. 2.5. Authorizing the Board of Directors to decide on share issue The Board of Directors propose that it is authorized to give or convey company's own shares, maximum amount being 3.000.000 shares. The shares can be given or conveyed in order to finance and fulfil terms of an acquisition or similar or develop company's capital structure or be used as part of the incentive scheme of the personnel or otherwise develop the company's business operations. The authorization includes a right to deviate from the shareholders' pre-emptive right of subscription if there is a weighty financial reason for the company. The authorization includes that the Board of Directors may decide the terms and other matters concerning the share issue according to the instructions of the Finnish Companies Act. The authorization is proposed to be valid for five years starting from the decision. 2.6. Lowering of share premium account The Board of Directors propose that the funds in the share premium account at the time of the Annual General Meeting totalling 2.164.197,45 euros are transferred to the distributable equity fund. Display of documents for public inspection The documents relating to the financial statements and the Board proposal with appendices will be available to shareholders' inspection in the company's headquarters in Eteläpuisto 2 C, 33200 Tampere, as of March 16, 2007. Shareholders will be sent copies of the said documents upon request. Participation right and registration All the shareholders recorded in the list of the company's shareholders, which is maintained by the Finnish Central Securities Depository Ltd, no later than March 13, 2007 shall have the right to attend the general meeting. A shareholder wishing to attend the Annual General Meeting should notify the company's headquarters by March 19, 2007, at 4 p.m. Registrations sent to the address Solteq Plc, Eteläpuisto 2 C, 33200 Tampere, phoned to +358 20 1444 202, faxed to +358 20 1444 222 or e-mailed to katiye.saadetdin@solteq.com will also be accepted. All registrations for participation should be submitted to the office before the registration deadline. Possible letters of authority should be delivered at registration. Tampere February 27, 2007 Solteq Plc's Board of Directors For further information please contact: Ali U. Saadetdin, Chairman of the Board Tel +358 20 1444 201 or Tel +358 40 8444 201, e-mail ali.saadetdin@solteq.com Hannu Ahola, Managing Director Tel +358 20 1444 211 or +358 40 8444 211, e-mail hannu.ahola@solteq.com Distribution: Helsinki Stock Exchange Major Media


 
Hitt og þetta
27. febrúar 2007

EPT Disclosure

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------+--------------------------| | Company dealt in | Barratt Developments Plc | |----------------------------------------+--------------------------| | Class of relevant security to which | Ordinary Shares | | the dealings being disclosed relate | | | (Note 1) | | |----------------------------------------+--------------------------| | Date of dealing | 26th February 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 35,525 | 1,282p | 1,264p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 224,851 | 1,279p | 1,264p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +-------------------------------------------------------------------+ | Date of disclosure | 27th February 2007 | |----------------------------------------------+--------------------| | Contact name | Seema Soni | |----------------------------------------------+--------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+--------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+--------------------| | Nature of connection (Note 6) | Connected Advisor | +-------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

AMERICAN MARKETS OUTLOOK: U.S. stock markets are expected to open lower Tuesday, following a weak performance on both Asian and European markets. A sharp sell-off on Chinas stock market amid concerns about possible interest rate and tax hikes is being factored into the markets, says Martin Slaney of GFT Global Markets. "The China sell-off has provided the excuse for Europe, and the U.S. is set to take a hit as a result," says Slaney. GFT Global Markets is calling the Dow Jones Industrial Average to open down 62 points at 12,570, the Nasdaq 100 13.6 points lower at 1817 and the S&P 500 down 8.3 points at 1441. On the economic front, investors will closely watch U.S. durable good orders data due at 1330 GMT, followed by consumer confidence and existing home sales data at 1500 GMT. EUROPEAN MARKETS: European stocks are trading lower midday in Europe, with miners under pressure from rising oil prices. In London, the FTSE 100 index is down 1.3% at 6352, with mining stocks leading the downside after a recent strong run. Rio Tinto and BHP Billiton fell 3.5% and 4.2% respectively. In Frankfurt, the DAX 30 index is down 1.3% at 6937, following the weaker performance on Asian markets and some concerns about a possible interest rate hike in China, traders say. In Paris, the CAC 40 is down 1.5% at 5679. Bunds and gilts tick higher as concerns over Iran and the state of the subprime U.S. mortgage sector override mixed euro-zone data. The March bund future is up 0.15 at 116.07, while the March gilt future edges up 0.19 at 107.50. In the currency markets, concern over the U.S. subprime borrowers market is helping to undermine the dollar in Europe as the market waits for the latest U.S. housing data. At 1130 GMT, the dollar was down at Y119.40, the euro was up at $1.3205 and the pound was unchanged at $1.9635. =========================== TOP STORIES: ACCIONA 2006 NET PROFIT MORE THAN TRIPLED ON ASSET SALES: Spanish infrastructure and energy company Acciona SA (ANA.MC) said net profit more than tripled in 2006, largely due to the sale of the companys 15% stake in construction firm Fomento de Construcciones y Contratas SA (FCC.MC). (By David Roman) AIR LIQUIDE 06 PFT +7.4%, RAISES REV, PFT TARGETS: French industrial and medical gases producer LAir Liquide SA (12007.FR) reported a 7.4% rise in net profit for 2006 mainly on cost-cutting measures. (By Anne-Sylvaine Chassany and Jocelyn Jovene) AIRBUS SET TO REVEAL POWER 8 DETAILS WEDNESDAY: European Aeronautic Defence & Space Co NV (5730.FR) is set to detail its Power 8 restructuring plan for Airbus at a press conference Wednesday, but is facing the threat of industrial action over massive job cuts, people familiar with the situation and media reports said. (By Steve McGrath and Kirsten Bienk) STANDARD CHARTERED FY06 PRETAX PROFIT +19%: Standard Chartered PLC (STAN.LN) reported a 19% rise in full-year pretax profit, paced by strong performances in consumer and wholesale banking. (By Henry Teitelbaum) ============================ INSIGHT & ANALYSIS FROM DOW JONES NEWSWIRES: =FOREX FOCUS: The dollar faces a tough economic ride this week that could leave it falling to new lows against the euro for 2007. (By Nicholas Hastings) =CHARTING EUROPE: European equity indexes have almost certainly formed a medium-term top Monday now that Tuesdays sharp decline, by over 1% in most indexes in the first three hours of the day alone, has taken place. (By Axel Rudolph) =FOCUS: Banks in the burgeoning private banking centers of Singapore and Hong Kong are using inventive methods to attract personnel amid fierce competition for well-connected staff. (By Katharina Bart, Aaron Back and Sai Man) =ASSET CLASS: Europes equity markets dont like the 9.2% drop in the Shanghai market index overnight. (By Alan Mattich) =========================== STILL TO COME ET/GMT COUNTRY PERIOD 0745/1245 US Feb 24 ICSC-UBS Chain Store Sales 0815/1315 EU ECB member Bini Smaghi speaks on the economic governance of the euro zone in Brussels 0830/1330 US Jan Durable Goods 0855/1355 US Feb 24 Redbook Retail Sales Index 0900/1400 EU ECB gold, forex reserves 0930/1430 EU ECB calls for long-term refi tender 1000/1500 US Jan Existing Home Sales 1000/1500 US Feb Richmond Fed Mfg Index 1000/1500 US Feb Conference Board Consumer Confidence Index 1100/1600 US Tsy Undersecy Steel speaks in Washington 1700/2200 US Feb 25 ABC/Washington Post Consumer Confidence Index 1830/2330 JPN Feb Japan Nomura/JMMA PMI Mfg 1850/2350 JPN Jan Current Survey of Commerce, prelim 1850/2350 JPN Jan Indus Production, prelim =========================== OTHER NEWS: Spanish-Argentine oil and energy company Repsol YPF SA (REP) said fourth-quarter net profit fell 14%, due to lower output and higher exploration costs. (By David Roman) Money supply growth in the euro zone surged again in January, underpinning expectations that the European Central Bank will raise interest rates more than once this year. (Data Snap by Monica Houston-Waesch) Iberia Lineas Aereas de Espana SA (IBLA.MC) said its fourth-quarter losses widened amid continued cost pressures and tax adjustments. (By Santiago Perez) Entrepreneur Mike Ashley netted at least GBP928.8 million as Sports Direct International PLC (SPD), the retailer he founded 25 years ago, debuted on the London Stock Exchange after its initial public offering was priced at the top end of the range. (By Lilly Vitorovich) Swiss industrial company Georg Fischer AG (FI-N.EB) reported a 48% increase in 2006 net profit and said it plans to nearly double the dividend, a move which may be designed to deter potential bidders, analysts said. (By Martin Gelnar) Irans foreign minister said his country would never again suspend uranium enrichment, a move that the U.S. insists on for any negotiations with Tehran. (AP) 888 Holdings PLC (888.LN) and Ladbrokes PLC (LAD.LN) shares fell on fears that a tie-up between the gaming groups may be in jeopardy after French authorities requested to speak to 888s former Chief Executive John Anderson. (By Lilly Vitorovich) Automotive and aerospace equipment maker GKN PLC (GKN.LN) said 2006 pretax profit more than doubled, helped by profit growth for its aerospace unit, and said acquisitions, new business wins and strong key markets should drive further growth in 2007. (By Steve McGrath) U.K. mortgage lending fell for the second straight month in January with the number of mortgage approvals slumping to the lowest level for two years, the British Bankers Association said. (Data Snap by Ilona Billington) Satellite service provider Inmarsat PLC (ISAT.LN) reported a 6% drop in full year pretax profit and reported sales of its new BGAN satellite product that were below analysts hopes. (By Daniel Thomas)


 

According to Finnish Securities Market Act, Chapter 2, Section 10 c, Neste Oil Corporation has today published the Annual Summary of stock exchange releases and announcements published in 2006. The document is available on the company web site at www.nesteoil.com. Neste Oil Corporation Corporate Communications tel. +358 10 458 5132 Neste Oil Corporation is a refining and marketing company focused on advanced, clean traffic fuels, with a strategy that prioritizes growing its refining and premium-quality biodiesel businesses. Neste Oil's refineries are located in Porvoo and Naantali in Finland, and have a total refining capacity of approx. 250,000 bbl/d. The company employs around 4,700 people. Neste Oil is listed on the Helsinki Stock Exchange. For further information, see www.nesteoil.com.


 

Primorsk International Shipping Limited (PISL) has issued a 4-year bond loan. The bond issue totals NOK 300 million with a borrowing limit of NOK 1,000 million, and offers a coupon rate of 3 months NIBOR +3.60% p.a. Payment date is February 28, 2007. Nordea's credit analyst assigned a BB corporate rating to PISL and the Bond issue was rated two notches lower at B+ due to its unsecured nature. The NOK denominated bonds were launched on February 8, 2007, at an investor presentation in Oslo. The bonds were well received in the market and PISL decided to close the book last week. The proceeds will be used for general corporate purposes, including part-funding of the newbuilding program. Prisco's current newbuilding programme is part of an ongoing fleet rejuvenation plan which, over the last few years, has seen the disposal of old tonnage smaller than the MR vessels and the ordering of 15 X MR, LR, Aframax and Suezmax high specification winterised ice class newbuildings. The focus for the newbuildings will be long-term contract employment in the developing crude and product export business out of Russia. The success of this bond issue is a significant step in the continued development of the company and opens up a new access of capital for PISL that the company intends to use in the future for further support of its newbuilding programme. Nordea acted as arranger for the bond issue. For further information, please contact: Prisco (Singapore) Pte Ltd As manager for PISL Alexander Migunov, CEO Dmitry Golomovzy, CFO Nordea Markets Ole Christian Schjørn Head of Institutional Sales Tel: +47 22 48 77 85


 

(IFN) The Nordic OMXN40 and Norways OBX are both down 2% after an 8.8% fall in Shanghai, says Handelsbankens Head of Trading Nicklas Granath.


 

TietoEnator Corporation Press Release 27 February 2007, 12.00 am EET TietoEnator is divesting its holding in TietoEnator Libraries Oy to AXIELL bibliotek AB. The transaction follows the process started in September 2005 when TietoEnator and AXIELL bibliotek established a joint venture. The divestment supports TietoEnator's strategy to focus on selected vertical industries. With over 200 library customers serving about 2.5 million people, TietoEnator Libraries Oy is the leading IT supplier for libraries in Finland. The company employs 29 people and is a pioneer in the implementation of Internet-based and mobile library solutions supporting electronic services over the Internet. Net sales of TietoEnator Libraries Oy in 2006 were EUR 2.4 million. The closing of the transaction will take place on 1 April 2007, when the name of the company will be changed to Ab AXIELL kirjastot Oy. The transaction improves both employees' and library customers' international networking and gives them more possibilities to utilize knowledge and ideas across borders. The customers will also benefit from a strengthened development, as the forces in Sweden and Denmark will be combined with the development in Finland. Juhani Kaisanlahti, the head of TietoEnator Libraries Oy's Board, said: "The opportunities to develop new IT solutions are advancing all the time. In our opinion it's more effective to centralize competences for contributing libraries to face their future challenges. I'm convinced that, focusing only on the library market, AXIELL is an international supplier that can support libraries cost-effectively and is an excellent partner for Finnish libraries." Jerk Sintorn, Managing Director of AXIELL bibliotek AB, said: "More development, quicker, advanced, and purposive, is a great challenge for all firms. But in the Nordic region every domestic area in the library market is too small to be able to pay for the necessary development in the long run. Therefore, it makes sense to unify TietoEnator Libraries Oy in AXIELL so the Nordic librarianship can continue to have an exceptional position among the libraries of the world with regard to accessibility, utilization and efficiency. AXIELL will continue to help the Nordic libraries in their mission to be one of the cornerstones in building the new digital world." For further Information, please contact: Juhani Kaisanlahti, Deputy President, TietoEnator Healthcare & Welfare, tel. +358 400 643 371 Jerk Sintorn, Managing Director, AXIELL bibliotek AB, tel. +46 317 10 29 51. TIETOENATOR CORPORATION DISTRIBUTION Principal Media TietoEnator is among the leading architects in building a more efficient information society and one of the largest IT services providers in Europe. TietoEnator specializes in consulting, developing and hosting its customers' business operations in the digital economy. The Group's services are based on a combination of deep industry-specific expertise and the latest information technology. TietoEnator has about 16 000 experts in close to 30 countries. www.tietoenator.com AXIELL bibliotek is the leading supplier of IT Systems and services to Nordic libraries - and also one of the top 10 companies of the world in this industry. AXIELL is a vendor that is dedicated solely to libraries as a target group and has its focus on library development. AXIELL develops technically advanced library management systems in close cooperation with the customers. More than 700 libraries in the Nordic countries are using AXIELL's systems. Besides library management systems, AXIELL sells RFID and self-service automats to libraries together with Bibliotheca Nordic A/S. AXIELL has 90 employees in Denmark and Sweden. www.axiell.com


 

HIGHLIGHTS OF THE YEAR The consolidated profit after tax for 2006 amounted to SKr 116.3 million (162.9). The profit for the fourth quarter amounted to SKr 35.0 million (23.9). Earnings per share for 2006 were SKr 28.20 (37.70). The fourth quarter's earnings per share amounted to SKr 8.50 (5.70). The market value of the Equities Portfolio rose by a net amount of 21.2%, and amounted to SKr 563 million (534) on 31 December 2006. In the fourth quarter the market value of the Equities Portfolio increased by 10.8% (8.1). Industrial Operations' turnover increased by 4.4% in relation to the previous year and amounted to SKr 1,035.0 million (991.2). Turnover for the fourth quarter amounted to SKr 232.8 million (197.0). Industrial Operations' operating profit amounted to SKr 38.6 million (51.0). In the fourth quarter the operating result was a loss of SKr 11.4 million (loss 19.9). A weak start to the year as a result of a late opening to the road-marking season in the Nordic region and Romania resulted in an operating loss being incurred for the first half of the year. In the second half of the year the result amounted to SKr 67.4 million (49.5), i.e. an increase of 36%. The return on Geveko's Series "B" shares during the year, including paid dividends, was 9.6%. The SIX Return Index rose by 26.3 % over the same period. A dividend of SKr 11 per share was paid in the second quarter. Net worth per share increased by 12.1% during the year to reach SKr 268 (239) on 31 December 2006. 2007 The net worth per share was SKr 272 on February 15. As of 15 February 2007, the market value of the Equities Portfolio had increased by 5.2% since the beginning of the year. Dividend and redemption of shares The Board proposes to the AGM that a dividend of SKr 11 (11) per share be paid for 2006. The proposed dividend is 4.1% of the closing net worth and represents a direct yield of 5.0% on the transaction price of Geveko's shares at 31 December 2006. The Board also proposes a 2:1 share split combined with automatic redemption. For each share owned, shareholders will receive one new share, which will be automatically redeemed for SKr 75 per share. As a result of this proposal, a sum of SKr 316 million will be transferred to shareholders, in addition to the proposed ordinary dividend. The total amount transferred to Geveko's shareholders will therefore amount to SKr 363 million. AB GEVEKO (publ) Co.reg.no.: 556024-6844 Box 2137, S-403 13 Göteborg, Sweden. +46 31 172945, info@geveko.se www.geveko.se The full report including tables can be downloaded from the following link:


 

In 2006, Sjælsø Gruppen recorded substantial growth in revenue and profits. The Group's profit before tax totalled DKK 722.5 million, equating to a growth of 41% on 2005. The result is regarded as highly satisfactory.


 

Please find enclosed the presentation of the Preliminary Fourth Quarter and Financial Year 2006 Results, held in the morning on Tuesday February 27, in the link below. Oslo February 27, 2007 Cathrine Fosse


 

Video interviews and transcripts available now on www.cantos.com with Peter Sands, CEO, and Richard Meddings, Group FD (LSE:STAN) * Results and strategy * M&A * Managing costs * Consumer and Wholesale banking * Balance sheet and capital strength * Outlook This programming is available in video, audio and transcript. It's free to view. All you need to do is register at www.cantos.com Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses. If you would like to contact us, please email enquiries@cantos.com.


 

DJIA 12632.26 -15.22 -0.12% Nasdaq 2504.52 -10.58 -0.42% S&P 500 1449.37 -1.82 -0.13% FTSE 100 6434.70 +33.20 +0.52% Xetra DAX 7027.59 +35.01 +0.50% CAC40 5762.54 +46.16 +0.81% Above are closing prices Nikkei 225 18121.24 -94.11 -0.5% Hang Seng 20264.34 -243.61 -1.2% S&P/ASX 200 5977.60 -44.30 -0.7% Taiwan Index 7901.96 +1.76 +0.00% S.Korea Kospi 1455.53 -14.50 -1.00% Dow Future 12655.00 +1.00 0.00% NASDAQ Future 1837.25 -0.50 0.00% S&P Future 1452.25 -0.25 0.00% Above are as of 0550 GMT USD/JPY 120.42-45 -0.15% Range 120.75 - 120.35 EUR/USD 1.3182-85 -0.02% Range 1.3204 - 1.3174 AUD/USD 0.7943-48 +0.1% Range 0.7943 - 0.7933 GBP/USD 1.9635-38 +0.02% Range 1.9654 - 1.9628 USD/CHF 1.2289-92 -0.07% Range 1.2305 - 1.2282 Above are as of 0550 GMT vs NY close USD/JPY Vol Option Contract 7.05%/7.35% EUR/USD Vol Option Contract 5.53%/5.78% AUD/USD Vol Option Contract 6.28%/6.52% GBP/USD Vol Option Contract 5.92%/6.17% USD/CHF Vol Option Contract 6.25%/6.50% Above are 1-Mo prices as of 0530 GMT 2Y Tsy 99 31/32 +3/32 4.76% -4.6 5Y Tsy 100 1/32 +7/32 4.61% -4.8 10Y Tsy 99 30/32 +12/32 4.63% -4.7 10Y JGB 1.6450% -0.0100 Closing Treasury prices vs prior NY close; JGB as of 0550 GMT Asian Spot Gold $684.80 -$1.20 -0.2% Comex Gold $688.80 -$1.00 +0.1% Brent Crude Oil $61.33 $0.00 0.0% Above are as of 0500 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: European stock markets face consolidation Tuesday as investors lock-in profits. The euro is holding firm, government debt prices are expected to tick higher, while metals are lower and oil is steady. STOCKS: European markets are set to follow their global counterparts lower to start as investors take a pause in a consolidation of recent gains. Cantor Index, the U.K. spreadbettor, is calling the FTSE down 2 points at 6432, the DAX down 10 at 7017 and the CAC off 2 at 5760. In the news, Canadian auto-parts supplier Magna International has contacted at least one of its major labor unions as part of a wider due-diligence process it is conducting about a possible bid to acquire struggling U.S. auto maker Chrysler Group from DaimlerChrysler. Wall Street extended its recent decline Monday as concerns about a market correction offset investor optimism that acquisition activity is on pace to set a record this year. "Despite the buyout news, were seeing the broader market a little concerned that weve had such strength without a correction," said Peter Dunay, an investment strategist with New York-based Leeb Capital Management. "We may be in a period where the market wants to step back for a bit." Asian stocks were lower Tuesday, with Japans Nikkei average in danger of breaking a two-session winning streak as Mitsui Fudosan and other property shares fell back on concerns they may have outpaced fundamentals after recent strong gains. FOREX: The euro is heading toward a test of $1.3200, after the dollar on Monday drifted moderately lower in New York, losing the most ground against its European rivals. The market will digest a U.S. existing home sales report Tuesday, which could help to determine whether Decembers gradual recovery in the housing sector has legs. Investors are also awaiting the release of a U.S. durable goods report as well as a February consumer confidence survey. "We expect the dollar to remain on the defensive against the euro and sterling this week on signs that U.S. economic activity is weakening but prices are rising," Monica Fan, global head of foreign exchange strategy at RBC Capital Markets, said. BONDS: European government bond prices may edge higher to start, but the markets recent strength faces a barrier. "One thing that may weigh on the European market is supply," said Jason Simpson, a strategist at ABN AMRO. "Although it is spread relatively evenly along the curve, there is a fair amount of it, with EUR4.0 billion 3-year paper, EUR3.0 billion 5-year and a total of EUR7.0 billion 10-year and 15-year." Simpson added, "With the German Ifo having given some hints the peak in activity is behind us, a further decline in PMI Thursday, confirming the Ifos move in the broader European context, would be supportive of the market." European Central Bank board member Guy Quaden on Monday described the banks "current posture is of strong vigilance," suggesting once again that interest rate increases may take place soon. U.S. Treasury prices held steady in Asia Tuesday, after having rallied again the previous day, as former Federal Reserve Chairman Alan Greenspan cheered investors with bond-friendly remarks. Looking ahead to the rest of the week, Bernd Wuebben, senior bond market strategist at BNP Paribas in New York, said the theme for Treasurys now seems to be moving away from inflation and toward growth and housing, with investors keeping an eye on the subprime mortgage market in light of Fridays rally. "The market is preparing itself for likely soft numbers this week," said Wuebben, with market participants anticipating a substantial downward revision in fourth-quarter gross domestic product from the hefty 3.5% reported last month. Investors will also look to housing data for indications as to whether prior strong figures were in fact related to unseasonably warm weather, he said. In Tokyo, Japans government debt rose in price after a successful two-year auction. ENERGY: Oil prices were steady at around $61.40 in Asian trading Tuesday amid forecasts that U.S. data due Wednesday will show a decline in U.S. gasoline and distillate stockpiles. Prices also drew support from by worries over tensions between Western powers and Iran, OPECs No. 2 supplier, and winter weather in the U.S. northeast, the countrys largest heating oil market. Prices rose 0.4% in New York trading on Monday. METALS: Spot gold was last at $684.80, down $1.20 from the New York finish, as the market consolidated recent gains. Strategist Serge Laureau at Saxo Bank said its increasingly likely that gold futures will break the $700 mark this week. LME 3-month copper was last at $6,270/ton, down $10 on the London PM kerb, where it experienced slight losses on consolidation after gaining almost 10% since Feb. 21. BNP Paribas said short-covering is expected in the coming sessions. CALENDAR: Tuesday, February 27, 2007 GMT Expected Previous 0700 GER Jan Foreign Trade Price Indexes 0745 FRA Jan Housing Starts 0745 FRA 4Q New Home Sales 0800 GER Feb CPI, prelim +0.6%MM -0.2%MM +1.9%YY +1.6%YY 0900 EU Jan Monetary developments in the euro area +9.5%YY +9.7%YY +9.2%YY 0910 EU Feb Bloomberg euro-zone Retail PMI 0930 UK Jan Major British Banking Groups Mortgage & Consumer Lending 1000 ITA 3-Year Bond Auction 1000 ITA 10-Year Bond Auction 1000 ITA 7-Year Bond Auction 1000 EU Jan Stock Market Capitalization 1015 EU ECB settles main refi tender 1245 US Feb 24 ICSC-UBS Chain Store Sales -0.1% 1315 EU ECB member Bini Smaghi speaks on the economic governance of the euro zone in Brussels 1330 US Jan Durable Goods -3.2% +2.9% 1355 US Feb 24 Redbook Retail Sales Index -1.2% 1400 EU ECB gold, forex reserves 1430 EU ECB calls for long-term refi tender 1500 US Jan Existing Home Sales +0.5% -0.8% 1500 US Feb Richmond Fed Mfg Index -11 1500 US Feb Conference Board Consumer Confidence 108.0 110.3 Index 1600 US Tsy Undersecy Steel speaks in Washington 2200 US Feb 25 ABC/Washington Post Consumer Confidence +1 Index 2330 JPN Feb Japan Nomura/JMMA PMI Mfg 2350 JPN Jan Current Survey of Commerce, prelim 2350 JPN Jan Indus Production, prelim -1.9%MM +0.9%MM N/A UK RICS Quarterly Lettings Survey -By Dennis Baker; Dow Jones Newswires; dennis.baker@dowjones.com (MORE TO FOLLOW) Dow Jones Newswires February 27, 2007 01:45 ET (06:45 GMT) Copyright (c) 2007 Dow Jones & Company, Inc. 27 Feb 2007 06:45 GMT =DJ EUROPEAN MORNING BRIEFING: Corporate Events Air Liquide (12007.FR): FY Earnings Average net profit (DJ, 5 analysts): EUR988M (EUR933M) Average EBITDA: EUR2.58B (EUR2.42B) Average EBIT: EUR1.63B (EUR1.47B) Note: EBIT seen +10% from 2005, driven by solid growth in hydrogen sales and stable margins, analysts say. Analysts expect company to raise growth guidance for 2007. BBA Aviation (BBA.LN): FY Earnings Average pretax profit (Co, 6 analysts): GBP78.5M (N/A) Note: No year earlier comparative available follwing the demerger of Fiberweb materials unit last November. Results being helped by strong demand for its business aviation and plane maintenance operations. Bolsas y Mercados Espanoles (BME.MC): FY Earnings Average net profit (DJ, 4 analysts): EUR123.8M (EUR102.1M) Average EBITDA: EUR186.3M (EUR146.4M) Note: EBITDA +27%, helped by buoyant trading volumes thanks to ongoing M&A activity among Spanish companies. Analysts to be on the look-out for any hints of potential alliances as consolidation among global exchanges continues. BMEs shares are already up 23% ytd, fueled by M&A speculation. Eiffage (13045.FR): FY Earnings Average net profit (FactSet Estimates, 12 analysts): EUR378M (EUR303M) Average revenue: EUR10.7B (EUR8.43B) Note: Frances number-three construction group has already reported a 27% rise in 2006 revenue from a year earlier, helped by the acquisition of APRR toll roads company and strong construction market in France. Georg Fischer (FI-N.EB): FY Earnings Average net profit (DJ, 4 analysts): CHF219M (CHF155M) Average operating profit: CHF323M (CHF252M) Average sales: CHF4.0B (CHF3.7B) Note: Cost savings, better product mix on divestments and new product launches seen driving bottom line. Dividend seen around CHF18 compared with CHF15 last year. Company expected to give an upbeat outlook, possibly increasing guidance for some divisions. GKN (GKN.LN): FY Earnings Average pretax profit (Co, 10 analysts): GBP212M (GBP203M) Note: Profits likely to be driven by smaller aerospace equipment operations with the key automotive business hit by weaker western European and North American markets. Acquisition strategy in focus after ceasing talks late in 2006 on the possible acquisition of certain Visteon assets. Hays (HAS.LN): 1H Earnings Average pretax profit (Co, 10 analysts): GBP100.5M (GBP94.6M) Average net fees: GBP297.6M (GBP259.1M) Note: The rise is seen due to continued strength in Asia-Pacific and Europe but analysts expect the UK temp market to remain slow. A lack of network expansion opportunities in accounting and pressure in the public sector divisions will lead to negative operating gearing, analysts predict. Iberia (IBLA.MC): FY Earnings Average net profit (DJ, 5 analysts): EUR96.9M (EUR395.6M) Average EBITDA: EUR782.8M - EUR1.07B Average sales: EUR5.32B (EUR5.60B) Note: A lack of asset sales and lower revenue are seen hitting profits. The focus is on fuel hedging. Inmarsat (ISAT.LN): FY Earnings Average revenues (Co, 9 analysts): $496M ($491M) Average EPS: 12c (N/A) Note: Analysts will look for an update on the companys new satellite broadband product and performance of its maritime business which is seen providing the most growth. EPS for 2006 cannot be compared year-on-year due to its IPO in 2005. Kerry Group (KRZ.DB): FY Earnings Average EPS (DJ, 5 analysts): 131.6c (flat) Note: The food ingredients division is seen posting a "solid performance" versus consumer foods, "which experienced more acute supply chain cost increases," says NCB Stockbrokers; maintains add. Davy sees 07 EPS of 138.3c and 08 EPS of 147.8c; it doesnt rate the shares. Repsol-YPF (REP): 4Q Earnings Average adjusted net profit, excluding non-recurring items (DJ, 3 analysts): EUR615.3M (EUR998M) Average EBIT: EUR1.29B (EUR1.36B) Note: Lower output and refining margins, as well as higher exploration costs, are seen as the main culprits. Earnings before interest and tax is seen -5.1%. The focus is on plans to increase output, reserves, updates on key LNG and Gulf of Mexico projects. Standard Chartered (STAN.LN): FY Earnings Average underlying pretax profit (DJ, 3 analysts): $3.17B ($2.68B) Average EPS: $1.692 (N/A) Note: Dividend is expected to rise 11% to 71 cents. Analysts see the banks revenue growing in line with costs as it expands in Asia Pacific markets, including Taiwan and Korea. But analysts at Keefe, Bruyette & Woods see a possible overshoot on costs versus income growth due to accelerated investment. They also cite declining second half profits in Korea and a weak Hong Kong mortgage market as concerns. Vinci (12148.FR): FY Earnings Average net profit (FactSet Estimates, 14 analysts): EUR1.24B (EUR871M) Forecast range: EUR1.12B - EUR1.54B Average operating profit: EUR2.66B (EUR1.48B) Note: Net profit estimates are seen in this range, thanks to an exceptionally strong French building market and last years acquisition of toll road operator ASF, analysts say. Analysts are looking for the company to firm up 07 guidance for its "excellent" business outlook in 07, as well as any comment on Artemis stake buying in Vinci. OTHER SCHEDULED EVENTS: Abengoa (ABG.MC): FY Earnings Affichage Holding (AFFN.EB): FY Earnings AI Claims Solutions (ACS.LN): 1H Earnings Allbecon (ABX.XE): FY Earnings Alm. Brand (ALMB.KO): FY Earnings Alternative Investment (AIS.LN): AGM Amper (AMP.MC): FY Earnings Arla Foods (ARU.LN): AGM Ashmore Group (ASHM.LN): 1H Earnings Atria (ATRAV.HE): FY Earnings Avis Europe (AVE.LN): FY Earnings Awilco Offshore (AWO.OS): 4Q Earnings Baltika (BLT1T.ET): FY Earnings Banco Espanol de Credito (BTO.MC): AGM Baron de Ley (BDL.MC): FY Earnings Batenburg Beheer (33765.AE): FY Earnings Biotec Pharmacon (BIOTEC.OS): 4Q Earnings Bodycote International (BOY.LN): FY Earnings Brammer (BRAM.LN): FY Earnings Brinova Fastigheter (BRIN-B.SK): FY Earnings Byggma (BMA.OS): 4Q Earnings Camillo Eitzen & Co (CECO.OS): 4Q Earnings Cencorp Corporation (CNC1V.HE): FY Earnings CeWe Color Holding (CWC.XE): FY Earnings Charterhouse Communications (CHO.LN): 1H Earnings Datamonitor (DTM.LN): FY Earnings Dechra Pharmaceuticals (DPH.LN): 1H Earnings Demag Cranes (D9C.XE): 1Q Earnings Ecosecurities Group (ECO.LN): FY Earnings Eidesvik Offshore (EIOF.OS): FY Earnings Eidsiva Rederi (EID.OS): FY Earnings Elementis (ELM.LN): FY Earnings ErSol Solar Energy (ES6.XE): FY Earning Europistas (EUR.MC): FY Earnings EVN (EVNV.VI): Q1 Earnings Evolutec (EVC.LN): FY Earnings Evox Rifa Group (ERG1V.HE): FY Earnings Expert (EXPERT.OS): 4Q Earnings Fiberweb (FWEB.LN): FY Earnings Fionia Bank (FIONIA.KO): FY Earnings Firstrand Limited (FSR.JO): 1H Earnings Fischer (FI-N.EB): FY Earnings Fotoquick : FY Earnings Geodis (3828.FR): FY Earnings Geox (GEO.MI): FY Earnings Global Geo Services (GGS.OS): 4Q & FY Earnings Harju Elekter (HAE1T.ET): FY Earnings Hellenic Telecommunications (HTO.AT): 4Q Earnings Henkel (HEN.XE): FY Earnings HK Ruokatalo (HKRAV.HE): FY Earnings Imtech (36126.AE): FY Earnings Inbesos (BES.MC): FY Earnings Incap Corp (ICP1V.HE): FY Earnings Invista Real Estate: (INRE.LN): FY Earnings Jeudan (JDAN.KO): FY Earnings Kaitech (KAI.MI): FY Earnings Kendrion (KENDR.AE): FY Earnings Kredyt Bank (KRB.WA): 4Q Earnings Lan & Spar Bank (LASP.KO): FY Earnings Latvijas Kugniecib (LSC1R.RG): FY Earnings Lietuvos Dujos Pva (11622.LH): FY Earnings Lincat (LCT.LN): 1H Earnings Macro 4 (MAO.LN): 1H Earnings MWB (MWB.XE): FY Earnings Naftobudowa (NFT.WA): 4Q Earnings Neways Electronics (44061.AE): FY Earnings Norgani Hotels (NORGAN.OS): 4Q Earnings Nutri Pharma (NUT.OS): FY Earnings Olav Thon Eiendomsselskap (OLT.OS): FY Earnings Oz Holdings: FY Earnings Per Aarsleff (PAAL-B.KO): 1Q Earnings Primedia Limited (PMA.JO): 1H Earnings Rocksource (RGT.OS): 4Q Earnings Rorvik Timber (RTIM-B.SK): FY Earnings SeaBird Exploration (SBX.OS): 4Q presentation SimCorp (SIM.KO): FY Earnings Sinvest (SIN.OS): FY Earnings Sjaelso Gruppen (SJGR.KO): FY Earnings Small Cos Div Trust (SDV.LN): 3Q Earnings Sogefi (SO.MI): FY Earnings Sol Melia (SOL.MC): FY Earnings Sopra Group (5080.FR): FY Earnings SOS Cuetara (SOS.MC): 4Q Earnings Sports Direct: Final IPO Pricing St Jamess Place (STJ.LN): FY Earnings Stavanger Aftenblad (STA.OS): FY Earnings Synnove Finden (SFM.OS): 4Q Earnings Trefoil (TREF.OS): 4Q Earnings Turkcell Iletsim (TKC): 4Q Earnings UK Commercial Property Trust (UKCM.LN): EGM Unilabs (ULB.EB): Q2 Earnings Unit 4 Agresso (38909.AE): FY Earnings United Drug (UDG.DB): AGM Ventspils Nafta (VNF1R.RG): FY Earnings Viscofan (VIS.MC): FY Earnings White Young Green (WHY.LN): 1H Earnings BasWare (BAS1V.HE): FY 2006 Ex-Dividend Date Componenta (CTH1V.HE): FY 2006 Ex-Dividend Date Royal Caribbean Cruises (RCL): Q4 2006 Ex-Dividend Date (END) Dow Jones Newswires


 

Bandaríska körfuboltastjarnan Steve Nash hefur verið orðaður við hugsanleg kaup í enska úrvalsdeildarliðinu Tottenham Hotspur. Nash, sem leikur með Phoenix Suns í NBA-deildinni bandarísku, er rótgróinn aðdáandi Spurs, og samkvæmt fréttum breskra fjölmiðla er hann áhugasamur um að fjárfesta fyrir hluta auðæfa sinna í Lundúnaliðinu.


 

Philipp Cordes hefur verið sagt upp sem yfirmanni Sportfive. Sportfive er sannkallaður risi á sviði markaðssetningar á íþróttaviðburðum og var fyrirtækið keypt fyrir nokkrum mánuðum af frönsku fjölmiðlasamsteypunni Lagardère.


 

* revenue rose by 17% on the previous year to EUR 89.3 million (EUR 76.7 million in 2005) * operating profit was EUR 2.8 million (EUR 3.8 million), or 3.2% of revenue (4.9%) * net profit for the financial year was EUR 3.2 million (EUR 5.1 million) * earnings per share amounted to EUR 0.26 (EUR 0.42) * total capital expenditures came to EUR 7.1 million (EUR 0.8 million), or about 8.0% of revenue (1.1%) * Incap continued to invest strongly in growth and internationalisation in accordance with strategy Juhani Hanninen, President and CEO of Incap Corporation: "Our business operations enjoyed a favourable trend in 2006. Demand for Incap's manufacturing services continued at a good level and revenue grew more vigorously than the market average." "We boosted our competitiveness by investing heavily in production equipment and in improving our operations. Although operating profit fell from last year due to these investments, our profitability remains on a satisfactory level and our operating profit represented more than 3% of revenue." Revenue and earnings in October-December Fourth-quarter revenue totalled EUR 24.0 million, or 20.2% more than in the same period last year (Oct.-Dec. 2005: EUR 20.0 million). Operating profit in October-December amounted to EUR -0.3 million (EUR 0.7 million), representing -1.4% of revenue (3.4%). Vuokatti personnel arrangements reduced profitability in the final quarter of 2006 when EUR 0.5 million were recorded as costs of lay-offs. Other non-recurring costs were created by the market study in India and product transfers from Finland to Estonia. Quarterly Oct.-Dec./ July-Sept./ April-June/ Jan.-March/ Oct.-Dec./ July-Sept./ April-June/ Jan.-March/ comparison 2006 2006 2006 2006 2005 2005 2005 2005 (EUR thousands) Revenue 24 014 21 810 22 486 21 038 19 975 16 600 19 891 20 208 Operating -331 599 1 163 1 396 680 756 1 088 1 227 profit Net profit -376 728 1 320 1 553 1 234 1 286 2 176 796 for the financial year Earnings -0,03 0,06 0,11 0,13 0,10 0,11 0,18 0,06 per share, EUR Operational performance in 2006 Consolidated revenue rose by 17% on the previous year to EUR 89.3 million (EUR 76.7 million in 2005). Operating profit amounted to EUR 2.8 million (EUR 3.8 million), representing 3.2% of revenue (4.9%). Operating profit was weakened by non-recurring expenses of about EUR 0.9 million, from which majority was spent on research of business opportunities in India and start-up of the new Kuressaare factory. Also a cost of EUR 0.5 million was written off for personnel arrangements at the Vuokatti factory. Excluding non-recurring expenses, operating profit reached almost the same level as in 2005, representing about 4.7% of revenue. Net profit for the financial year totalled EUR 3.2 million (EUR 5.1 million). Result includes a change in deferred tax assets. Earnings per share were EUR 0.26 (EUR 0.42) and equity per share was EUR 1.67 (EUR 1.39). Financial year comparison 2006 2005 Change (EUR thousands) % Revenue 89 347 76 673 17 Operating profit 2 828 3 750 -25 Net profit for the financial year 3 225 5 109 -37 Earnings per share, EUR 0,26 0,42 -38 The demand for electronics manufacturing services experienced great seasonal and quantitative fluctuations. Customers' need to reduce the manufacturing costs of their products kept competition tight and prompted the providers of manufacturing services to constantly increase the efficiency of their operations. Production and operations closely related to it continued to be transferred to lower-cost areas. Incap maintained its strong position as a contract manufacturing partner to its significant customers and enlarged the scope of services it provided to several of its customers. Deliveries to equipment manufacturers in the telecommunications, electrical and measurement technology industries in particular grew. The customer mix was further balanced, with the largest single customer accounting for less than 25% of revenue. The largest customer sector was telecommunications, deliveries to which represented about 45% of consolidated revenue. There was increased interest towards Incap's manufacturing services, and bidding was brisk. Investments to increase and modernise production capacity reinforced the company's capability to expand its services to the present clientele and to acquire new customers. The extension of the Kuressaare factory, where operations were started in the summer, improved Incap's ability to actively market its services to equipment manufacturers operating in Scandinavia and central Europe. The signing of a co-operation agreement with Electron Tubes Ltd, a UK company that manufactures measurement devices, was proof of the fact that Estonia is a competitive manufacturing location for products destined for European markets. The acquisition of new customer relationships was beefed up by the signing of agency agreements with companies operating in Germany, the UK and Ireland. The sales process was also enhanced, following an earlier development project which focused on customer relationship management, and sales operations were bolstered with new recruitments. Development of operations In a move to improve its competitiveness, Incap increased the efficiency of its operations with a clearer division of tasks among its factories. The Vuokatti facility was developed to specialise in electronics prototype fabrication, the ramp-up of new products and demanding testing and maintenance operations. The factory's new role was reinforced by the transfer of Tellabs' prototype fabrication and preproduction manufacturing to Incap at the beginning of the year. The Vuokatti factory's expertise in NPI (New Product Introduction) operations, which take place at the early stages of the production chain, was strengthened by the procurement of modern equipment suited to prototype fabrication and preproduction manufacturing. Vuokatti's functions were reorganised in line with the new operational model, and the factory launched a new development programme with the aim of significantly boosting efficiency. Labour-intensive products and volume production of electronics were concentrated at the Kuressaare factory. Operations in Estonia expanded considerably in the summer with the opening of a new factory extension. In addition to about 3,700 square metres of floor space in the new building, Incap is using an older factory building with about 1,300 metres of floor space for product assembly and the training of new employees. Major investments at the new factory included an SMD assembly line and an ancillary optical quality inspection device. The design of the new building allows for the expansion of production space to almost double its current size in a short period of time. The manufacture of certain customers' volume products was moved from the Vuokatti factory to the Kuressaare facility. Due to the strong growth in demand, the production transfers took place mostly in the latter half of the year. The manufacture of sheet-metal mechanics was made more efficient by procuring a modern punch press and an automated warehouse for the Helsinki factory. The Vaasa factory upgraded its equipment and revised its organisation. The operations of Ultraprint Oy, the subsidiary that manufactures chemically milled sheet-metal products, flexible PCBs and RFID products, were concentrated at a single business location, and the unit's production methods were developed. In order to improve its delivery reliability and quality assurance capability, Incap undertook large-scale development measures aimed at ensuring the smooth functioning of manufacturing processes through the systematic management and planning of production and materials resources. The new operational model was first adopted at the Vuokatti factory, and it will be applied at other facilities during 2007. The coming into force of the RoHS directive, which restricts the use of environmentally hazardous materials, in the beginning of July, did not call for changes in Incap's operations, as the company's facilities were fully compliant with the directive already at the beginning of the year. Financing and cash flow The Group's equity ratio remained at a good level and was 45% (43%). Interest-bearing net liabilities totalled EUR 8.9 million (EUR 5.3 million) and the ratio of net liabilities to equity (gearing) was 43.9% (31.2%). Net financial expenses amounted to EUR 0.5 million (EUR 0.6 million) and depreciation to EUR 2.3 million (EUR 2.6 million). The Group's equity increased, totalling EUR 20.3 million (EUR 17.0 million) at the close of the financial year. Liabilities amounted to EUR 25.2 million (EUR 22.2 million), of which interest-bearing liabilities amounted to EUR 9.4 million (EUR 7.5 million). The company did not use any short-term credit facilities available at the close of the financial year. The Group's liquidity was satisfactory: the quick ratio was 0.8 (0.9) and the current ratio 1.6 (1.7). Cash flow from operations totalled EUR 3.0 million (EUR 7.6 million) and the change in cash and cash equivalents was a decrease of EUR 1.7 million (an increase of EUR 1.8 million). The change in cash and cash equivalents was influenced in particular by non-recurring items and the increase in working capital. Research and development Incap's research and development expenses were spent on the improvement of the company's operational processes, and totalled EUR 0.5 million (EUR 0.6 million). Capital expenditures The Group's capital expenditures in the financial year totalled EUR 7.1 million (EUR 0.8 million), or about 8.0% of revenue (1.1%). The largest investments were made in connection with the start-up of the Kuressaare factory and the increase and modernisation of production capacity in Vuokatti and Helsinki. Finance leases accounted for EUR 5.6 million (EUR 0.1 million) of the investments. Environmental issues All of Incap's factories have environmental and quality assurance systems certified by Lloyd's, and these are used as tools for continuous improvement. The environmental system complies with the ISO 14001:2004 standard, while the quality assurance system complies with the ISO 9001:2000 standard. The Kuressaare factory was audited for obtaining a certificate under the ISO 13485:2003 standard which is widely applied to the manufacture of medical devices. Similar audits will also be carried out at the company's Helsinki and Vuokatti factories. Personnel At the beginning of the year, the Incap Group employed 450 people and, at the end of the year, 541. On average, there were 521 (468) people on the payroll in 2006. The strongest growth in the number of personnel occurred at Kuressaare, where 72 new employees were recruited during the year. At the close of the year, about 70% of all personnel worked in the Finnish units. Of Incap's personnel at the end of the year, 282 were women and 259 men. 452 are permanently employed staff and 89 fixed-term employees. There were 11 part-time employment contracts at the end of the year. The average age of the personnel was 37 years. Due to the arrangements related to the distribution of the factories' tasks, co-determination negotiations concerning a maximum of 130 employees were started at the Vuokatti factory. As a result of the negotiations concluded after the close of the financial year in January 2007, 53 people were laid off from the unit. Management Team The company's president and CEO during the financial year was Juhani Hanninen, M.Sc. (Eng.). In addition to him, the members of the Group's Management Team included Liam Kenny (Materials and Logistics), Hannele Pöllä (Communications and Investor Relations), Anja Rouhiainen (Manufacturing Services, as from 1 September), Petri Saari (Sales and Marketing), Niklas Skogster (Development of Operations, as from 1 August), Timo Sonninen (Manufacturing Services, until 31 July) and Tuula Ylimäki (Finance and Administration). Group's Chief Financial Officer Tuula Ylimäki was appointed as CEO of Ultraprint Oy, a subsidiary of Incap Corporation, as from 1 January 2007. Anne Sointu, M.Sc. (Econ.), eMBA, was appointed as the new Chief Financial Officer. The President and CEO and the members of the Group Management Team receive bonuses linked to the company's annual result in accordance with the earnings-tied bonus scheme confirmed by the Board of Directors. The bonus for 2006 was tied to the targets that had been set for revenue, net profit and the inventory turnover rate. Annual General Meeting The Annual General Meeting of Incap Corporation was held on 11 April 2006 in Oulu. The Annual General Meeting adopted the consolidated and parent company financial statements for 2005 and granted release from liability to the responsible officers. No dividend was paid for the 2005 financial year. The Annual General Meeting authorised the Board of Directors to decide on increasing the share capital through one or more rights issues, the floating of one or more issues of convertible bonds and/or granting stock options. The authorisation provides for raising the company's share capital by a maximum of about EUR 4,092,776, and it is valid up to 11 April 2007. The Board of Directors did not exercise its authorisation during the financial year. Board of Directors The Annual General Meeting re-elected Seppo Arponen, Juha-Pekka Kallunki, Kalevi Laurila, Timo Leinilä, Sakari Nikkanen and Jorma Terentjeff to seats on the Board of Directors. From amongst its number, the Board of Directors re-elected Jorma Terentjeff as Chairman. Jari Pirinen, (LL.M.), served as secretary to the Board of Directors. The Board of Directors met 17 times in 2006 and the average attendance of the directors at meetings was 99 per cent. Auditors The firm of independent accountants Ernst & Young Oy were the company's auditors, with Rauno Sipilä, Authorised Public Accountant, acting at principal auditor. Shares and shareholders Incap had 12,180,880 shares in issue. The price of the Incap Corporation share varied in the range of EUR 1.82 to EUR 2.90 during the financial year, and the share price at the close of the year was EUR 2.51. The trade volume was 90% of the shares outstanding. At the end of the report year, the company had 1,179 shareholders. Foreign and nominee-registered owners held 10% of all shares. The company's market capitalisation at 31 December 2006 was EUR 30.6 million. Share options The Incap Group currently runs a share option scheme that was introduced in 2004 and that commits key employees to long-term share ownership. There are a total of 630,000 option rights, entitling their holders to subscribe for an equal number of shares. On the basis of the subscriptions, Incap's share capital can rise by a maximum of about EUR 1,058,400. At the close of the year, the option scheme covered 10 key employees. Board of Directors' proposal for the disposal of profits The parent company's distributable funds total EUR 633 581.59 including EUR 2 805 820.03 in net profit for the financial year. The Board of Directors will propose to the Annual General Meeting to be held on 3 April 2007 that no dividend be distributed and that the profit for the financial year be transferred to retained earnings. Announcements in accordance with Chapter 2, Section 9, of the Securities Market Act on changes in holdings Eqvitec Partners Oy announced on 19 April 2006 that the mutual funds managed by it had decreased their holdings of Incap Corporation's shares to 4.9% of Incap Corporation's share capital and votes. Ingman Group Oy Ab announced on 7 September 2006 that the total holdings of the companies under its management, Leimark Invest Oy Ab and Ingman Finance Oy Ab, had increased to 5.9% of the share capital and votes of Incap Corporation. Teknoventure Oy announced that it had sold all of its holdings in Incap Corporation, or 6.4% of the share capital and votes of Incap Corporation, in a transaction concluded on 27 September 2006. Etra Invest Oy announced on 29 September 2006 that its holdings of the share capital and votes of Incap Corporation had increased to 14.2%. Finnvera plc, in turn, announced that it had sold its 14.2% holding in a deal concluded on 29 September 2006. After the close of the financial year, on 26 January 2007, Ingman Finance Oy Ab announced that its holdings of the share capital and votes of Incap Corporation had increased to 10.1%. OKO Bank plc announced on 31 January 2007 that its holdings had fallen below 5%. Operational risks and factors of uncertainty The electronics and mechanics contract manufacturing market is estimated to grow steadily in the coming years, even though the pace of growth is expected to slow down slightly. There are strong fluctuations in the sector's demand, which makes it difficult to provide even short-term forecasts of the industry's future trend. The sector is highly competitive and, in order to remain profitable, contract manufacturers are constantly forced to improve the efficiency of their own operations and supply chains. The efficiency of materials management and productivity of manufacturing operations are key to maintaining cost-competitiveness. Incap's customers operate in a number of different industries, and this balanced customer structure shields the company from sharp seasonal fluctuations. Although the company is not overly dependent on any single customer, the simultaneous loss of one or more important customers may have an impact on the company's finances. Targeting strong growth and more international operations Incap's objective is to achieve strong, profitable growth through internationalisation. Organic growth in revenue can be achieved by increasing the volume of deliveries to present customers and by taking over customers' entire production under outsourcing agreements. New customer relationships are sought particularly among device manufacturers in the healthcare industry. The increased manufacturing capacity of the Estonian unit has created good conditions for growth in revenue and the acquisition of new customers especially in Scandinavia and central Europe. In addition to organic growth, Incap is examining the possibility of expanding its operations through mergers and acquisitions. Most device manufacturers with global operations expect their contract manufacturing partners to have international operations and to provide service near customers' main markets. In response to this challenge, Incap has extensively studied the possibility of starting manufacturing operations in Asia, close to rapidly growing markets where Incap's present customers are already operating. At the beginning of 2006, Incap opened an office in New Delhi for the purpose of charting the local contract manufacturing market. Events after the close of the financial year In February 2007, Incap signed a Letter of Intent with TVS Electronics Limited for the acquisition of an electronics contract manufacturing unit in India. The facility assembles circuit boards and manufactures power supply units, among other products. The objective is to transfer the unit's business operations during the second quarter of 2007 to a new subsidiary to be established. Outlook for 2007 The outlook for electronics manufacturing services remains bright and various research institutes estimate that the worldwide EMS market will continue to grow at around 10% annually in the near future. The majority of Incap's customers have given positive forecasts of their demand in 2007 and, judging by the offer backlog, interest in the company's services has increased. Incap's deliveries to the telecommunications sector will decline, and compensating revenue is sought from other customer branches and from new market areas such as India. Revenue of the first quarter of the year 2007 is expected to be smaller than during the same period last year due to a decline in revenue in the telecommunications sector. Operating profit in the first quarter is estimated to be significantly smaller than during January-March 2006. Incap will publish its Interim Report for January-March on Wednesday, 9 May 2007. INCAP CORPORATION Board of Directors For additional information, contact: Juhani Hanninen, President and CEO, tel. +358 50 556 7199 Anne Sointu, Chief Financial Officer, tel. +358 40 347 2059 Hannele Pöllä, Director, Communications and Investor Relations, tel. +358 40 504 8296 PRESS CONFERENCE Incap will arrange a conference for the press and financial analysts today at 10.00 a.m. at the World Trade Center Helsinki, in Meeting Room 1 on the 2nd floor, at the address Aleksanterinkatu 17, FI-00100 Helsinki. DISTRIBUTION Helsinki Stock Exchange Principal media INCAP IN BRIEF Incap Corporation is a fast-growing electronics contract manufacturer whose comprehensive service covers the entire product life cycle from design and manufacture to repair and maintenance services. The company's main customer sectors are leading equipment suppliers in telecommunications, electrical power technology, the automation and process industries as well as measurement technology, safety electronics and healthcare. The Incap Group's revenue in 2006 amounted to EUR 89 million and the company currently employs about 540 people. Incap's share is listed on the Helsinki Stock Exchange and it is a component of the Nordic Small Cap list within the information technology sector. For additional information, please visit www.incap.fi. ANNEXES Consolidated Income Statement Consolidated Balance Sheet Consolidated Cash Flow Statement Consolidated Statement of Changes in Equity Group Key Figures and Contingent Liabilities


 

(to download invitation click on link below) The Adecco Institute, a think tank and center for research on the future of work, would like to invite you to the: Adecco Institute Press Conference taking place during the European Business Summit in Brussels, Belgium to present exclusively its research results and white paper on Increasing Youth Employment by Facilitating the Transition from School to Work as well as its survey results on The (Fast) Ageing Workforce in Belgium and The Netherlands: How Prepared Are Local Companies? March 15, 2007, 12.10 CET TOUR & TAXIS, avenue du Port 86c, 1000 Brussels (visit the central registration desk for directions to press conference room) Speakers at the Press Conference will include: * Wolfgang Clement, Chairman of the Adecco Institute and former German Minister of Labor and Economics (2002-2005) * Dieter Scheiff, Adecco Group CEO * Mark de Smedt, Country Manager Adecco Benelux Note that the Adecco Institute press conference takes place during the European Business Summit (www.ebsummit.org, March 15-16, Brussels). Journalists should register at http://www.ebsummit.org/index.html?current=9&page=9&page2=9&lang=en to ensure free admittance. For interviews with the speakers, please contact Axel J. Schafmeister, Director Public Relations, axel.schafmeister@adecco.com, or call Tel. +41 79 571 8832. For further information on the Adecco Institute please visit: www.adeccoinstitute.com Please click here to view or download the Adecco Institute Press Conference Invitation Please click here to download registration form for free registration at the European Business Summit Please click here to download European Business Summit Itinerary --- End of Message --- WKN: 922031; ISIN: CH0012138605; Index: SLCI, SMI, SPI, SMIEXP; Listed: Main Market in SWX Swiss Exchange;


 

TRADING SYMBOL: TORONTO & OSLO: CRU FRANKFURT: KNC OTC-BB-other: CRUGF LONDON, United Kingdom: February 27, 2007 - Crew Gold Corporation ("Crew" or the "Company") (TSE & OSE: CRU; Frankfurt: KNC; OTC-BB- other: CRUGF.PK. Crew is pleased to advise the resumption of normal operations at its mine in Guinea, following the end of the national strike. Fuel deliveries recommenced during the weekend and normal production will resume on Tuesday February 27th. As previously advised, the company used the period of suspension to undertake maintenance programmes identified during the commissioning of the plant and the Company remains confident that the 2007 forecast production of 300,000 to 320,000 ounces will be achieved. Jan A Vestrum President & CEO Safe Harbour Statement This news release contains forward-looking statements which reflect the expectations of management and the board of directors, and are made pursuant to applicable and relevant national legislation (including the Safe-Harbour provisions of the United States Private Securities Litigation Reform Act of 1995) in countries where Crew Gold Corporation is conducting business and/or investor relations. Forward looking statements typically contain words such as "believes", "anticipates", "continue", "could", "expects", "indicates", "plans", "will", "may", "projects", "would" or similar expressions suggesting future outcomes or events, although not all forward-looking statements contain these identifying words. Such forward-looking statements reflect the current beliefs of management and the board of directors based on information currently available to them. Forward-looking statements involve inherent risks and uncertainties, and Crew cautions readers not to place undue reliance on these statements as a number of important factors could cause Crew's actual results to differ materially from the beliefs and expectations expressed in such forward-looking statements. Factors that could cause actual results to differ materially from the results discussed in the forward-looking statements, include, but are not limited to, the factors discussed under the heading "Risks and Uncertainties" in Crew's Annual Information Form dated October 10, 2006, as filed on SEDAR at www.sedar.com. Although the forward-looking statements contained in this news release are based upon what management and the board of directors believes to be current and reasonable assumptions, Crew cannot assure readers that actual results will be consistent with these forward-looking statements. The forward-looking statements contained herein are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Crew undertakes no obligation to publicly update or revise these forward-looking statements to reflect subsequent events or circumstances. Cautionary Note to US Investors - The United States Securities and Exchange Commission permits US mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. We use certain terms on this website (or press release), such as "measured", "indicated", and "inferred" "resources", which the SEC guidelines strictly prohibit US registered companies from including in their filings with the SEC. US Investors are urged to consider closely the disclosure from the SEC's website at http://www.sec.gov/edgar.shtml. --- End of Message --- WKN: 226534105 ; ISIN: CA2265301036; ;


 

The revenues in the 4th quarter were the highest in the Company's history and increased with 18% from the 3rd quarter to NOK 181,3 mill. In addition comes a NOK 26 mill. gain from sale of ship building contracts. EBITDA for the 4th quarter was 113,5 mill. and net profit was NOK 127,4 mill. or NOK 0,98 / share. 2006 was the first full year of operation for Deep Sea Supply. Total revenues were NOK 472,7 mill., EBITDA 265,3 mill. and net result NOK 245,2 mill. or NOK 2,29 per share. The Board suggests a dividend payment for the financial year of 2006 of NOK 102,5 mill. or NOK 0,80 per share. This is equivalent to a dividend yield of approximately 4,3% (dividend per share / stock price of NOK 18.50) and furthermore in line with the Company's strategy earlier communicated which is to distribute excess cash to its shareholders and raise equity when required in relation to future acquisitions. In 2006, Deep Sea Supply's Board of Directors decided to change the Company's domicile to Cyprus, a process which is now completed. In 2007, the fleet of Deep Sea Supply is expected to more than double (from 7 to 16 vessels) as a consequence of the current newbuilding program. This growth in fleet plus an expected strong offshore supply market should provide even stronger financial performance from Deep Sea Supply in 2007. 26 February 2007 Deep Sea Supply PLC


 

* Revenues: CHF 147.2 million, up 5.3% * EBITDA: CHF 21.8 million, down 2.2% * EBIT: CHF 14.7 million, down 11.3% * Net income: CHF 7.4 million, down 13.8% For the first half of the fiscal year 2006/2007, which ended on November 30, 2006, Unilabs (SWX: ULB) recorded revenues of CHF 147.2 million, an increase of 5.3 % compared with CHF 139.8 million in the same period of the previous financial year. At constant exchange rates, revenues grew by 4.4%. Earnings before interest, taxes, depreciation and amortisation (EBITDA) decreased by 2.2% to reach CHF 21.8 million, or 14.8% of sales. Operating profit decreased by 11.3% to CHF 14.7 million. This result reflects largely the impact of the Swiss Federal Council to impose a 10% linear reduction in the reimbursement prices for tests as of January 1, 2006. Net income attributable to the equity holders of the parent decreased by 13.8% to CHF 7.4 million, mainly as a result of the lower operating income and increased interest expenses. Second quarter revenues reached CHF 82.2 million, up 7.4% compared with CHF 76.5 million the previous year. EBITDA reached as in the previous year CHF 15.4 million, or 18.7% of revenues compared with 20.2% in the previous year. Net income reached CHF 7.3 million. As a result of the 10% linear reduction in the reimbursement prices for tests which took effect on January 1, 2006, half year revenues in Switzerland, Unilabs' largest market, decreased by 7.6% to CHF 85.1 million versus CHF 92.1 million the previous year. The cost-cutting measures implemented by Unilabs partially compensated this negative impact. Excluding the impact of the 10% price cut, Swiss revenues would have increased by 3.6% in the second quarter versus a recorded decrease of CHF 5.4% to CHF 47.0 million. Half year revenues grew by 12.0% in Spain to CHF 21.4 million and by 3.0% in France to CHF 23.4 million. As a result of its successful entry in the Portuguese market in the previous fiscal year, Unilabs posted half year revenues of CHF 11.7 million in this country. Through select acquisitions, Unilabs intends to pursue its external growth strategy, both in Switzerland as in the rest of Europe. For the first half year 2006/2007 operating profit (EBIT) reached CHF 14.7 million, or 10.0% of revenues, compared with CHF 16.6 million, or 11.9% of revenues in the previous fiscal year, a decrease of 11.3%. In connection with a swap contract, which purports to protect the company against an increase in interest rates, in accordance with accounting rule IAS 39, an amount of CHF 0.5 million remains, as of November 30, 2006, out of the previously-established provisions. As indicated previously, such balance will be written back to profit at the latest upon termination of the contract on April 1, 2007. Earnings before taxes decreased by 22.5% to CHF 11.7 million, compared with CHF 15.1 million in the comparable prior year period, mainly as a result of the lower operating income and increased interest expenses. Income tax provisions were CHF 3.1 million as compared to CHF 4.1 million. Minority interests in net income decreased to 1.2 compared to CHF 2.4 million a year ago. Net income attributable to the equity holders of the parent amounted to CHF 7.4 million (or CHF 0.77 per bearer share), compared with CHF 8.6 million (or CHF 0.87 per bearer share) in the previous financial year. Strong balance sheet and debt position At November 30, 2006, total equity grew to CHF 140.4 million versus CHF 130.7 million as of May 31, 2006, an increase of 7.4% As a result of its Portuguese acquisitions, net financial debt increased by 13.2% to 81.9 million, and unused credit facilities and cash were CHF 94.6 million on November 30, 2006. During the half year ended November 30, 2006, Unilabs: * Completed two acquisitions in Portugal * Consolidated its market share in Switzerland, Spain, Portugal and France * Pursued the identification and review of acquisition targets * Started the construction of its new production platform in Coppet, Switzerland * Received the approval of the General Shareholders Meeting to authorize the Board of Directors, valid up to November 28, 2008, to increase the share capital up to a maximum of 2 million shares, divided into a maximum of 1'520'00 bearer shares of a par value of CHF 1.00 and a maximum of 960'000 registered shares of a par value of CHF 0.50. In addition, Shareholders approved not to distribute a dividend for the current fiscal year 2006/2007, in order to allocate these resources to the growth of the Company. Updated outlook For the current fiscal year, ending May 31, 2007, Unilabs now expects organic Group revenue growth of 1% in local currencies versus 2-2.5% initially. Including the positive impact of realized acquisitions, revenues should reach CHF 305-310 million, representing an overall growth rate of approximately 5 - 6.5% for the fiscal year. The company anticipates an unchanged EBITDA margin between 17-18% of revenues. This outlook takes into account the full year impact of the Swiss price reduction as well as the cost-cutting measures that are implemented by the Company to achieve savings to a level close to the expected loss of margin. The Company pursues this effort by developing and implementing a number of additional cost savings measures for the next two years. Through select acquisitions, Unilabs intends to further take advantage of the European consolidation process of the clinical laboratory market. Conference call To discuss the financial results for the first half-year 2006/2007, Unilabs will hold a conference call today at 3:00 p.m. CET. To participate, dial: +41 (0)91 610 5600 (Europe and Switzerland), +44 207 107 06 11 (UK), +1 866 291 41 66 (US/Canada). Digital playback is available for 48 hrs from February 27th at 18:00 pm CET until March 1st until 18:00 pm CET. Dial: +41 91 612 4330 (Europe); +44 207 108 62 33 (UK); + (1) 866 416 2558 (USA/Canada); Conference ID: 437 followed by #. In order to view the slide presentation, please go to the home page of Unilabs at www.unilabs.com, select "Investors" and "Q2 and half year results 2006/2007 - Conference Call" where a link to the presentation will be provided immediately prior to the event. Please note that sound will only be provided through the telephone conference. About Unilabs The Unilabs Group (SWX: ULB) is the European leader of clinical testing laboratories. With over 50 laboratories and over 1500 employees operating in 6 countries, Unilabs tests over 3.5 million samples per year using more than 1500 different tests. Unilabs' clinical testing services are used by over 60 public and private hospitals in France, Spain and Switzerland. Unilabs has been listed on the SWX Swiss Stock Exchange since 1997. Edgard Zwirn, Executive Chairman, is at your disposal for any further query (tel. +4122 909 77 77). Our press releases are also available on the Internet at our web site www.unilabs.com --- End of Message --- WKN: 906648; ISIN: CH0012561640; Index: SPI, SSCI, SBIOM, SLIFE, SPIEX; Listed: Main Market in SWX Swiss Exchange;


 

Although a Small Portion of Overall Venture Capital Activity, Cleantech Deal Flow Is Growing at Rapid Pace, According to Research From Dow Jones VentureOne and Ernst & Young LONDON and SAN FRANCISCO, CA -- (MARKET WIRE) -- February 27, 2007 -- The growing level of environmentally focused clean technology companies, dubbed "cleantech," is garnering significant interest in the venture capital market. According to new global research from Dow Jones VentureOne and Ernst & Young, US$1.28 billion was invested in 140 financing rounds in 2006 in China, Europe, Israel, and the US. That compares to US$664.1 million invested in 103 financings in 2005, showing that capital investment in the field has nearly doubled over the past year. Because of the significant level of attention being focused on cleantech, VentureOne's research department adopted a strict methodology for categorizing potential companies in this new industry. They were defined as companies that directly enable the efficient use of natural resources and reduce the ecological impact of production. Areas of focus include energy, water, agriculture, transportation, and manufacturing where the technology creates less waste or toxicity. The impact of cleantech can be either to provide superior performance at lower costs or to limit the amount of resources needed while maintaining comparable productivity levels. "Global climate change, high oil prices, accelerated growth in emerging markets, energy security and the finite nature of resources are some of the key drivers of global demand for clean technologies in energy and water," said Gil Forer, Global Director of Ernst & Young's Venture Capital Advisory Group. "In addition, the increased willingness of consumers and governments to pay for and use green technologies combined with the positive exit environment of the last couple of years has provided venture capitalists with the confidence to invest in emerging clean technology companies around the globe." While the investment levels are growing, cleantech is a relatively small portion of the overall venture capital market. For comparison's sake, a total of about US$34 billion was invested in 3,748 financings across all industries in the US, Europe, China and Israel in 2006. "Although small, the impressive growth rate over the past year shows it is not an insignificant portion of the market. The increased attention to environmental concerns is causing venture capital investors to recognize and support the entrepreneurial companies that are focused on making a difference and aiming to find market opportunities in this industry," said Stephen Harmston, Director of Global Research for VentureOne. "And certainly, that is the foundation of the venture capital model -- to locate and sustain the next wave of innovation in the global marketplace." Along with the growing level of investment, the size of financings for cleantech companies is growing as well. The median size of a cleantech financing round in 2006, on a global basis, was US$6 million. For US headquartered companies the median round size was US$7.5 million, slightly higher than the overall median for a US venture capital financing in 2006. Perhaps not surprisingly, the US saw the most activity in this industry in 2006, with 87 deals and US$883.6 million invested. But Europe grew as well, with 38 deals and US$157 million invested in 2006, nearly twice as much investment as in 2005. Cleantech investing in China also increased to 12 deals, up from five in 2005, and US$221.8 million invested, up from US$85.5 million in the preceding year. Israel had no deals in 2005, but three deals and US$22.5 million was invested in 2006. "In the last 12 months we have seen an increasing number of venture capital funds start to invest in emerging clean technology companies. Although we expect the number of investors in this sector to grow, both in terms of sector-focused funds and mainstream funds, the challenge for venture capitalists will be to understand which clean technology segments fit the venture capital model and where venture capital involvement adds the most value. We also believe that China and India will play a major role in building the innovation pipeline in clean technology," Mr. Forer added. The cleantech companies also are receiving solid premoney valuations. For example, the median valuation of a US cleantech company in 2006 was US$13.5 million, which is lower than overall median valuations for venture-backed companies in the US which are at US$18 million. The global median valuation for a cleantech company is US$8.3 million. The most active global investors in cleantech in 2006 include Draper Fisher Jurvetson, DFJ Element, Khosla Ventures, Nth Power and Rockport Capital Partners. The investment figures included in this release are based on aggregate findings of VentureOne's proprietary global research. This data was collected by surveying professional venture capital firms, through in-depth interviews with company CEOs and CFOs, and from secondary sources. These venture capital statistics are for equity investments into early-stage, innovative companies and do not include companies receiving funding solely from corporate, individual, and/or government investors. No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice. Copyright © 2007, VentureOne. About VentureOne Dow Jones VentureOne (www.ventureone.com and www.venturecapital.dowjones.com), a unit of Dow Jones Financial Information Services, has been the leading provider of finance and investment data to the venture capital industry for almost 20 years. Dow Jones VentureSource, a sophisticated electronic database on the venture capital industry, is published by VentureOne. About Dow Jones Financial Information Services Through its Financial Information Services group, Dow Jones produces focused, sector-specific online databases, newsletters and industry events for the private equity, venture capital and diversified markets. Newsletters published include Private Equity Analyst, VentureWire and Daily Bankruptcy Review. In addition, Dow Jones & Company (NYSE: DJ) (www.dowjones.com) is a leading provider of global business news and information services. Its Consumer Media Group publishes The Wall Street Journal, Barron's, MarketWatch and the Far Eastern Economic Review. Its Enterprise Media Group includes Dow Jones Newswires, Factiva, Dow Jones Licensing Services, Dow Jones Indexes and Dow Jones Financial Information Services. Its Local Media Group operates community-based information franchises. Dow Jones provides news content to CNBC and radio stations in the U.S. About Ernst & Young Ernst & Young, a global leader in professional services, is committed to restoring the public's trust in professional services firms and in the quality of financial reporting. Its 114,000 people in 140 countries pursue the highest levels of integrity, quality, and professionalism in providing a range of sophisticated services centered on our core competencies of auditing, accounting, tax, and transactions. Further information about Ernst & Young and its approach to a variety of business issues can be found at www.ey.com/perspectives. Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited does not provide services to clients. For more information: Michelle Jeffers Dow Jones VentureOne (415) 439-6666 Mobile: (415) 608-1593 michelle.jeffers@dowjones.com Morten Hussmann Ernst & Young Global +44 20 7980 0299 morten.hussmann@uk.ey.com SOURCE: Dow Jones VentureOne


 

Cargotec Corporation, Stock Exchange Release, February 26, 2007 at 6:55 p.m. Finnish time Cargotec's Board of Directors has decided to exercise the authorization of the Annual General Meeting on February 26, 2007 to repurchase the Company's own shares. The maximum amount of repurchased own shares will be less than ten percent of the Company's share capital and total voting rights. This corresponds to a maximum of 6,400,000 shares so that a maximum of 952,000 class A shares and 5,448,000 class B shares can be repurchased. In accordance with the authorization the shares will be repurchased in order to develop the capital structure of the Company, finance or carry out possible acquisitions, implement the Company's share-based incentive plans, or to be transferred for other purposes or to be cancelled. Class B shares will be purchased at public trading in the Helsinki Stock Exchange at the market price. Class A shares will be purchased outside the Stock Exchange at the price equivalent to the average price of class B shares paid in the Helsinki Stock Exchange on the purchase date. Share repurchases will be released on the transaction days through stock exchange announcements. The repurchases will at the earliest start on March 12, 2007. Sender: Cargotec Corporation Kari Heinistö Senior Executive Vice President and CFO Eeva Mäkelä SVP, Investor Relations and Communications For further information, please contact: Kari Heinistö, Senior Executive Vice President and CFO, tel. +358 204 55 4256 Eeva Mäkelä, SVP, Investor Relations and Communications, tel. +358 204 55 4281 Cargotec is the world's leading provider of cargo handling solutions whose products are used in the different stages of material flow in ships, ports, terminals, distribution centers and local transportation. Cargotec Corporation's brands, Hiab, Kalmar and MacGREGOR, are market leaders in their fields and well-known among customers all over the world. Cargotec's net sales are EUR 2.6 billion. The company employs close to 9,000 people and operates in approximately 160 countries. Cargotec's class B shares are quoted on the Helsinki Stock Exchange. www.cargotec.com


 

Kaupthing Bank hf. - Related Party Trading Norvest ehf., a company which is financially related to Brynja Halldórsdóttir, a member of the Board of Directors of Kaupthing Bank hf., has today, 26 February 2007, purchased 1,000,000 shares in the Bank at a price of 1,025 ISK per share. Furthermore, Norvest ehf., has today extended a forward contract dated November 23, 2006, on the purchase of 1,300,000 shares in the Bank, cf. a notice published on November 23, 2006. The price in the transaction is 111.75 SEK plus interest and cost. The maturity date of the contract is now August 27, 2007. Brynja Halldórsdóttir owns 9,206 shares in the bank. Parties financially related to Brynja Halldórsdóttir own a total of 14,112,048 shares in the Bank following the transaction. Furthermore parties financially related to Brynja Halldórsdóttir own 4,817,500 shares in the Bank according to forward contracts.


 

Hat Pin plc (the "Company") Additional Listing Hat Pin plc announces that it has applied for the Admission to AIM ("Admission") of 87,360 new ordinary shares of 2.5 pence each in the capital of the Company, which comprise part of the deferred consideration payable in connection with the acquisition of Akamai Financial Markets on 8 September 2006. The new ordinary shares will rank pari passu in all respects with the Company's existing ordinary shares. It is expected that Admission of the new ordinary shares will become effective on or around 2 March 2007. ---END OF MESSAGE---


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |----------------------------------------------+--------------------| | Company dealt in | Gallaher Group plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | 10p Ordinary | | dealings being disclosed relate (Note 2) | | |----------------------------------------------+--------------------| | Date of dealing | 23 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------------+--------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (2) Derivatives (other than | 7,381,371 | 1.1233 | | | | options) | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------+-----------+--------+--------+-----| | Total | 7,381,371 | 1.1233 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per unit | | name, | (Note 6) | (Note 7) | (Note 5) | | e.g. CFD | | | | |----------+------------+--------------------------+----------------| | CFD | LONG | 50,000 | 1129.7646 | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 26th February 2007 | |----------------------------------------------+--------------------| | Contact name | James Feast | |----------------------------------------------+--------------------| | Telephone number | 0207 469 1901 | |----------------------------------------------+--------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |----------------------------------------------+--------------------| | If a connected EFM, state nature of | | | connection (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Cargotec Corporation, Stock Exchange Release, February 26, 2007 at 5:00 p.m. Finnish time Cargotec Corporation's Annual General Meeting was held today, February 26, 2007 in Helsinki. The Annual General Meeting approved a dividend of EUR 0.99 for each of the 9,526,089 class A shares and EUR 1.00 for the 53 815 646 outstanding class B shares. The record date for dividend distribution is March 1, 2007, and the dividend payment date is March 8, 2007. The rest of the distributable equity, EUR 841,767,514.72, will be retained and carried forward. The meeting approved the financial statements and consolidated financial statements. The meeting granted discharge from liability to the President and CEO and the members of the Board of Directors for the accounting period January 1-December 31, 2006. The number of members of the Board of Directors was confirmed at six according to the proposal of Cargotec's Nomination and Compensation Committee. Carl-Gustaf Bergström, Henrik Ehrnrooth, Tapio Hakakari, Ilkka Herlin, Peter Immonen and Karri Kaitue were re-elected as members of the Board of Directors. The Chairman of the Board's monthly remuneration was decided to be EUR 5,000. The Deputy Chairman's monthly remuneration was decided to be EUR 3,500. Other Board members' remuneration was decided to be EUR 2,500. In addition, it was decided that members receive EUR 500 for attendance at Board and Committee meetings. Authorized public accountants Johan Kronberg and PricewaterhouseCoopers Oy were elected as auditors according to the proposal of Audit Committee of Cargotec Corporation's Board of Directors. The auditors' fees were decided to be paid according to invoice. The Annual General meeting authorized the Board of Directors of Cargotec to decide to repurchase the Company's own shares with assets distributable as profit. The shares may be repurchased in order to develop the capital structure of the Company, finance or carry out possible acquisitions, implement the Company's share-based incentive plans, or to be transferred for other purposes or to be cancelled. The shares may be purchased through a private offering as defined in Finnish Companies Act, Chapter 15 § 6. Altogether no more than 6,400,000 own shares may be repurchased, of which no more than 952,000 are class A shares and 5,448,000 are class B shares. The above-mentioned amounts include the 704,725 class B shares already in the Company's possession. The maximum amount corresponds to less than 10 percent of the share capital of the Company and the total voting rights. The repurchase of shares will decrease the non-restricted equity of the Company. This authorization shall remain in effect for a period of 18 months from the date of decision of the Annual General Meeting. In addition, the Annual General Meeting authorized the Board of Directors to decide on the distribution of any shares repurchased. The Board of Directors is authorized to decide on the distribution of a maximum of 952,000 class A shares and 5,448,000 class B shares. The Board of Directors is authorized to decide to whom and in which order the shares will be distributed. The Board of Directors may decide on the distribution of repurchased shares otherwise than in proportion to the existing pre-emptive right of shareholders to purchase the Company's own shares. The shares may be used as compensation in acquisitions and in other arrangements as well as to implement the Company's share-based incentive plans in the manner and to the extent decided by the Board of Directors. The Board of Directors has also the right to decide on the distribution of the shares in public trading at the Helsinki Stock Exchange to be used as compensation in possible acquisitions. This authorization shall remain in effect for a period of 18 months from the date of decision of the Annual General Meeting. Sender: Cargotec Corporation Kari Heinistö Senior Executive Vice President and CFO Eeva Mäkelä SVP, Investor Relations and Communications For further information, please contact: Kari Heinistö, Senior Executive Vice President and CFO, tel. +358 204 55 4256 Eeva Mäkelä, SVP, Investor Relations and Communications, tel. +358 204 55 4281 Cargotec is the world's leading provider of cargo handling solutions whose products are used in the different stages of material flow in ships, ports, terminals, distribution centers and local transportation. Cargotec Corporation's brands, Hiab, Kalmar and MacGREGOR, are market leaders in their fields and well-known among customers all over the world. Cargotec's net sales are EUR 2.6 billion. The company employs close to 9,000 people and operates in approximately 160 countries. Cargotec's class B shares are quoted on the Helsinki Stock Exchange. www.cargotec.com


 

Please find FL Group's annual report for 2006 attached to the link below. For further information please contact FL Group's Investor Relations at +354 591 4400.


 

Nortel Solutions Enhance Patient Care, Expand Call Center Functionality NEW ORLEANS, LOUISIANA -- (MARKET WIRE) -- February 26, 2007 -- Geisinger Health System, which serves 2.5 million people in its network of hospitals and physicians across 20,000 square miles, is tapping the power of Nortel(1) (TSX: NT)(NYSE: NT) IP Contact Center solutions to deliver time-saving services for both practitioners and patients. The solutions are part of Nortel's clinical grade Healthcare Solutions. By improving its call center communications, Geisinger has created a single virtual contact center spanning wide geographical areas, allowing calls that were once manually routed by operators at various locations to now be automatically routed to the most appropriate agent. Geisinger's new contact center capabilities also include immediate routing of calls to doctors IP wireless phone, regardless of their location. "We handle more than 9,000 calls a day across various call centers that staff 400 agents to perform various tasks," said Gary Keefer, director of voice systems for Geisinger Health System. "With each of those calls averaging 2.5 minutes, it became obvious that we needed a solution that would enhance collaboration between the call center and doctors while making it faster for patients to get answers to their questions." Previously, multiple call centers were fielding calls such as scheduling and confirming patient appointments, calls from referring physicians, or handling IT inquiries. Now, skill-based routing directs calls to the appropriate specialty such as orthopedics or obstetrics, to a general appointment queue, or to wherever client assistance can be best provided. Also, Geisinger is starting to utilize Nortel IP wireless phones to allow physicians and administrators to work collaboratively with the contact center and the patient, regardless of location, quickly answering complex questions and improving first call resolution. "The flexibility that IP has brought to Geisinger is hard to express in dollars and cents," Keefer said. "We can quickly and easily install IP phones where they are needed. Having that convenience to save a doctor even 10 seconds could be worth a great deal to Geisinger and its patients." With the introduction of Nortel's Contact Center using Expert Anywhere solution that also includes Multimedia Communication Server (MCS) 5100, Nortel IP Phones, and Media Processing Server (MPS) 500, Geisinger has transformed multiple call centers into a single virtual contact center with Interactive Voice Response (IVR). Nortel's IVR technology empowers patients to manage their own service. Callers can listen to instructions on pre- and post- surgery care, answer quick health surveys and still be assured that answers which fall out of the "normal" range will alert a nurse to provide additional care or consultation. "Nortel's Multimedia solutions for healthcare are bringing practitioners and patients together faster and much more effectively," said Dave Murashige, general manager, Multimedia Applications, Nortel. "Geisinger has extended its reach and optimized resources by creating a virtual contact center that has improved communication between staff, doctors and patients. But most importantly, it has made accessing care simpler for thousands of people who need immediate attention." Through previous deployment of products and solutions from Nortel's award-winning Self-Service Solutions portfolio, as well as products from the Nortel IP Telephony portfolio, Geisinger had a foundation of Nortel technology and was able to expand its capabilities without adding additional hardware. Nortel's Communication Server 1000 was selected because hardware could be kept at the main site, which simplified maintenance to that one location. Additional Nortel solutions implemented at Geisinger Health System include CallPilot Unified Messaging to help simplify faxing and reduce expenses, and WLAN IP Telephone Handsets for wireless mobility. About Nortel Nortel is a recognized leader in delivering communications capabilities that make the promise of Business Made Simple a reality for our customers. Our next-generation technologies, for both service provider and enterprise networks, support multimedia and business-critical applications. Nortel's technologies are designed to help eliminate today's barriers to efficiency, speed and performance by simplifying networks and connecting people to the information they need, when they need it. Nortel does business in more than 150 countries around the world. For more information, visit Nortel on the Web at www.nortel.com. For the latest Nortel news, visit www.nortel.com/news. Certain statements in this press release may contain words such as "could", "expects", "may", "anticipates", "believes", "intends", "estimates", "targets", "envisions", "seeks" and other similar language and are considered forward-looking statements or information under applicable securities legislation. These statements are based on Nortel's current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which Nortel operates. These statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and the actual outcome may be materially different. Further, actual results or events could differ materially from those contemplated in forward-looking statements as a result of the following (i) risks and uncertainties relating to Nortel's restatements and related matters including: Nortel's most recent restatement and two previous restatements of its financial statements and related events; the negative impact on Nortel and NNL of their most recent restatement and delay in filing their financial statements and related periodic reports; legal judgments, fines, penalties or settlements, or any substantial regulatory fines or other penalties or sanctions, related to the ongoing regulatory and criminal investigations of Nortel in the U.S. and Canada; any significant pending civil litigation actions not encompassed by Nortel's proposed class action settlement; any substantial cash payment and/or significant dilution of Nortel's existing equity positions resulting from the approval of its proposed class action settlement; any unsuccessful remediation of Nortel's material weaknesses in internal control over financial reporting resulting in an inability to report Nortel's results of operations and financial condition accurately and in a timely manner; the time required to implement Nortel's remedial measures; Nortel's inability to access, in its current form, its shelf registration filed with the United States Securities and Exchange Commission (SEC), and Nortel's below investment grade credit rating and any further adverse effect on its credit rating due to Nortel's restatements of its financial statements; any adverse affect on Nortel's business and market price of its publicly traded securities arising from continuing negative publicity related to Nortel's restatements; Nortel's potential inability to attract or retain the personnel necessary to achieve its business objectives; any breach by Nortel of the continued listing requirements of the NYSE or TSX causing the NYSE and/or the TSX to commence suspension or delisting procedures; (ii) risks and uncertainties relating to Nortel's business including: yearly and quarterly fluctuations of Nortel's operating results; reduced demand and pricing pressures for its products due to global economic conditions, significant competition, competitive pricing practice, cautious capital spending by customers, increased industry consolidation, rapidly changing technologies, evolving industry standards, frequent new product introductions and short product life cycles, and other trends and industry characteristics affecting the telecommunications industry; the sufficiency of recently announced restructuring actions, including the potential for higher actual costs to be incurred in connection with these restructuring actions compared to the estimated costs of such actions and the ability to achieve the targeted cost savings and reductions of Nortel's unfunded pension liability deficit; any material and adverse affects on Nortel's performance if its expectations regarding market demand for particular products prove to be wrong or because of certain barriers in its efforts to expand internationally; any reduction in Nortel's operating results and any related volatility in the market price of its publicly traded securities arising from any decline in its gross margin, or fluctuations in foreign currency exchange rates; any negative developments associated with Nortel's supply contract and contract manufacturing agreements including as a result of using a sole supplier for key optical networking solutions components, and any defects or errors in Nortel's current or planned products; any negative impact to Nortel of its failure to achieve its business transformation objective; additional valuation allowances for all or a portion of its deferred tax assets; Nortel's failure to protect its intellectual property rights, or any adverse judgments or settlements arising out of disputes regarding intellectual property; changes in regulation of the Internet and/or other aspects of the industry; Nortel's failure to successfully operate or integrate its strategic acquisitions, or failure to consummate or succeed with its strategic alliances; any negative effect of Nortel's failure to evolve adequately its financial and managerial control and reporting systems and processes, manage and grow its business, or create an effective risk management strategy; and (iii) risks and uncertainties relating to Nortel's liquidity, financing arrangements and capital including: the impact of Nortel's most recent restatement and two previous restatements of its financial statements; any inability of Nortel to manage cash flow fluctuations to fund working capital requirements or achieve its business objectives in a timely manner or obtain additional sources of funding; high levels of debt, limitations on Nortel capitalizing on business opportunities because of support facility covenants, or on obtaining additional secured debt pursuant to the provisions of indentures governing certain of Nortel's public debt issues and the provisions of its support facility; any increase of restricted cash requirements for Nortel if it is unable to secure alternative support for obligations arising from certain normal course business activities, or any inability of Nortel's subsidiaries to provide it with sufficient funding; any negative effect to Nortel of the need to make larger defined benefit plans contributions in the future or exposure to customer credit risks or inability of customers to fulfill payment obligations under customer financing arrangements; any negative impact on Nortel's ability to make future acquisitions, raise capital, issue debt and retain employees arising from stock price volatility and further declines in the market price of Nortel's publicly traded securities, or the share consolidation resulting in a lower total market capitalization or adverse effect on the liquidity of Nortel's common shares. For additional information with respect to certain of these and other factors, see Nortel's Annual Report on Form10-K/A, Quarterly Reports on Form 10-Q and other securities filings with the SEC. Unless otherwise required by applicable securities laws, Nortel disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. (1)Nortel, the Nortel logo and the Globemark are trademarks of Nortel Networks. Contacts: Nortel Mary Pretotto (905) 863-7777 Email: maryp@nortel.com Website: www.nortel.com


 

Moody's has implemented a new rating methodology and has published new ratings for Norwegian banks. Sparebanken Midt-Norge's Long Term Deposit Rating has been upgraded to Aa2 (stable outlook) from A3 (positive outlook). The rating for Short Term Bank Deposits has been upgraded to P-1 from P-2 while the Bank Financial Strength Rating (BFSR) has been upgraded to C+ from C. Executive Director Kjell Fordal, tlf.: + 47 905 41 672 About us SpareBank 1 Midt-Norge is Central Norway's leading financial group. We are market leaders in personal and business banking and have 58 offices in 49 municipalities, in addition to distributing our services through 17 in-shop banks. Our head office is in Trondheim. The group has approximately 700 employees and comprises, in addition to banking operations, the subsidiaries SpareBank 1 Finans Midt-Norge AS, EiendomsMegler 1 Midt-Norge AS, Allegro Finans ASA and Midt-Norge Regnskap AS. Our mission is to be the recommended bank for customers in Central Norway and, as a local, independent savings bank, we feel a special responsibility for stimulating growth and quality of life in the region. We base our business on proximity to customers, good accessibility, a complete range of banking, financial and insurance products, and holistic financial advisory services. SpareBank 1 Midt-Norge is one of six owners of SpareBank 1 Gruppen AS. For more information, visit our website at http://www.smn.no


 

Shareholders in Klövern AB (publ) are hereby notified of the Annual General Meeting of Shareholders at 4pm on Wednesday, 28 March 2007 at Restaurangskolan, Nyköping Strand in Nyköping. Registration Shareholders wishing to participate in the Annual General Meeting of Shareholders must * be registered as owner in the print-out of the share register made by VPC AB on Thursday, 22 March 2007 * and notify their attendance to Klövern at the latest by 4 pm on Thursday, 22 March 2007 Notice of attendance at the meeting may be made in the following ways: * by post to Klövern AB (publ), Box 1024, SE-611 29 Nyköping (Sweden) * by telephone +46-(0)155 44 33 00 * by fax +46-(0)155 44 33 22 * or via Klövern's website www.klovern.se When making notification, shareholders must state their name, date of birth/Swedish personal ID no./company registration no., address and telephone number and shareholding. To participate in the meeting, shareholders whose shares are nominee registered, must request that their shares be temporarily registered in their own name at VPC AB in sufficiently good time that re-registration has taken place by Thursday, 22 March 2007. In order for this to be possible, requests for such registration must have been made to the administrator in good time before this date. In cases where representatives participate in the meeting, authorisation documents should be sent to the company at the time of notification of attendance. Shareholder representatives shall present a written dated power of attorney, which must not be more than one year old on the date of the meeting. If the provider of the power of attorney is a legal entity, a certified registration certificate or other document showing the authorisation of the signatory is to be presented. Agenda 1. Opening of the meeting 2. Appointment of a chairperson at the meeting 3. Preparation and approval of the voting list 4. Appointment of one or two persons to check the minutes 5. Consideration of whether the meeting has been duly called 6. Approval of the agenda 7. Speech by the President & CEO 8. Presentation of the annual report and the auditors' report and the consolidated income and the auditors' report for the group 9. Decisions on: a) the adoption of the income statement and balance sheet and consolidated income statement and consolidated balance sheet b) appropriations concerning the company's profit in accordance with the adopted balance sheet (see below) c) discharge from liability for the board members and the President & CEO d) the record date, in the event of the Annual General Meeting deciding on a dividend (see below) 10. Determination of the number of board members (see below) 11. Determination of fees for the board and auditors (see below) 12. The chairperson of the Annual General Meeting will provide information on those taking part in elections to the board on their positions in other companies and organisations 13. Election of the board and auditors (see below) 14. Adoption of principles for remuneration and terms of employment of the executive management (see below) 15. Principles for the appointment of a nominations committee (see below) 16. Decisions on authorisation for the board to acquire and transfer the company's own shares (see below) 17. The board's proposal on brokerage-free trading (see below) 18. Other business 19. Closure of the meeting Proposed decisions Dividend, item 9 b and d The board recommends to the Annual General Meeting of Shareholders that a dividend of SEK 1.25 per share be paid for 2006. It is proposed that Monday, 2 April 2007 be record date. If the Annual General Meeting decides in accordance with the proposal, it is expected that cash dividend will be paid by VPC AB on Thursday, 5 April 2007. Election of the board of directors, items 10, 11 och 13 The nominations committee, i.e. the representatives of the company's shareholders who have been appointed to make proposals for the board consists of the following representatives: Göran Almberg, chairman of the nominations committee (LRF), Rickard Svensson (Arvid Svensson Invest), Bo Jansson (Skandia Liv), Erik Törnberg (Investment AB Öresund), Klas Andersson (representing other shareholders) and Stefan Dahlbo (Chairman of the board of Klövern) proposes that the board shall consist of seven members, which is unchanged compared with the present number. It is proposed that Stefan Dahlbo, Gustaf Hermelin, Lars Holmgren, Anna-Greta Lundh, Johan Piehl, Lars Rosvall and Fredrik Svensson be re-elected. The nominations committee proposes that Stefan Dahlbo be elected as chairman. It is proposed that a fee of SEK 875,000 be paid to the board, of which SEK 250,000 is to be paid to the Chairman of the board and SEK 125,000 each to the other members, which is unchanged compared with the present fee. No fee is to be paid to the President & CEO of Klövern. It is proposed that payment be made to the auditors in accordance with the invoice amount submitted. It is proposed that the authorised firm of public accountants Ernst & Young AB be reappointed for a period of four years with authorised public accountant Mikael Ikonen as auditor in charge. The present auditor in charge Björn Fernström, who has been auditor for the company since 2000, cannot be reappointed due to the current rotation rules. Adoption of principles for remuneration and other conditions of employment for the senior management, item 14 The board makes the following proposals for remuneration and other conditions of employment for the senior management: The monthly basic salary is to be at a market level and competitive and take into account the areas of responsibility and experience of the individual. The basic salary is reviewed every year. For the President & CEO, the variable salary shall be paid at 1 per cent of the company's profit before tax, to the extent that this amount exceeds the set operational targets for the property operations. Annual maximum bonus may, for the President & CEO, amount to an amount corresponding to at most six months basic salary. The pension premium for the President & CEO can at the most amount to 35 per cent of the basic salary and the retirement age is 65. The period of notice for the President & CEO is twelve months if notice is given by the company and six months if given by the President & CEO. Severance pay is not paid. For other senior executives, the maximum annual bonus may total an amount corresponding to six months basic salary. The pension premium may at most amount to 35 per cent of the basic salary and the retirement age is 65. For other senior executives, the period of notice is at most twelve months if notice is given by the company and six months if given by the employee. Severance pay is not paid for four of the five senior executives. In the case of one senior executive, there are conditions on severance pay, in addition to the above-mentioned period of notice, which mean twelve months salary in the event of notice being given by the company. Benefits in addition to salary and pension are, for all senior executives, cost benefit, and a share in Klövern's profit-sharing fund. The President and three other senior executives have a company car benefit. One other senior executive is entitled to home help service. The board of directors is entitled to depart from the guidelines if there are special reasons for doing so in particular cases. Senior executives include the President & CEO and other members of the executive management group. The executive management at present consists of Gustaf Hermelin, President & CEO, Britt-Marie Einar, Corporate Communications Officer, Tomas Hermansson, Head of Business Unit in Kista, Anders Lundquist, CFO, Thomas Nilsson, Real Estate Manager and Caesar Åfors, Finance Manager. Nominations Committee, item 15 The nominations committee's proposals for the composition of the nominations committee are in accordance with those decided upon at the Annual General Meeting in 2006 and which thus apply for the Annual General Meeting in 2007. The principles can be read on Klövern's website, www.klovern.se. Decisions on authorisation for the board of directors to acquire and transfer the company's own shares, item 16 The board of directors proposes that the Annual General Meeting authorise the board of directors, at the latest until the next annual general meeting, to acquire and transfer Klövern's own shares. This authorisation is intended to make it possible to continuously adjust the company's capital requirements and thus contribute to increased shareholder value, and to be able to transfer shares in connection with financing of any property or company acquisitions, by payment with the company's own shares. Acquisition may take place of as many shares so that the company's holding amounts at most to the number of shares that at any point in time corresponds to 10 per cent of the shares issued by the company. Acquisitions may take place by purchase on the Stockholm stock exchange, Stockholmsbörsen. Transfer may take place of at most the number of shares that at any point in time corresponds to 10 per cent of all of the shares issued by the company. Transfer shall be able to take place both on Stockholmsbörsen and, deviating from the priority right of shareholders, to a third party in connection with property or company acquisitions. Payment for transferred shares can be made in cash, as payment in kind, a set-off, or otherwise with conditions. Brokerage-free trade, item 17 The board of directors proposes that the Annual General Meeting decide to invite shareholders to purchase or sell the number of shares required to achieve a holding equivalent to whole trading lots (a trading lot = 500 shares). If the shareholder holds less than 500 shares, the whole holding can be sold free of brokerage. It is proposed that it be left to the board to decide on the period of the offer and the detailed terms and conditions. Other matters The annual report, the auditors' report and the board's complete proposals in other matters are available at Klövern's office in Nyköping from Wednesday. 7 March 2007. Copies of the documents will be sent to the shareholders who make a request to that effect and provide their postal address. Programme at the Annual General Meeting 3 pm Entrance to the premises for the meeting opened 4 pm Opening of the Annual General Meeting Light refreshments will be served after the Annual General Meeting. Nyköping, 26 February 2007 Klövern AB (publ) The board of directors For further information, please contact: Gustaf Hermelin, CEO, tel +46-(0)155-44 33 10, +46-(0)70-560 00 00, gustaf.hermelin@klovern.se Anders Lundquist, CFO, tel +46-(0)155-44 33 20, +46-(0)70-528 43 33, anders.lundquist@klovern.se Britt-Marie Einar, Corporate Communications Officer, tel +46-(0)155-44 33 12, +46-(0)70-224 29 35, britt-marie.einar@klovern.se Klövern is a real estate company with a local presence that actively develops properties in large Swedish cities. Klövern has geographical units in twelve cities: Borås, Eskilstuna, Kalmar, Karlstad, Kista, Linköping, Norrköping, Nyköping, Täby, Uppsala, Västerås and Örebro. As at 31 December 2006, the value of the properties totalled approximately SEK 10.7 billion and the rental income on an annual basis is approximately SEK 1,070 million. The Klövern share is listed on the Stockholm stock exchange, Stockholmsbörsen's Nordic list for medium-sized companies. Klövern AB (publ), Box 1024, SE- 611 29 Nyköping, Sweden * Tel +46 (0)155-44 33 00, Fax +46-(0)155-44 33 22. Company registration no. 556482-5833 * Registered office: Nyköping * Website: www.klovern.se


 

26 February 2007 PayPoint plc (the "Company") - Total Voting Rights In conformity with the Transparency Directive the Company hereby notifies the market of the following: The Company's capital consists of 67,678,642 ordinary shares with voting rights. The Company does not hold any shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. - Ends - ---END OF MESSAGE---


 

KONE Corporation, Stock Exchange Release, 26 February, 2007 KONE Corporation's Annual General Meeting held on 26 February, 2007 authorized the Board of Directors to repurchase and redistribute the company's own shares. On the basis of this authorization KONE Corporation's Board of Directors has decided to commence repurchasing shares at the earliest on 8 March, 2007. The repurchasing of shares will continue until otherwise announced. The shares may be repurchased in order to develop the capital structure of the Company, finance or carry out possible acquisitions, implement the Company's share-based incentive plans, or to be transferred for other purposes or be cancelled. Altogether no more than 12,785,000 shares may be repurchased, of which no more than 1,905,000 are to be class A shares and 10,880,000 class B shares, taking into consideration the provisions of the Companies Act regarding the maximum amount of own shares that the Company is allowed to possess. The proposed amount corresponds to nearly 10 percent of both the share capital of the Company and the total voting rights. The KONE Group currently has 2,744,753 class B shares in its possession. The minimum and maximum consideration for the shares to be purchased is determined for both class A and class B shares on the basis of the trading price for class B shares determined on the Helsinki Stock Exchange on the time of purchase. Sender: KONE Corporation Jukka Ala-Mello Secretary to the Board of Directors Minna Mars Senior Vice President, Corporate Communications & IR For further information, please contact: Minna Mars, SVP, Corporate Communications & IR, tel. +358 (0)204 75 4501 KONE is one of the world's leading elevator and escalator companies. It provides its customers with industry-leading elevators and escalators and innovative solutions for their maintenance and modernization. KONE also provides maintenance of automatic building doors. In 2006, KONE had annual net sales of EUR 3.6 billion and about 29,000 employees. Its class B shares are listed on the Helsinki Stock Exchange in Finland. www.kone.com


 

KONE Corporation, Stock Exchange Release, 26 February, 2007 Matters Relating to the Annual General Meeting KONE Corporation's Annual General Meeting was held in Helsinki on 26 February, 2007. The meeting approved the financial statements and discharged the responsible parties from liability for the financial period 1 January-31 December, 2006. The Annual General Meeting approved dividends of EUR 0.99 for each of the 19,052,178 class A shares and EUR 1.00 for the 106,669,697 outstanding class B shares. The date of record for dividend distribution is 1 March, 2007, and dividends will be payable on 8 March, 2007. The rest of the distributable equity, EUR 1,146 million, will be retained and carried forward. The number of Members of the Board of Directors was confirmed as seven and it was decided to elect one deputy Member. Re-elected as full Members of the Board were Matti Alahuhta, Reino Hanhinen, Antti Herlin, Sirkka Hämäläinen-Lindfors, Masayuki Shimono, Iiro Viinanen and Sirpa Pietikäinen. Jussi Herlin was elected as deputy Member. The term of the Board ends at the next Annual General Meeting. The Annual General Meeting confirmed a monthly salary of EUR 4,000 for the Chairman of the Board, EUR 3,000 for the Vice Chairman, EUR 2,000 for Board Members and EUR 1,000 for the deputy Member. In addition, a compensation of EUR 500 was approved for attendance at Board and Committee meetings. Authorized public accountants Heikki Lassila and PricewaterhouseCoopers Oy were nominated as auditors. Authorization to Acquire and Distribute Own Shares The Board of Directors' proposal that the Annual General Meeting authorize the Board of Directors to repurchase KONE's own shares with assets distributable as profit was approved. The shares may be repurchased in order to develop the capital structure of the Company, finance or carry out possible acquisitions, implement the Company's share-based incentive plans, or to be transferred for other purposes or to be cancelled. Altogether no more than 12,785,000 shares may be repurchased, of which no more than 1,905,000 may be class A shares and 10,880,000 class B shares, taking into consideration the provisions of the Companies Act regarding the maximum amount of its own shares that the Company is allowed to possess. The proposed amount corresponds to nearly 10 percent of the share capital of the Company and the total voting rights. In addition, the Board of Directors' proposal that the Annual General Meeting authorize the Board of Directors to decide on the distribution of any shares repurchased by the company was approved. The authorization is limited to a maximum of 1,905,000 class A shares and 10,880,000 class B shares. The Board of Directors is authorized to decide to whom and in which order the repurchased shares are distributed. The Board of Directors may decide on the distribution of repurchased shares otherwise than in proportion to the existing pre-emptive right of shareholders to purchase the Company's own shares. The repurchased shares may be used as compensation in acquisitions and in other arrangements as well as to implement the Company's share-based incentive plans in the manner and to the extent decided by the Board of Directors. The Board of Directors also has the right to decide on the distribution of the shares in public trading in the Helsinki Stock Exchange for the purpose of financing possible acquisitions. The shares shall be distributed at least at the market price at the moment of their transfer determined on the basis of the trading price for class B shares determined in public trading in the Helsinki Stock Exchange. These authorizations shall remain in effect for a period of one year from the date of decision of the Annual General Meeting. Precise information about the authorization to acquire and distribute own shares can be found in the invitation to the Annual General Meeting, which has been published on the KONE website at www.kone.com. Authorization to decide to grant option rights in deviation from the shareholders' pre-emptive subscription right to key personnel of the group and to a wholly owned subsidiary of the company The Board of Directors' proposal that the Annual General Meeting authorize the Board of Directors to grant option rights was approved. On the basis of this authorization, the Board of Directors may decide to grant to the key personnel of the group or to the company's wholly owned subsidiary, Kone Capital Oy, option rights, which entitle to subscribe a maximum of 2,000,000 new class B shares. The company has a weighty financial reason to grant option rights, because the option rights are intended to form a part of the group's incentive and commitment plan for key personnel. This authorization will remain in force for one year following the decision of the Annual General Meeting. Decisions by the Board of Directors At its meeting held after the Annual General Meeting, the Board of Directors elected from among its members Antti Herlin as its Chairman and Sirkka Hämäläinen-Lindfors as Vice Chairman. Antti Herlin was elected as Chairman of the Audit Committee. Sirkka Hämäläinen-Lindfors and Iiro Viinanen were elected as independent members of the Committee. Antti Herlin was elected as Chairman of the Nomination and Compensation Committee. Reino Hanhinen and Sirkka Hämäläinen-Lindfors were elected as independent members of the Committee. Sender: KONE Corporation Jukka Ala-Mello Secretary to the Board of Directors Minna Mars Senior Vice President, Corporate Communications & IR For further information, please contact: Minna Mars, SVP, Corporate Communications & IR, tel. +358 (0)204 75 4501 KONE is one of the world's leading elevator and escalator companies. It provides its customers with industry-leading elevators and escalators and innovative solutions for their maintenance and modernization. KONE also provides maintenance of automatic building doors. In 2006, KONE had annual net sales of EUR 3.6 billion and about 29,000 employees. Its class B shares are listed on the Helsinki Stock Exchange in Finland. www.kone.com


 

Frankfurt, February 26, 2007: IFM Immobilien AG, spezialized upon the development and revitalization of commercial real estate with a high potential for appreciation, achieved to rent a further 2,300 sqm of its Frankfurt based prestigious object westendFirst, thus naming the Deutsche Fußball Liga (DFL) as being the first class tenant. With the move-in of DFL in the middle of May, the object in Frankfurt's Westend will be almost fully rented then. The gutted and fully revitalized building complex comprises a 16-floor-high-rise block with an adjacent six-floor building at right angles, of which DFL will make use of completely. The complex of buildings, located best in Frankfurt, was acquired in 2003 and was fully revitalized until April 2006. The 8,000 sqm of top-class office space are used already by tenants of various branches (financial services companies, law firms etc.). The Board IFM IMMOBILIEN AG Karl-Ludwig-Straße 2 Ulmenstraße 23-25 D-69117 Heidelberg D-60325 Frankfurt T. +49 (0) 6221 434098-0 T. +49 (0) 69 7040386-0 F. +49 (0) 6221 434098-66 F. +49 (0) 69 7040386-25 info@ifm.ag www.ifm.ag For queries, please contact GFEI Gesellschaft für Effekteninformation mbH Beethovenstraße 60 D-60325 Frankfurt www.gfei.de T. +49 (0) 69 743037-00 F. +49 (0) 69 743037-06 About IFM Immobilien AG: IFM Immobilien AG is an investor and a project developer of commercial real estate focusing on office and retail utilization. Center of the business activities is the restructuring, the redevelopment and the asset management of commercial real estate as well as the development of appealing marketing respectively rental concepts. The objects being acquired by IFM Immobilien AG, in general show an attractive risk-reward-ratio, high potential for development as well as appreciation and an ever preferable location. With this strategy and its four core competencies, IFM Immobilien AG establishes a re-positioning of real estate thus creating lasting property values. For 20 years, the company's management has been involved in the real estate sector. Since May 19, 2006, IFM Immobilien AG is listed on the Entry Standard of the Frankfurt Stock Exchange. The press release can be downloaded from the following link:


 
Hitt og þetta
26. febrúar 2007

EPT Disclosure

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------------+--------------------| | Company dealt in | Corus Group plc | |----------------------------------------------+--------------------| | Class of relevant security to which the | Ordinary Shares | | dealings being disclosed relate (Note 1) | | |----------------------------------------------+--------------------| | Date of dealing | 23rd February 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price | | securities | (Note 3) | paid | | purchased | | (Note 3) | |---------------------------+--------------------+------------------| | 30,065 | 602p | 602p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |-------------------------+--------------------+--------------------| | 29,420 | 602p | 602p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +-------------------------------------------------------------------+ | Date of disclosure | 26th February 2007 | |----------------------------------------------+--------------------| | Contact name | Seema Soni | |----------------------------------------------+--------------------| | Telephone number | 0207 992 1565 | |----------------------------------------------+--------------------| | Name of offeree/offeror with which connected | Corus Group Plc | |----------------------------------------------+--------------------| | Nature of connection (Note 6) | Connected Advisor | +-------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Reykjavik - 26 February 2007 - Moody's Investors Service upgraded Glitnir Bank's credit rating, along with the other Icelandic banks, on Friday to Aaa due to changes in JDA Methodology. This is the highest possible rating. Moody's affirmed the P-1 credit rating of Glitnir and the financial strength, C. Moody's press release and rating changes for Iceland are attached via link. Moody's Rating Moody's Press Release - Glitnir was rated A1 and the upgrade is the outcome of a change in Moodys' methodology. This exceeded our expectations and is broadly positive for Glitnir and the other Icelandic banks, says Bjarni Ármannsson CEO of Glitnir in a comment. - Moody's announced Friday afternoon that due to changes in its JDA Methodology it has decided to upgrade all the Icelandic banks to Aaa. The new ratings of the Icelandic banks reflect the strength of the Icelandic economy and the Icelandic banking sector. This should strengthen the funding operations of the Bank as it should give access to a wider group of investors. Therefore this should generally improve the operating environment, says Tómas Kristjánsson CFO of Glitnir in a comment. Moody's stated 24 February 2007 in a release "Moody's Announces Bank Rating Actions Resulting From Implementation of JDA Methodology - Iceland". As part of the planned application of its joint default analysis (JDA) methodology and its updated bank financial strength rating (BFSR) methodology, Moody's Investors Service Friday published the rating results for banks in Iceland. In February 2007 Moody's published a Special Comment, entitled "Incorporation of Joint-Default Analysis into Moody's Bank Rating Methodology". The JDA methodology identifies four potential sources of external support for banks: (1) parental support, (2) support from a cooperative or mutualist group, (3) support from a regional or local government, and (4) systemic support. For more information: Tómas Kristjánsson. CFO, Glitnir, mobile: +354-844-4656 Bjørn Richard Johansen, Managing Director, Corporate Communication, Glitnir, e-mail: brj@glitnir.no, mobile +47-47 800 100 Vala Palsdottir, Head of Investor Relations, Glitnir, e-mail: vala.palsdottir@glitnir.no, mobile: +354-844 4989 About Glitnir The financial group Glitnir offers universal banking and is a leading niche player in three global segments; seafood/food, sustainable energy, and offshore supply. Glitnir is a Nordic bank and consider Iceland and Norway as home markets. Services include retail, corporate and investment banking, stock trade and capital management. Glitnir is the sole owner of a bank in Luxembourg (Glitnir Bank Luxembourg S.A) and banks and financial services companies in Norway (BNbank and Glitnir bank, Glitnir Securities and Glitnir Kapitalforvaltning, the factoring company Glitnir Factoring, and 50.1 percent of Union Gruppen. Glitnir's subsidiary BNbank own 45 per cent of Norsk Privatøkonomi ASA). In Sweden, Glitnir owns the leading Swedish brokerage firm Glitnir AB (former Fischer Partners). Glitnir recently announced its intention to make a public tender offer for the shares in FIM Group Corporation in Finland. Glitnir has received an undertaking from the 11 major owners of FIM, who currently hold 68.1 percent of FIM, to sell their shares to Glitnir. Glitnir operates branches in London and Copenhagen and representative offices in Halifax, Canada and in Shanghai, China. Glitnir plan to open an office in New York, USA, to support the North American business in the spring of 2007. Glitnir own 54 percent of MasterCard in Iceland. Glitnir is listed on the Icelandic Stock Exchange. Glitnir has shown remarkable growth in recent years. The 2006 results, published 30 January, show record after-tax profits of EUR 435 million, an increase of 102% over 2005. Glitnir reported a record high after-tax return on equity of 39.4 percent in 2006. For more information: www.glitnirbank.com


 

Leverkusen, Germany - Biofrontera announced today that it has successfully completed a first human trial with its migraine prophylaxis compound BF-1. The study revealed that Biofrontera's development compound has excellent pharmacokinetic properties. After oral application the compound was absorbed completely from the digestive tract of healthy volunteers within few hours. In addition, the half-life of the compound was determined to be longer than 24 hours. This important result indicates that the development of a standard formulation for a convenient once daily tablet is feasible. BF-1 is the leading product of Biofrontera's maturing preclinical product portfolio of anti-inflammatory drugs. Biofrontera develops the potent and highly specific 5-HT2B receptor blocker for the prophylactic treatment of severe migraine. "We believe that migraine prophylaxis is a potential block-buster market. A drug like BF-1, which we expect to be effective in migraine prophylaxis without any relevant adverse side effects, should therefore be an interesting product for a large pharmaceutical company. Since it is outside of our dermatology focus, we intend to license it to a big company after the demonstration of its efficacy in patients. The results of the current clinical trial are so exciting because most drugs fail due to pharmacokinetic problems. With such excellent pharmacokinetic properties the overall chance of a successful development of BF-1 is greatly increased," commented Prof. Dr. Hermann Lübbert, Biofrontera's CEO. Migraines are acute, periodically occurring attacks of very severe headache, usually affecting only one side of the head and often accompanied by nausea and vomiting. It is estimated that approximately 10-12% of the population in industrialized countries suffer from migraine attacks. Biofrontera believes that prophylactic treatment is indicated for the 10-20% of the patients with frequent attacks. About Biofrontera AG Biofrontera AG is specialized in the development of pharmaceutical products in the area of dermatology. The company is characterized by a broad, relatively close to the market product portfolio and a solid liquidity. Biofrontera is listed in the regulated market of the Düsseldorf stock exchange under the symbol B8F and the ISIN number DE0006046113. http://www.biofrontera.com/ Important notice: This notification contains certain future-related statements based on present assumptions and forecasts made by Biofrontera AG management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company/the Biofrontera group and the estimates and expectances given here. Biofrontera assumes no liability whatsoever to update these future-related statements or to conform them to future events or developments. For further information please contact: Anke zur Mühlen Corporate Communication + 49 (0) 214 87632 22 + 49 (0) 214 87632 90 a.zurmuehlen@biofrontera.com Biofrontera AG Hemmelrather Weg 201 D- 51377 Leverkusen, Germany The press release can be downloaded from the following link: --- End of Message --- WKN: 604611; ISIN: DE0006046113; Listed: Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Frankfurter Wertpapierbörse, Geregelter Markt in Börse Düsseldorf;


 

Hannover Re securitises reinsurance recoverables worth around EUR 1 billion Hannover, 26 February 2007: Following successful securitisations in property/casualty and life/health reinsurance business, Hannover Re has now for the first time transferred the risks deriving from so-called "reinsurance recoverables" to the capital market. Reinsurance recoverables, in other words outstanding claims held by reinsurers against their retrocessionaires, traditionally constitute a substantial item on Hannover Re's balance sheet - both in relation to its competitors and the company's shareholders' equity. These recoverables are of a high credit quality and their level per company has always been strictly limited. Nevertheless they adversely affect the assessment of the Group's solvency by rating agencies, primary insurers and brokers. Therefore monitoring these balances forms an integral part of internal risk management. With the present securitisation Hannover Re is substantially reducing the default risk associated with reinsurance recoverables. "We assume that the rating agencies of relevance to our industry, will consider this transaction - in quantitative and qualitative respects - positively", Chief Executive Officer Wilhelm Zeller emphasised: "With this transaction Hannover Re has effectively immunised itself against a potential credit risk". The underlying portfolio has a nominal value of EUR 1 billion; it is comprised of exposures to insurers and reinsurers that are classified according to risk classes. The securities issued as collateral through a special purpose entity are split - in accordance with Standard & Poor's rating categories - into four tranches "AAA", "AA", "A" and "BBB". A payment to Hannover Re - after allowance for its deductible - is triggered by the insolvency of a retrocessionaire. Since as long ago as 1994 Hannover Re has played a pioneering role in the securitisation of risks for the capital market. This latest example marks another innovation inasmuch as it involves a fully secured synthetic CDO structure applied for the first time to a portfolio of credit risks associated with insurance and reinsurance enterprises. For further information please contact: Press and Public Relations / Investor Relations: Eric Schuh, CFA (tel. +49 / 511 / 56 04-15 00, e-mail: eric.schuh@hannover-re.com) Press and Public Relations: Gabriele Handrick (tel. +49 / 511 / 56 04-15 02, e-mail: gabriele.handrick@hannover-re.com) Investor Relations: Gabriele Bödeker (tel. +49 / 511 / 56 04-17 36, e-mail: gabriele.boedeker@hannover-re.com) Hannover Re, with a gross premium of approximately EUR 10 billion, is one of the leading reinsurance groups in the world. It transacts all lines of property/casualty, life/health and financial reinsurance as well as specialty insurance. It maintains business relations with more than 5,000 insurance companies in about 150 countries. Its worldwide network consists of more than 100 subsidiaries, branch and representative offices in around 20 countries with a total staff of roughly 2,000. The rating agencies most relevant to the insurance industry have awarded Hannover Re very strong insurer financial strength ratings (Standard & Poor's AA- "Very Strong" and A.M. Best A "Excellent"). Disclaimer: Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. Hannover Re does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements. Therefore, in no case whatsoever will Hannover Re and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.


 

KYOTO, Japan, Feb. 26, 2007 (PRIME NEWSWIRE) -- Nidec Corporation ("Nidec") (NYSE:NJ) announced today that it completed all transactions relating to the acquisition of Brilliant Manufacturing Limited ("BML") on February 23, 2007 by acquiring 87% of the outstanding shares of BML common stock for approximately 170 million Singapore dollars. As a result, BML and its ten subsidiaries have been included in Nidec's scope of consolidation. The acquisition of BML is aligned with Nidec's aim to expand in-house manufacturing capability for HDD motor parts and related precision parts including base plates. Nidec expects that BML's competitive manufacturing expertise ranging from aluminum die casting, machining, pressing to electroplating will significantly strengthen Nidec's core competence in the HDD motor production. Full copy of the press release: http://www.nidec.co.jp/english/ir/indexdata_e/2007/0226.pdf The Nidec Corporation logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1734 CONTACT: Nidec Corporation Hiroshi Toriba, Senior General Manager, Investor Relations +81-75-935-6140 HIROSHI_TORIBA@notes.nidec.co.jp


 

Wärtsilä Corporation, Trade & Technical Press Release, 26 February, 2007 Wärtsilä Corporation and the Norwegian gas transportation company BW Gas ASA of Oslo signed a contract in January 2007 for the training of BW Gas personnel. The contract is for two years. The training courses provided under this contract are tailored to the specific requirements of BW Gas to cover the specific operational and performance aspects of the ships in the BW Gas fleet. The objective is to give ships' personnel and shore management a sound basis for cost-efficient, safe and reliable operation of the company's ships. It is intended that the training courses go beyond the usual practical training for various ship systems and equipment to transfer knowledge about engine performance and operation philosophy in order to ensure optimum operation of the ships' plants. One of the objectives is thus to create a basis for long-term successful operation of the ships as part of the BW Gas business. This long-term view is part of Wärtsilä's philosophy of providing lifetime support to customers, not just on engines, technology and equipment but also with respect to human resources' aspects. The training courses will be provided by Wärtsilä Land & Sea Academy (WLSA) to ships' crews, superintendents and other shore personnel. There will be some 300 people from BW Gas taking part in the courses. They work on the 72 ships that are owned or part-owned by BW Gas. The courses will be provided at different WLSA training centres, whichever are the most convenient for BW Gas. WLSA has principal training centres in Turku in Finland, in Subic Bay in the Philippines, and in Fort Lauderdale in Florida, USA. These centres provide a wide range of courses, extending from basic off-the-shelf, standard product courses to the full range of maritime training in connection with competence and career management. Among the centres' comprehensively facilities are ship-handling simulator bridges, as well as top-of-the-line engine room simulators, cargo-handling simulators, and steam and gas simulators, all ideal for thorough hands-on training. The simulators can even be connected for full ship operation simulation. In addition to well-equipped classrooms, there are workshops for practical training on engines, propulsion equipment, marine high-voltage electrical equipment, engine room ancillary equipment and control systems. BW Gas is a leading global provider of marine gas transportation services. BW Gas is the largest owner and operator of LPG (liquefied petroleum gas) carriers and one of the largest independent owners and operators of LNG (liquefied natural gas) carriers. BW Gas owns, part-owns or operates a fleet of 101 vessels (including newbuildings) having a combined capacity of some 7.2 million cubic metres. Since 2000, BW Gas has ordered 11 LNG newbuildings. Related material: http://wlsa.wartsila.com/ Link to picture Caption: Berge Denise - one of the gas tankers in the fleet of BW Gas Media contact: Marit Holmlund-Sund Public Relations Manager Wärtsilä Corporation Direct tel: +358 10 709 1439 Direct fax: +358 10 709 1425 e-mail: marit.holmlund-sund@wartsila.com Internet: www.wartsila.com Notes to the editor: Wärtsilä enhances the business of its customers by providing them with complete lifecycle power solutions. When creating better and environmentally compatible technologies, Wärtsilä focuses on the marine and energy markets with products and solutions as well as services. Through innovative products and services, Wärtsilä sets out to be the most valued business partner of all its customers. This is achieved by the dedication of more than 14,000 professionals manning 130 Wärtsilä locations in close to 70 countries around the world. www.wartsila.com


 

At the close of the subscription period, Teligent's new share issue had been subscribed at a level of approximately 135 per cent. Consequently, the share issue was fully subscribed and Teligent was provided with proceeds of SEK 109 million, before issue costs. Slightly less than 99 per cent of the share issue was subscribed for on the basis of preferential rights. Large shareholders had committed to subscribing for the equivalent of 44 percent of the new share issue, and the remaining 56 per cent was underwritten by a guarantee consortium. As the new share issue was oversubscribed, it was not necessary to invoke the issue guarantee. The allotment of shares not subscribed for on the basis of subscription rights has taken place in accordance with the terms and conditions for the new share issue, which are described in Teligent's new share issue prospectus. Notification of allotment will take place in the form of a contract note, which is expected to be issued on or about 26 February. Those individuals to whom shares have not been allotted will not receive notification. On the basis of this share issue, the total number of shares in Teligent will increase by 29,018,983 to 57,835,866. Trading in the new paid subscription shares (BTA) on the Stockholm Stock Exchange began on 21 February 2007. The BTA will be rebooked as shares when the new share issue has been registered with the Swedish Companies Registration Office, which is expected to take place in the beginning of March 2007. Kaupthing Bank and Aureus AB were engaged by Teligent as financial advisors in conjunction with this new share issue. For further information, please contact: Lars-Erik Nilsson Chairman of the Board Teligent AB Tel. +46 (0)733 11 72 76 lars.nilsson@teligent.se Tomas Duffy, CEO & President Teligent AB Tel. +46 (0)8 410 172 76 tomas.duffy@teligent.se


 

Norwegian Property ASA announced in the fourth quarter report for 2006 an overall refinancing plan. One element of the refinancing is issuance of bonds in the Norwegian capital markets for an amount of approximately NOK 2.1 billion in order to refinance five of the group's properties, including two of the recently acquired Nydalen properties. As announced DnB NOR Markets, Fokus Markets, Nordea Markets and SEB Merchant Banking has been mandated as joint lead arrangers. The transaction will consist of 2 tranches, and expected payment date of the bonds are 7 March 2007. Main terms are as follows: Tranche 1 Temor: 5 years Borrowing limit: NOK 1,726 million Security: First priority pledge in designated properties Rate: Floating rate note and/or Fixed rate Tranche 2 Tenor: 3 years Borrowing limit: NOK 431 million Security: Second priority pledge in designated properties Rate: Floating rate note Average margin on the Group's total borrowings will be approximately 60 basis points after the issuance of the bonds. For further information, please contact: For Norwegian Property ASA: CEO Petter Jansen, mobile + 47 900 98 728 CFO Svein Hov Skjelle, mobile + 47 930 55 566 For DnB NOR Markets: Jan Krogh-Vennemo, Head of Fixed Income Sales, +47 22 01 77 89 Christian Ramm, Head of Debt Capital Markets, +47 22 01 77 61 For Fokus Markets: Per Olav Glendrange , Head of Fixed Income Sales, +47 85 40 91 94 Knut R. Halden, Head of Debt Capital Markets, +47 22 01 77 61 For Nordea Markets: Ole Christian Schjørn, Head of Fixed Income Sales, +47 22 48 77 85 Preben Stray, Chief Origination Manager , +47 22 48 78 04 For SEB Merchant Banking: John Hoel, Fixed Income Sales, +47 22 82 72 65 Geir Sørflaten, Head of Credit Origination, +47 22 82 72 56


 

Best year ever - Strong outlook February 26, 2007: OSLO, NORWAY - Petroleum Geo-Services ASA ("PGS" or the "Company") (OSE and NYSE: PGS) today announced its unaudited fourth quarter 2006 results under U.S. GAAP. * Record earnings in 2006: Operating profit of $409.9 million, up $279.7 million (215%) compared to 2005. Revenues of $1,308.5 million, up $420.5 million (47%). Operating efficiency of fleet improved even further. Marine increased its revenues by 44% to $1,044.5 million, above $1 billion, for the first time ever. Onshore increased its revenues by $110.9 million, or 73% to $263.4 million. * Continued strength in Q4 2006: Operating profit of $117.5 million, the best quarter ever and up 100.6 million (595%) compared to Q4 2005. Revenues of $361.0 million, up $96.9 million (37%). * Strong Marine performance: Operating profit of $118.3 million in Q4 2006, up $94.5 million (397%) from Q4 2005 driven by strong pricing and performance in the contract segment, as well as lower multi-client amortization. Best Marine EBIT contract margin ever. * Strong profitability in Onshore: Operating profit of $6.8 million in Q4 2006, compared to a loss of $1.8 million in Q4 2005, positively impacted by increased activity and performance, especially in Libya. * Substantial cash flow: Cash flow from operations of $204.7 million. Net interest bearing debt reduced by $72.7 million to $195.5 million in Q4. Share buy back program approved at extraordinary general meeting in December 2006 and execution started in January 2007. Key figures 1 +-------------------------------------------------------------------+ | | Quarter ended | Years ended | | | December 31, | December 31, | |-------------------+-----------------------+-----------------------| | | 2006 | 2005 | 2006 | 2005 | | (In millions of | Unaudited | Unaudited | Unaudited | Unaudited | | dollars, except | | | | | | per share data) | | | | | |-------------------+-----------+-----------+-----------+-----------| | Revenues | $ 361.0 | $ 264.1 | $ 1,308.5 | $ 888.0 | |-------------------+-----------+-----------+-----------+-----------| | Operating | 117.5 | 16.9 | 409.9 | 130.2 | | profit/EBIT | | | | | |-------------------+-----------+-----------+-----------+-----------| | Income (loss) | | | | | | before income tax | 116.2 | (113.9) | 356.1 | (68.6) | | expense (benefit) | | | | | | and minority | | | | | | interest | | | | | |-------------------+-----------+-----------+-----------+-----------| | Net income (loss) | 78.7 | (89.0) | 298.6 | 112.6 | |-------------------+-----------+-----------+-----------+-----------| | Earnings (loss) | 0.44 | (0.49) | 1.66 | 0.63 | | per share ($ per | | | | | | share) | | | | | |-------------------+-----------+-----------+-----------+-----------| | Adjusted EBITDA | 167.8 | 102.9 | 608.5 | 324.4 | | (as defined) | | | | | |-------------------+-----------+-----------+-----------+-----------| | Net cash provided | 204.7 | 66.7 | 563.4 | 280.7 | | by operating | | | | | | activities | | | | | |-------------------+-----------+-----------+-----------+-----------| | Cash investment | 43.7 | 6.0 | 113.7 | 55.7 | | in multi-client | | | | | | library | | | | | |-------------------+-----------+-----------+-----------+-----------| | Capital | 66.8 | 39.3 | 165.4 | 90.4 | | expenditures | | | | | |-------------------+-----------+-----------+-----------+-----------| | Total assets | 1,234.6 | 1,717.6 | 1,234.6 | 1,717.6 | | (period end) | | | | | |-------------------+-----------+-----------+-----------+-----------| | Cash and cash | 124.0 | 121.5 | 124.0 | 121.5 | | equivalents | | | | | | (period end) | | | | | |-------------------+-----------+-----------+-----------+-----------| | Net interest | $ 195.5 | $ 828.7 | $ 195.5 | $ 828.7 | | bearing debt | | | | | | (period end) | | | | | +-------------------------------------------------------------------+ [1] Following the completion of the demerger and public offering of Petrojarl on June 29, 2006, the Key figures reflects, for all periods presented, a presentation of the operations of the Production segment and the gain from sale of Petrojarl shares, as discontinued operations. Total assets include Production assets up to date of the demerger. Svein Rennemo, PGS President and Chief Executive Officer, commented: "2006 was the best year ever for PGS. We delivered substantial growth in revenues, operating profit and cash flow, driven by strengthened market conditions and improved operational performance. Marine realized a record high contract margin, while Onshore improved its profitability significantly from 2005. We experienced a stronger underlying demand for multi-client seismic in 2006 compared to 2005 and despite fewer licensing rounds internationally we further improved our late sales. Our Gulf of Mexico depth processing products, strong performance of our library offshore West Africa and increased demand for our Brazil library were important elements in this success. We expect a continued strong seismic market driven by increased E&P spending worldwide and the demand for more advanced seismic solutions. Construction of the new Ramform Sovereign remains on budget and on time. Acquisition of the large wide azimuth multi-client survey in Gulf of Mexico, Crystal, is progressing according to plan. Both projects illustrate our efforts to increase high-end capacity and to provide our customers with more advanced seismic technology. Due to a substantial over performance on the business goals set for 2006, PGS has rewarded all our employees with a cash bonus equaling 1.5 months salary in recognition of their outstanding contribution. We look forward to an exciting 2007." Q4 Highlights PGS group * Revenues of $361.0 million, up $96.9 million (37%) from Q4 2005, driven by record high Marine contract revenues and a significant increase in Onshore contract activity * Operating profit of $117.5 million, up $100.6 million (595%) from Q4 2005 * Income before income tax expense and minority interest of $116.2 million compared to a loss of $113.9 million in Q4 2005 (which included costs in relation to debt redemption and refinancing of $103.8 million) * Net income of $78.7 million, compared to a loss of $89.0 million in Q4 2005 (which included a net income from discontinued operations of $17.9 million and debt redemption and refinancing costs of $103.8 million) * Cash flow from operations of $204.7 million, up $138.0 million from Q4 2005 * Net interest bearing debt of $195.5 million at December 31, 2006, down $72.7 million in Q4, despite high levels of growth investments, driven by strong cash flow from operations Marine * Total revenues of $292.9 million, up $78.0 million (36%) from Q4 2005 * Contract seismic revenues of $189.6 million, up $58.8 million (45%) from Q4 2005 * Operating margin for Marine contract seismic around 49%, bringing full year contract margin above 40% * Multi-client late sales of $54.4 million, down $14.3 million (21%) from Q4 2005. Full year 2006 multi-client late sales were $222.0 million, up $3.2 million (1%) from 2005 * Multi-client pre-funding revenues of $32.7 million, up $27.4 million (517%) from Q4 2005 * Operating profit of $118.3 million, up $94.5 million (397%) from Q4 2005 * Order backlog at December 31, 2006 of $512 million compared to $365 million at December 31, 2005 and $635 million at September 30, 2006. The backlog number includes $175 million of committed pre-funding on scheduled multi-client projects Onshore * Revenues of $67.6 million, up $18.8 million (39%) from Q4 2005 * Operating profit of $6.8 million compared to a loss of $1.8 million in Q4 2005 * Performance improvement driven mainly by increased activity in Nigeria and Libya * Order backlog at December 31, 2006 of $138 million compared to $137 million at December 31, 2005 and $132 million at September 30, 2006 Outlook 2007 Marine * Full year streamer contract EBIT margins are expected to increase substantially over 2006 to around 50-55% * Multi-client revenues are expected to be somewhat higher than 2006 * Multi-client investments are expected to be approximately $180-200 million * Capital expenditure is expected to be approximately $200 million Onshore * Revenues and operating profit are expected to be approximately in line with 2006 * Multi-client investments are planned to be approximately $60 million * Capital expenditure is expected to be in the range of $20-25 million FOR DETAILS, CONTACT: Ola Bøsterud Phone +47 6752 6400 Mobile: +47 90 95 47 43 Christopher Møllerløkken Phone: +47 6751 4316 Mobile: +47 90 27 63 55 US Investor Services Katrina Green Phone: +1 281 509 8000 The full report with tables can be downloaded from the following link:


 

"2006 Full Year Results Roadshow" This is the presentation that is going to be given by Mrs Peter Brabeck and Paul Polman, Nestlé CEO and CFO, on the coming roadshows in Europe and the US. You will find this presentation in the section Presentations > Sales & Results http://www.ir.nestle.com/News_Events/Presentations/Group_Presentations/Sales_Results/Sales_Results.htm Coming Webcast As we have already informed you, the London roadshow on Tuesday 27 at 8:00 am UK time / 9:00 am CET will be webcast. You will be able to access it through our homepage http://www.ir.nestle.com --- End of Message --- WKN: 887208; ISIN: CH0012056047; Index: SLCI, SMI, SPI, SMIEXP; Listed: Main Market in SWX Swiss Exchange;


 

Stavanger, Norway The drilling rig Eirik Raude has been taken out of operation and is on its way to a shipyard in Newfoundland to repair a small crack in one of the bracings. This course of action has been taken in agreement with the client and the class society, DNV. There is no potential risk to the structural integrity of the rig or to personnel on board the rig, but Ocean Rig wishes to ensure that the rig is fully fit for purpose to complete the well in progress under the currently extreme weather conditions in the area. The repair time including transit is estimated to approximately three weeks depending on weather conditions. Ocean Rig owns and operates two of the world's largest and most modern drilling rigs, built for ultra deep waters and extreme weather conditions. The units are currently operating offshore Angola and Canada. NOTE: This press release contains forward-looking statements (within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended) which reflect the Company's current views with respect to certain future events and financial performance. Actual events or results may differ materially from those projected or implied in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or otherwise. The following important factors, among other, could cause actual results to differ materially from those projected or implied in any forward-looking statements: (i) our results of operation and financial conditions in the future; (ii) the performance of our rigs, including the sufficiency of their design and their ability to prevent discharges of hazardous materials and pollutants; (iii) our ability to generate sufficient cash-flow to meet our debt service requirements; (iv) our ability to retain existing contracts and secure future drilling contracts for our rigs at attractive day rates; (v) our ability to perform our operations in accordance with our plans; (vi) the impact of changed conditions in the oil and gas industry; (vii) the occurrence of any accidents involving the Company or its assets; (viii) changes in governmental regulations, particularly with respect to environmental matters; (ix) increased competition or the entry of new competitors into the Company's markets; and (x) unforeseen occurrences in any of the areas in which the Company may conduct its operations, such as war, expropriation, nationalization, renegotiation or nullification of existing licenses or treaties, taxation and resource development policies, foreign exchange restrictions, changing political conditions and other risks relating to foreign governmental sovereignty over certain areas in which the Company will conduct operations. Due to such uncertainties and risks, investors are cautioned not to place undue reliance upon such forward-looking statements. For further information, please contact CEO Trygve Arnesen, tel +47 5196 9000 CFO Jan Rune Steinsland, tel +47 5196 9000 Senior Vice President Finance Per-Hermod Rasmussen, tel +47 5196 9000 Stavanger, February 26, 2007 Ocean Rig ASA


 

* Novartis confident in safety and efficacy of Galvus as a once-daily oral treatment for patients with type 2 diabetes, over 8,000 patients in clinical trial program * US Food and Drug Administration (FDA) requests additional data, including a clinical study in patients with renal impairment * Discussions to continue with the FDA to obtain final US approval for Galvus Basel, February 26, 2007 - Novartis announced today that it has received an "approvable letter" from the US Food and Drug Administration (FDA) for Galvus® (vildagliptin), under review for US approval as a new once-daily oral treatment for patients with type 2 diabetes. An "approvable letter" means the FDA is prepared to approve an investigational medicine and contains conditions that must be met prior to final US approval. The FDA has requested additional data, including a clinical study to demonstrate the safety and efficacy of Galvus in specific patient groups with renal (kidney) impairment. "We are confident in the safety and efficacy of Galvus and will continue working closely with the FDA to agree on what final actions are required to obtain US approval," said James Shannon, MD, Global Head of Development at Novartis Pharma AG. The 2007 financial outlook previously communicated in January remains unchanged for the Pharmaceuticals division and for the Group. Galvus was submitted for US approval in January 2006 as a new therapy to reduce blood sugar levels in patients with type 2 diabetes, both as a monotherapy and in use with other anti-diabetic medicines. The global clinical trial program to date has included over 8,000 patients, with some 5,500 treated with Galvus. Submission for European Union approval was made in August 2006. Disclaimer The foregoing release contains certain forward-looking statements that can be identified by terminology such as "committed," "approvable," "confident," "continue," "will continue," "financial outlook," or similar expressions, or by express or implied discussions regarding potential future Galvus clinical trial results, potential future approvals to market Galvus, potential future sales of Galvus, or the financial outlook of the Group and its Pharmaceuticals Division. Such forward-looking statements involve known and unknown risks, uncertainties or other factors that may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. There can be no guarantee as to the results of any future clinical trials regarding Galvus, that any future regulatory filings will satisfy the FDA's and other health authorities' requirements regarding Galvus, that Galvus will be approved by the FDA for any indication, that Galvus will ever be brought to market in the US, the EU or any other market, or that Galvus will reach any particular level of sales. Neither can there be any guarantee that the Group, or the Pharmaceuticals Division, will achieve any particular level of financial results. In particular, management's expectations regarding the approval and commercialization of Galvus could be affected by, among other things, unexpected clinical trial results, including additional analysis of existing clinical data, or unexpected new clinical data, including unexpected results from the clinical trials required by FDA; unexpected regulatory actions or delays or government regulation generally; competition in general; government, industry and general public pricing pressures; the ability to obtain or maintain patent or other proprietary intellectual property protection, as well as factors discussed in the Company's Form 20-F filed with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. # # # Media contacts John Gilardi Novartis Global Media Relations +41 61 324 3018 (direct) +41 79 596 1408 (mobile) john.gilardi@novartis.com Richard Booton Novartis Pharma Communications +41 61 324 4356 (direct) +41 79 753 2593(mobile) richard.booton@novartis.com Novartis Global Investor Relations International: Ruth Metzler-Arnold +41 61 324 99 80 Katharina Ambühl +41 61 324 53 16 Nafida Bendali +41 61 324 35 14 Jason Hannon +41 61 324 21 52 Richard Jarvis +41 61 324 43 53 North America: Ronen Tamir +1 212 830 24 33 Arun Nadiga +1 212 830 24 44 Jill Pozarek +1 212 830 24 45 Edwin Valeriano +1 212 830 24 56 e-mail: investor.relations@novartis.com --- End of Message --- WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

Standards Leader Ships JSR 170 Interoperability for Legacy Repositories Basel, Switzerland and Newport Beach, California - February 26, 2007 - Day Software (SWX: DAYN, OTC:DYIHY), a leading provider of global content management and content infrastructure software, today announced that the company is continuing to deliver standardized connectors for leading legacy repositories. The repository connectors are fully compliant with the Content Repository for Java Technology API standard (JSR 170). The latest of these groundbreaking interfaces is for Interwoven TeamSite, creating greater interoperability and openness for the legacy document repository vendor. Other connectors that are in development include interfaces for Microsoft SharePoint, IBM Domino.doc, and Software AG Tamino, among others. The Interwoven TeamSite connector is part of Day's Content Integration family of products that enable enterprises to access and manage all organizational content through a standardized API. This technology allows the implementation of content access, synchronization and consolidation, leveraging future-proof standardization, even if the content resides in data stores that do not provide a JCR compliant API. Key JCR Features * Ability to access (read) critical content, including metadata, users, groups and group memberships from the TeamSite repository * Access Control List (ACL) association to fulfill enterprise security requirements * Content Search of the TeamSite repository using the Xpath or SQL query language * Access to all content stored in the TeamSite repository, or to a subset using repository views. * Observation capabilities to monitor changes in content, including metadata, users, groups and user permissions in the TeamSite repository * Ability to export repository content Operational Features * Configurable content mapping from the connector to a TeamSite repository * Configurable repository views allowing a connector to access only a selected portion of a TeamSite repository * Parallel connector instances on multiple disjointed repository views * Configurable deferred loading of binaries accessible by an application via a URL * Configurable observation intervals Day's Repository Connectors provide a standardized JCR interface, allowing companies to access their most valuable assets - information about its specific business, its processes, products, customers and documents that previously resided in a proprietary repository. These documents and information can be accessed through the JSR 170 interface. About Day (www.day.com) Day is a leading provider of integrated content, portal and digital asset management software. Day's technology Communiqué offers a comprehensive, rapidly deployable framework to unify and manage all digital business data, systems, applications and processes through the web. Communiqué's content-centric architecture, and its innovative ContentBus, turns the entire business into a virtual repository bringing together content from any system, regardless of location, language or platform. Day is an international company, founded in 1993, and listed on the SWX Swiss Exchange (SWX:DAYN) since April 2000. Day's customers are some of the largest global corporations and include Audi, Credit Suisse First Boston (CSFB), DaimlerChrysler, Deutsche Post World Net, Deutsche Bank, Intercontinental Hotels Group, McDonald's and Volkswagen. For Further Information Jackie Cadorin Katie Eakins Day Software LEWIS PR for Day Software 23 Corporate Plaza Drive, Suite 215 Newport Beach, CA 92660 T +1 949 706 5300 T +1 619 516 2559 E-Mail: jackie.cadorin@day.com E-Mail: day@lewispr.com The English text of this press release represents the binding version. The media information can also be downloaded from the following link: --- End of Message --- WKN: 936168; ISIN: CH0010474218; Index: SPI, SPIEX, SSCI; Listed: Main Market in SWX Swiss Exchange;


 

We herewith inform you that the Stork annual report 2006 is available on our website, as well in Dutch as in English. Hard copies of the English version will be available from 2 March 2007. Hard copies of the Dutch version from 26 January 2007. Kind regards, Dick Kors Director Corporate Communications & Investor Relations Stork N.V.


 

Reservoir Exploration Technology ASA (RXT) will present their Q4 2006 results on Wednesday 28 February 2007. RXT will present their results Wednesday 28 February 2007 at Felix Konferansesenter, Bryggetorget 3, Oslo. The presentation will start 8:00 (CET). The presentation can be followed live on the internet at www.rxt.com, and a recorded version will be available shortly thereafter. Please register your attendance by Tuesday 27th February 2007 at 13:00 (CET) to: pamela.voll@rxt.com, telephone +47 67828500. For further information, please contact CFO Odd Erik Rudshaug in RXT. Cell : + 47 41612858 About RXT: Reservoir Exploration Technology ASA (RXT) is a marine geophysical company specializing in multi component seismic sea-floor acquisition. Multi component seismic solves several imaging challenges that cannot be resolved with towed streamer seismic, and targets improved oil recovery from existing fields. The technology also gives better data quality for exploration, and is also the solution where towed streamers are impractical due to high density of platforms and/ or shallow waters. The Company has offices in Oslo, London and Houston. RXT is listed on the stock exchange in Norway (OSE ticker: RXT). URL: http://www.rxt.com/


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |-----------------------------------------------+-------------------| | Company dealt in | EMI Group plc | |-----------------------------------------------+-------------------| | Class of relevant security to which the | 14p Ordinary | | dealings being disclosed relate (Note 2) | | |-----------------------------------------------+-------------------| | Date of dealing | 22 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------------+---------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------------+------------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (2) Derivatives (other than | 13,850,000 | 1.7310 | | | | options) | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (3) Options and agreements | | | | | | to purchase/sell | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | Total | 13,850,000 | 1.7310 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | LONG | 200,000 | 245.2230 | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry|Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+------+--------------| | | | | | | | | +------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) NO +-------------------------------------------------------------------+ | Date of disclosure | 23rd February 2007 | |----------------------------------------------+--------------------| | Contact name | James Feast | |----------------------------------------------+--------------------| | Telephone number | 0207 469 1901 | |----------------------------------------------+--------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |----------------------------------------------+--------------------| | If a connected EFM, state nature of | | | connection (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

Date: February 23, 2007 Basis for disposal: Based on the Board of Directors' decision, Kemira Oyj has transferred shares to persons involved in the 2006 share ownership plan. Trading code: KRA1V Number of shares: 144,143 Price/share:Gratuitous After the transfer on 23 February 2007, company holds a total of 3,835,527 shares. Kemira Oyj Timo Leppä Executive Vice President, Communications For further information please contact: Kemira Oyj Timo Leppä Executive Vice President, Communications tel. +358 (0)10 862 1700 Kemira is a chemicals group made up of four business areas: Kemira Pulp&Paper, Kemira Water, Kemira Specialty and Kemira Coatings. Kemira is a global group of leading chemical businesses with a unique competitive position and a high degree of mutual synergy. In 2006, Kemira recorded revenue of around EUR 2.5 billion and had a payroll of 9,000 employees. Kemira operates in 40 countries.


 

Water Mist Engineering AS has placed an order with Simtronics ASA for delivery of flame detection systems. The end user is Yara International and the systems will be part of the current upgrade of fire safety solutions at Yara International plants in Norway, the Netherlands, Germany, Italy, France, Sweden and Trinidad and Tobago. The order has a value in excess of NOK 1,6 mill. The order includes an additional optional delivery in excess of NOK 0,5 mill. Delivery will take place during 2007 and early 2008. Simtronics ASA has expressed an ambition to expand the business into new industry segments. This order represents Simtronics first delivery of flame detection systems within the global turbine market segment. For further information, please contact: Rune Martini - CEO - (+47) 48 07 80 80 Pål Selboe Valseth - CFO - (+47) 91 70 02 70


 

- Increase in product range and development competence in the area of information systems - New subsidiary achieves two-digit margins and will make positive earnings contribution by the end of 2007 - microSYST is innovation leader in profitable niche markets Kölleda/Weiden, 23 February 2007. In its latest efforts to access new customer groups and development competences in the area of information systems for industrial applications, Funkwerk AG (ISIN: DE 0005753149) has acquired 100 per cent of shares of microSYST Systemelectronic GmbH, Weiden. This 3.25 million Euro investment will be effective retroactively to 1 January 2007. "microSYST is an important technological asset to us, with access to industrial customers in various sectors of the industry which have not previously been our focus," Dr. Hans Grundner, CEO of Funkwerk, explained today on signing the contract. The acquisition will provide Funkwerk with additional sales potential of well over 5 mill. Euro and a positive contribution to the group results as early as in the current financial year. In the medium to long term, the new subsidiary is also expected to bring about a lasting increase in corporate value. Dr. Grundner: "microSYST is a company which alone gives rise to expectations of steady growth in the two-digit range in both sales and earnings over the next few years. Through networking with other operating units in our Traffic & Control Communication segment, however, we will be able to achieve even more synergies." High innovative ability and flexibility produce two-digit margins Headquartered in the Upper Palatinate town of Weiden, microSYST Systemelectronic GmbH has planned, developed and produced electronic components and systems for special requirements in industry and logistics for over 20 years. Its efforts are focused on display systems for industrial applications and electronic solutions for voucherless goods picking for warehousing and logistics. Due to its innovative, customised product developments and flexible productions, microSYST has been able to achieve two-digit margins. The customers of microSYST include companies from different sectors of the industry, predominantly the automobile industry, along with mechanical engineering, automatic machine manufacturers and mail order businesses. On account of its high innovative ability, microSYST is leading in special industrial fields of application such as displays for production lines, goods picking systems and electronic controls for automatic machines. "Customers value the efficiency, robust nature and reliability of the products and solutions developed by microSYST. Ensuring increased productivity and quicker processes, their use will prove a good return on investment before very long," affirmed Dr. Grundner. Above-average growth in market niches By introducing innovations in various market niches, microSYST has gained a competitive edge of several years, presenting products such as its proprietary pick-to-light system. "This promises a unique position in the market, coupled with above-average growth. From that point of view, microSYST fits the Funkwerk business model perfectly, all the more since we can also use its creativity in product development for our entire Traffic & Control Communication segment," emphasised the Funkwerk CEO. In addition to extending the current range of displays and information systems of Funkwerk and increasing its customer base in the industrial sector, the acquisition will boost the company's own product development efforts in the long run. The bottom-line conclusion drawn by Dr. Grundner: "All these factors should provide for new dynamic growth not only in the current financial year but specifically also in the years to come." Further information on Funkwerk AG: Based in Kölleda near Erfurt, Funkwerk AG develops, produces and markets professional communication systems used in vehicles, transport and other companies and institutions. With its three segments Traffic & Control Communication (communication, management and information systems for transport and logistics companies), Automotive Communication (communication equipment for vehicles) and Enterprise Communication (personal security, messaging systems and access solutions for companies and institutions), Funkwerk occupies a strategically excellent position in future markets. For further information contact Funkwerk AG rw konzept GmbH Im Funkwerk 5 Emil-Riedel-Straße 18 99625 Kölleda/Thuringia 80538 Munich Germany Germany Katrin Schwarz Sebastian Brunner Investor Relations Tel: +49 89/13 95 96 -33 Telephone: +49 36 35/6 00 -3 35 Fax: +49 89/13 95 96 -34 Fax: +49 36 35/6 00 -3 99 Mobile: +49 1 75/5 60 46 73 schwarz@funkwerk.com brunner@rw-konzept.de Disclaimer "Diese Pressemitteilung sowie die darin enthaltenen Informationen dürfen nicht in die Vereinigten Staaten von Amerika (USA) gebracht oder übertragen werden oder an US-amerikanische Personen (einschließlich juristischer Personen) sowie an Publikationen mit einer allgemeinen Verbreitung in den USA verteilt oder übertragen werden. Jede Verletzung dieser Beschränkung kann einen Verstoß gegen US-amerikanische wertpapierrechtliche Vorschriften begründen. Aktien der Funkwerk Aktiengesellschaft werden in den USA nicht zum Kauf angeboten. Diese Pressemitteilung ist kein Angebot zum Kauf oder zur Zeichnung von Aktien." "This press release is not being issued in the United States of America and should not be distributed to United States Persons or publications with a general circulation in the United States. This document does not constitute an offer or invitation to subscribe for or purchase any securities in addition, the securities of Funkwerk AG have not been registered under the United States securities laws and may not be offered, sold or delivered within the United States or to U.S. Persons absent from registration under or an applicable exemption from the registration requirements of the United States securities law." --- End of Message --- WKN: 575314; ISIN: DE0005753149; Index: HDAX, MIDCAP, CDAX, Prime All Share, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;


 

Kölleda, 23 February 2007. In its latest efforts to access new customer groups and development competences in the area of information systems for industrial applications, Funkwerk AG (ISIN: DE 0005753149) has acquired 100 per cent of shares of microSYST Systemelectronic GmbH, Weiden, dated 1 January 2007. This 3.25 million Euro investment will provide the specialist in professional communication systems with additional sales potential of over 5 mill. Euro in the current financial year. Due to its innovative, customised product developments and flexible productions, microSYST has been able to achieve two-digit margins and will make a correspondingly positive contribution to the group results of Funkwerk as early as by the end of this year. Over the next few years, microSYST is expected to grow steadily in the two-digit range in both sales and earnings. Headquartered in the Upper Palatinate town of Weiden, the company has planned, developed and produced electronic components and systems for special requirements in industry and logistics for over 20 years. Its efforts are focused on display systems for industrial applications and electronic solutions for voucherless goods picking for warehousing and logistics. The customers of microSYST include companies from different sectors of the industry, predominantly the automobile industry, along with mechanical engineering, automatic machine manufacturers and mail order businesses. On account of its high innovative ability, microSYST is leading in special industrial fields of application such as displays for production lines, goods picking systems and electronic controls for automatic machines. Funkwerk will use this acquisition to complement its market competences in the area of information systems for transport companies and increase the product range in its Traffic & Control Communication segment. At the same time, this move will produce synergy effects in both product development and sales. For further information contact: Funkwerk AG Im Funkwerk 5 99625 Kölleda/Thuringia Germany Katrin Schwarz Investor Relations Telephone: 0 36 35/6 00 -3 35 Fax: 0 36 35/6 00 -507 schwarz@funkwerk.com


 

Data Respons Norway has signed a contract worth NOK 20 million with a world-leading OEM-customer in the Telecom market. - This contract contributes to an already strong order intake, says Kenneth Ragnvaldsen, CEO of Data Respons ASA. We will be a part of the customer's outsourcing strategy, where Data Respons will assume responsibility for solutions while the customer stays focused on its own core processes. The contract includes delivery of embedded solutions that will be integrated in the customer's product. In addition, Data Respons will perform assembling, extensive testing, and logistics services for the customer. Delivery will take place during 2007. FOR FURTHER INFORMATION PLEASE CONTACT: Kenneth Ragnvaldsen, CEO, Data Respons ASA, phone: +47 67 11 20 00 Mob: +47 913 90 918. Rune Wahl, CFO, Data Respons ASA, Tlf.: +47 67 11 20 00 eller Mobil: +47 95 03 60 46. ABOUT DATA RESPONS Data Respons` vision is to become leading in Europe within 2010 on Embedded Solutions in the industrial market. Embedded Solutions can be described as being the brains of a machine, system or industrial end product. Data Respons supplies Embedded Solutions to leading OEM companies, system integrators and vertical product suppliers in a range of market segments such as defence, offshore, automation, medical equipment, surveillance, transport, telecommunications and other industries. Data Respons` customers include Ericsson, Nera, ABB, Brüel & Kjær, Tandberg, Anritsu and Saab. Data Respons ASA is listed on the Oslo Stock Exchange (Ticker: DAT), and is part of the information technology index. The company has offices in Denmark, Finland, Norway, Sweden and Germany. At the close of the 4th quarter 2006 the company had a total of 226 employees. More information on Data Respons ASA can be found on our website: www.datarespons.com


 

The annual general meeting of Cardo AB (publ) will be held on Monday, April 2 at 5.00 pm at Malmö Opera, Östra Rönneholmsvägen 20 in Malmö, Sweden. An agenda containing the matters that are proposed to be brought before the general meeting is included in the official notice to attend the meeting, which will be published on February 25 in the Swedish newspapers Svenska Dagbladet and Sydsvenska Dagbladet and on February 26 in Post- och Inrikes Tidningar and Dagens Industri. The notice is also available on Cardo's website at www.cardo.com As will be seen from the notice, the board of directors recommends to the annual general meeting that, among other things, a dividend of SEK 9.00 per share be declared for the financial year 2006 and that the board be authorized to repurchase own shares before the next annual general meeting in accordance with the detailed terms set out in the notice. As has been announced previously, it is proposed that the present members of the board of directors be re-elected. Notification Shareholders wishing to participate in the annual general meeting must be entered in the register of shareholders maintained by VPC AB (Swedish Central Securities Depository & Clearing Organization) no later than Tuesday, March 27 2007 and have given notice of their intention to attend the meeting no later than 4.00 pm, Tuesday, March 27 2007. Notice of intention to attend the annual general meeting shall be given in one of the following ways: - by mail: Cardo AB, Box 486, 201 24 Malmö - on Cardo's website: www.cardo.com - by e-mail: info@cardo.com - by telephone: +46 40 35 04 49, fax: +46 40 97 64 40 Detailed information on giving notice of intention to attend the meeting can be found in the official notice. Malmö, Sweden, February 23 2007 Cardo AB (publ) For further information, please contact: Maria Bergving, Senior Vice President Communications & Investor Relations, tel +46 40 35 04 25, +46 70 602 61 81, maria.bergving@cardo.com Cardo is an international industrial group with leading brands, offering solutions with quality products, a high level of service and great applications know-how to industrial customers. Operations are pursued in the group's divisions: Door & Logistics Solutions, Wastewater Technology Solutions, Pulp & Paper Solutions and Residential Garage Doors, which all enjoy strong positions in their respective markets. The group has approximately 5,900 employees in more than 30 countries and sales of approximately SEK 8.6 billion. The head office is situated in Malmö, Sweden.


 

Acquisition of rotoclean GmbH, Freiburg, signed technotrans AG is extending its product area of blanket cleaners through the purchase of rotoclean GmbH and of the technologies that this company uses. The corresponding agreements were signed today. rotoclean is one of the leading manufacturers of cleaning systems for newspaper web presses and has enjoyed rapid expansion in recent years. It posted revenue of approx. ¤ 7 million in 2006. In acquiring rotoclean's technologically convincing, patent-protected technology, technotrans is extending its own product range of cleaning systems. The blanket cleaner (contex.c) that it has developed independently in recent years is now complemented by a brush-type cleaner for newspaper web presses; the possibility of transferring individual elements of this technology to the brush version contex.b that technotrans is currently developing will enable it to reduce its own development expenditure in that area. technotrans anticipates substantial revenue growth in the next few years from the international roll-out of the acquired brush concept for newspaper web presses, associated cross-selling opportunities for other technotrans products and swifter development progress on the contex.b. The acquired technology will be fully integrated into the technotrans Gersthofen location, near Augsburg, which serves as the group's centre of expertise for blanket cleaners. The previous owner Mr. Richard Munz will join the technotrans management team. Contact for further information: Thessa Roderig, Investor Relations technotrans AG, phone +49 (0)2583-301-1887


 

* Highly Statistically Significant Results for Improvement in Progression-Free Survival * Progression-Free Survival Results Consistent Irrespective of Prior Chemotherapy Treatment, including Taxotere® * Satraplatin was Well Tolerated with Myelosuppression the Most Commonly Observed Toxicity * Data Being Presented Today at ASCO Prostate Cancer Symposium in Orlando, Florida * GPC Biotech Conference Call Scheduled Today at 9:00 AM EST * Pharmion Investor Event Scheduled Today at 6:30 PM EST Martinsried/Munich (Germany), Waltham, Mass., Princeton, N.J. and Boulder, Colo., February 23, 2007 - GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; NASDAQ: GPCB) and Pharmion Corporation (NASDAQ: PHRM) today announced that final progression-free survival (PFS) results for the double-blind, randomized satraplatin Phase 3 registrational trial, the SPARC trial (Satraplatin and Prednisone Against Refractory Cancer) are being presented today at the ASCO Prostate Cancer Symposium in Orlando, Florida. The trial is evaluating satraplatin plus prednisone versus placebo plus prednisone in 950 patients with hormone-refractory prostate cancer (HRPC) who have failed prior chemotherapy. All analyses of PFS being presented were conducted on an intent-to-treat basis. The study data show that satraplatin significantly reduces the risk of disease progression in these patients using the protocol-specified log-rank test. The hazard ratio of 0.6 (95% CI: 0.5-0.7, p<0.00001), which was first reported in September 2006, adjusted for nine pre-specified prognostic factors. Using a more conservative analysis, which adjusted only for the three pre-specified stratification factors, the hazard ratio is 0.67 (95% CI: 0.57-0.77, p=0.0000003). These hazard ratio numbers correspond to a reduction in relative risk of disease progression of 40% and 33%, respectively. Both analyses are being presented today in Orlando. In accordance with the recommendation of the independent Data Monitoring Board for the SPARC trial, patients who have not progressed continue to be treated and all patients will be followed for overall survival. Overall survival data are expected to be available later this year. GPC Biotech recently completed the New Drug Application (NDA) submission for satraplatin to the U.S. Food and Drug Administration (FDA). Pharmion expects to complete the Marketing Authorization Application (MAA) for Europe in the second quarter of 2007. Daniel Petrylak, M.D., Associate Professor of Medicine at Columbia University College of Physicians & Surgeons, Director of the Genitourinary Oncology Program at New York-Presbyterian Hospital/Columbia, and a Principal Investigator in the SPARC trial, said: "As there are currently no approved therapies for patients with hormone-refractory prostate cancer whose disease has already failed on one chemotherapy regimen, satraplatin has the potential to address a mounting area of unmet medical need. The data I am presenting today show statistically significant results in progression-free survival in favor of those patients treated with satraplatin. These results are consistent no matter what the prior chemotherapy treatment, including Taxotere®." All disease progression events were adjudicated by an independent expert review committee of medical oncologists and radiologists. The vast majority of progression events were based on radiological progressions and pain progressions. Pain associated with bone metastases is the dominant cause of morbidity in patients with metastatic HRPC. Increase in prostate specific antigen (PSA) was not part of the progression endpoint. PFS at the median demonstrated a 14% improvement in patients who received satraplatin plus prednisone (11.1 weeks) compared to patients who received prednisone plus placebo (9.7 weeks). The improvement seen in PFS by patients treated with satraplatin increased over time. PFS at the 75th percentile showed an 81% improvement for patients in the satraplatin arm (34.6 weeks) versus patients in the placebo arm (19.1 weeks). At six months, 30% of patients in the satraplatin arm had not progressed, compared to 17% of patients in the control arm. At twelve months, 16% of patients who received satraplatin had not progressed, compared to 7% of patients in the control arm. The median number of cycles was four for the satraplatin group compared to two for the control group. Nearly 40% of patients treated with satraplatin received five or more cycles of treatment compared to approximately 20% of patients in the control arm. The improvement in PFS in the satraplatin arm was not affected by the type of prior chemotherapy; importantly, the improvement was similar for patients who had received prior Taxotere® (docetaxel), as well as those who received other types of chemotherapy treatments. Fifty-one percent of patients in the trial were previously treated with Taxotere. The hazard ratio for patients in the SPARC trial who were previously treated with Taxotere was 0.67 (95% CI: 0.54-0.83; p=0.0006, adjusted for the pre-specified stratification factors) and therefore numerically equivalent to the entire study population. Safety findings were consistent with previous clinical studies involving satraplatin. The reported adverse reactions were mostly mild to moderate in severity. The most common adverse reactions consisted of myelosuppression (bone marrow functions): Twenty-one percent of patients in the satraplatin arm experienced grade 3 or 4 thrombocytopenia; 14 percent had leucopenia and 21 percent had neutropenia. Eight percent of patients in the satraplatin arm experienced grade 3 or 4 gastrointestinal toxicities, including nausea, vomiting, diarrhea and constipation. Five percent or less of patients in the satraplatin arm experienced grade 3 or 4 fatigue, grade 3 or 4 infections and pulmonary/respiratory grade 3 or 4 toxicities. "We are delighted with the strong detailed results presented today from the satraplatin SPARC Phase 3 trial," said Bernd R. Seizinger, M.D., Ph.D., Chief Executive Officer of GPC Biotech. "Moving forward, we plan to work closely with the FDA regarding our application for marketing approval of satraplatin in the U.S. We also are continuing to aggressively build our marketing and sales organization in the U.S. to prepare for a potential launch of satraplatin later this year." "We have been very pleased with the response of the prostate cancer treatment community to the SPARC data and believe that satraplatin will become a very important treatment option for men with HRPC," said Patrick J. Mahaffy, President and Chief Executive Officer of Pharmion Corporation. "We are currently preparing our regulatory submission and expect to file a marketing authorization application for satraplatin in the EU by the end of the second quarter." The SPARC trial is a double-blinded, randomized, placebo-controlled multinational Phase 3 trial assessing satraplatin plus prednisone as a second-line chemotherapy treatment for patients with HRPC. A total of 950 patients were accrued to the trial at approximately 170 clinical sites in sixteen countries on four continents. In addition to the results presented today, the companies expect that more data from the SPARC trial will be presented at future upcoming major medical conferences. GPC Biotech and Pharmion Investor Events GPC Biotech will hold a conference call today at 9:00 A.M. EST/15:00 CET to which participants may listen via live webcast, accessible through the Company's Web site at www.gpc-biotech.com, or via telephone. Dr. Daniel Petrylak will participate in the call, in addition to corporate management. The dial-in numbers for the call are as follows: Participants from Europe: 0049 (0)69 2222 2246 or 0044 (0)20 7138 0835 Participants from the U.S.: 1-718-354-1172 Pharmion will hold an investor event today at 6:30 P.M. EST in Emerald 4 at the Gaylord Palms Resort and Conference Center in Orlando, Florida. For those unable to attend, the event will be accessible via a teleconference and will be webcast live on our website at www.pharmion.com. The dial in for U.S. participants is 1.800.901.5231 and 1.617.786.2961 for International participants. The passcode is 84420838. Corporate management will briefly review today's data and then a panel of European physicians will discuss their clinical experience with satraplatin and its potential role in the treatment of HRPC in Europe. About Prostate Cancer Prostate cancer is the most common cancer among men in the U.S. and Europe. Approximately 219,000 men in the U.S. are expected to be diagnosed with the disease in 2007 and over 27,000 men are expected to die from the disease. In the European Union, over 200,000 new cases are expected to be diagnosed, and over 60,000 patients are expected to die each year. Since the incidence of prostate cancer increases with age, the aging of the overall population is expected to further increase the number of prostate cancer patients. Most patients diagnosed with prostate cancer initially receive surgery or radiation therapy, and some of these patients are cured. For many others, though, the disease recurs. At this point, the recurrent disease is treated with hormone therapy, and most patients initially respond well to this treatment. Eventually, however, the tumor cells become resistant to the hormones - or "hormone-refractory" - and the tumor again progresses. Increasingly, chemotherapy is being used as an effective first-line treatment for hormone-refractory prostate cancer. However, it is not a cure, and so this is creating a need for effective therapeutic options for these patients once they have progressed. About Satraplatin Satraplatin, an investigational drug, is a member of the platinum family of compounds. Over the past two decades, platinum-based drugs have become a critical part of modern chemotherapy treatments and are used to treat a wide variety of cancers. Unlike the platinum drugs currently on the market, all of which require intravenous administration, satraplatin is an orally bioavailable compound and is given as capsules that patients can take at home. GPC Biotech and Pharmion have a co-development and license agreement under which Pharmion has been granted exclusive commercialization rights to satraplatin for Europe and certain other territories. Satraplatin has been studied in clinical trials involving a range of tumors. Trials evaluating the effects of satraplatin in combination with radiation therapy, in combination with other cancer therapies and in a number of cancer types are underway or planned. GPC Biotech in-licensed satraplatin from Spectrum Pharmaceuticals, Inc. in 2002. Additional information on satraplatin can be found in the Anticancer Programs section of the GPC Biotech Web site at www.gpc-biotech.com. About Pharmion Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic cancer drug, Vidaza®, a DNA demethylating agent. For additional information about Pharmion, please visit Pharmion's website at www.pharmion.com. About GPC Biotech GPC Biotech AG is a biopharmaceutical company discovering and developing new anticancer drugs. GPC Biotech's lead product candidate - satraplatin - has achieved target enrollment in a Phase 3 registrational trial as a second-line chemotherapy treatment in hormone-refractory prostate cancer. The U.S. FDA has granted fast track designation to satraplatin for this indication, and GPC Biotech has completed the rolling NDA submission process for this compound. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors. GPC Biotech AG is headquartered in Martinsried/Munich (Germany), and its wholly owned U.S. subsidiary has sites in Waltham, Massachusetts and Princeton, New Jersey. For additional information, please visit GPC Biotech's Web site at www.gpc-biotech.com. This press release contains forward-looking statements, which express the current beliefs and expectations of the management of GPC Biotech AG and Pharmion Corporation, including statements relating to results of the SPARC trial and statements relating to the potential efficacy and safety profile of satraplatin. Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially depending on a number of factors, and we caution investors not to place undue reliance on the forward-looking statements contained in this press release. In particular, there can be no guarantee that additional information relating to the safety, efficacy or tolerability of satraplatin may be discovered upon further analysis of data from the SPARC trial or analysis of additional data from other ongoing clinical trials for satraplatin. Furthermore, we cannot guarantee that satraplatin will be approved for marketing in a timely manner, if at all, by regulatory authorities nor that, if marketed, satraplatin will be a successful commercial product. We direct you to GPC Biotech's Annual Report on Form 20-F for the fiscal year ended December 31, 2005, Pharmion's Annual Report on Form 10-K for the fiscal year ended December 31, 2005, its most recent filings on Form 10-Q and other reports filed with the U.S. Securities and Exchange Commission for additional details on the important factors that may affect the future results, performance and achievements of either Pharmion or GPC Biotech. Forward-looking statements speak only as of the date on which they are made and neither Pharmion nor GPC Biotech undertakes any obligation to update these forward-looking statements, even if new information becomes available in the future. The scientific information discussed in this press release related to satraplatin is investigative. Satraplatin has not yet been approved by the FDA in the U.S., the EMEA in Europe or any other regulatory authority and no conclusions can or should be drawn regarding its safety or effectiveness. Only the relevant regulatory authorities can determine whether satraplatin is safe and effective for the use(s) being investigated. Taxotere® (docetaxel) is a registered trademark of Aventis Pharma S.A. Editor's Note: A virtual press kit is available for downloading from the News and Media section of the GPC Biotech website at http://www.gpc-biotech.com/en/news_media/virtual_press_kit/index.html or by contacting one of the GPC Biotech individuals listed below. For further information, please contact: GPC Biotech AG Martin Braendle Director, Investor Relations & Corporate Communications Phone: +49 (0)89 8565-2693 ir@gpc-biotech.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 781 890 9007 X267 usinvestors@gpc-biotech.com Pharmion Corporation Breanna Burkart/Anna Sussman Directors, Investor Relations and Corporate Communications Phone: 720.564.9150 ir@pharmion.com Additional Media Contacts for GPC Biotech: In Europe: Maitland Noonan Russo Brian Hudspith Phone: +44 (0)20 7379 5151 bhudspith@maitland.co.uk In the U.S.: Noonan Russo David Schull Phone: +1 212 845-4271 david.schull@eurorscg.com --- End of Message --- WKN: 585150; ISIN: DE0005851505; Index: CDAX, MIDCAP, Prime All Share, TecDAX, HDAX, TECH All Share; Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Geregelter Markt in Frankfurter Wertpapierbörse;


 

The multi component seismic company Reservoir Exploration Technology ASA (RXT) has received a contract award from BP for a survey in the Caspian Sea. Estimated contract survey duration is approximately five months. Under the contract, RXT will acquire 4C seismic data over the Shah Deniz field, offshore Azerbaijan in the South Caspian Sea. The field is operated by BP. The survey will be acquired with RXT's third operation, "RXT3", which is scheduled to commence operation in April/May, 2007 over the Kashagan field offshore Kazakhstan. Acquisition over the Shah Deniz field is planned to commence in the fourth quarter 2007, at contract rates favourable to RXT's annualised projections. -The Caspian Sea has huge areas of prospective acreage requiring high quality seismic data for future development. The VectorSeis Ocean technology, combined with RXT's innovative acquisition methods, is ideally suited to meet these data requirements, together with the highly varied operational challenges, Michael Scott, CEO of RXT, comments. This contract complements very well the Kashagan project already awarded to RXT and further validates RXT's strategy to keep a crew permanently in the Caspian region. For further information, please contact CFO Odd Erik Rudshaug in RXT. Cell : + 47 41612858 About RXT: Reservoir Exploration Technology ASA (RXT) is a marine geophysical company specializing in multi component seismic sea-floor acquisition. Multi component seismic solves several imaging challenges that cannot be resolved with towed streamer seismic, and targets improved oil recovery from existing fields. The technology also gives better data quality for exploration, and is also the solution where towed streamers are impractical due to high density of platforms and/ or shallow waters. The Company has offices in Oslo, London and Houston. RXT is listed on the stock exchange in Norway (OSE ticker: RXT). URL: http://www.rxt.com/ About Shah Deniz field: Shah Deniz gas field is the largest natural gas field in Azerbaijan. The field is situated in the South Caspian Sea, offshore Azerbaijan, approximately 70 kilometers south-east of the capital Baku. The field spans shallow to deepwater from 50 to 600 metres (approx. 160 - 2,000 ft) and covers approximately 860 square kilometres (330 sq. miles). The Shah Deniz field is operated by BP (25.5%). Co-venturers are Statoil (25.5%), SOCAR (10%), Total (10%), Lukoil (10%), NICO (10%), and Turkish Petroleum Overseas Company Limited (9%).


 

* Approval of Focetria, an immune enhancing pandemic influenza vaccine, would allow for more rapid response in the event of influenza pandemic Basel, February 23, 2007 - Novartis announced today that it has received a positive opinion supporting European Union regulatory approval of the human vaccine Focetria® for use in the event of an pandemic influenza outbreak, such as one that could be caused by the H5N1 virus. The Committee for Medicinal Products for Human Use (CHMP), which reviews applications for all 27 countries in the European Union as well as Iceland and Norway, has recommended approval of this new vaccine. The European Commission generally follows the recommendations of the CHMP and delivers its final decision within two to three months. The EU submission for Focetria was considered a "mock-up" since it lays the groundwork for a more rapid approval and availability of a specific vaccine once a pandemic has been declared. Focetria would be manufactured to contain the pandemic influenza strain declared at the time of a pandemic along with the proprietary adjuvant MF59 developed by Novartis. Studies have shown that MF59 could boost the body's immune response to the vaccine's active constituent and extend vaccine supplies by allowing for smaller amounts of viral antigens to be used in each dose compared to vaccines without this additive. "The availability of a pandemic influenza vaccine soon after the declaration of a pandemic is essential to reduce disease burden and deaths. This positive recommendation for our proprietary MF59-adjuvanted pandemic vaccine brings us one step closer to achieving public health and pandemic preparedness goals," said Dr. Jörg Reinhardt, CEO of Novartis Vaccines and Diagnostics, a division of Novartis. "We are committed to working with governments and international organizations to reduce the impact of an influenza pandemic through ongoing research and development projects for pre-pandemic and pandemic influenza vaccines," Reinhardt said. Novartis submitted the Focetria mock-up file for EU approval in early 2006. Once the World Health Organization (WHO) declares a pandemic, Novartis will submit a revised application to the European Medicines Agency (EMEA) to incorporate the identified viral strain. This revised application can be approved more quickly than a totally new application. The filing for the Novartis mock-up vaccine was based on clinical studies involving the MF59 adjuvant and different H5N1 strains with pandemic potential. Separately, Novartis has submitted an MF59-adjuvanted H5N1 pre-pandemic influenza vaccine for EU approval based on the same technology as Focetria. This vaccine is intended for use prior to a pandemic declaration to help prime and boost the immune system of those receiving the vaccine to better defend against infections from a H5N1 virus. Novartis commitment to pandemic preparedness Novartis is working closely with government and regulatory officials worldwide to support pandemic preparedness efforts. Novartis has engaged in discussions with several governments concerning pandemic influenza vaccine supply and has provided H5N1 vaccines for stockpiling, notably in the US and UK. In January 2007, the US Department of Health and Human Services awarded Novartis a USD 55 million contract to further develop the adjuvant technology of MF59 in the US to potentially extend vaccine supplies in case of a pandemic outbreak. An adjuvant is a substance added to a vaccine to enhance the body's immune response to the vaccine's active constituent, called the antigen. Research supporting the use of the MF59 adjuvant includes: * Clinical trial data presented at the Second International Conference on Influenza Vaccines for the World (IVW 2006) confirming that the addition of the MF59 adjuvant can augment antibody response and increase protection of subjects against circulating influenza strains not included in the vaccines * Clinical research published in The Lancet in 2001 demonstrating that an MF59-adjuvanted vaccine, based on the non-pathogenic H5N3 virus strain, induced antibodies against H5N1 influenza virus at lower antigen levels * A study published in the Journal of Infectious Diseases in 2005 showing that an MF59-adjuvanted vaccine induced broadly cross-reactive antibodies capable of neutralizing H5N1 viruses isolated from a number of Southeast Asian countries between 1997 and 2004 * Clinical trial data, supported by the US National Institutes of Health (NIH), of an MF59-adjuvanted vaccine against an H9N2 avian influenza virus that were published in 2006 in the online edition of Clinical Infectious Diseases; in this study, an MF59-adjuvanted vaccine induced antibody levels believed to offer protection using one quarter of the dose level used against a seasonal flu strain Additionally, Novartis has developed a new vaccine manufacturing process that uses cell cultures rather than chicken eggs for antigen production. The new technology may reduce production time to meet demands of influenza outbreaks and to combat evolving strains of the virus, including avian influenza strains that are difficult to grow in eggs. The cell culture-based vaccine Optaflu® was submitted for EU regulatory approval in July 2006 and is currently in clinical studies in the US. About H5N1 avian influenza Global health authorities have identified H5N1 avian influenza as an aggressive viral strain with pandemic potential. While researchers have not quantified the likelihood of an outbreak, to date H5N1 has caused serious illness in Southeast Asia in more than 250 people. The mortality rate of patients investigated has been over 50 percent.[1] An influenza pandemic would be expected to spread quickly globally; licensing and production of sufficient quantities of pandemic vaccines is therefore an enormous challenge. The WHO recommends early vaccine development and use to reduce disease severity and mortality and stresses the need to work collaboratively with researchers and manufacturers towards ensuring that as much as possible, vaccines and antiviral drugs are available at the start of a pandemic[2]. Disclaimer This release contains certain forward-looking statements, relating to the Novartis Group's business, which can be identified by the use of forward-looking terminology such as "supporting approval," "would," "could", "committed", "will," "can be," "may reduce" or similar expressions, or by express or implied discussions regarding potential marketing approvals or future sales of Focetria or other vaccines. Such statements reflect current views with respect to future events and are subject to certain risks, uncertainties and assumptions. There can be no guarantee that Focetria or other vaccines will be approved for any indications in any market or that Focetria or any vaccines will reach any particular sales levels. In particular, management's expectations regarding Focetria and other vaccines could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including additional analysis of existing clinical data and new clinical data; competition in general; the ability of Novartis to obtain or maintain patent or other proprietary intellectual property protection; increased government, industry, and general public pricing pressures; and other risks and factors referred to in the Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. About Novartis Novartis Vaccines and Diagnostics is a new division of Novartis focused on the development of preventive treatments and tools. Novartis Vaccines is the world's fifth-largest manufacturer and second-largest supplier of influenza vaccines in the US. The division's products also include meningococcal, pediatric and travel vaccines. Chiron, the blood testing and molecular diagnostics business, is dedicated to preventing the spread of infectious diseases through the development of novel blood-screening tools that protect the world's blood supply. Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com. # # # Media contacts John Gilardi Novartis Global Media Relations +41 61 324 3018 (direct) +41 79 596 1408 (mobile) john.gilardi@novartis.com Eric Althoff Novartis Vaccines and Diagnostics Communications +1-510-923-6500 +1-510-387-7604(US mobile) eric.althoff@novartis.com e-mail: media.relations@novartis.com or nvd.communications@novartis.com Media materials For images and video related to the Novartis Vaccines influenza products, please visit www.thenewsmarket.com/novartisvaccines. Journalists may register and download print-quality images and broadcast-standard video from this site at no charge. Investor Relations International Ruth Metzler-Arnold +41 61 324 7944 Katharina Ambühl +41 61 324 5316 Nafida Bendali +41 61 324 3514 Jason Hannon +41 61 324 2152 Richard Jarvis +41 61 324 4353 North America Ronen Tamir +1 212 830 2433 Arun Nadiga +1 212 830 2444 Jill Pozarek +1 212 830 2445 Edwin Valeriano +1 212 830 2456 e-mail: investor.relations@novartis.com References [1] WHO Cumulative Number of Confirmed Human Cases of Avian Influenza, WHO Web site http://www.who.int/csr/disease/avian_influenza/ country/cases_table_2006_10_31/en/index.html, accessed February 6, 2007 [2] WHO Strategic Action Plan for Pandemic Influenza 2006-2007, WHO website http://www.who.int/csr/resources/publications/ influenza/WHO_CDS_EPR_GIP_2006_2c.pdf, accessed February 6, 2007 --- End of Message --- WKN: 904278; ISIN: CH0012005267; Index: SLCI, SMI, SPI, SLIFE; Listed: Main Market in SWX Swiss Exchange, ZLS in BX Berne eXchange;


 

Vancouver, February 23, 2007 - GUANGZHOU, CHINA -- (MARKET WIRE) -- BioLife Remedies Inc. (PINKSHEETS: BLRS) is pleased to announce that the company will be featured on BTV - Business Television. The feature is set to air on Feb. 24th and Feb. 25th, 2007 on National TV, BTV-Business Television. BioLife Remedies Inc. combines traditional Chinese medicine (TCM) with western academic research and development practices to produce medical and health-care products. The Company's products include Chiagra for erectile dysfunction and Betatrol for diabetes. The link for the feature on BioLife Remedies may be viewed below or may be seen on the website: www.blfrproducts.com, under news or see http://www.b-tv.com/i/videos/Biolife.wmv BTV, a half-hour weekly business program, profiles emerging public companies across Canada and the USA. With Host Taylor Thoen, BTV features companies at their location, interviews the company's key executives, features their products and services and unveils their plans for future growth. BTV BROADCAST TIMES: CANADA: - Ontario: SUNTV - Sun. Feb. 25th @ 9:00am EST, BC/Washington: KVOS TV - Sun. Feb. 25th @ 4:30pm PST AB/Edmonton: CITY TV - Sat. Feb. 24th @ 10:30am MST Bell Express VU and Star Choice - West SUNTV Sun. Feb. 25th @ 6:00am PST U.S. national: - America One - Sat. Feb. 24th@10:30 am EST www.americaone.com WVVH South Hampton, NY WSPY Plano, IL WZBN Trenton, NJ ShelbyTV Shelby Township KKAX Kingman, AZ WIVM Canton, OH K48BK Dove Creek, CO K27FA Craig, CO WRCF Orlando, FL WLLS Indiana WLNN Boone, NC W34AX Henderson, NC W67CD Sanford, NC WYBE Southern Pines, NC WBKA Bucyrus, OH CTV12 Cedar City, UT VTV Vernal, UT WBII Ashland, MS WPRQ Clarksdale, MS KXOK Enid, OK KXOC Oklahoma City, OK KWEM Stillwater, OK KEEN Las Vegas KMCA Redding, CA TV9 Troy, OH WRBD Pensacola, FL KDAO Marshalltown KTYJ Coeur d' Alene, ID NSU22 Natchitoches, LA WBCF Florence, AL W35AY Hilton Head Island, SC WJTS Jasper, IN WGTN Worthington, MN KCCE San Luis Obispo, CA W35BB Dublin, GA IMAGE Erie, PA KPIF Pocatello, ID K23BJ Lake Havasu City, AZ UPN23 Hornell, NY WEBU Webb, MS WLMO Lima, OH WHAN Salem, IN About Bio Life Remedies, Inc BIO LIFE REMEDIES, INC. combines Traditional Chinese Medicine and Western academic research and development practices with the latest scientific technology to produce effective medical and health-care products to combat serious diseases. The Bio Life Group has developed 108 master medical formulas to treat various diseases including diabetes, prostateria, osteoporosis, cerebrovascular disease, cardiac vascular disease, hypertension, menopausal syndrome, and sexual disorders in men and women. Please visit http://www.blfrproducts.com for more information. Forward-Looking Statements You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as ``will,'' ``anticipates,'' ``believes,'' ``plans,'' ``goal,'' ``expects,'' ``future,'' ``intends,'' and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about Bio Life Remedies Inc. please refer to its Web site at http://www.blfrproducts.com Contact: For Further Information: Email: info@blfrproducts.com http://www.blfrproducts.com Tel: 604-630-8881 Fax:604-630-8877 Toll Free: 1-866-630-8881


 

Vancouver, February 23, 2007 - GUANGZHOU, CHINA -- - It has come to BioLife Remedies Inc's (PINKSHEETS: BLRS) attention that email spam about the Company has been circulated. BioLife Remedies strongly denies any claims that the Company has been involved in this email spam activity. We do not endorse the dissemination of promotional emails. Rather, we are focused on the development of our business and products. BioLife Remedies combines Traditional Chinese Medicine (TCM) and modern research to develop and produce natural herbal products that combat chronic ailments. TCM is a natural medical framework developed in China over 3000 years. During this time, countless medical formulas were developed to treat a multiplicity of chronic ailments. Under the leadership of Mr. Jack Guo, a group of leading rhizotomists, herbologists, pharmacists, and TCM practitioners began to develop effective natural herbal solutions to remedy chronic ailments. These natural herbal solutions were based on ancient Chinese formulas. Bio Life Bioengineering (China) Inc. (BLBE), wholly owned by BioLife Remedies, was established to conduct R&D and produce these herbal remedies. BioLife Remedies has successfully developed 11 natural herbal products to remedy various diseases including diabetes, prostateria, osteoporosis, cerebrovascular disease, cardiac vascular disease, hypertension, menopausal syndrome, male sexual disorder, female sexual disorder, and intelligence development of children. Presently the company is concentrating on the launch of six branded products: Zutrol(TM), Betatrol(TM), Dia-Kids(TM), Di-Agra(TM), Cholessra(TM) and Chi-Agra(TM). Zutrol(TM) and Betatrol(TM). Terry Xie, a Director of BioLife Remedies Inc., commented, "TCM is a medical framework developed over the period of thousands of years, its safety and effectiveness are proven by generations of TCM practitioners. Today TCM is widely applied in China for treating serious diseases. Our team of researchers is doing a fantastic job in refining TCM formulae into safe and effective products." The President and the CEO of the Company, Jack Guo stated, "The products we develop at BioLife Remedies are safe for use. We plan to run a monitoring program with top Universities within North America that will demonstrate the safety and the effectiveness of our products." In a recent interview on Business TV, Jack Guo commented that clinical analysis and research on the BioLife Remedies' products are going to be conducted in North America to demonstrate the effectiveness of the products. About Bio Life Remedies, Inc BIO LIFE REMEDIES, INC. combines Traditional Chinese Medicine and Western academic research and development practices with the latest scientific technology to produce effective medical and health-care products to combat serious diseases. The Bio Life Group has developed 108 master medical formulas to treat various diseases including diabetes, prostateria, osteoporosis, cerebrovascular disease, cardiac vascular disease, hypertension, menopausal syndrome, and sexual disorders in men and women. Please visit http://www.blfrproducts.com for more information. Forward-Looking Statements You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as ``will,'' ``anticipates,'' ``believes,'' ``plans,'' ``goal,'' ``expects,'' ``future,'' ``intends,'' and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about Bio Life Remedies Inc. please refer to its Web site at http://www.blfrproducts.com Contact: For Further Information: Email: info@blfrproducts.com http://www.blfrproducts.com Tel: 604-630-8881


 

Frontline's Fourth Quarter 2006 results will be released on Tuesday February 27, 2007. In connection with this a presentation and a teleconference / webcast will be held as described below: 1. Presentation A presentation of Frontline's Fourth Quarter 2007 will take place in Oslo at Stranden 21 (DnB NOR building at Aker Brygge) in the Auditorium on second floor on Tuesday February 27, 2007 at 08:30 A.M. If you wish to attend please confirm to our Reception at +47 23 11 40 00. 2. Teleconference and Webcast A conference call will be held at 03:00 P.M. CET (Norwegian time) on Tuesday February 27, 2007. The presentation will be available to download from the Investor Relations section at www.frontline.bm (go to "Presentations") from Tuesday morning. To listen you may do one of the following: a. Webcast Go to the Investor Relations section at www.frontline.bm and click on the link to "Webcast". To listen to the conference call from the web, you need to have installed Windows Media Player, and you need to have a sound card on your computer. b. Teleconference PARTICIPANTS DIAL IN TELEPHONE NUMBERS Country Number Norway Free Call 800 193 95 International Dial In +44 (0) 1452 552 510 UK Fee Call 0800 694 2370 USA Free Call 1866 966 9444 Participants will be asked for their full name & Conference ID. The Conference ID is 9995605. There will be a Q&A session after the presentation. Information on how to ask questions will be given at the beginning of the Q&A session. Please download the presentation material from www.frontline.bm to view it while listening to the conference. Encore Replay will be available for 7 days. The encore replay details will be read out at the end of the conference. Best regards Cathrine Fosse


 

Klövern's Annual Report in Swedish for 2006 can now be downloaded from Klövern's website. It is now in the process of being printed and a printed copy of the annual report can be ordered via Klövern's website www.klovern.se. The English version will be presented on the website during week 11. Nyköping, 23 February 2007 Klövern AB (publ) For further information, please contact: Gustaf Hermelin, CEO, tel +46-(0)155-44 33 10, +46-(0)70-560 00 00, gustaf.hermelin@klovern.se Anders Lundquist, CFO, tel +46-(0)155-44 33 20, +46-(0)70-528 43 33, anders.lundquist@klovern.se Britt-Marie Einar, Corporate Communications Officer, tel +46-(0)155-44 33 12, +46-(0)70-224 29 35, britt-marie.einar@klovern.se Klövern is a real estate company with a local presence that actively develops properties in large Swedish cities. Klövern has geographical units in twelve cities; Borås, Eskilstuna, Kalmar, Karlstad, Kista, Linköping, Norrköping, Nyköping, Täby, Uppsala, Västerås and Örebro. As at 31 December 2006, the value of the properties totals approximately SEK 10.7 billion and the rental income on an annual basis was approximately SEK 1,070 million. The Klövern share is listed on the Stockholm stock exchange, Stockholmsbörsen's Nordic list, mid-cap companies. Klövern AB (publ), Box 1024, SE-611 29 Nyköping, Sweden * Tel +46 155 44 33 00, Fax +46 155 44 33 22. Corporate registration no. 556482-5833 * Registered office: Nyköping * Website: www.klovern.se


 

The new website of Iittala Group now has even more to offer. The visual appearance of the site combined with the increase in content strengthens Iittala's image as a dynamic design company. The website project went to bids in March 2006, and Satama emerged as the contract winner. Satama has since then completely overhauled Iittala Group's website, giving it a brand new structure, visual appearance and content that strengthens the design company's corporate image. According to Tuija Aalto-Setälä, Communications Manager, Iittala Group, the need to renew Iittala's website arose when the company's ownership structure underwent changes in 2004. Iittala Group is now owned by the operative management, the private equity firm ABN AMRO Capital and investor Harry Harkimo. "Our aim was to balance the brands with more corporate communications," Aalto-Setälä explains. "We chose Satama for the job because of its reputation as a reliable service provider and its ability to turn the project around within a tight timescale. The company's good reputation and quality also factored in the decision," Aalto-Setälä says. Satama's designs for the new website were completed by the deadline, in summer 2006. The new website went live in November last year. The site is structured into eight main sections: Iittala Group, Brands, Financial, Press, Business Services, Careers, Design Heritage and Sales & Contracts. Each section is divided into sub-sections that make finding information quick and easy. Iittala Group aspires to make it on the international market, and consequently the website is currently available in both Finnish and English. "So far, we have only received positive feedback. Visitors find the structure of the site easy to navigate and feel that information is easy to find. More people have contacted us through the website, which has helped to reduce the number of telephone enquiries that we get," Aalto-Setälä says. Visitors have also found the site's visual appearance a good match for Iittala's corporate image. The site makes great use of the high-quality photography associated with the Iittala brand. "I can believe that we were probably an extremely demanding client since finding and devising a consistent visual backdrop for our strong brands required in-depth understanding and fastidious attention to every detail," Aalto-Setälä says. According to Aalto-Setälä, Satama handled the project satisfactorily. "The deadlines were met and the end result was what we set out to achieve," she concludes. Iittala Group's renewed website can be found at www.iittalagroup.com Further Information: Jari Pullinen Director, Sales & Marketing Satama, Productivity Tel. +358 (0)40 769 4443 Email: jari.pullinen@satama.com Tuija Aalto-Setälä Manager, PR & Communications Iittala Group Tel. +358 (0)40 501 0303 Email: tuija.aalto-setala@iittala.com Iittala Group Iittala is the registered trademark of the Iittala Group. Iittala Group is a leading homeware design company, and offers a wide range of products representing the best in modern Scandinavian design. Iittala Group is the market leader in its home markets of Finland, Sweden, and Norway. In the international markets, the company focuses on developing the Iittala brand and the Iittala Shops. The Group recorded a turnover of EUR 168 million in 2005. At the end of 2005, the Group had 1,425 employees. / www.iittalagoup.com


 
Hitt og þetta
23. febrúar 2007

EPT Disclosure

FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of exempt principal trader | HSBC Bank Plc | |----------------------------------------+--------------------------| | Company dealt in | Barratt Developments Plc | |----------------------------------------+--------------------------| | Class of relevant security to which | Ordinary Shares | | the dealings being disclosed relate | | | (Note 1) | | |----------------------------------------+--------------------------| | Date of dealing | 22nd February 2007 | +-------------------------------------------------------------------+ 2. DEALINGS (Note 2) (a) Purchases and sales +-------------------------------------------------------------------+ | Total number of | Highest price paid | Lowest price paid | | securities | (Note 3) | (Note 3) | | purchased | | | |--------------------------+--------------------+-------------------| | 11,266 | 1,265.20p | 1,253.20p | +-------------------------------------------------------------------+ +-------------------------------------------------------------------+ | Total number of | Highest price | Lowest price | | securities | received | received | | sold | (Note 3) | (Note 3) | |------------------------+---------------------+--------------------| | 12,741 | 1,266.60p | 1,251.60p | +-------------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product name, | Long/short | Number of | Price per | | e.g. CFD | (Note 4) | securities | unit | | | | (Note 5) | (Note 3) | |----------------+------------+---------------------+---------------| | | | | | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +------------------------------------------------------------------------------------------+ |Product |Writing, |Number of securities to|Exercise|Type, e.g.|Expiry|Option | |name,e.g|selling, |which the option |price |American, |date |moneypaid/received| |call |purchasing,|relates (Note 5) | |European | |per unit (Note 3) | |option |varying etc| | |etc. | | | |--------+-----------+-----------------------+--------+----------+------+------------------| | | | | | | | | +------------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit | | | | (Note 3) | |-----------------------+----------------------+--------------------| | | | | +-------------------------------------------------------------------+ 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .................................................. .................................................. +-------------------------------------------------------------------+ | Date of disclosure | 23rd February 2007 | |----------------------------------------------+--------------------| | Contact name | Edward Hodge | |----------------------------------------------+--------------------| | Telephone number | 0207 992 16661 | |----------------------------------------------+--------------------| | Name of offeree/offeror with which connected | Wilson Bowden Plc | |----------------------------------------------+--------------------| | Nature of connection (Note 6) | Connected Advisor | +-------------------------------------------------------------------+ Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

DJIA 12686.02 -52.39 -0.41% Nasdaq 2524.94 +6.52 +0.26% S&P 500 1456.38 -1.25 -0.09% FTSE 100 6380.90 +23.80 +0.37% Xetra DAX 6973.73 +32.07 +0.46% CAC40 5707.86 +13.30 +0.23% Above are closing prices Nikkei 225 18224.83 +116.00 +0.6% Hang Seng 20647.15 -162.08 -0.78% S&P/ASX 200 6009.30 +18.20 +0.3% Taiwan Index Closed S.Korea Kospi 1468.59 +3.18 +0.2% Dow Future 12703.00 -1.00 0.00% NASDAQ Future 1853.25 -1.00 0.1% S&P Future 1458.75 -0.50 0.0% Above are as of 0550 GMT USD/JPY 121.45-48 -0.06% Range 121.63 - 121.41 EUR/USD 1.3122-26 -0.05% Range 1.3129 - 1.3115 AUD/USD 0.7882-85 -0.06% Range 0.7893 - 0.7883 GBP/USD 1.9559-62 -0.01% Range 1.9569 - 1.9553 USD/CHF 1.2394-96 +0.10% Range 1.2400 - 1.2382 Above are as of 0550 GMT vs NY close USD/JPY Vol Option Contract 6.64%/6.86% EUR/USD Vol Option Contract 5.33%/5.58% AUD/USD Vol Option Contract 6.18%/6.42% GBP/USD Vol Option Contract 5.82%/6.07% USD/CHF Vol Option Contract 6.10%/6.70% Above are 1-Mo prices as of 0454 GMT 2Y Tsy 99 25/32 N/A 4.87% +4.7 5Y Tsy 100 4/32 -6/32 4.72% +4.3 10Y Tsy 99 6/32 -10/32 4.73% +3.8 10Y JGB 1.6700% +0.0150 Closing Treasury prices vs prior NY close; JGB as of 0550 GMT Asian Spot Gold $675.05 -$4.50 -0.7% Comex Gold $674.00 -$5.40 -0.8% Brent Crude Oil $60.62 $0.00 0.0% Above are as of 0500 GMT vs NY close EUROPEAN OUTLOOK & US/ASIAN SUMMARIES: European investors remain bullish on stocks, which are likely to start the session moderately higher. The euro is little changed against other major currencies, while government bonds face opening pressure. Gold is expected to continue to lose ground with the price of oil steady. STOCKS: Markets are on the rise again at the open on the belief that strong corporate profits are set to continue. Spreadbettor Cantor Index is calling the FTSE up 17 points at 6397, the DAX up 21 at 6994 and the CAC up 18 at 5725. Heino Ruland, a strategist at Steubing in Frankfurt, said, "Investors are starting to be more confident that were not going to have a setback in earnings." In the news, Microsoft must pay EUR1.14 billion in damages to telecommunications equipment maker Alcatel-Lucent for violating two patents related to digital music, a U.S. federal jury ruled Thursday. DaimlerChrysler plans to offer detailed financial information about its Chrysler Group selectively, as it discusses a sale of the division with potential buyers, people familiar with the matter told The Wall Street Journal New York turned in a mixed performance Thursday as Irans refusal to suspend uranium enrichment rattled investors and tempered a rally in the technology sector spurred by a strong outlook from chip maker Analog Devices. Also hurting stocks was a U.S. government report that showed a larger-than-expected drop in gasoline and heating oil inventories, causing crude prices to bound above $60 a barrel. This chilled the mood among investors who at first were encouraged by upbeat corporate announcements and a rally in foreign stock markets. Strength among semiconductor stocks drove the Nasdaq composite index to six-year highs. Ryan Larson, senior equity trader at Voyageur Asset Management, a division of RBC Dain Rauscher, said the markets initially pulled back after word of the diplomatic tensions with Iran and then dropped further as stocks hit technical resistance levels. Traders believe those levels are 12,760 for the Dow and 2,530 for the Nasdaq. Japans markets rose by midmorning Friday on fresh buying after volatile moves earlier. Sanyo Electric unsettled investors when it said it was fully cooperating with an investigation by securities authorities into suspected window-dressing of earnings. FOREX: The euro and dollar are steady against the yen, which continued to see carry-trade activity. "Carry trade fever is not going away," said Tom Levinson, currency strategist at ING Capital Markets in London. "Given the glacial rise in Japanese rates, markets are happy to push further the bounds of the carry trade." But the euro dipped slightly against the dollar, as investors stayed focused on the higher U.S. inflation data that has some market participants pricing in a much smaller chance of a third quarter rate cut by the Fed. Dealers cited the possibility of a dip in the German IFO report Friday for the markets readiness to target support of $1.3074. A strong IFO, though could boost the euro, especially against the yen, dealers said. BONDS: European government bond prices may see a lower start, following losses on Thursday in line with weaker Treasurys. The focus now turns to Fridays German February IFO business climate index. HSBC noted that 2007 started with a declining business climate, but recent anecdotal evidence suggests there has been no strong setback from Januarys German value-added tax hike. The bank therefore expects a small improvement to current business conditions, with the index rising to 113.7 from 112.8, nearly unchanged business expectations, 103.1 from 103.2, and a rise in the business climate to 108.2 from 107.9 in January. "If consensus forecasts for an improved IFO are correct bunds could come under further downside pressure and, despite the usual pre-weekend squaring, end the week with a very soft tone," said one European bond salesman. Treasurys held even in Asian trading Friday after heavy losses on Thursday. Federal Reserve speakers of late have persuaded investors that the Feds policy seems to be on hold for now. "I think the market continues to be worried about the Feds focus on inflation," said Mary Ann Hurley, vice president of fixed-income trading at D.A. Davidson. Prices of Japans government bonds were mixed, after rallying on Thursday once the Bank of Japan officially raised its interest rates to 0.50% from 0.25%. While the market saw a bit of profit-taking, traders doubted there would be serious losses. ENERGY: Oil trading was slow Friday as the market adjusted to a surprising drop in U.S. gasoline and heating oil inventories. Light, sweet crude for April delivery nudged 3 cents higher to $60.98 in light electronic trading on the New York Mercantile Exchange Singapore. Prices jumped 88 cents Thursday to settle at $60.95 a barrel, continuing a rally that analysts said has largely been driven by demand for petroleum products. Tension between Western powers and Iran has also boosted energy prices this week. A tight range of $57 to $62 a barrel is likely in the coming days, dealers said. METALS: Spot gold fell $4.50 to $675.05 on profit-taking by Japanese traders after recent gains, though it is consolidating around the middle of its short-term range of $670-$682, said ScotiaMocattas Peter Tse. He looks for gold to bounce back in Europe as sentiment remains strong, though large open interest suggests a bearish trigger would provoke a sharp fall. LME copper is massively shorted by funds and consumers, but talk of strong Chinese buying next week after the Lunar New Year break is tempting short holders to cover, said BNP Paribas. LME 3-month copper was at $6,119/ton, down $11 on the London PM kerb. CALENDAR: Friday, February 23, 2007 GMT Expected Previous 0745 FRA Jan Household consumption expenditure in +0.2%MM +1.3%MM mfg goods +5.5%YY +6.8%YY 0900 GER Feb Business Climate 107.5 107.9 0900 GER Feb Current Situation 112.0 112.8 0900 GER Feb Business Expectations 103.1 103.2 0900 ITA Jan Foreign Trade, non-EU +EUR0.5B 0930 UK 4Q UK Output, Income & Expenditure 0930 GER Feb Ifo German Business Climate Index with Ifo Business Survey in the German Services Sector 0930 UK 4Q GDP, 2nd estimate +0.8%QQ +0.7%QQ +3.0%YY +2.9%YY 1000 ITA EUR2.5B in 24-month Zero Coupon Bonds Auction 1000 ITA EUR8.5B in 6-month T-Bills Auction 1545 US Dallas Fed Pres Fisher speaks on the US economy in a global context in Los Angeles 1900 US Tsy Dep Secy Kimmitt, Bulgaria Fin Min Orescharski sign tax treaty in Washington 2035 US San Francisco Fed Pres Yellen speaks on the economic outlook in Sacramento Bank Polski (PKO2.WA): 4Q Earnings Average consolidated net profit (DJ, 6 analysts): PLN550M (PLN386M) Average net interest income: PLN986M (PLN906M) Note: Analysts expect to see strong volume growth, especially in retail mortgage loans and consumer lending, but at the same time they worry that the protracted replacement of the CEO may hit the share price. Capitalia (CAP.MI): FY & 4Q Earnings Average FY net profit (DJ, 11 analysts): EUR1.103B (EUR1.035B) Average 4Q net profit: EUR300M (EUR398M) Average FY operating income: EUR2.2B (EUR2.0B) Average FY net interest income: EUR2.815B (EUR2.534B) Average total income: EUR1.422B (EUR1.359B) Note: The FY net profit gain is attributed to higher profit from holding and higher net interest income. 4Q06 net profit seen coming in 32% lower than in the same period last year, when Capitalia booked non-recurring gains from the listing of Parmalat (PLT.MI). Eyes on any comments about possible top management moves and M&A. Report due pre-market. Analysts presentation at 0830 GMT Friday in Milan. Davis Service Group (DVSG.LN): FY Earnings Average pretax pre-item profit (Co, 11 analysts): GBP86.5M (GBP84.5M) Average EPS: GBP35.4p (GBP31.7p) Note: Analysts expect the rise to be driven by growth in European markets, but expect continued pressure on UK textiles margins due to rising energy costs. Eni (E): 4Q Earnings Average adjusted net profit (DJ, 17 analysts): EUR2.30B (EUR2.40B) Average adjusted operating profit: EUR4.55B (EUR4.93B) Average FY dividend: EUR1.28 (EUR1.1) Note: Hydrocarbon 4Q output is seen at 1.972M barrels of oil equivalent a day, down from 1.806M boe/d. Profits are seen hit by lower refining margins, production disruption and a weaker USD/EUR exchange rate. Eyes will be on 07-10 strategy presentation and updates on the massive Kashagan oil field. Husqvarna (HUSQ-B.SK): 4Q Earnings Average operating profit (SME Direkt, 10 analysts): SEK297M (SEK308M) Average revenues: SEK4.54B (SEK5.0B) Note: Since the 4Q is traditionally a weak quarter, eyes will mainly be on the 2007 outlook, the size of resellers stocks and any indication Husqvarna is about to make acquisitions in North America. Report due at 0700 GMT. Lafarge (12053.FR): Event Average net profit (FactSet Estimates, 15 analysts): EUR1.37B (EUR1.1B) Average EBIT: EUR2.8B (EUR2.36B) Note: Net profit seen +25% on already-reported 17% rise in revenue to EUR16.9B. , EBIT seen +19%, but not all analysts have stripped out roofing units results which company is deconsolidating due to sale of control. Company has guided for slower EBIT growth in 2H vs year earlier. Analysts looking for any update on 2008 targets, including progress towards 1 point increase in operating margin. Lloyds TSB (LYG): FY Earnings Average pretax profit before items (Co, 24 analysts): GBP3.70B (GBP3.45B) Average EPS: GBP46p (GBP44.6p) Note: Latest year has a one off pension liability credit of GBP125M. Analysts see a key positive in Scottish Widows sales through the branch network. Credit Suisse says Lloyds TSBs large number of low-margin retail deposit accounts position it for a 9% retail revenue uplift in 2007 due to the recent interest rate rise. RWE (RWE.XE): FY Earnings Average net profit (DJ, 10 analysts): EUR3.57B (EUR2.23B) Average operating profit: EUR6.19B (EUR5.37B) Average sales: EUR44.14B (EUR39.49B) Note: The net profit improvement mainly comes from a EUR700M book gain from the sale of U.K. water unit Thames Water Holdings PLC and a EUR600M gain from a German corporate tax rebate. This will likely result in an increased dividend payout for full-year 2006, given that RWE has pledged to increase its dividend payout ratio to 70% and 80% for 2006 and 2007. Analysts said high European power and natural gas prices should also have continued to drive earnings and sales in 2006. However, an outage at RWEs nuclear power plant Biblis, stretching over several months, as well as regulatory intervention into grid fees will likely show a negative impact on earnings, analysts said. RWE is expected to give an update on its plan to publicly float its U.S. water unit American Water Works. The company previously said an initial public offering could happen in the second half of 2007. Investors focus Friday will also be on RWEs comments on its growth strategy in a consolidating European energy sector and a full-year 2007 outlook. WPP Group (WPPGY): FY Earnings Average pretax profit before amortization (Co, 11 analysts):GBP755M (GBP699M) Average sales: GBP5.879B (GBP5.373B) Note: Organic revenue growth - stripping out acquisitions, disposals and currency movements - seen at 5%, compared with 5.5% in FY 2005. Operating margin seen at 14.5%, compared with 14.0% in FY 2005. Analysts will be looking for guidance on signs of a pick-up in the European advertising economy, growth prospects for the US and China and the possibility of further acquisitions. OTHER SCHEDULED EVENTS: 4imprint Group (FOUR.LN): FY Earnings AarhusKarlshamn (AAK.SK): FY Earnings Aguas de Barcelona (AGS.MC): FY Earnings AI Claims Solutions (ACS.LN): 1H Earnings Aktiv Kapital (AIK.OS): 4Q Earnings APRR (680700.FR): FY Earnings Banca Transilvania (TLV.RO): AGM & EGM Brostrom (BRO-B.SK): FY Earnings Bure Equity (BURE.SK): FY Earnings Cementos Portland Valderrivas (CPL.MC): FY Earnings CISL Gruppen (CISL.SK): FY Earnings Corporacion Dermoestetica (DERM.MC): FY Earnings Decora (DCR.WA): 4Q Earnings Domstein (DOM.OS): 4Q Earnings DPA Flex Group (34731.AE): FY Earnings FKI (FKI.LN): 1H 2006 Dividend Payment Date Gamma (35582.AE): FY Earnings Hardanger Sunhordlanske DS (): 4Q Earnings LISI (5035.FR): FY Earnings LjungbergGruppen (LJGR-B.SK): FY Earnings Masters (MST.WA): FY Earnings Millennium & Copthorne Hotels (MLC.LN): FY Earnings Opcon (OPCO.SK): FY Earnings Paged (PGD.WA): 4Q Earnings Prim (PRMI.MC): FY Earnings Puleva Biotech (BIO.MC): FY Earnings Sanochemia Pharmazeutika (SAC.XE): Q1 Earnings Service Point Solutions (SPS.MC): FY Earnings Skanditek Industriforvaltning (STEK.SK): FY Earnings Spectris (SXS.LN): FY Earnings Tavex Algodonera (ASA.MC): FY Earnings TelePizza (TPZ.MC): FY Earnings Tras Intur (TST.WA): 4Q Earnings Vastned Offices/ Industr (28893.AE): FY Earnings Vastned Retail (28891.AE): FY Earnings Wereldhave (28921.AE): FY Earnings Wise Group (WISE.SK): FY Earnings (Arcelor Mittal (MT.AE): 1Q 2007 Ex-Dividend Date Bespak (BPK.LN): 1H 2006 Dividend Payment Date Derwent London (DLN.LN): 2Q 2007 Special Dividend Payment Date Hitt (35815.AE): FY 2006 Ex-Dividend Date ICAP (IAP.LN): 1H 2006 Dividend Payment Date ISIS Property Trust (IPT.LN): 4Q 2006 Dividend Payment Date Morant Wright Japan Income (MWJ.LN): 2Q 2006 Dividend Payment Date RHM (RHM.LN): 1H 2006 Dividend Payment Date Scott Wilson Group (SWG.LN): 1H 2007 Dividend Payment Date Theratase (THE.LN): FY 2006 Dividend Payment Date Titon Holdings (TON.LN): FY 2006 Dividend Payment Date Warner Estate Holdings (WNER.LN): 1H 2006 Dividend Payment Date (END) Dow Jones Newswires


 

- A quality label for .eu registrars Having launched the draft version of the .eu Code of Conduct amongst its accredited registrars, EURid, the registry for the Internet top level domain .eu, now also invites members of the public to submit their comments on the document. The concept of a .eu Code of Conduct as an incentive for subscribing registrars to provide a high quality of service was first proposed some months ago, with a draft version of the Code being made available to registrars for assessment in December 2006. Registrars have since been given the opportunity to comment on the Code and EURid is now inviting the general public to do the same. The Code will come into effect on March 29th and registrars subscribing to it will be listed on the official Code of Conduct website. The establishment of a Code of Conduct forms part of the service contract between the .eu registry and the Commission. Both parties believe that an entity of this nature is indispensable to Internet world. "We felt the time had come to recognise accredited registrars offering a best in class service and that a Code of Conduct was the ideal way in which to do this. The registry believes that allowing registrars subscribing to the Code to carry the official subscriber logo on their websites will enable the public to make a more informed decision when choosing which accredited registrar to use when registering their .eu domains," says Bob Walraet, business manager at EURid. The Code will also be used as a means of dealing with issues that are inherent to the domain name industry but that are difficult to regulate adequately in a legal context. A platform for receiving complaints against registrars subscribing to the Code will be set up by the .eu registry, who will act as a secretariat for the Code of Conduct. The .eu Code of Conduct will be governed by an elected Council of Conduct; a self regulating body comprised of members of .eu registrar community, the internet community at large, and a EURid representative. A draft version of the Code and of the Rules for dispute handling and Council election can be viewed on the official Code of Conduct website, www.coc.eu. The public is invited to email their comments on the Code to conduct@eurid.eu until the 16th of March 2007, when the document will be finalized and the Council of Conduct will be elected. About EURid - The European Registry of Internet Domain Names Eurid is the not-for-profit organization appointed by the European Commission to register and manage .eu domain names. EURid was founded in April 2003, with headquarters in Brussels and a regional office in Stockholm. Further regional offices are planned in Italy and the Czech Republic. The founding members, DNS.be, NIC-SE, and IIT CNR, operate the country top-level domains for Belgium (.be,) Sweden (.se) and Italy (.it) respectively. The registries Arnes (Slovenian domain, .si,) CZ-NIC (Czech domain, .cz) and the European chapter of the Internet Society, ISOC, are associated members. For further information, please contact Bob Walraet, EURid's business manager, on +32 (0)2 401 27 50 or by email conduct@eurid.eu.


 

Svenska Handelsbanken sells its 37 % stake in the Swedish card processing company CEKAB. The consideration for 100% of the equity in CEKAB amounts to 257 MSEK. The transaction is conditional on, inter alia, receipt of relevant approvals from competition authorities. The resulting capital gain will be reported in Q1 or Q2 2007. Svenska Handelsbanken owns CEKAB together with Nordea (39%), Swedbank (21%) and Danske Bank (3%). All banks are selling their stakes at the same time to the Norwegian company EDB Business Partner. EDB will secure continuity in operating the growing card business. CEKAB was founded in 1989 to build the new and common infrastructure needed at the time. As the card business has matured a clearer division of responsibilities between the infrastructure vendors and the banks is preferred. For further information: Anna Gabrielsson, Senior Manager Strategic Development Card Services, Handelsbanken, phone: +46 8 701 14 957 Johan Lagerström, deputy head of Corporate Communications, Handelsbanken phone: +46 8 70 265 8014


 

Schibsted has today sold all their 1,039,560 shares in Asker og Bærums Budstikke ASA for NOK 46 million. The stake corresponds to an ownership of 10.1%. The buyers are Asker og Bærums Budstikke ASA, 1,030,000 aksjer, and Stiftelsen Magnus Blikstads Stipendiefond, 9,560 shares. Schibsted will have an accounting gain from the disposal of approx. NOK 25 million. The background for the sale is the positive decision on all the Extraordinary General Meetings for the Media Norge parties on 15 February 2007. Preliminary estimates from The Norwegian Media Authority indicate that should Media Norge become a reality, Schibsted is likely to exceed the ownership limit of one third of the newspaper circulation based on the 2006 figures. The divestment of the stake in Asker og Bærum Budstikke is aimed at reducing Schibsted's market share. Contact persons: CFO Trond Berger, tel.: +47 91 68 66 95 EVP Schibsted Norway Birger Magnus tel.: +47 90 03 00 93 Oslo, February 23rd, 2006 SCHIBSTED ASA --- End of Message --- ISIN: NO0003028904; ;


 

(Oslo, 23 February 2007) EDB has entered into an agreement to buy the Swedish card processing company CEKAB. This agreement makes EDB the leading player for capturing and managing card transactions in the Nordic market. EDB is to pay SEK 257 million for the business acquired. The company is expected to have in the order of SEK 20 million in cash at the time of acquisition. "This acquisition puts EDB in the driver's seat for the future of card processing in the Nordic countries. CEKAB is an exciting company and opens up entirely new opportunities for EDB in both the Swedish and Nordic banking and finance markets", comments Endre Rangnes CEO of EDB. Card processing involves the capture and management of transactions carried out by card users through devices such as minibanks and payment terminals. Transactions are processed on behalf of the banks that issue the debit and credit cards used to initiate the transactions. Billions of such transactions are carried out in the Nordic countries each year, and transaction numbers are expected to increase in future years. Market leader in Sweden CEKAB is one of the leading public companies for processing card transactions from minibanks (ATMs) and payment terminals. The company has a strong position in the Swedish market, and in 2006 it processed over 1 billion transactions from a large number of ATMs and payment terminals. CEKAB has 52 employees and operates from Stockholm. The company reported turnover of SEK 134 million for 2006. CEKAB provides its services to many of the largest Nordic banks, including Nordea, Svenska Handelsbanken, SEB, Swedbank and Danske Bank. The company was established in 1989 by a number of banks to facilitate collaboration on the use of Bankomat minibanks in Sweden, and is still owned by banks that purchase services from the company. Internationalisation of the card market The card market in both the Nordic countries and Europe as a whole is driven by strong forces for internationalisation, with new EU rules promoting greater cross-border competition and the banks seeking solutions that simplify international card transactions. At the same time, card use throughout Europe is on a rising trend. "EDB is seeking to expand its position, and sees major opportunities in the field of card transaction processing. CEKAB will be an important element in working towards realising our ambitions for EDB in the card area. In addition, the acquisition will create a broader platform and new opportunities for sales of EDB's other Bank & Finance solutions to the Nordic market", adds Endre Rangnes. The acquisition of CEKAB will make EDB the leading company for capture and processing of card transactions in the Nordic countries, with cross-border delivery of services to banking customers. EDB already has sizeable operations for processing minibank and credit card transactions in Norway. These operations, together with CEKAB, will form the basis for EDB's focus on the card processing area. EDB believes that bringing the two operations together offers economies of scale and synergies that will pave the way for further growth and new opportunities in this and other areas. EDB's business model involves delivering services to banks that issue cards and provide merchant services so that they can offer their Nordic and international customers (card holders and merchants) new and more efficient services. EDB attaches considerable importance to offering a range of services to banks that meet their needs for expansion into new markets outside the Nordic countries. More about the transaction EDB is to buy 100% of the share capital of Centralen för Elektroniska Korttransaktioner AB, CEKAB, from the current owners Nordea (39%), Handelsbanken (37%), Swedbank (21%) and Danske Bank (3%). EDB will pay SEK 257 million for the shares in total. The company is expected to have in the order of SEK 20 million in cash at the time of acquisition. CEKAB will continue as a wholly-owned subsidiary of EDB Business Partner AB. The business will continue to be run by Eva Menzing, the current Managing Director of CEKAB. The acquisition is expected to take place during March 2007. The transaction is conditional on the necessary approvals being granted by the relevant authorities. Contact persons: Endre Rangnes, CEO, EDB. Tel: +47 22 52 80 80 Tore Valderhaug, EVP and CFO, EDB. Tel: + 47 995 60 925 Geir Remman, EVP - Corporate Communications, EDB. Tel: +47 970 55017 EDB Business Partner is listed on Oslo Børs with the ticker code: EDBASA. For further information see: www.edb.com


 

Highlights 4th quarter in 2006 (4th quarter in 2005) * Payments from portfolios NOK 497.4 million (+3.8%) * Total operating revenue NOK 370.7 million (-3.7%) * Profit before tax NOK -128.2 million (-314.0%) * EBITDA NOK 375.8 million (386.0) * Pre tax cash flow per share NOK 7.05 (7.39) * Change in portfolio collection estimates of NOK -220.5 million (-78.4) * Total acquisitions in 4th quarter of NOK 367.0 million Highlights for the 12 months ended December 31, 2006 (December 31, 2005) * Payments from portfolios NOK 1 845.3 million (+6.8%) * Total operating revenue NOK 1 461.5 million (+1.6%) * Profit before tax NOK -307.7 million * EBITDA NOK 1 434.4 million (1 410.2) * Pre tax cash flow per share NOK 26.56 (27.09) * Change in portfolio collection estimates of NOK -714.9 million (-279.2) * Total portfolio acquisitions of NOK 1 602.2 million EBITDA is defined as operating profit + depreciation of tangible fixed assets+amortisation of intangible fixed assets- interest income on portfolios (including the change in portfolio collection estimates) + cash received on portfolios. In the 4th quarter of 2006, Aktiv Kapital achieved operating revenues of NOK 370.7 million (385.0). Based on our review of the updated future cash flow estimates for the debt portfolios, there was reason to revise the net book values of the loans and receivables in the 4th quarter. The expected cash flow of a large German portfolio purchased in Q4 2005 with delivery in 2006 has been significantly revised. The portfolio was purchased for NOK 561 million and is not meeting collection expectations. The German portfolio has been written down by NOK 281 million. Some other smaller portfolios have also been revised. Aktiv Kapital had at end of Q3 06 accrued NOK 77.3 million for future cash flow revisions. As such, the change in portfolio collection estimates amounts to NOK -220.5 million. The German portfolio are not performing according to projections set at the time of purchase. Developing a professional operation in Germany has required and will require more time than anticipated. Operational and organisational improvements have been, and will be, implemented in Aktiv Kapital Germany to ensure that current expectations will be met. Cash received from portfolios in the 4th quarter amounted to NOK 497.4 million (479.0), an increase of 3.8% compared to the 4th quarter of 2005. Operating profit was NOK -84.5 million. EBITDA in the 4th quarter was NOK 375.8 million (386.0). The increase in payroll and other operating expenses is mainly due to expansion of businesses in Spain, Germany, Canada and further expansion in the UK. Operational improvements In order to more accurately price portfolio acquisitions and to improve collection efficiency, Aktiv Kapital has in 2006 implemented changes to acquisition policies and collection practice. For every portfolio purchase a reference portfolio with collection history is identified and the cash flow expectations of the potential portfolio is benchmarked against one or more reference portfolios. Throughout 2007, Aktiv Kapital will develop a data warehouse containing historical collection data with information of more than 4 million debtors. Based on this Aktiv Kapital will introduce multi variable regression modelling enabling Aktiv Kapital to be the best at forecasting expected cash flows from portfolios being acquired, and hence avoid paying a too high price in the initial phase. Aktiv Kapital believes that quantitative analysis combined with our market specific knowledge and experience will enable us to dominate the industry for non performing consumer loans in our markets. Accounting principles These interim financial statements have been prepared in accordance with IAS 34 and with the same accounting principles as in the annual financial statements. The financial statements for the 4th quarter in 2005 have been restated to best reflect the adjustments recorded in 2005. Comments on the results for the 4th quarter of 2006 Portfolios In the 4th quarter in 2006, cash collections on portfolios were NOK 497.4 million representing an increase of 3.8% compared to the 4th quarter in 2005. Total cash collections in 2006 amounted to NOK 1 845.3 million compared to NOK 1 727.5 million in 2005. Interest income on portfolios for the 4th quarter 2006 amounted to NOK 272.5 million, a decrease of 3% compared to the 4th quarter in 2005. Operating profit for portfolios in the 4th quarter in 2006 amounted to NOK -80.6 million. In the 4th quarter 2006, Aktiv Kapital invested close to NOK 380 million in new portfolios, including existing forward flow agreements, compared to NOK 443 million in the 4th quarter 2005. Portfolio purchases and forward flow arrangements in UK resulted in more than 52 000 new accounts with a face value of approximately £ 101,8 million (NOK 1 250 million). In Spain, portfolios with a face value of approximately ¤ 207,1 million (NOK 1 712 million) was acquired. The portfolios consists of more than 328 000 accounts. In addition, portfolios were acquired in Austria, Canada, Germany, Portugal and Sweden. The put backs of claims to vendors for the quarter was approximately NOK 13 million, resulting in net acquisitions for the quarter of NOK 367 million. Debt collection Income from debt collection in the 4th quarter of 2006 amounted to NOK 67.4 million (64.0). The operating profit decreased from NOK 12.6 million in the 4th quarter of 2005 to NOK 9.0 million in the 4th quarter of 2006. The decrease in operating profit during the 4th quarter is mainly due to the competitive situation with margin pressure. As communicated last quarter a cost reduction program is being implemented in Norway in order to reduce costs. A new country manager for Aktiv Kapital Norway has been recruited, and a number of projects have been and will be initiated with purpose of reducing costs in 2007 and 2008. Administrative and financial services (AFS) With revenues of NOK 28.6 million (24.9) in the 4th quarter, the revenue growth for the AFS business segment is 15%. The operating profit in the 4th quarter of 2006 amounted to NOK 4.5 million (9.9). All Nordic countries experienced revenue growth in the quarter, especially Sweden. The decrease in operating profit of NOK 5.4 million, is mainly due to a NOK 3 million reclassification of non recurring interest expense in the 4th quarter 2005 and an additional provision for doubtful accounts. Net financial items The quarters net financial items amounted to NOK 43.8 million (37.3). Interest expense has increased over the corresponding period of the previous year due to a higher debt level. In addition, net financial items for 4th quarter 2006, includes a net foreign currency exchange loss of NOK 12.2 million (8.8), a gain on realisation of an interest hedge contract NOK 4.1 million and NOK 4.2 million of unrealised gains on financial instruments. Dividend payment Due to the write downs of portfolios resulting in a net loss for 2006 and limited technically free reserves in the parent company Aktiv Kapital ASA, the board will not recommend to the annual general assembly any dividend payment for 2006. The Board expects that the capacity to pay dividends is restored in 2007. Financing The initial drawdown on the loan agreement of NOK 3 500 million signed in June 2006, was completed in mid July and refinanced the Group's existing interest-bearing secured debt related to existing portfolios. The Group's finance strategy is to manage and to limit both currency and interest risk. The loan is made in relevant currencies reflecting the underlying expected future cash flow from the portfolios. As such, the loan amounting to NOK 3.186 million (net of amortised arrangement fee) as of 31 December 2006 is, in combination with a loan financing the Canadian operation, reflecting a currency basket with 34% GBP, 31% EUR, 20% SEK, 8% NOK and remaining 7% as a combination of CHF, DKK and CAD. The interest exposure related to the borrowed amount in different currencies are reduced through the use of a combination of interest swaps and interest caps in the main currencies GBP, EUR, SEK and NOK. The upfront fees related to the refinancing are amortised over the loan period of 5 years. The charterer of the two Crystal Production vessels exercised the option to purchase the vessels and both vessels have been delivered in the 4th quarter. The remaining outstanding loan of USD 6 million financing the acquisition of the distressed debt towards Crystal Production has been repaid accordingly. At December 31, 2006 the Group had liquid assets of NOK 478.7 million of which NOK 454.3 million were unrestricted and NOK 24.4 million were restricted. The net interest bearing debt of the Group was NOK 2 864.3 million. Outlook Due to a general consumer credit growth in most European markets we expect that the number of non performing consumer loan portfolios available for sale will increase in the years to come. This increased number of portfolios available may lead to lower prices and stimulate growth. The good liquidity position and significant asset base gives the Company a solid foundation. The strong cashflow from existing portfolios provides significant opportunities to grow the company further. The Board has a positive outlook for the Company and believes the changes management is implementing will have significant positive effects. It is expected that Aktiv Kapital ASA will return to a dividend paying position in 2007. Oslo, 22 February 2007 The Board of Directors of Aktiv Kapital ASA The fourth quarter report can be found on www.newsweb.no. The presentation and the report with tables can be downloaded from the following links:


 

London, UK and Orlando, FL: 23 February 2007 - Antisoma plc (LSE: ASM, US OTC: ATSMY) announces the presentation today at the ASCO Prostate Cancer Symposium of positive interim findings from its ongoing phase II trial of AS1404 in hormone-refractory prostate cancer. Men receiving AS1404 plus standard docetaxel chemotherapy had a substantially higher PSA response rate than men receiving chemotherapy alone. As previously reported, among the first 64 of 74 patients randomised, PSA response rates were 57% with the AS1404-docetaxel combination and 35% with docetaxel alone. Addition of AS1404 to chemotherapy also produced a near halving in the frequency of progression judged by PSA (17% with AS1404 plus docetaxel versus 29% with docetaxel alone). Final PSA data are expected during the first half of this year, with time to tumour progression and survival data to follow in the second half. Today's presentation also includes updated safety findings from the trial. These remain consistent with earlier reports in showing that the addition of AS1404 to chemotherapy has been well tolerated, with no evidence for exacerbation of chemotherapy-related side effects. The data are presented by a leading investigator in the trial, Professor Mark Rosenthal of the Royal Melbourne Hospital, Victoria, Australia. Professor Rosenthal commented: "The PSA findings from the AS1404 prostate cancer trial are very encouraging, as they suggest a marked improvement in activity when AS1404 is added to standard docetaxel therapy. If these findings translate into improved time to progression and survival, that would be a really exciting development." Prostate cancer is among the most prevalent cancers in the developed world. It often responds initially to hormonal therapies, but each year some 200,000 men across the US, Europe and Japan develop 'hormone-refractory' disease. The taxane drug docetaxel has become an important treatment for such hormone-refractory prostate cancer. AS1404 has shown synergistic anti-cancer effects in combination with docetaxel and other taxanes in preclinical tests. Recently, phase II trials have found that combination of AS1404 with another taxane, paclitaxel, considerably extended survival in lung cancer and increased response rates in ovarian cancer. Glyn Edwards, CEO of Antisoma, said: "Prostate cancer is the second of the big four cancer indications, alongside lung cancer, in which AS1404 has shown promising results in phase II trials. We are very excited about the prospects for AS1404 in this disease and more broadly as a novel approach with potential to improve the treatment of a wide variety of cancers." Antisoma is currently in talks to license AS1404 to a development and marketing partner. Given the growing evidence for activity in several tumour types, a key consideration in these talks has been potential partners' ability to explore the drug's full potential across a variety of cancers. Antisoma announced last week that it expects to conclude a deal with a strong partner during the first half of 2007. A copy of the poster presented at the ASCO Prostate Cancer Symposium is available at www.antisoma.com. Enquiries: Glyn Edwards, Chief Executive Officer (in London) +44 (0)20 8799 8200 Daniel Elger, Director of Communications (in +44 7909 915 068 Orlando) Antisoma plc Mark Court/Lisa Baderoon/Rebecca Skye Dietrich Buchanan Communications +44 (0)20 7466 5000 Brian Korb The Trout Group +1 212 477 9007 Antisoma disclaimer Certain matters discussed in this statement are forward looking statements that are subject to a number of risks and uncertainties that could cause actual results to differ materially from results, performance or achievements expressed or implied by such statements. These risks and uncertainties may be associated with product discovery and development, including statements regarding the company's clinical development programmes, the expected timing of clinical trials and regulatory filings. Such statements are based on management's current expectations, but actual results may differ materially. Details of the PSA findings PSA is a protein, prostate-specific antigen. Levels of PSA in the blood are used in the diagnosis of prostate cancer and the tracking of responses to its treatment. PSA is one of the most widely recognised disease markers in oncology, and PSA responses have been related to clinical outcomes in numerous studies. PSA data are currently available from 64 of the 74 men participating in the trial. PSA response is defined as a 50% or greater reduction in PSA level from baseline, in accordance with the Bubley criteria (Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. Journal of Clinical Oncology 1999, Volume 17, pp 3461-67). On this measure, of the 64 men currently evaluable, 17/30 in the AS1404 + docetaxel group and 12/34 in the docetaxel alone group, had PSA responses. Of these, all but three in each group have been confirmed by a second reading 6 weeks after the initial result. The other three responses in each group are unconfirmed pending data from further tests. Progression by PSA is defined as a 25% or greater increase. Among the first 64 patients, 5 in the AS1404 + docetaxel group and 10 in the docetaxel alone group showed progressive disease by this measure. Background on AS1404 AS1404 (DMXAA) is a small-molecule vascular disrupting agent which targets the blood vessels that nourish tumours. The drug was discovered by Professors Bruce Baguley and William Denny and their teams at the Auckland Cancer Society Research Centre, University of Auckland, New Zealand. It was in-licensed by Antisoma from Cancer Research Ventures Limited (now Cancer Research Technology), the development and commercialisation company of the Cancer Research Campaign (now Cancer Research UK), in August 2001. CRUK had supported two phase I studies in the UK and New Zealand. AS1404 has shown a substantial survival benefit in patients with non-small cell lung cancer when added to paclitaxel-based chemotherapy in a randomised phase II study. Background on Antisoma Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information. ---END OF MESSAGE---


 

KYOTO, Japan, Feb. 23, 2007 (PRIME NEWSWIRE) -- Pursuant to Section 203.01 of New York Stock Exchange Listed Company Manual, Nidec Corporation ("Nidec") announces that its annual report on Form 20-F for the fiscal year ended March 31, 2006 was filed with the Securities and Exchange Commission on September 25, 2006. Nidec's website address (in the English language), from which the Form 20-F can be accessed, is: http://www.nidec.co.jp/english/ir/lib/index.html Upon request, Nidec's shareholders (including holders of its American Depositary Shares) may receive hard copies of Nidec's most recent audited consolidated financial statements (F-pages of the Form 20-F) free of charge. Such request should be made at: http://www.nidec.co.jp/english/ir/lib/20f/form.html The Nidec Corporation logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1734 CONTACT: Nidec Corporation Hiroshi Toriba, Senior General Manager, Investor Relations +81-75-935-6140 HIROSHI_TORIBA@notes.nidec.co.jp


 

Ahlstrom Corporation STOCK EXCHANGE RELEASE 23.2.2007 Ahlstrom, a global leader in fiber-based materials, today announced that it has signed a Memorandum of Understanding with Brazilian Votorantim Celulose e Papel (VCP) to form a joint venture for specialty paper production in Brazil. The assets in the joint venture, currently owned by VCP, comprise a paper machine, an offline coater and extensive finishing equipment at the Jacarei mill, close to São Paulo. According to the Memorandum of Understanding, Ahlstrom will hold a majority of the joint venture. Ahlstrom expects to close the deal on or before June 30, 2007, subject to antitrust clearances and satisfactory conclusion of the ongoing due diligence process. The paper production capacity of the assets is approximately 110,000 tons per year. The joint venture will be part of Ahlstrom's Specialty Papers segment and serve mainly the labeling and flexible packaging markets. In addition, it will continue to produce coated and uncoated paper grades for other end-uses. Currently, most of the paper production is supplied on the local markets but Ahlstrom aims to expand the customer base and serve the markets by utilizing its global specialty materials sales network. The Jacarei facility is an integrated pulp and paper mill and one of the most modern and competitive eucalyptus pulp producers in the world with a pulp production capacity of one million tons per year. VCP has been supplying eucalyptus pulp for Ahlstrom on a global basis for more than seven years. "The deal is in line with Ahlstrom's strategy to expand its operations in the fast-growing markets outside Europe. Moreover, the joint venture offers us an excellent opportunity to strengthen our position as the global leader in the specialty papers markets. The integrated mill also gives us an exceptional access to competitively priced eucalyptus pulp and energy", comments Jukka Moisio, President and CEO of Ahlstrom. "We will develop this state of the art site into a highly competitive manufacturing platform to serve our customers in the labeling and packaging industry. This move is also a strong sign of commitment and confidence in the Latin American markets showing rapid economic growth", says Diego Borello, Senior Vice President, Label & Packaging Papers of Ahlstrom. The global market for Ahlstrom's label and packaging papers is estimated to grow 3-4% annually with double-digit growth rates seen in Latin America and Asia. Ahlstrom's current operations in Brazil consist of a plant manufacturing filtration materials in Louveira. In 2006, Ahlstrom announced an investment in a wiping fabrics production line utilizing spunlace technology, also located in Louveira. The new line is estimated to be operational in early 2008. Ahlstrom Corporation Jukka Moisio, President & CEO For further information, please contact: Jukka Moisio, President & CEO, Ahlstrom Corporation, +358 (0)10 888 4700 Diego Borello, Senior Vice President, Label & Packaging Papers, +39 011 92 60 193 Risto Anttonen, Senior Vice President, Commercial Operations, +358 50 597 8400 Distribution: Helsinki Stock Exchange Main media www.ahlstrom.com Votorantim Celulose e Papel in brief Votorantim Celulose e Papel (VCP) is part of the Votorantim Group, a major Brazilian conglomerate. VCP is one of the leading integrated pulp and paper manufacturer in Latin America with four manufacturing sites and a harbor. In 2006, VCP's net sales amounted to USD 1.3 billion, EBITDA to USD 487 million and EBIT to USD 285 million. VCP's shares are listed on the São Paulo Stock Exchange and on the ADR list of the New York Stock Exchange. Ahlstrom in brief Ahlstrom is a global leader in the development, manufacture and marketing of high performance fiber-based materials. Nonwovens and specialty papers, made by Ahlstrom, are used in a large variety of everyday products, e.g. in filters, wipes, flooring, labels, and tapes. The company has a strong market position in several business areas in which it operates, built upon the company's unique fiber expertise and innovative approach. Ahlstrom's 5,700 employees serve customers via sales offices and production facilities in more than 20 countries on six continents. In 2006, Ahlstrom's net sales amounted to EUR 1.6 billion. Ahlstrom's share is listed on the Helsinki Stock Exchange. The company website is www.ahlstrom.com.


 

Radiographic Data Demonstrated Significant Reduction in Joint Damage Brussels (Belgium), February 23, 2007 at 7:00 AM CET - UCB today announced key results of a pivotal Phase III study (RAPID 1) involving nearly 1,000 patients on CIMZIA(TM) (certolizumab pegol), the first PEGylated, Fc-free anti-TNF, intended for the treatment of moderate to severe rheumatoid arthritis (RA). RAPID 1's radiographic data showed that CIMZIA(TM) in combination with methotrexate prevented structural damage of the joints to a significantly greater degree than placebo plus methotrexate after one year's treatment. RAPID 1 achieved its co-primary endpoint, the inhibition of progression of structural damage, with a statistically significantly smaller change from baseline in modified Total Sharp Score (mTSS)[a] observed at week 52 in both CIMZIA(TM) treatment arms (400mg at week zero, week two and week four followed by 200mg every two weeks; or 400mg every two weeks) compared with the placebo treated arm (p<0.001). The study also showed that in both active treatment arms CIMZIA(TM) improved the signs and symptoms of RA to a clinically statistically significantly greater degree than the placebo arm in patients who had inadequately responded to methotrexate alone (p<0.001). Similar results were observed with a second pivotal Phase III study of CIMZIA(TM) in RA, RAPID 2, using CIMZIA(TM)'s new subcutaneous liquid formulation. In both RAPID 1 and RAPID 2, the primary endpoint, ACR 20 response[b] at 24 weeks, was significantly higher in both CIMZIA(TM) treated arms than in the placebo treated arm (p<0.001) . In both studies there was no significant difference between response levels in either of the CIMZIA(TM) treatment arms. ACR 50 and ACR 70 responses were also both achieved with statistical significance in both studies. RAPID 1 and RAPID 2 demonstrated that effective results in the treatment of RA can be achieved with a 400mg total monthly dose of CIMZIA(TM) -- a higher dose is not necessary. "These results are significant. They showed, for the first time, that the Fc region present in conventional anti-TNFs is not required for activity in rheumatoid arthritis", commented Professor Edward Keystone, Professor of Medicine, University of Toronto, Canada. "These data confirm that certolizumab pegol may provide a valuable new treatment option for patients with this condition." CIMZIA(TM) was also shown to have a rapid onset of action: approximately three-quarters of actively-treated patients, who achieved ACR 20 at week 24, actually reached ACR 20 within four weeks. "The RAPID 1 and 2 studies showed consistent and robust efficacy with both the lyophilized and liquid formulations of certolizumab pegol," added Professor Joseph Smolen, Chairman of the Department of Rheumatology, Medical University of Vienna, Austria. "Interestingly, both studies show that maximal response can be achieved as early as 12 to 16 weeks." The safety and tolerability profile of CIMZIA(TM) in both studies was consistent with that expected of an anti-TNF agent. Further data from both RAPID 1 and RAPID 2 will be presented at major international rheumatology congresses later this year. Preparation for a licence submission in the treatment of RA is ongoing, with filing planned in the second half of 2007. Enquiries, please contact: Investor Relations International Media U.S. Media Jean-Christophe Donck, UCB Garry Daniels, UCB Emily Wilson, Phone: +32.2.559.9346 Phone : +44.1753.777.116 Fleishman-Hillard E-mail: Email: Phone: TBC jc.donck@ucb-group.com garry.daniels@ucbgroup.com E-mail: emily.wilson@fleishman.com Mareike Mohr Phone: +32 2 559 9246 Richard Kenyon Email: Fleishman-Hillard mareike.mohr@ucb-group.com Phone: +44 7831 569940 E-mail: kenyonr@fleishmaneurope.com [a] The mTSS (modified Total Sharp Score) assesses bone erosion and joint space narrowing measured by X-ray. A smaller change in mTSS reflects less progression of joint damage.[1] [b] ACR (American College of Rheumatology) response scores measure improvement in the tender and swollen joint count and also include assessment of the following five parameters: patient's global assessment, physician's global assessment, patient's assessment of pain, degree of disability, and level of acute-phase reactant. ACR20 is achieved when there is 20% improvement in the tender and swollen joint count as well as a 20% improvement in at least three of the five parameters. ACR50 & ACR70 are an extension of these criteria corresponding to a 50% and 70% improvement respectively.[2] [1]. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: Correlation of radiographic, clinical and laboratory abnormalities. Arthritis & Rheumatism , 1971, Vol. 14, No. 6 [2]. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the Management of Rheumatoid Arthritis 2002 update. Arthritis & Rheumatism, 2002 Vol. 46, No. 2 For the pdf-version of this press release, please click on the link below:


 

EVIAN, FRANCE -- (MARKET WIRE) -- February 22, 2007 -- Editors and other readers are advised to disregard the news release with the headline, "Actelis Unveils ML 640 Carrier Ethernet Over Copper Switch, Creating an Intelligent Ethernet Access Edge," issued earlier today by Actelis Networks. A revised press release will be issued. Actelis Agency Contact (North America) Joelle Kenealey (650) 373 2005 Joelle_Kenealey@coltrin.com Actelis Networks Contact Judy Bligh (510) 545-1050 jbligh@actelis.com Actelis Agency Contact (EMEA) Jessica Beffa +44 (207) 734 7350 JessicaBeffa@coltrin.com


 

SAINTE-FOY, Quebec, Feb. 22, 2007 (PRIME NEWSWIRE) -- Plexmar Resources Inc. (TSX-V:PLE) is pleased to report an exploration update from the Escondida project in southeastern Ecuador. A preliminary, non systematic, conventional stream sediment survey was carried out in December 2006 and has been recently compiled. It consisted of 34 stream sediment samples covering concessions Escondida III and Escondida IV, taken in the drainage system surrounding a series of plateaux between the Zamora and Nagaritza rivers. During sampling, a review of the geological units was done at the sampling sites. On Escondida IV, the government geological map previously showed the Zamora batholith covering most of the concession. After field review, the Misahualli volcanic and tuff unit, the same volcanic unit hosting Aurelian's Fruta del Norte deposit, was observed in numerous outcrops and boulders in the southern part of Escondida IV and northern part of Escondida III and covers most of the concession. The map can be found on the company's website www.plexmar.com The geochemistry results behavior may be explained by the revision of geological units: * In the Zamora batholith, gold in stream sediments is usually very low (less than 10ppb) * In the general area where the volcanic unit was observed, gold values in stream sediments were higher, between 14 and 47 ppb, with three higher values (91 ppb, 319ppb, 600ppb). Higher values are distributed in three different drainage systems in the northeastern section of Escondida IV. "This is very significant as we can now say that on Escondida IV, we have the same volcanic unit as Fruta del Norte, located 20 kms away, and there is gold in the streams running down from this unit. We hope the next phase of work will locate the source of gold on the higher plateaux," says Guy Bedard, president. Detailed follow-up work will help define the newly discovered potentially gold-bearing geological environment. A systematic stream sediment sampling and mapping program will be undertaken shortly and will cover most of the Escondida concessions. Samples were assayed by ALS Chemex in Lima, Peru. Stephane Amireault, P.Eng, acted as the QP for the preparation of this release and is in charge of the field exploration programs in Ecuador. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. About the Escondida project The Escondida project represents one of the largest land positions in the Cordillera del Condor near Aurelian Resources' Fruta del Norte gold discovery. The project covers 84,110 hectares (841.1 km2) and borders Aurelian's large land package on the western flank and north of Corriente Mirador project. Fruta del Norte is believed to be the most significant gold discovery made by a junior miner in over a decade. Corriente is planning to produce annually 250 million lbs. of copper starting in 2008. During its due diligence process on the Escondida I and II concessions, Plexmar took 44 samples, 12 returned anomalous values of gold and the best values were: 14.2 g/t, 38.4 g/t, 91.4 g/t and 396.0 g/t Au confirming the high potential of the area. The samples are located on the Escondida II concession adjacent to Aurelian's ground and approximately 8 kilometers northwest of Fruta del Norte. This press release includes certain statements that may be deemed "forward-looking statements." All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. CONTACT: Plexmar Resources Inc. Guy Bedard, President 418-658-6776 Paradox Public Relations 1-866-460-0408 1-514-341-0408


 

Becomes largest announced shareholder At FL Group's Annual General Meeting today, Hannes Smarasson, CEO of FL Group, updated shareholders on FL Group's investment in AMR Corporation, parent of American Airlines, the world's largest airline. He confirmed that FL Group, an Iceland-based international investment company, has increased its holding in AMR Corporation and now holds 8.63% of its shares. On December 26th, 2006, FL Group announced that it had acquired 5.98% of shares in AMR Corporation. Since this announcement, FL Group has continued to build its stake in the company. Having owned Icelandair and Sterling Airlines, Scandinavia's largest low cost carrier, and 16.9% in British low cost carrier easyJet, FL Group has significant experience in being a shareholder in household name air carriers. In addition to its stake in AMR Corporation, FL Group's current airline holdings include a 22,4% ownership in Finnair, the Finnish flag carrier. Hannes Smárason, CEO of FL Group commented on the AMR purchase: "At our AGM today I updated our shareholders on our significant stake in AMR Corporation. We remain very excited about this investment. We have been following the airline industry in the United States and we believe AMR Corporation presents strong prospects for 2007." Notes to Editors: About FL Group Hannes Smárason Kristjan Kristjansson CEO Director Corp. Communications Tel: +354 591 4400 Tel: +354 591 4400/+354 899 9352 UK / Brunswick Group LLP Denmark / Jöp, Ove & Myrthu A/S Anita Scott, Nigel Prideaux, Lars Jörgensen Leonora Pou Tel: +45 29 78 49 32 Tel: +44 (0) 20 7404 5959 +45 39 27 50 50 FL Group is a unique international investment company, focusing primarily on private equity and strategic investments. FL Group's business also includes proprietary trading, with a particular emphasis on active participation in markets with listed securities. With its head office in Reykjavik and offices in Copenhagen and London, FL Group invests in companies in Northern Europe but also has investments elsewhere. The investment model differs from traditional private equity investors as the company is able to show great flexibility by using its own balance sheet to build stakes in listed companies. FL Group published its full year figures for 2006 on February 2, announcing a 158% rise in profits and a doubling of total assets compared to the end of 2005. FL Group's total assets at the end of 2006 amounted to ISK 262,9 billion (Euro 2.81 billion). The company's profit in 2006 was ISK 44.5 billion (EUR 476 million). Its market capitalisation at the end of the year was ISK 203 billion (EUR 2.17 billion). Less than 25% of FL Groups total assets are in the airline industry. FL Group is listed on the Icelandic Stock Exchange (ICEX: FL). The largest shareholders of FL Group are Oddaflug BV (19.8%), owned by Hannes Smárason, CEO; Baugur Group (18.1%), Gnúpur fjárfestingafélag hf. (17.2%), Icon and Materia Invest (10.7%). The shareholding can in some cases be in the name of Icelandic financial institutions because of forward contracts. More information on www.flgroup.is


 

BASWARE CORP. STOCK EXCHANGE ANNOUNCEMENT FEBRUARY 22, 2007 BasWare Corporation's Annual Report for the year 2006 has been published. The Annual Report is available at the Company's web site at www.basware.com/annualreport (in English) and www.basware.fi/vuosikertomus (in Finnish). For the year 2006, BasWare has also published a printed version as an Annual review and the Financial Statements as a PDF, both of which are possible to subscribe to by e-mailing IR@basware.com or by phoning +358 9 8791 7417. For further information, please contact: Susanna Marklund, Communications Manager, BasWare Corp. Tel. +358 9 8791 7284 BASWARE CORPORATION Ilkka Sihvo CEO Distribution: Helsinki Stock Exchange Principal media www.basware.com


 

Reykjvik (IFN) Icelandic investment firm FL Group said on Thursday that it has increased its stake in AMR Corporation (AMR), parent of American Airlines, to 8.63% of its shares.FL Group said that with the acquired stake, it is the largest announced shareholder in AMR Corporation.FL Group said in December that it had acquired 5.98% of shares in AMR Corporation. Since then, FL Group has continued to build its stake in the company, FL Group said."At our AGM today I updated our shareholders on our significant stake in AMR Corporation," FL Group CEO Hannes Smarason, said. "We remain very excited about this investment. We have been following the airline industry in the United States and we believe AMR Corporation presents strong prospects for 2007." 


 

+--------------------------------------------------------------------------+ |* Profit EUR 15.4 mln higher (+53.7%) | |* Higher direct result EUR 20.4 mln (+1.1%) | |* Increase net asset value to EUR 67.22 (+7.4%) | |* Proposed gross dividend EUR 3.75 | |--------------------------------------------------------------------------| | | | |--------------------------------------------------------------------------| |Key |(amounts x EUR | 2006 | 2005 | | |figures |1,000) | | | | |---------+---------------+-------------------+------------------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Direct result | 20,411| | 20,182| | +1.1%| |---------+---------------+-----------+-------+-----------+------+---------| | |Indirect result| 23,677| | 8,506| | +178.4%| |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Profit | 44,088| | 28,688| | +53.7%| |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Direct result | 3.83| | 3.79| | +1.1%| | |per share | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Profit per | 8.27| | 5.38| | +53.7%| | |share | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Equity | | | | | | |---------+---------------+-------------------+------------------+---------| | | | 31-12-2006 | 31-12-2005 | | |---------+---------------+-------------------+------------------+---------| | | | | | | | | | |Investment | 348,959| | 319,894| | +9.1%| | |properties | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Project | 6,847| | | | | | |developments | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Shareholders' | 358,428|¹ | 333,824|¹ | +7.4%| | |Equity | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Net asset value| 67.22| EUR¹ | 62.61|EUR¹ | +7.4%| | |per share | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Debt ratio on | 2.6|% | 0.79|% | | | |total of assets| | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |Number of | 5,331,947| | 5,331,947| | | | |shares | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | | | | | | | | |---------+---------------+-----------+-------+-----------+------+---------| | |1) before | | | | | | | |profit | | | | | | | |distribution | | | | | | +--------------------------------------------------------------------------+ Profit The profit for 2006 rose to EUR 44.1 mln (2005: EUR 28.7 mln). This is the result of a higher positive revaluation (EUR 15.2 mln) of the investment properties portfolio and a higher operating result before result on the portfolio (EUR 0.2 mln). Direct result During 2006, the direct result of Comm. VA Wereldhave Belgium SCA increased to EUR 20.4 mln (2005: EUR 20.2 mln). This increase is the result of higher net rental income (EUR 1.1 mln) and higher property charges and general expenses (EUR 0.9 mln). This increase of the costs is mainly due to a release of provisions in 2005. Shareholders' equity and net asset value Shareholders' equity at December 31, 2006 amounts to EUR 358.4 mln (December 31, 2005: EUR 333.8 mln). The net asset value per share at December 31, 2006, including the profit of the current year, amounts to EUR 67.22 (December 31, 2005: EUR 62.61). Property portfolio At December 31, 2006 the fair value of the property portfolio amounted to EUR 349.0 mln (December 31, 2005: EUR 319.9 mln). The net increase of EUR 29.1 mln can be attributed to investments on buildings in the portfolio of EUR 3.3 mln, to the purchase of a plot of land (28,000 m²) for an amount of EUR 2.1 mln for the expansion of the shopping centre "Les Bastions" in Tournai and to a positive net revaluation of the portfolio of EUR 23.7 mln. This substantial increase in the 4th quarter can be attributed to a number of macro-economical factors, e.g. the stability of the Belgian property market, the interest of institutional investors in commercial centres and the pressure on initial rents for top quality real estate. At December 31, 2006 the debt ratio on the total of assets amounts to 2.6%. The average occupancy rate over 2006, expressed in a percentage of market rent, amounts to 83.9% (2005: 82.9%). The vacancy concerns only the office portfolio. Development projects During 2006, Wereldhave Belgium the purchased 2 plots of land (42,000m²) alongside the shopping centre in Nivelles for an amount of EUR 6.8 mln. These plots have a residential destination. Annual Report and Dividend The Annual General Meeting of Shareholders is to be held on Wednesday April 11, 2007 at 11 a.m. at the company's registered office. A dividend of EUR 3.75 gross (EUR 3.19 net) per share will be proposed to the General Meeting of Shareholders. The dividend will be payable as from April 20, 2007. The 2007 annual report will be published in March. Dispute Wereldhave Belgium announces that the Raadkamer / Chambre du Conseil decided on February 20, 2007 to postpone the case regarding the matter of a penal dispute arising from the sale of a company, later reclassified as a cash company, till March 23, 2007. Prospects In 2007 the management expects a positive development of the direct result and a higher offices portfolio occupancy rate. In this regard, various rental agreements were already signed by the end of 2006 (e.g. Olieslagerslaan in Vilvoorde and the offices in Berchem). Substantial rent increases were agreed during lease renewals in the shopping centres. The start of the expansion of the shopping centre in Nivelles is planned end 2007. Vilvoorde, February 21, 2007 N.V. Wereldhave Belgium S.A. Statutory Management Company For the full pdf-version, please click the link below:


 

Following Promens' acquisition of Polimoon in December 2006 refinancing of the bank facilities in Polimoon as well as financing related to the acquisition itself has been completed. The financing also includes a facility to support further acquisitions by Polimoon. As a part of Promens' acquisition of Polimoon in December, refinancing of Polimoon's bank facilities has now been completed. The total facilities are arranged by DnB NOR as syndicated bank facilities, and committed by a group of relationship banks, including DnB NOR, Nordea and LBNord. The total syndicated facilities correspond to a EUR 275 million loan, including term loan, working capital facility, acquisition facility as well as facilities related to Promens' acquisition of Polimoon. The refinancing, which is led by DnB NOR, is built on the long relationship Polimoon has had with DnB NOR which has been Polimoon's main bank for several years and has supported Polimoon's extensive growth through acquisitions. Part of the bank facilities is an undrawn EUR 30 million acquisition facility that can be utilized in the next 5 years. The acquisition facility will make it possible for Polimoon to continue to grow through acquisitions. In the last two years Polimoon has acquired 12 businesses, and growth through acquisitions has been one of the key factors in ensuring that Polimoon has developed into a company with a strong and well-established position in rigid plastic packaging and components to the automotive industry. "I am pleased to find such strong support from those very well-known financial institutions, and to have completed funding which will give us the opportunity to continue the buy-and-build strategy that Polimoon's management team has successfully developed," says Ragnhildur Geirsdóttir, President & CEO of Promens. "This will, in addition to the strong support from our largest shareholder Atorka, allow the Promens Group to continue to grow further in the fragmented plastic market," concludes Ragnhildur Geirsdóttir. For further information, please contact: Ragnhildur Geirsdóttir, President & CEO, Promens, +354-580-5555, +354 898-5001 Promens is a leading global plastics manufacturer operating over 60 manufacturing facilities in Europe, North America and Asia. The company manufactures a wide range of products, including packaging for food, cosmetics, chemicals and pharmaceuticals and components for the automotive and heavy machine industry. Polimoon is the largest subsidiary of Promens. The total annual turnover of Promens is approx. EUR 710 million, and the total number of employees is close to 5,500. The largest shareholders of Promens are the investment company Atorka Group and Landsbanki. www.promens.com and www.polimoon.com Atorka Group is a progressive investment company that is listed on the OMX Nordic Exchange in Iceland and is included in the ICEX-15 index. Atorka invests in companies on global growth markets ans supports growth both internal and external. In its investments, Atorka emphasises companies characterised by solid operations and strong cash flow, strong management, promising conditions for internal and external growth, and opportunities for value enhancement. In general, the Company participates in three to five investment projects at a time, with the approximate time frame for each investment set at 3-5 years. www.atorka.is


 

Live audio webcast of SABMiller's presentation at the CAGNY conference on www.cantos.com with Gary Leibowitz, Senior VP Investor Relations, SABMiller. The presentation will be live at 2130GMT (1630EST) It's free to view. All you need to do is register at www.cantos.com Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses. If you would like to contact us, please email enquiries@cantos.com.


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | Tisbury Capital | | | Management LLP | |------------------------------------------------+------------------| | Company dealt in | EMI Group Plc | |------------------------------------------------+------------------| | Class of relevant security to which the | 14p ordinary | | dealings being disclosed relate (Note 2) | | |------------------------------------------------+------------------| | Date of dealing | 21 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |-------------------------+--------------------+--------------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------+------------+-------+------------+-------| | (1) Relevant securities | | | | | | | | | | | |-------------------------+------------+-------+------------+-------| | (2) Derivatives (other | | | | | | than options) | 4,934,059 | 0.617 | | | | | | | | | |-------------------------+------------+-------+------------+-------| | (3) Options and | | | | | | agreements to | 22,000,000 | 2.750 | 53,750,000 | 6.718 | | purchase/sell | | | | | | | | | | | |-------------------------+------------+-------+------------+-------| | Total | 26,934,059 | 3.367 | 53,750,000 | 6.718 | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | Convertible bonds due 2010 | | | |--------------------------------+-------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |--------------------------------+-----------+-------+--------+-----| | (1) Relevant securities | 7,000,000 | 2.877 | | | | | | | | | |--------------------------------+-----------+-------+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |--------------------------------+-----------+-------+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |--------------------------------+-----------+-------+--------+-----| | Total | 7,000,000 | 2.877 | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | Long | 520,000 | 240.8800 GBp | |----------+------------+---------------------------+---------------| | CFD | Long | 9,220,000 | 241.5000 GBp | +-------------------------------------------------------------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +----------------------------------------------------------------------------------------+ |Product |Writing, |Number of |Exercise|Type, e.g.|Expiry |Option money | |name, |selling, |securities to which|price |American, |date |paid/received | |e.g. call|purchasing, |the option relates | |European | |per unit (Note| |option |varying etc.|(Note 7) | |etc. | |5) | | | | | | | | | |---------+------------+-------------------+--------+----------+----------+--------------| |Long call| | | | | | | | option | Purchase | 15,000,000 | 240 | American |21/09/2007| 26.75 GBp | |---------+------------+-------------------+--------+----------+----------+--------------| | Short | | | | | | | | call | | | | | | | | option | Writing | 30,000,000 | 260 | American |21/09/2007| 15.50 GBp | |---------+------------+-------------------+--------+----------+----------+--------------| |Long call| Selling | | | | | | | option |(close out) | 15,000,000 | 280 | American |21/09/2007| 8.500 GBp | +----------------------------------------------------------------------------------------+ (ii) Exercising +-------------------------------------------------------------------+ | Product name, e.g. | Number of securities | Exercise price per | | call option | | unit (Note 5) | | | | | |--------------------+----------------------+-----------------------| | | | | | | | | +-------------------------------------------------------------------+ (d) Other dealings (including new securities) (Note 4) +-------------------------------------------------------------------+ | Nature of transaction | Details | Price per unit (if applicable) | | (Note 8) | | (Note 5) | | | | | |-----------------------+---------+---------------------------------| | | | | | | | | +-------------------------------------------------------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives +-------------------------------------------------------------------+ | Full details of any agreement, arrangement or understanding | | between the person disclosing and any other person relating to | | the voting rights of any relevant securities under any option | | referred to on this form or relating to the voting rights or | | future acquisition or disposal of any relevant securities to | | which any derivative referred to on this form is referenced. If | | none, this should be stated. | |-------------------------------------------------------------------| | | | None | | | +-------------------------------------------------------------------+ Is a Supplemental Form 8 attached? (Note 9) YES +-------------------------------------------------------------------+ | Date of disclosure | 22/02/2007 | |------------------------------------------------+------------------| | Contact name | Stephen Platts | |------------------------------------------------+------------------| | Telephone number | +44 20 7070 9635 | |------------------------------------------------+------------------| | If a connected EFM, name of offeree/offeror | | | with which connected | | |------------------------------------------------+------------------| | If a connected EFM, state nature of connection | | | (Note 10) | | +-------------------------------------------------------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) +----------------------------------------------------------------------+ |Product |Written or|Number of |Exercise|Type, e.g.|Expiry date| |name, |purchased |securities to |price |American, | | |e.g. call| |which the option |(Note 2)|European | | |option | |or derivative | |etc | | | | |relates | | | | |---------+----------+-----------------+--------+----------+-----------| |Short put|Written |7,000,000 |190 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |7,000,000 |200 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long put |Purchased |1,750,000 |200 GBp |American |15/06/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |15,000,000 |300 GBp |American |21/09/2007 | |call | | | | | | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Long call|Purchased |15,000,000 |240 GBp |American |21/09/2007 | |option | | | | | | |---------+----------+-----------------+--------+----------+-----------| |Short |Written |30,000,000 |260 GBp |American |21/09/2007 | |call | | | | | | |option | | | | | | +----------------------------------------------------------------------+ Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk ---END OF MESSAGE---


 

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION +-------------------------------------------------------------------+ | Name of person dealing (Note 1) | DEEPHAVEN CAPITAL | | | MANAGEMENT LLC | |-----------------------------------------------+-------------------| | Company dealt in | EMI Group plc | |-----------------------------------------------+-------------------| | Class of relevant security to which the | 14p Ordinary | | dealings being disclosed relate (Note 2) | | |-----------------------------------------------+-------------------| | Date of dealing | 21 February 2007 | +-------------------------------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +-------------------------------------------------------------------+ | | Long | Short | | | | | |------------------------------+---------------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |------------------------------+------------+--------+--------+-----| | (1) Relevant securities | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (2) Derivatives (other than | 13,650,000 | 1.7060 | | | | options) | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | (3) Options and agreements | | | | | | to purchase/sell | | | | | | | | | | | |------------------------------+------------+--------+--------+-----| | Total | 13,650,000 | 1.7060 | | | | | | | | | +-------------------------------------------------------------------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +-------------------------------------------------------------------+ | Class of relevant security: | Long | Short | | | | | |-------------------------------------+--------------+--------------| | | Number | (%) | Number | (%) | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (1) Relevant securities | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (2) Derivatives (other than | | | | | | options) | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | (3) Options and agreements to | | | | | | purchase/sell | | | | | | | | | | | |-------------------------------------+--------+-----+--------+-----| | Total | | | | | | | | | | | +-------------------------------------------------------------------+ (c) Rights to subscribe (Note 3) +---------------------------------------+ | Class of relevant security: | Details | | | | |-----------------------------+---------| | | | +---------------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +----------------------------------------------------------------+ | Purchase/sale | Number of securities | Price per unit (Note 5) | | | | | |---------------+----------------------+-------------------------| | | | | +----------------------------------------------------------------+ (b) Derivatives transactions (other than options) +-------------------------------------------------------------------+ | Product | Long/short | Number of securities | Price per | | name, | (Note 6) | (Note 7) | unit (Note 5) | | e.g. CFD | | | | |----------+------------+---------------------------+---------------| | CFD | LONG | 250,000 | 239.7084 | | | | | | | | | | | +-------------------------------------------------------------------+ (c)